hcp_Current folio_10K

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


Form 10-K

 

 

(Mark One)

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2016

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                          to                        

Commission file number 1-08895

 


HCP, Inc.

(Exact name of registrant as specified in its charter)

 

 

Maryland

33-0091377

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

1920 Main Street, Suite 1200
Irvine, California

92614
(Zip Code)

(Address of principal executive offices)

 

Registrant’s telephone number, including area code (949) 407-0700

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

Title of each class

Name of each exchange
on which registered

Common Stock

New York Stock Exchange

 


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes ☒ No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes ☐ No ☒

Indicate by check mark whether the registrant; (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes ☒  No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

 

 

 

 

Large accelerated filer ☒

Accelerated filer ☐

Non-accelerated filer ☐
(Do not check if a smaller
reporting company)

Smaller reporting company ☐

 

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act.) Yes ☐ No ☒

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $15.1 billion.

As of January 31, 2017 there were 468,178,740 shares of common stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the definitive Proxy Statement for the registrant’s 2017 Annual Meeting of Stockholders have been incorporated by reference into Part III of this Report.

 

 

 


 

Table of Contents

HCP, Inc.

Form 10-K

For the Fiscal Year Ended December 31, 2016

Table of Contents

 

 

 

 

 

 

Cautionary Language Regarding Forward-Looking Statements 

    

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Part I 

 

 

 

 

Item 1. 

 

Business

 

 

Item 1A. 

 

Risk Factors

 

11 

 

Item 1B. 

 

Unresolved Staff Comments

 

29 

 

Item 2. 

 

Properties

 

29 

 

Item 3. 

 

Legal Proceedings

 

34 

 

Item 4. 

 

Mine Safety Disclosures

 

34 

 

 

 

 

 

 

 

Part II 

 

 

 

35 

 

Item 5. 

 

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

35 

 

Item 6. 

 

Selected Financial Data

 

38 

 

Item 7. 

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

39 

 

Item 7A. 

 

Quantitative and Qualitative Disclosures About Market Risk

 

67 

 

Item 8. 

 

Financial Statements and Supplementary Data

 

69 

 

Item 9. 

 

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

125 

 

Item 9A. 

 

Controls and Procedures

 

125 

 

Item 9B. 

 

Other Information

 

127 

 

 

 

 

 

 

 

Part III 

 

 

 

127 

 

Item 10. 

 

Directors, Executive Officers and Corporate Governance

 

127 

 

Item 11. 

 

Executive Compensation

 

127 

 

Item 12. 

 

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

127 

 

Item 13. 

 

Certain Relationships and Related Transactions, and Director Independence

 

127 

 

Item 14. 

 

Principal Accounting Fees and Services

 

127 

 

 

 

 

 

 

 

Part IV 

 

 

 

128 

 

Item 15. 

 

Exhibits, Financial Statement Schedules

 

128 

 

 

 

 

 

 

 

 

 

 


 

Table of Contents

 

 

 

 

All references in this report to “HCP,” the “Company,” “we,” “us” or “our” mean HCP, Inc., together with its consolidated subsidiaries. Unless the context suggests otherwise, references to “HCP, Inc.” mean the parent company without its subsidiaries.

Cautionary Language Regarding Forward-Looking Statements

Statements in this Annual Report on Form 10-K that are not historical factual statements are “forward-looking statements.”  We intend to have our forward-looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “potential,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. Forward-looking statements reflect our current expectations and views about future events and are subject to risks and uncertainties that could significantly affect our future financial condition and results of operations. While forward-looking statements reflect our good faith belief and assumptions we believe to be reasonable based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this Annual Report, and such forward-looking statements are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under “Item 1A, Risk Factors” in this report, risks and uncertainties that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include, among other things:

 

·

our reliance on a concentration of a small number of tenants and operators for a significant percentage of our revenues, with our concentration in Brookdale increasing as a result of the consummation of the spin-off of Quality Care Properties, Inc. on October 31, 2016;

 

·

the financial condition of our existing and future tenants, operators and borrowers, including potential bankruptcies and downturns in their businesses, and their legal and regulatory proceedings, which results in uncertainties regarding our ability to continue to realize the full benefit of such tenants’ and operators’ leases and borrowers’ loans;

 

·

the ability of our existing and future tenants, operators and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;

 

·

competition for tenants and operators, including with respect to new leases and mortgages and the renewal or rollover of existing leases;

 

·

our concentration in the healthcare property sector, particularly in life sciences, medical office buildings and hospitals, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries;

 

·

availability of suitable properties to acquire at favorable prices,  the competition for the acquisition and financing of those properties, and the costs of associated property development;

 

·

our ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or we exercise our right to foreclose on loan collateral or replace an existing tenant or operator upon default;

 

·

the risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our partners’ financial condition and continued cooperation;

 

·

our ability to achieve the benefits of acquisitions or other investments within expected time frames or at all, or within expected cost projections;

 

·

operational risks associated with third party management contracts, including the additional regulation and liabilities of our RIDEA lease structures;

 

·

the potential impact on us and our tenants, operators and borrowers from current and future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;

 

1


 

Table of Contents

·

the effect on our tenants and operators of legislation, executive orders and other legal requirements, including the Affordable Care Act and licensure, certification and inspection requirements, as well as laws addressing entitlement programs and related services, including Medicare and Medicaid, which may result in future reductions in reimbursements;

 

·

changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations, of our tenants and operators;

 

·

volatility or uncertainty in the capital markets, the availability and cost of capital as impacted by interest rates, changes in our credit ratings, and the value of our common stock, and other conditions that may adversely impact our ability to fund our obligations or consummate transactions, or reduce the earnings from potential transactions;

 

·

changes in global, national and local economic and other conditions, including currency exchange rates;

 

·

our ability to manage our indebtedness level and changes in the terms of such indebtedness;

 

·

competition for skilled management and other key personnel; and

 

·

our ability to maintain our qualification as a real estate investment trust.

 

Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.

2


 

Table of Contents

PART I

ITEM 1.    Business

General Overview

HCP, an S&P 500 company, invests primarily in real estate serving the healthcare industry in the United States (“U.S.”). We are a Maryland corporation organized in 1985 and qualify as a self-administered real estate investment trust (“REIT”). We are headquartered in Irvine, California, with offices in Nashville and San Francisco. Our diverse portfolio is comprised of investments in the following reportable healthcare segments: (i) senior housing triple-net (“SH NNN”), (ii) senior housing operating portfolio (“SHOP”), (iii) life science and (iv) medical office.

On October 31, 2016, we completed the spin-off (the “Spin-Off”) of Quality Care Properties, Inc. (“QCP”) (NYSE:QCP). The Spin-Off included 338 properties, primarily comprised of the HCR ManorCare, Inc. (“HCRMC”) direct financing lease (“DFL”) investments and an equity investment in HCRMC. QCP is an independent, publicly-traded, self-managed and self-administrated REIT. See Notes 1 and 5 to the Consolidated Financial Statements for further information on the Spin-Off.

 

For a description of our significant activities during 2016, see Item 7 in this report.

 

Business Strategy

We invest and manage our real estate portfolio for the long-term to maximize the benefit to our stockholders and support the growth of our dividends. The core elements of our strategy are: (i) to acquire, develop, lease, own and manage a diversified portfolio of quality healthcare properties across multiple geographic locations and business segments including senior housing, medical office, and life science, among others; (ii) to align ourselves with leading healthcare companies, operators and service providers which, over the long-term, should result in higher relative rental rates, net operating cash flows and appreciation of property values; (iii) to maintain adequate liquidity with long-term fixed rate debt financing with staggered maturities, which supports the longer-term nature of our investments, while reducing our exposure to interest rate volatility and refinancing risk at any point in the interest rate or credit cycles; and (iv) to continue to manage our balance sheet with a targeted financial leverage of 40% relative to our assets.

Internal Growth Strategies

We believe our real estate portfolio holds the potential for increased future cash flows as it is well-maintained and in desirable locations within markets where new supply is generally  limited by the lack of available sites and the difficulty of obtaining the necessary licensing, other approvals and/or financing. Our strategy for maximizing the benefits from these opportunities is to: (i) work with new or existing tenants and operators to address their space and capital needs; and (ii) provide high-quality property management services in order to motivate tenants to renew, expand or relocate into our properties.

We expect to continue our internal growth as a result of our ability to:  

·

Build and maintain long-term leasing and management relationships with quality tenants and operators. In choosing locations for our properties, we focus on their physical environment, adjacency to established businesses (e.g., hospital systems) and educational centers, proximity to sources of business growth and other local demographic factors.

·

Replace tenants and operators at the best available market terms and lowest possible transaction costs. We believe that we are well-positioned to attract new tenants and operators and achieve attractive rental rates and operating cash flow as a result of the location, design and maintenance of our properties, together with our reputation for high-quality building services and responsiveness to tenants, and our ability to offer space alternatives within our portfolio.

3


 

Table of Contents

·

Extend and modify terms of existing leases prior to expiration. We structure lease extensions, early renewals or modifications, which reduce the cost associated with lease downtime or the re-investment risk resulting from the exercise of tenants’ purchase options, while securing the tenancy and relationship of our high quality tenants and operators on a long-term basis.

Investment Strategies

The delivery of healthcare services requires real estate and, as a result, tenants and operators depend on real estate, in part, to maintain and grow their businesses. We believe that the healthcare real estate market provides investment opportunities due to the: (i) compelling long-term demographics driving the demand for healthcare services; (ii) specialized nature of healthcare real estate investing; and (iii) ongoing consolidation of the fragmented healthcare real estate sector.

While we emphasize healthcare real estate ownership, we may also provide real estate secured financing to, or invest in equity or debt securities of, healthcare operators or other entities engaged in healthcare real estate ownership. We may also acquire all or substantially all of the securities or assets of other REITs, operating companies or similar entities where such investments would be consistent with our investment strategies. We may co-invest alongside institutional or development investors through partnerships or limited liability companies.

We monitor, but do not limit, our investments based on the percentage of our total assets that may be invested in any one property type, investment vehicle or geographic location, the number of properties that may be leased to a single tenant or operator, or loans that may be made to a single borrower. In allocating capital, we target opportunities with the most attractive risk/reward profile for our portfolio as a whole. We may take additional measures to mitigate risk, including diversifying our investments (by sector, geography, tenant or operator), structuring transactions as master leases, requiring tenant or operator insurance and indemnifications, and obtaining credit enhancements in the form of guarantees, letters of credit or security deposits.

We believe we are well-positioned to achieve external growth through acquisitions, financing and development. Other factors that contribute to our competitive position include:

 

·

our reputation gained through over 30 years of successful operations and the strength of our existing portfolio of properties;

·

our relationships with leading healthcare operators and systems, investment banks and other market intermediaries, corporations, private equity firms, non-profits and public institutions seeking to monetize existing assets or develop new facilities;

·

our relationships with institutional buyers and sellers of high-quality healthcare real estate;

·

our track record and reputation for executing acquisitions responsively and efficiently, which provides confidence to domestic and foreign institutions and private investors who seek to sell healthcare real estate in our market areas;

·

our relationships with nationally recognized financial institutions that provide capital to the healthcare and real estate industries; and

·

our control of sites (including assets under contract with radius restrictions).

Financing Strategies

Our REIT qualification requires us to distribute at least 90% of our REIT taxable income (excluding net capital gains); therefore, we don’t retain a significant amount of capital. As a result, we regularly access the public equity and debt markets to raise the funds necessary to finance acquisitions and debt investments, develop and redevelop properties, and refinance maturing debt. 

We may finance acquisitions and other investments through the following vehicles:

·

borrowings under our credit facility;

·

issuance or origination of debt, including unsecured notes, term loans and mortgage debt;

4


 

Table of Contents

·

sale of ownership interests in properties or other investments; or

·

issuance of common or preferred stock or equivalent.

We maintain a disciplined balance sheet by actively managing our debt to equity levels and maintaining multiple sources of liquidity. Our debt obligations are primarily long-term fixed rate with staggered maturities.

We finance our investments based on our evaluation of available sources of funding. For short-term purposes, we may utilize our revolving line of credit facility or arrange for other short-term borrowings from banks or other sources. We arrange for longer-term financing by offering debt and equity securities, placing mortgage debt and obtaining capital from institutional lenders and joint venture partners.

 

Segments

The following table summarizes our revenues by segment (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

Segment

    

2016

  

%

  

2015

  

%

  

2014

 

%

SH NNN

 

$

423,118

 

20

 

$

428,269

 

22

 

$

538,113

 

33

SHOP

 

 

686,822

 

32

 

 

518,264

 

27

 

 

243,612

 

15

Life science 

 

 

358,537

 

17

 

 

342,984

 

18

 

 

314,114

 

19

Medical office 

 

 

446,280

 

21

 

 

415,351

 

21

 

 

368,055

 

22

Other non-reportable segments

 

 

214,537

 

10

 

 

235,621

 

12

 

 

172,939

 

11

Total revenues

 

$

2,129,294

 

100

 

$

1,940,489

 

100

 

$

1,636,833

 

100

Senior housing (SH NNN and SHOP). Our senior housing facilities are managed utilizing triple-net leases and RIDEA structures, which are permitted by the Housing and Economic Recovery Act of 2008 (commonly referred to as “RIDEA”), and include independent living facilities (“ILFs”), assisted living facilities (“ALFs”), memory care facilities (“MCFs”), care homes, and continuing care retirement communities (“CCRCs”), which cater to different segments of the elderly population based upon their personal needs. Services provided by our tenants or operators in these facilities are primarily paid for by the residents directly or through private insurance and are less reliant on government reimbursement programs such as Medicare and Medicaid.

We have entered into long-term agreements with operators, including Brookdale Senior Living, Inc. (“Brookdale”) to operate and manage properties that are operated under a RIDEA structure. Under the provisions of RIDEA, a REIT may lease a “qualified healthcare property” on an arm’s length basis to a taxable REIT subsidiary (“TRS”), if the property is managed on behalf of such subsidiary by a person who qualifies as an “eligible independent contractor.” RIDEA structures allow us to own the risks and rewards of the operations of healthcare facilities (as compared to leasing the property for contractual triple-net rents) in a tax efficient manner. We view RIDEA as a structure primarily to be used on properties that present attractive valuation entry points and/or growth profiles by: (i) transitioning the asset to a new operator that can bring scale, operating efficiencies, and/or ancillary services; or (ii) investing capital to reposition the asset. Brookdale provides comprehensive facility management and accounting services with respect to a majority of our senior housing RIDEA properties, for which we pay annual management fees pursuant to the aforementioned agreements. Most of the management agreements have terms ranging from 10 to 15 years, with three to four 5-year renewals. The base management fees are 4.5% to 5.0% of gross revenues (as defined) generated by the RIDEA facilities. In addition, there are incentive management fees payable to Brookdale if operating results of the RIDEA properties exceed pre-established EBITDAR (defined as earnings before interest, taxes, depreciation and amortization, and rent) thresholds.

Our senior housing property types under both triple-net leases and RIDEA structures are further described below:

·

Independent Living Facilities.  ILFs are designed to meet the needs of seniors who choose to live in an environment surrounded socially by their peers with services such as housekeeping, meals and activities. Additionally, the programs and services may include transportation, social activities, exercise and fitness programs, beauty or barber shop access, hobby and craft activities, community excursions, meals in a dining room setting and other activities sought by residents. These residents generally do not need assistance with activities of daily living (“ADL”). However, in some of our facilities, residents have the option to contract for these services.

5


 

Table of Contents

·

Assisted Living Facilities.  ALFs are licensed care facilities that provide personal care services, support and housing for those who need help with ADL, such as bathing, eating, dressing and medication management, yet require limited medical care. These facilities are often in apartment-like buildings with private residences ranging from single rooms to large apartments. Certain ALFs may have a dedicated portion of a facility that offers higher levels of personal assistance for residents requiring memory care as a result of Alzheimer’s disease or other forms of dementia. Levels of personal assistance are based in part on local regulations.

·

Memory Care Facilities.  MCFs address the unique challenges of our residents with Alzheimer’s disease or other forms of dementia. Residents may live in semi-private apartments or private rooms and have structured activities delivered by staff members trained specifically on how to care for residents with memory impairment. These facilities offer programs that provide comfort and care in a secure environment.

·

Continuing Care Retirement Communities.  CCRCs offer several levels of assistance, including independent living, assisted living and nursing home care. CCRCs are different from other housing and care options for seniors because they usually provide written agreements or long-term contracts between residents and the communities (frequently lasting the term of the resident’s lifetime), which offer a continuum of housing, services and healthcare on one campus or site. CCRCs are appealing as they allow residents to “age in place.” CCRCs typically require the individual to be in relatively good health and independent upon entry.

The following table provides information about our SH NNN tenant concentration for the year ended December 31, 2016:

 

 

 

 

 

 

 

 

Percentage of

 

Percentage of

 

Tenant

 

Segment Revenues

 

Total Revenues

 

Brookdale(1)

 

59

%  

12

%

   

 

 

 

 

 


(1)

Excludes SHOP facilities operated by Brookdale in our SHOP segment, as discussed below. Includes revenues from 64 SH NNN facilities that were classified as held for sale at December 31, 2016.

As of December 31, 2016, Brookdale managed or operated, in our SHOP segment, approximately 18% of our real estate investments based on gross assets. Because an operator manages our facilities in exchange for the receipt of a management fee, we are not directly exposed to the credit risk of the operators in the same manner or to the same extent as our triple-net tenants. However, adverse developments in their business and affairs or financial condition could impair their ability to efficiently and effectively manage our facilities.

Life science.  These properties contain laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations involved in the life science industry. While these properties have characteristics similar to commercial office buildings, they generally contain more advanced electrical, mechanical, and heating, ventilating and air conditioning (“HVAC”) systems. The facilities generally have specialty equipment including emergency generators, fume hoods, lab bench tops and related amenities. In many instances, life science tenants make significant investments to improve their leased space, in addition to landlord improvements, to accommodate biology, chemistry or medical device research initiatives.

Life science properties are primarily configured in business park or campus settings and include multiple buildings. The business park and campus settings allow us the opportunity to provide flexible, contiguous/adjacent expansion to accommodate the growth of existing tenants. Our properties are located in well-established geographical markets known for scientific research and drug discovery, including San Francisco and San Diego, California, and Durham, North Carolina. At December 31, 2016, 97% of our life science properties were triple-net leased (based on leased square feet).

6


 

Table of Contents

The following table provides information about our life science tenant concentration for the year ended December 31, 2016:

 

 

 

 

 

 

 

    

Percentage of

    

Percentage of

 

Tenants

 

Segment Revenues

 

Total Revenues

 

Amgen, Inc.

 

15

%  

2

%

Genentech, Inc.(1)

 

14

%  

2

%


(1)

Pursuant to a purchase and sale agreement in January 2016, the tenant exercised its purchase options under its lease on eight facilities, of which four sold in November 2016, and four are expected to close in the third quarter of 2018. Accordingly, the percentage of segment revenues will decrease below 10% upon completion of these sales.  

 

Medical office.    Medical office buildings (“MOBs”) typically contain physicians’ offices and examination rooms, and may also include pharmacies, hospital ancillary service space and outpatient services such as diagnostic centers, rehabilitation clinics and day-surgery operating rooms. While these facilities are similar to commercial office buildings, they require additional plumbing, electrical and mechanical systems to accommodate multiple exam rooms that may require sinks in every room, and special equipment such as x-ray machines. In addition, MOBs are often built to accommodate higher structural loads for certain equipment and may contain vaults or other specialized construction. Our MOBs are typically multi-tenant properties leased to healthcare providers (hospitals and physician practices), with approximately 82% of our MOBs, based on square feet, located on hospital campuses and 95% are affiliated with hospital systems. Occasionally, we invest in MOBs located on hospital campuses which may be subject to ground leases. At December 31, 2016, approximately 53% of our medical office buildings were triple-net leased (based on leased square feet) with the remaining leased under gross or modified gross leases.

The following table provides information about our medical office tenant concentration for the year ended December 31, 2016:

 

 

 

 

 

 

 

    

Percentage of

 

Percentage of

 

Tenant

 

Segment Revenues

 

Total Revenues

 

Hospital Corporation of America ("HCA")(1)

 

17

%  

4

%


(1)

Percentage of total revenues from HCA includes revenues earned from both our medical office and other non-reportable segments.

 

Other non-reportable segments.  At December 31, 2016, we had interests in and managed 15 hospitals, 61 care homes in the United Kingdom (“U.K.”), five post-acute/skilled nursing facilities (“SNFs”), 4 of which were owned by our unconsolidated joint ventures, and $877 million of debt investments. Services provided by our tenants and operators in hospitals are paid for by private sources, third-party payors (e.g., insurance and HMOs) or through Medicare and Medicaid programs. Our hospital property types include acute care, long-term acute care, specialty and rehabilitation hospitals. Care homes offer personal care services, such as lodging, meal services, housekeeping and laundry services, medication management and assistance with ADL. Care homes are registered to provide different levels of services, ranging from personal care to nursing care. Some homes can be further registered for a specific care need, such as dementia or terminal illness. SNFs offer restorative, rehabilitative and custodial nursing care for people following a hospital stay or not requiring the more extensive and complex treatment available at hospitals. All of our care homes in the U.K., hospitals and SNFs are triple-net leased.

 

Competition

Investing in real estate serving the healthcare industry is highly competitive. We face competition from other REITs, investment companies, pension funds, private equity and hedge fund investors, sovereign funds, healthcare operators, lenders, developers and other institutional investors, some of whom may have greater flexibility (e.g., non-REIT competitors), resources and lower costs of capital than we do. Increased competition makes it more challenging for us to identify and successfully capitalize on opportunities that meet our objectives. Our ability to compete may also be impacted by global, national and local economic trends, availability of investment alternatives, availability and cost of capital, construction and renovation costs, existing laws and regulations, new legislation and population trends.

Income from our investments depends on our tenants’ and operators’ ability to compete with other companies on multiple levels, including: the quality of care provided, reputation, success of product or drug development, the physical appearance

7


 

Table of Contents

of a facility, price and range of services offered, alternatives for healthcare delivery, the supply of competing properties, physicians, staff, referral sources, location, the size and demographics of the population in surrounding areas, and the financial condition of our tenants and operators. For a discussion of the risks associated with competitive conditions affecting our business, see “Item 1A, Risk Factors” in this report.

 

Government Regulation, Licensing and Enforcement

Overview

Our tenants and operators are typically subject to extensive and complex federal, state and local healthcare laws and regulations relating to quality of care, licensure and certificate of need, government reimbursement, fraud and abuse practices, and similar laws governing the operation of healthcare facilities, and we expect that the healthcare industry, in general, will continue to face increased regulation and pressure in the areas of fraud, waste and abuse, cost control, healthcare management and provision of services, among others. These regulations are wide ranging and can subject our tenants and operators to civil, criminal and administrative sanctions. Affected tenants and operators may find it increasingly difficult to comply with this complex and evolving regulatory environment because of a relative lack of guidance in many areas as certain of our healthcare properties are subject to oversight from several government agencies, and the laws may vary from one jurisdiction to another. Changes in laws, regulations, reimbursement enforcement activity and regulatory non-compliance by our tenants and operators can all have a significant effect on their operations and financial condition, which in turn may adversely impact us, as detailed below and set forth under “Item 1A, Risk Factors” in this report.

Based on information primarily provided by our tenants and operators, including our medical office segment, at December 31, 2016, we estimate that approximately 13% and 12% (15% and 14%, excluding our medical office segment) of the annualized base rental payments received from our tenants and operators were dependent on Medicare and Medicaid reimbursement, respectively.

The following is a discussion of certain laws and regulations generally applicable to our operators, and in certain cases, to us.

Fraud and Abuse Enforcement

There are various extremely complex U.S. federal and state laws and regulations (and in relation to our facilities located in the U.K., national laws and regulations of England, Scotland, Northern Ireland, and Wales) governing healthcare providers’ relationships and arrangements and prohibiting fraudulent and abusive practices by such providers. These laws include: (i) U.S. federal, state false claims acts and U.K. anti-fraud legislation and regulation, which, among other things, prohibit providers from filing false claims or making false statements to receive payment from Medicare, Medicaid or other U.S. federal or state or U.K. healthcare programs; (ii) U.S. federal, state anti-kickback and fee-splitting statutes, including the Medicare and Medicaid anti-kickback statute, which prohibit or restrict the payment or receipt of remuneration to induce referrals or recommendations of healthcare items or services, and U.K. legislation and regulations on financial inducements and vested interests; (iii) U.S. federal and state physician self-referral laws (commonly referred to as the “Stark Law”), which generally prohibit referrals by physicians to entities with which the physician or an immediate family member has a financial relationship; (iv) the federal Civil Monetary Penalties Law, which prohibits, among other things, the knowing presentation of a false or fraudulent claim for certain healthcare services; and (v) U.S. federal, state and U.K. privacy laws, including the privacy and security rules contained in the Health Insurance Portability and Accountability Act of 1996 (commonly referred to as “HIPAA”) and the U.K. Data Protection Act 1988, which provide for the privacy and security of personal health information. Violations of U.S. and U.K. healthcare fraud and abuse laws carry civil, criminal and administrative sanctions, including punitive sanctions, monetary penalties, imprisonment, denial of Medicare and Medicaid reimbursement and potential exclusion from Medicare, Medicaid or other federal or state healthcare programs. These laws are enforced by a variety of federal, state and local agencies and in the U.S. can also be enforced by private litigants through, among other things, federal and state false claims acts, which allow private litigants to bring qui tam or “whistleblower” actions. Many of our tenants and operators are subject to these laws, and may become the subject of governmental enforcement actions if they fail to comply with applicable laws.

8


 

Table of Contents

Reimbursement

Sources of revenue for many of our tenants and operators include, among others, governmental healthcare programs, such as the federal Medicare programs and state Medicaid programs and, in the U.K., the National Health Service (“NHS”) and local authority funding, and non-governmental third-party payors, such as insurance carriers and HMOs. As federal and state governments focus on healthcare reform initiatives, and as the federal government, many states, face significant current and future budget deficits, efforts to reduce costs by these payors will likely continue, which may result in reduced or slower growth in reimbursement for certain services provided by some of our tenants and operators. Similarly, in the U.K., the NHS and the local authorities are undertaking efforts to reduce costs, which may result in reduced or slower growth in reimbursement for certain services provided by our U.K. tenants and operators. Additionally, new and evolving payor and provider programs in the U.S., including but not limited to Medicare Advantage, Dual Eligible, Accountable Care Organizations (“ACO”), and Bundled Payments could adversely impact our tenants’ and operators’ liquidity, financial condition or results of operations.

Healthcare Licensure and Certificate of Need

Certain healthcare facilities in our portfolio (including our facilities located in the U.K.) are subject to extensive national, federal, state and local licensure, certification and inspection laws and regulations. In addition, various licenses and permits are required to handle controlled substances (including narcotics), operate pharmacies, handle radioactive materials and operate equipment. Many states in the U.S. require certain healthcare providers to obtain a certificate of need, which requires prior approval for the construction, expansion or closure of certain healthcare facilities. The approval process related to state certificate of need laws may impact some of our tenants’ and operators’ abilities to expand or change their businesses.

Life Science Facilities

While certain of our life science tenants include some well-established companies, other tenants are less established and, in some cases, may not yet have a product approved by the Food and Drug Administration, or other regulatory authorities, for commercial sale. Creating a new pharmaceutical product or medical device requires substantial investments of time and capital, in part because of the extensive regulation of the healthcare industry; it also entails considerable risk of failure in demonstrating that the product is safe and effective and in gaining regulatory approval and market acceptance.

Senior Housing Entrance Fee Communities

Certain of our senior housing facilities are operated as entrance fee communities. Generally, an entrance fee is an upfront fee or consideration paid by a resident, a portion of which may be refundable, in exchange for some form of long-term benefit. Some of the entrance fee communities are subject to significant state regulatory oversight, including, for example, oversight of each facility’s financial condition, establishment and monitoring of reserve requirements and other financial restrictions, the right of residents to cancel their contracts within a specified period of time, lien rights in favor of the residents, restrictions on change of ownership and similar matters.

Americans with Disabilities Act (the “ADA”)

Our properties must comply with the ADA and any similar state or local laws to the extent that such properties are “public accommodations” as defined in those statutes. The ADA may require removal of barriers to access by persons with disabilities in certain public areas of our properties where such removal is readily achievable. To date, we have not received any notices of noncompliance with the ADA that have caused us to incur substantial capital expenditures to address ADA concerns. Should barriers to access by persons with disabilities be discovered at any of our properties, we may be directly or indirectly responsible for additional costs that may be required to make facilities ADA-compliant. Noncompliance with the ADA could result in the imposition of fines or an award of damages to private litigants. The obligation to make readily achievable accommodations pursuant to the ADA is an ongoing one, and we continue to assess our properties and make modifications as appropriate in this respect.

Environmental Matters

A wide variety of federal, state and local environmental and occupational health and safety laws and regulations affect healthcare facility operations. These complex federal and state statutes, and their enforcement, involve a myriad of regulations, many of which involve strict liability on the part of the potential offender. Some of these federal and state statutes may directly impact us. Under various federal, state and local environmental laws, ordinances and regulations, an

9


 

Table of Contents

owner of real property or a secured lender, such as us, may be liable for the costs of removal or remediation of hazardous or toxic substances at, under or disposed of in connection with such property, as well as other potential costs relating to hazardous or toxic substances (including government fines and damages for injuries to persons and adjacent property). The cost of any required remediation, removal, fines or personal or property damages and any related liability therefore could exceed or impair the value of the property and/or the assets. In addition, the presence of such substances, or the failure to properly dispose of or remediate such substances, may adversely affect the value of such property and the owner’s ability to sell or rent such property or to borrow using such property as collateral which, in turn, could reduce our earnings. For a description of the risks associated with environmental matters, see “Item 1A, Risk Factors” in this report.

 

Insurance

We obtain various types of insurance to mitigate the impact of property, business interruption, liability, flood, windstorm, earthquake, environmental and terrorism related losses. We attempt to obtain appropriate policy terms, conditions, limits and deductibles considering the relative risk of loss, the cost of such coverage and current industry practice. There are, however, certain types of extraordinary losses, such as those due to acts of war or other events that may be either uninsurable or not economically insurable. In addition, we have a large number of properties that are exposed to earthquake, flood and windstorm occurrences which carry higher deductibles.

We maintain property insurance for all of our properties, and this insurance is primary for our SHOP (RIDEA), life science and medical office segments. Tenants under triple-net leases, primarily in our SH NNN segment, are required to provide primary property, business interruption and liability insurance. We maintain separate general and professional liability insurance for our SHOP (RIDEA) facilities. Additionally, our corporate general liability insurance program also extends coverage for all of our properties beyond the aforementioned. We periodically review whether we or our RIDEA operators will bear responsibility for maintaining the required insurance coverage for the applicable SHOP properties, but the costs of such insurance are facility expenses paid from the revenues of those properties, regardless of who maintains the insurance. 

We also maintain directors and officers liability insurance which provides protection for claims against our directors and officers arising from their responsibilities as directors and officers. Such insurance also extends to us in certain situations.

 

Employees of HCP

At December 31, 2016, we had 188 full-time employees, none of whom were subject to a collective bargaining agreement.

 

Sustainability

We believe that sustainability initiatives are a vital part of corporate responsibility, which supports our primary goal of increasing stockholder value through profitable growth. We continue to advance our commitment to sustainability, with a focus on achieving goals in each of the Environmental, Social and Governance (“ESG”) dimensions of sustainability.

Our environmental management programs strive to capture cost efficiencies that ultimately benefit our investors, tenants, operators, employees and other stakeholders, while providing a positive impact on the communities in which we operate. Our social responsibility team leads our local philanthropic and volunteer activities, and our transparent corporate governance initiatives incorporate sustainability as a critical component to achieving our business objectives and properly managing risks.

10


 

Table of Contents

Our 2016 sustainability achievements include being named the Healthcare Leader in the Light Award winner by the National Association of Real Estate Investment Trusts (“NAREIT”) and constituency in the FTSE4Good Index series for the fifth consecutive year.

Additionally, we achieved constituency in the North America Dow Jones Sustainability Index (“DJSI”) for the fourth consecutive year, as well as the World DJSI for the second time. Accordingly, HCP was included in The Sustainability Yearbook, a listing of the world’s most sustainable companies which includes only those companies in the top 15% of their industry, as scored by the DJSI assessment. For additional information regarding our ESG sustainability initiatives and our approach to climate change, please visit our website at www.hcpi.com/sustainability.

 

Available Information

Our website address is www.hcpi.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) are available on our website, free of charge, as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the U.S. Securities and Exchange Commission (“SEC”).

Current copies of our Code of Business Conduct and Ethics and Vendor Code of Business Conduct and Ethics are posted on our website at www.hcpi.com/codeofconduct. In addition, waivers from, and amendments to, our Code of Business Conduct and Ethics that apply to our directors and executive officers, including our principal executive officer, principal financial officer, principal accounting officer or persons performing similar functions, will be timely posted on our website at www.hcpi.com/codeofconduct.

ITEM 1A.    Risk Factors 

The section below discusses the most significant risk factors that may materially adversely affect our business, results of operations and financial condition.

As set forth below, we believe that the risks we face generally fall into the following categories:

·

risks related to our business and operations;

·

risks related to our capital structure and market conditions;

·

risks related to other events; and

·

risks related to tax, including REIT-related risks.

 

 

Risks Related to Our Business and Operations

We depend on one tenant and operator, Brookdale, for a significant percentage of our revenues and net operating income. Continuing adverse developments, including operational challenges, in Brookdale’s business and affairs or financial condition would likely have a materially adverse effect on us.

We manage our facilities utilizing RIDEA and triple-net lease (“lease arrangements”) structures. As of December 31, 2016, Brookdale leased or managed 212 senior housing facilities that we own and 16 SHOP facilities owned by our unconsolidated joint venture pursuant to long-term lease and management agreements.

 

Properties managed by Brookdale under RIDEA structures as of December 31, 2016, accounted for 18% of our gross segment assets. Services provided by our managers in facilities managed under a RIDEA structure are primarily paid for by the residents directly or through private insurance and are less reliant on government reimbursement programs. We report the resident level fees and services revenues and corresponding operating expenses in our consolidated financial statements.

 

11


 

Table of Contents

In addition to our RIDEA structures with Brookdale, our leases with respect to Brookdale as a tenant accounted for 12% of our revenues for the year ended December 31, 2016.

 

Although we have various rights as the property owner under our management agreements, we rely on Brookdale’s personnel, expertise, technical resources and information systems, proprietary information, good faith and judgment to manage our related senior living operations efficiently and effectively. We also rely on Brookdale to set appropriate resident fees, manage occupancy, provide accurate and complete property-level financial results for these senior housing communities in a timely manner and otherwise operate them in compliance with the terms of our management agreements and all applicable laws and regulations.

 

In its capacity as a manager in the RIDEA structures, Brookdale does not lease our properties and, therefore, our exposure to its credit risk is in a different manner as compared to a triple-net tenant. Brookdale has experienced significant challenges in integrating its July 2014 acquisition of Emeritus Corp. and has been adversely affected by increased competition that has negatively impacted occupancy rates and, in certain cases, Brookdale has offered additional discounts and incentives to residents. Brookdale, as well as our other operators, has also experienced labor expense pressure and increased labor turnover.

 

In its capacity as a triple-net tenant, we depend on Brookdale to pay all insurance, tax, utilities, maintenance and repair expenses in connection with the leased properties. We depend on adequate maintenance and repair of the properties to remain competitive and attract and retain patients and residents. Adverse developments in Brookdale’s business and related declining rent coverage ratios have increased its credit risk. If these adverse developments result in prolonged inadequate property maintenance or improvements, or impair Brookdale’s access to capital necessary for maintenance or improvements, it could lead to a significant reduction in occupancy rates and market rents, which would likely have a materially adverse effect on us.

 

Brookdale’s operational challenges and potential adverse developments in its business, affairs and financial results could significantly divert management’s attention, increase employee turnover, and impair its ability to manage the properties or its operations efficiently and effectively. This could ultimately result in, among other adverse events, acceleration of Brookdale’s indebtedness, impairment of its continued access to capital, the enforcement of default remedies by its counterparties or the commencement of insolvency proceedings by or against it under the U.S. Bankruptcy Code.

 

In addition, Brookdale depends on private sources for its revenues and the ability of its patients and residents to pay its fees. For example, costs associated with independent and assisted living services are not generally reimbursable under governmental reimbursement programs such as Medicare and Medicaid. Accordingly, Brookdale depends on attracting seniors with appropriate levels of income and assets, which may be affected by many factors including prevailing economic and market trends, consumer confidence and demographics. Consequently, if Brookdale fails to effectively conduct its operations, or to maintain and improve our properties, it would adversely affect its business reputation and its ability to attract and retain patients and residents in our properties, which would have a materially adverse effect on its and our business, results of operations and financial condition.

 

Brookdale also relies on reimbursements from governmental programs for a portion of its revenues. Changes in reimbursement policies and other governmental regulation, such as potential changes to, or repeal of, the Patient Protection and Affordable Care Act, along with the Health Care and Education Reconciliation Act of 2010 (collectively, the “Affordable Care Act”) that may result from the new presidential administration, may result in reductions in Brookdale’s revenues, operations and cash flows and affect its ability to meet its obligations to us. For a further discussion of the legislation and regulation that are applicable to us and our tenants, operators and borrowers, see “—Legislation and Regulation—The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid, may adversely affect our tenants’, operators’ and borrowers’ ability to meet their financial and other contractual obligations to us.” While Brookdale generally has also agreed to indemnify us for various claims, litigation and liabilities arising in connection with its business, it may have insufficient assets, income, access to financing and/or insurance coverage to enable them to satisfy its indemnification obligations.

 

12


 

Table of Contents

The inability, unwillingness or other failure of Brookdale under its lease agreements and RIDEA structures to meet its obligations to us could materially reduce our cash flow, net operating income and results of operations and have other materially adverse effects on our business, results of operations and financial condition.

The bankruptcy, insolvency or financial deterioration of one or more of our major tenants, operators or borrowers may materially adversely affect our business, results of operations and financial condition.

We lease our properties directly to operators in most cases, and in certain other cases, we lease to third party tenants who enter into long-term management agreements with operators to manage the properties. We are also a direct or indirect lender to various tenants and operators. We have very limited control over the success or failure of our tenants’ and operators’ businesses. Any of our tenants or operators may experience a downturn in its business that materially weakens its financial condition. As a result, they may fail to make  payments when due. Although we generally have arrangements and other agreements that give us the right under specified circumstances to terminate a lease, evict a tenant or operator, or demand immediate repayment of certain obligations to us, we may determine not to do so if we believe that enforcement of our rights would be more detrimental to our business than seeking alternative approaches.

A downturn in any of our tenants’ or operators’ businesses could ultimately lead to bankruptcy if it is unable to timely resolve the underlying causes, which may be largely outside of its control. Bankruptcy and insolvency laws afford certain rights to a party that has filed for bankruptcy or reorganization that may render certain of these remedies unenforceable, or, at the least, delay our ability to pursue such remedies and realize any recoveries in connection therewith. For example, we cannot evict a tenant or operator solely because of its bankruptcy filing.

A debtor has the right to assume, or to assume and assign to a third party, or to reject its executory contracts and unexpired leases in a bankruptcy proceeding. If a debtor were to reject its leases with us, obligations under such rejected leases would cease. The claim against the rejecting debtor would be an unsecured claim, which would be limited by the statutory cap set forth in the U.S. Bankruptcy Code. This statutory cap may be substantially less than the remaining rent actually owed under the lease. In addition, a debtor may also assert in bankruptcy proceedings that leases should be re-characterized as financing agreements, which could result in our being deemed a lender instead of a landlord. A lender’s rights and remedies, as compared to a landlord’s, generally are materially more unfavorable.

Furthermore, the automatic stay provisions of the U.S. Bankruptcy Code would preclude us from enforcing our remedies unless we first obtain relief from the court having jurisdiction over the bankruptcy case. This would effectively limit or delay our ability to collect unpaid rent, and we may ultimately not receive any payment at all. In addition, we would likely be required to fund certain expenses and obligations (e.g., real estate taxes, insurance, debt costs and maintenance expenses) to preserve the value of our properties, avoid the imposition of liens on our properties or transition our properties to a new tenant, operator or manager. Additionally, we lease many of our facilities to healthcare providers who provide long-term custodial care to the elderly. Evicting these operators for failure to pay rent while the facility is occupied may involve specific procedural or regulatory requirements and may not be successful. Even if eviction is possible, we may determine not to do so due to reputational or other risks. 

Bankruptcy or insolvency proceedings may also result in increased costs to the operator and significant management distraction. If we are unable to transition affected properties, they could experience prolonged operational disruption, leading to lower occupancy rates and further depressed revenues. Publicity about the operator’s financial condition and insolvency proceeds may also negatively impact their and our reputations, decreasing customer demand and revenues. Any or all of these risks could have a material adverse effect on our revenues, results of operations and cash flows. These risks would be magnified where we lease multiple properties to a single operator under a master lease, as an operator failure or default under a master lease would expose us to these risks across multiple properties.

13


 

Table of Contents

Additionally, the financial weakness or other inability of our tenants, operators or borrowers to make payments or comply with certain other lease obligations may affect our compliance with certain covenants contained in our debt securities, credit facilities and the mortgages on the properties leased or managed by such borrowers, tenants and operators, or otherwise adversely affect our results of operations. Under certain conditions, defaults under the underlying mortgages may result in cross default under our other indebtedness. Although we may be able to secure amendments under the applicable agreements in those circumstances, the bankruptcy of a borrower, tenant or operator may result in less favorable borrowing terms than currently available, delays in the availability of funding or other materially adverse consequences.

Increased competition and market and legislative changes have resulted and may further result in lower net revenues for some of our tenants, operators and borrowers and may affect their ability to meet their financial and other contractual obligations to us.

The healthcare industry is highly competitive. The occupancy levels at, and rental income from, our facilities are dependent on our ability and the ability of our tenants, operators and borrowers to compete with other tenants and operators on a number of different levels, including the quality of care provided, reputation, the physical appearance of a facility, price, the range of services offered, family preference, alternatives for healthcare delivery, the supply of competing properties, physicians, staff, referral sources, location, and the size and demographics of the population in the surrounding area. In addition, our tenants, operators and borrowers face an increasingly competitive labor market for skilled management personnel and nurses. An inability to attract and retain skilled management personnel and nurses and other trained personnel could negatively impact the ability of our tenants, operators and borrowers to meet their obligations to us. A shortage of nurses or other trained personnel or general inflationary pressures on wages may force tenants, operators and borrowers to enhance pay and benefits packages to compete effectively for skilled personnel, or to use more expensive contract personnel, but they be unable to offset these added costs by increasing the rates charged to residents. Any increase in labor costs and other property operating expenses or any failure by our tenants, operators or borrowers to attract and retain qualified personnel could adversely affect our cash flow and have a materially adverse effect on our business, results of operations and financial condition.

Our tenants, operators and borrowers also compete with numerous other companies providing similar healthcare services or alternatives such as home health agencies, life care at home, community-based service programs, retirement communities and convalescent centers. This competition, which is due, in part, to over-development in some segments in which we invest, has caused the occupancy rate of newly constructed buildings to slow and the monthly rate that many newly built and previously existing facilities were able to obtain for their services to decrease. Our tenants, operators and borrowers may be unable to achieve occupancy and rate levels, and to manage their expenses, in a way that will enable them to meet all of their obligations to us. Further, many competing companies may have resources and attributes that are superior to those of our tenants, operators and borrowers. Our tenants, operators and borrowers may encounter increased competition that could limit their ability to maintain or attract residents or expand their businesses or to manage their expenses, either of which could materially adversely affect their ability to meet their financial and other contractual obligations to us, potentially decreasing our revenues and impairing our assets and/or increasing collection and dispute costs.

In addition, our operators’ revenues are determined by a number of factors, including licensed bed capacity, occupancy, the healthcare needs of residents, the rate of reimbursement, and or a decrease the income or assets of seniors in the regions in which we operate. For example, due to generally increased vulnerability to illness, occupancy at our senior housing facilities could significantly decrease in the event of a severe flu season, an epidemic or any other widespread illness. Additionally, new and evolving payor and provider programs in the United States, including but not limited to Medicare Advantage, Dual Eligible, Accountable Care Organizations, and Bundled Payments, have resulted in reduced reimbursement rates, average length of stay and average daily census, particularly for higher acuity patients.

Furthermore, the new presidential administration and new Congress has introduced uncertainty in the direction of the healthcare regulatory landscape and we cannot predict the impact of any regulatory or legislative changes on the industry or our ability to compete effectively therein. See the risks described under “—Legislation and Regulation—The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid, may adversely affect our tenants’, operators’ and borrowers’ ability to meet their financial and other contractual obligations to us.” 

14


 

Table of Contents

Competition may make it difficult to identify and purchase, or develop, suitable healthcare facilities to grow our investment portfolio, to finance acquisitions on favorable terms, or to retain or attract tenants and operators.

We face significant competition from other REITs, investment companies, private equity and hedge fund investors, sovereign funds, healthcare operators, lenders, developers and other institutional investors, some of whom may have greater resources and lower costs of capital than we do. Increased competition makes it more challenging for us to identify and successfully capitalize on opportunities that meet our business goals and could improve the bargaining power of property owners seeking to sell, thereby impeding our investment, acquisition and development activities. Similarly, our properties face competition for tenants and operators from other properties in the same market, which may affect our ability to attract and retain tenants and operators, or may reduce the rents we are able to charge. If we cannot capitalize on our development pipeline, identify and purchase a sufficient quantity of healthcare facilities at favorable prices, finance acquisitions on commercially favorable terms, or attract and retain profitable tenants and operators, our business, results of operations and financial condition may be materially adversely affected.

We depend on investments in the healthcare property sector, making our profitability more vulnerable to a downturn or slowdown in that specific sector than if we were investing in multiple industries.

We concentrate our investments in the healthcare property sector. As a result, we are subject to risks inherent to investments in a single industry. A downturn or slowdown in the healthcare property sector would have a greater adverse impact on our business than if we had investments in multiple industries. Specifically, a downturn in the healthcare property sector could negatively impact the ability of our tenants, operators and borrowers to meet their obligations to us, as well as the ability to maintain rental and occupancy rates. This could adversely affect our business, financial condition and results of operations. In addition, a downturn in the healthcare property sector could adversely affect the value of our properties and our ability to sell properties at prices or on terms acceptable to us.

In addition, real estate investments are relatively illiquid. Our ability to quickly sell or exchange any of our properties in response to changes in the performance of our properties or economic and other conditions is limited. We may be unable to recognize full value for any property that we seek to sell for liquidity reasons. Our inability to respond rapidly to changes in the performance of our investments could adversely affect our financial condition and results of operations. In addition, we are exposed to the risks inherent in concentrating investments in real estate, and in particular, health care industries.

Changes within the life science industry may adversely impact our revenues and results of operations.

Our life science investments could be adversely affected if the life science industry is impacted by an economic, financial, or banking crisis or if the life science industry migrates from the U.S. to other countries or to areas outside of primary markets in South San Francisco and San Diego. Also, some of our properties may be better suited for a particular life science industry client tenant and could require modification before we are able to re-lease vacant space to another life science industry client tenant. Generally, our properties may not be suitable for lease to traditional office client tenants without significant expenditures on renovations.

Our ability to negotiate contractual rent escalations on future leases and to achieve increases in rental rates will depend upon market conditions and the demand for life science properties at the time the leases are negotiated and the increases are proposed.

Many life science entities have completed mergers or consolidations. Mergers or consolidations of life science entities in the future could reduce the amount of rentable square footage requirements of our client tenants and prospective client tenants, which may adversely impact our revenues from lease payments and results of operations.

The hospitals on whose campuses our MOBs are located and their affiliated healthcare systems could fail to remain competitive or financially viable, which could adversely impact their ability to attract physicians and physician groups to our MOBs and our other facilities that serve the healthcare industry.

Our MOBs and other facilities that serve the healthcare industry depend on the viability of the hospitals on whose campuses our MOBs are located and their affiliated healthcare systems in order to attract physicians and other healthcare-related users. The viability of these hospitals, in turn, depends on factors such as the quality and mix of healthcare services provided, competition, demographic trends in the surrounding community, market position and growth potential, as well

15


 

Table of Contents

as the ability of the affiliated healthcare systems to provide economies of scale and access to capital. If a hospital whose campus is located on or near one of our MOBs is unable to meet its financial obligations, and if an affiliated healthcare system is unable to support that hospital, the hospital may not be able to compete successfully or could be forced to close or relocate, which could adversely impact its ability to attract physicians and other healthcare-related users. Because we rely on our proximity to and affiliations with these hospitals to create tenant demand for space in our MOBs, their inability to remain competitive or financially viable, or to attract physicians and physician groups, could adversely affect our MOB operations and have a materially adverse effect on us.

In addition, the potential repeal of the Affordable Care Act and related regulations and uncertainty regarding potential replacement legislation, could result in significant changes to the scope of insurance coverage and reimbursement policies, which could put negative pressure on the operations and revenues of our MOBs.

We may be unable to maintain or expand our relationships with our existing and future hospital and health system clients.

The success of our medical office portfolio depends, to a large extent, on past, current and future relationships with hospitals and their affiliated health systems. We invest significant amounts of time in developing relationships with both new and existing clients. If we fail to maintain these relationships, including through a lack of responsiveness, failure to adapt to the current market and employment of individuals with adequate experience, our reputation and relationships will be harmed and we may lose business to competitors. If our relationships with hospitals and their affiliated health systems deteriorate, it could have a materially adverse effect on us.

Economic and other conditions that negatively affect geographic areas from which a greater percentage of our revenues is recognized could materially adversely affect our business, results of operations and financial condition.

For the year ended December 31, 2016, 26% of our revenue was derived from properties located in California, which is also where substantially all of our life-science portfolio is located. As a result, we may be subject to increased exposure to adverse conditions affecting the state, including downturns in the local economies or changes in local real estate conditions, increased competition or decreased demand, changes in state-specific legislation and local climate events and natural disasters (such as earthquakes, wildfires and hurricanes), which could cause significant disruption in our businesses in the region, harm our ability to compete effectively, result in increased costs and divert more management attention, any or all of which could adversely affect our business and results of operations.

If we must replace any of our tenants or operators, we may have difficulty identifying replacements and we may be required to incur substantial renovation costs to make certain of our healthcare properties suitable for other tenants and operators.

We cannot predict whether our tenants will renew existing leases beyond their current term. If we or our tenants terminate or do not renew the leases for our properties, we would attempt to reposition those properties with another tenant or operator. Healthcare facilities are typically highly customized and may not be easily adapted to non-healthcare-related uses. The improvements generally required to conform a property to healthcare use, such as upgrading electrical, gas and plumbing infrastructure, are costly and at times tenant-specific and may be subject to regulatory requirements. A new or replacement tenant or operator may require different features in a property, depending on that tenant’s or operator’s particular business. In addition, infrastructure improvements for life science facilities typically are significantly more costly than improvements to other property types, and we may be unable to recover part or all of these higher costs. Therefore, if a current tenant or operator is unable to pay rent and/or vacates a property, we may incur substantial expenditures to modify a property and experience delays before we are able to secure another tenant or operator or to accommodate multiple tenants or operators. These expenditures or renovations and delays may materially adversely affect our business, results of operations and financial condition.

Additionally, we may fail to identify suitable replacements or enter into leases or other arrangements with new tenants or operators on a timely basis or on terms as favorable to us as our current leases, if at all. We may be required to fund certain expenses and obligations such as real estate taxes, debt costs and maintenance expenses, to preserve the value of, and avoid the imposition of liens on, our properties while they are being repositioned. In addition, we may incur certain obligations and liabilities, including obligations to indemnify the replacement tenant or operator, which could have a materially adverse

16


 

Table of Contents

effect on us.

We face additional risks associated with property development and redevelopment that can render a project less profitable or not profitable at all and, under certain circumstances, prevent completion of development activities once undertaken.

Property development is a component of our growth strategy. For example, in October 2016 we commenced the third phase of The Cove at Oyster Point, our newest life science development in South San Francisco. At December 31, 2016, our actual investment and estimated commitments under our development and redevelopment platforms, including land held for development, represented approximately $673 million, or 4% of our total assets. Large-scale, ground-up development of healthcare properties presents additional risks for us, including risks that:

·

a development opportunity may be abandoned after expending significant resources resulting in the loss of deposits or failure to recover expenses already incurred;

·

the development and construction costs of a project may exceed original estimates due to increased interest rates and higher materials, transportation, labor, leasing or other costs, which could make the completion of the development project less profitable;

·

the project may not be completed on schedule as a result of a variety of factors that are beyond our control, including natural disasters, labor conditions, material shortages, regulatory hurdles, civil unrest and acts of war, which can result in increases in construction costs and debt service expenses or provide tenants or operators with the right to terminate pre-construction leases; and

·

occupancy rates and rents at a newly completed property may not meet expected levels and could be insufficient to make the property profitable.  

Any of the foregoing risks could materially adversely affect our business, results of operations and financial condition.

Our use of joint ventures may limit our flexibility with jointly owned investments.

We have and may continue in the future to develop and/or acquire properties in joint ventures with other persons or entities when circumstances warrant the use of these structures. Our participation in joint ventures is subject to risks that may not be present with other methods of ownership, including:

·

we could experience an impasse on certain decisions because we do not have sole decision-making authority, which could require us to expend additional resources on resolving such impasses or potential disputes, including litigation or arbitration;

·

our joint venture partners could have investment and financing goals that are not consistent with our objectives, including the timing, terms and strategies for any investments, and what levels of debt to incur or carry;

·

our ability to transfer our interest in a joint venture to a third party may be restricted and the market for our interest may be limited;

·

our joint venture partners may be structured differently than us for tax purposes, and this could create conflicts of interest and risk to our REIT status;

·

our joint venture partners might become bankrupt, fail to fund their share of required capital contributions or fail to fulfill their obligations as a joint venture partner, which may require us to infuse our own capital into the venture on behalf of the partner despite other competing uses for such capital; and

·

our joint venture partners may have competing interests in our markets that could create conflict of interest issues.

Any of the foregoing risks could materially adversely affect our business, results of operations and financial condition.

From time to time, we acquire other companies, and if we are unable to successfully integrate these operations, our business, results of operations and financial condition may be materially adversely affected.

Acquisitions require the integration of companies that have previously operated independently. Successful integration of

17


 

Table of Contents

the operations of these companies depends primarily on our ability to consolidate operations, systems, procedures, properties and personnel, and to eliminate redundancies and costs. We may encounter difficulties in these integrations. Potential difficulties associated with acquisitions include our ability to effectively monitor and manage our expanded portfolio of properties, the loss of key employees, the disruption of our ongoing business or that of the acquired entity, possible inconsistencies in standards, controls, procedures and policies, and the assumption of unexpected liabilities, including:

·

liabilities relating to the cleanup or remediation of undisclosed environmental conditions;

·

unasserted claims of vendors, residents, patients or other persons dealing with the seller;

·

liabilities, claims and litigation, whether or not incurred in the ordinary course of business, relating to periods prior to our acquisition;

·

claims for indemnification by general partners, directors, officers and others indemnified by the seller;

·

claims for return of government reimbursement payments; and

·

liabilities for taxes relating to periods prior to our acquisition.

In addition, the acquired companies and their properties may fail to perform as expected, including in respect of estimated cost savings. Inaccurate assumptions regarding future rental or occupancy rates could result in overly optimistic estimates of future revenues. Similarly, we may underestimate future operating expenses or the costs necessary to bring properties up to standards established for their intended use or for property improvements.

If we have difficulties with any of these areas, or if we later discover additional liabilities or experience unforeseen costs relating to our acquired companies, we might not achieve the economic benefits we expect from our acquisitions, and this may materially adversely affect our business, results of operations and financial condition.

From time to time we have made, and we may seek to make, one or more material acquisitions, which may involve the expenditure of significant funds.

We regularly review potential transactions in order to maximize stockholder value. Our review process may require significant management attention and a potential transaction could be abandoned or rejected by us or the other parties involved after we expend significant resources and time. In addition, future acquisitions may require the issuance of securities, the incurrence of debt, assumption of contingent liabilities or incurrence of significant expenditures, each of which could materially adversely impact our business, financial condition or results of operations. In addition, the financing required for such acquisitions may not be available on commercially favorable terms or at all.

Our tenants, operators and borrowers face litigation and may experience rising liability and insurance costs.

In some states, advocacy groups have been created to monitor the quality of care at healthcare facilities, and these groups have brought litigation against the tenants and operators of such facilities. Also, in several instances, private litigation by patients, residents or “whistleblowers” has sought, and sometimes resulted in, large damage awards. See “—The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid, may adversely affect our tenants’, operators’ and borrowers’ ability to meet their financial and other contractual obligations to us.” The effect of this litigation and other potential litigation may materially increase the costs incurred by our tenants, operators and borrowers for monitoring and reporting quality of care compliance. In addition, their cost of liability and medical malpractice insurance can be significant and may increase or not be available at a reasonable cost so long as the present healthcare litigation environment continues. Cost increases could cause our tenants and operators to be unable to make their lease or mortgage payments or fail to purchase the appropriate liability and malpractice insurance, or cause our borrowers to be unable to meet their obligations to us, potentially decreasing our revenues and increasing our collection and litigation costs. In addition, as a result of our ownership of healthcare facilities, we may be named as a defendant in lawsuits arising from the alleged actions of our tenants or operators, for which claims such tenants and operators have agreed to indemnify us, but which may require unanticipated expenditures on our part. Furthermore, although our leases and agreements provide us with certain information rights with respect to our tenants and operators, one or more of our tenants may be or become party to pending litigation or investigation to which we are unaware or do not have a right to participate or evaluate. In such cases, we would be unable to determine the potential impact of such litigation or

18


 

Table of Contents

investigation on our tenants or our business or results. Moreover, negative publicity of any of our operators’ or tenants’ litigation, other legal proceedings or investigations may also negatively impact their and our reputation, resulting in lower customer demand and revenues, which could have a material adverse effect on our financial condition, results of operations and cash flow.

We, through our subsidiaries, enter into management contracts with third party eligible independent contractors to manage some of our facilities whereby we assume additional operational risks and are subject to additional regulation and liability.

RIDEA structures at the year ended December 31, 2016, accounted for 24% of our gross segment assets. RIDEA permits REITs, such as us, to lease healthcare facilities that we own or partially own to a TRS, provided that our TRS hires an independent qualifying management company to operate the facility. Under the RIDEA lease structure, the independent qualifying management company receives a management fee from our TRS for operating the facility as an independent contractor. As the owner of the facility contracting out operational responsibility, we assume more of the operational risk relative to other structures because we lease our facility to our own partially- or wholly-owned subsidiary rather than a third party operator. Our resulting revenues therefore depend more on occupancy rates, the rates charged to residents and the ability to control operating expenses. Our TRS, and hence we, are responsible for any operating deficits incurred by the facility.

The operator, which would be our TRS when we use a RIDEA lease structure, of a healthcare facility is generally required to be the holder of the applicable healthcare license. This licensing requirement subjects our TRS and us (through our ownership interest in our TRS) to various regulatory laws, including those described above. Most states regulate and inspect healthcare facility operations, patient care, construction and the safety of the physical environment. If one or more of our healthcare real estate facilities fails to comply with applicable laws, our TRS, if it holds the healthcare license and is the entity enrolled in government health care programs, could be subject to penalties including loss or suspension of license, certification or accreditation, exclusion from government healthcare programs (i.e., Medicare, Medicaid), administrative sanctions, civil monetary penalties, and in certain instances, criminal penalties. Additionally, if our TRS holds the healthcare license, it could have exposure to professional liability claims arising out of an alleged breach of the applicable standard of care rules.

In addition, rents from this TRS structure are treated as qualifying rents from real property if (i) they are paid pursuant to an arms-length lease of a “qualified healthcare property” with the TRS and (ii) the manager qualifies as an “eligible independent contractor,” as defined in the Code. If either of these conditions is not satisfied, then the rents will not be qualifying rents.

The requirements of, or changes to, governmental reimbursement programs such as Medicare or Medicaid, may adversely affect our tenants’, operators’ and borrowers’ ability to meet their financial and other contractual obligations to us.

Certain of our tenants, operators and borrowers are affected, directly or indirectly, by an extremely complex set of federal, state and local laws and regulations pertaining to governmental reimbursement programs. These laws and regulations are subject to frequent and substantial changes that are sometimes applied retroactively. See “Item 1—Business—Government Regulation, Licensing and Enforcement” above. For example, to the extent that our tenants, operators or borrowers receive a significant portion of their revenues from governmental payors, primarily Medicare and Medicaid, they are generally subject to, among other things:

·

statutory and regulatory changes;

·

retroactive rate adjustments;

·

recovery of program overpayments or set-offs;

·

federal, state and local litigation and enforcement actions;

·

administrative proceedings;

·

policy interpretations;

19


 

Table of Contents

·

payment or other delays by fiscal intermediaries or carriers;

·

government funding restrictions (at a program level or with respect to specific facilities); and

·

interruption or delays in payments due to any ongoing governmental investigations and audits at such properties.

The failure to comply with the extensive laws, regulations and other requirements applicable to their business and the operation of our properties could result in, among other challenges: (i) becoming ineligible to receive reimbursement from governmental reimbursement programs; (ii) bans on admissions of new patients or residents; (iii) civil or criminal penalties; and (iv) significant operational changes. These laws and regulations are enforced by a variety of federal, state and local agencies and can also be enforced by private litigants through, among other things, federal and state false claims acts, which allow private litigants to bring qui tam or “whistleblower” actions. For example, we have provided a loan to Tandem Health Care (“Tandem”), a property company with ownership interests in 69 facilities totaling 6,924 beds (see Note 7 to the Consolidated Financial Statements for additional information). The sole operator of Tandem’s facilities, Consulate Health Care (“Consulate”), is facing a qui tam or “whistleblower” action alleging that Consulate overbilled the federal government and the State of Florida (United States of America v. CMC II, LLC, et al, U.S. District Court, M.D. Florida). Trial commenced on January 17, 2017 and we are unable to assess a likely outcome. However, a negative outcome could have a materially adverse effect on Consulate, which in turn could have a resulting materially adverse effect on Tandem’s ability to meet its debt service obligations to us. Regardless of the ultimate outcome, our tenants, operators and borrowers could be adversely affected by the resources required to respond to an investigation or other enforcement action. In such event, the results of operations and financial condition of our tenants and the results of operations of our properties operated by those entities could be materially adversely affected, which, in turn, could have a materially adverse effect on us. We are unable to predict future federal, state and local regulations and legislation, including the Medicare and Medicaid statutes and regulations, or the intensity of enforcement efforts with respect to such regulations and legislation, and any changes in the regulatory framework could have a materially adverse effect on our tenants and operators, which, in turn, could have a materially adverse effect on us.

Sometimes, governmental payors freeze or reduce payments to healthcare providers, or provide annual reimbursement rate increases that are smaller than expected, due to budgetary and other pressures. Healthcare reimbursement will likely continue to be of significant importance to federal and state authorities. We cannot make any assessment as to the ultimate timing or the effect that any future legislative reforms may have on our tenants’, operators’ and borrowers’ costs of doing business and on the amount of reimbursement by government and other third-party payors. The failure of any of our tenants, operators or borrowers to comply with these laws and regulations, and significant limits on the scope of services reimbursed and on reimbursement rates and fees, could materially adversely affect their ability to meet their financial and contractual obligations to us.

Furthermore, executive orders and legislation may repeal the Affordable Care Act and related regulations in whole or in part. We also anticipate that Congress, state legislatures, and third-party payors may continue to review and assess alternative healthcare delivery and payment systems and may propose and adopt legislation or policy changes or implementations effecting additional fundamental changes in the healthcare system. We cannot quantify or predict the likely impact of these possible changes on our business model, prospects, financial condition or results of operations.

Legislation to address federal government operations and administration decisions affecting the Centers for Medicare and Medicaid Services could have a materially adverse effect on our tenants’, operators’ and borrowers’ liquidity, financial condition or results of operations.

Congressional consideration of legislation pertaining to the federal debt ceiling, the Affordable Care Act, tax reform and entitlement programs, including reimbursement rates for physicians, could have a materially adverse effect on our tenants’, operators’ and borrowers’ liquidity, financial condition or results of operations. In particular, reduced funding for entitlement programs such as Medicare and Medicaid may result in increased costs and fees for programs such as Medicare Advantage Plans and additional reductions in reimbursements to providers. Amendments to or repeal of the Affordable Care Act and decisions by the Centers for Medicare and Medicaid Services could impact the delivery of services and benefits under Medicare, Medicaid or Medicare Advantage Plans and could affect our tenants and operators and the manner in which they are reimbursed by such programs. Such changes could have a materially adverse effect on our tenants’, operators’ and borrowers’ liquidity, financial condition or results of operations, which could adversely affect their ability to satisfy their obligations to us and could have a materially adverse effect on us.

20


 

Table of Contents

Tenants and operators that fail to comply with federal, state, local and international laws and regulations, including licensure, certification and inspection requirements, may cease to operate or be unable to meet their financial and other contractual obligations to us.

Our tenants, operators and borrowers are subject to or impacted by extensive, frequently changing federal, state, local and international laws and regulations. These laws and regulations include, among others: laws protecting consumers against deceptive practices; laws relating to the operation of our properties and how our tenants and operators conduct their business, such as fire, health and safety and privacy laws; federal and state laws affecting hospitals, clinics and other healthcare communities that participate in both Medicare and Medicaid that mandate allowable costs, pricing, reimbursement procedures and limitations, quality of services and care, food service and physical plants, and similar foreign laws regulating the healthcare industry; resident rights laws (including abuse and neglect laws) and fraud laws; anti-kickback and physician referral laws; the ADA and similar state and local laws; and safety and health standards set by the Occupational Safety and Health Administration or similar foreign agencies. Certain of our properties may also require a license, registration and/or certificate of need to operate. 

Our tenants’, operators’ or borrowers’ failure to comply with any of these laws, regulations or requirements could result in loss of accreditation, denial of reimbursement, imposition of fines, suspension or decertification from government healthcare programs, loss of license or closure of the facility and/or the incurrence of considerable costs arising from an investigation or regulatory action, which may have an adverse effect on facilities owned by or mortgaged to us, and therefore may materially adversely impact us. See “Item 1—Business—Government Regulation, Licensing and Enforcement—Healthcare Licensure and Certificate of Need” above.

Our tenants in the life science industry face high levels of regulation, expense and uncertainty.

Life science tenants, particularly those involved in developing and marketing pharmaceutical products, are subject to certain unique risks, including the following:

·

some of our tenants require significant outlays of funds for the research, development, clinical testing and manufacture of their products and technologies. If private investors, the government or other sources of funding are unavailable to support such activities, a tenant’s business may be adversely affected or fail;

·

the research, development, clinical testing, manufacture and marketing of some of our tenants’ products require federal, state and foreign regulatory approvals which may be costly or difficult to obtain, may take several years and be subject to delay, require valuation through clinical trials and the use of substantial resources, and may often be unpredictable;

·

even after a life science tenant gains regulatory approval and market acceptance, the product may still present significant regulatory and liability risks, including, among others, the possible later discovery of safety concerns and other defects and potential loss of approvals, competition from new products and the expiration of patent protection for the product;

·

our tenants with marketable products may be adversely affected by healthcare reform and the reimbursement policies of government or private healthcare payors;

·

dependence on the commercial success of certain products, which may be reliant on the efficacy of the products, acceptance of the products among doctors and patients, negative publicity and the negative results or safety signals from the clinical trials of competitors which may reduce demand or prompt regulatory actions; and

·

our tenants may be unable to adapt to the rapid technological advances in the industry and to adequately protect their intellectual property under patent, copyright or trade secret laws and defend against third party claims of intellectual property violations.

If our tenants’ businesses are adversely affected, they may have difficulty making payments to us, which could materially adversely affect our business, results of operations and financial condition.

21


 

Table of Contents

We may be unable to successfully foreclose on the collateral securing our real estate-related loans, and even if we are successful in our foreclosure efforts, we may be unable to successfully operate, occupy or reposition the underlying real estate, which may adversely affect our ability to recover our investments.

If a tenant or operator defaults under one of our mortgages or mezzanine loans, we may have to foreclose on the loan or protect our interest by acquiring title to the collateral and thereafter making substantial improvements or repairs in order to maximize the property’s investment potential. In some cases, the collateral consists of the equity interests in an entity that directly or indirectly owns the applicable real property or interests in operating facilities and, accordingly, we may not have full recourse to assets of that entity, or that entity may have incurred unexpected liabilities. Tenants, operators or borrowers may contest enforcement of foreclosure or other remedies, seek bankruptcy protection against our exercise of enforcement or other remedies and/or bring claims for lender liability in response to actions to enforce mortgage obligations. Foreclosure-related costs, high loan-to-value ratios or declines in the value of the facility may prevent us from realizing an amount equal to our mortgage or mezzanine loan upon foreclosure, and we may be required to record a valuation allowance for such losses. Even if we are able to successfully foreclose on the collateral securing our real estate-related loans, we may inherit properties for which we may be unable to expeditiously secure tenants or operators, if at all, or we may acquire equity interests that we are unable to immediately resell due to limitations under the securities laws, either of which would adversely affect our ability to fully recover our investment.

Required regulatory approvals can delay or prohibit transfers of our healthcare facilities.

Transfers of healthcare facilities to successor tenants or operators may be subject to regulatory approvals or ratifications, including, but not limited to, change of ownership approvals and Medicare and Medicaid provider arrangements that are not required for transfers of other types of commercial operations and other types of real estate. The replacement of any tenant or operator could be delayed by the regulatory approval process of any federal, state or local government agency necessary for the transfer of the facility or the replacement of the operator licensed to manage the facility. If we are unable to find a suitable replacement tenant or operator upon favorable terms, or at all, we may take possession of a facility, which might expose us to successor liability, require us to indemnify subsequent operators to whom we might transfer the operating rights and licenses, or require us to spend substantial time and funds to preserve the value of the property and adapt the facility to other uses, all of which may materially adversely affect our business, results of operations and financial condition.

 

Risks Related to Our Capital Structure and Market Conditions

We rely on external sources of capital to fund future capital needs, and if access to such capital is unavailable on acceptable terms or at all, it could have a materially adverse effect on our ability to meet commitments as they become due or make future investments necessary to grow our business.

We may not be able to fund all future capital needs, including capital expenditures, debt maturities and other commitments, from cash retained from operations. If we are unable to obtain enough internal capital, we may need to rely on external sources of capital (including debt and equity financing) to fulfill our capital requirements. Our access to capital depends upon a number of factors, some of which we have little or no control over, including but not limited to:

·

general availability of capital, including less favorable terms, rising interest rates and increased borrowing costs;

·

the market price of the shares of our equity securities and the credit ratings of our debt and any preferred securities we may issue;

·

the market’s perception of our growth potential and our current and potential future earnings and cash distributions;

·

our degree of financial leverage and operational flexibility;

·

the financial integrity of our lenders, which might impair their ability to meet their commitments to us or their willingness to make additional loans to us, and our inability to replace the financing commitment of any such lender on favorable terms, or at all;

·

the stability of the market value of our properties;

·

the financial performance and general market perception of our tenants and operators;

22


 

Table of Contents

·

changes in the credit ratings on U.S. government debt securities or default or delay in payment by the United States of its obligations;

·

issues facing the healthcare industry, including, but not limited to, healthcare reform and changes in government reimbursement policies; and

·

the performance of the national and global economies generally.

If access to capital is unavailable on acceptable terms or at all, it could have a materially adverse impact on our ability to fund operations, repay or refinance our debt obligations, fund dividend payments, acquire properties and make the investments needed to grow our business.

Adverse changes in our credit ratings could impair our ability to obtain additional debt and equity financing on favorable terms, if at all, and negatively impact the market price of our securities, including our common stock.

Our credit ratings can affect the amount and type of capital we can access, as well as the terms of any financing we may obtain. We may be unable to maintain our current credit ratings, and in the event that our current credit ratings deteriorate, we would likely incur higher borrowing costs, and it may be more difficult or expensive to obtain additional financing or refinance existing obligations and commitments. Also, a downgrade in our credit ratings would trigger additional costs or other potentially negative consequences under our current and future credit facilities and debt instruments. The credit ratings of our senior unsecured debt are based on, among other things, our operating performance, liquidity and leverage ratios, overall financial position, level of indebtedness and pending or future changes in the regulatory framework applicable to our operators and our industry.

Our level of indebtedness may increase and materially adversely affect our future operations.

Our outstanding indebtedness as of December 31, 2016, was approximately $9.2 billion. We may incur additional indebtedness in the future, including in connection with the development or acquisition of assets, which may be substantial. Any significant additional indebtedness could negatively affect the credit ratings of our debt and require us to dedicate a substantial portion of our cash flow to interest and principal payments due on our indebtedness. Greater demands on our cash resources may reduce funds available to us to pay dividends, conduct development activities, make capital expenditures and acquisitions or carry out other aspects of our business strategy. Increased indebtedness can also make us more vulnerable to general adverse economic and industry conditions and create competitive disadvantages for us compared to other companies with relatively lower debt levels. Increased future debt service obligations may limit our operational flexibility, including our ability to finance or refinance our properties, contribute properties to joint ventures or sell properties as needed.

Covenants in our debt instruments limit our operational flexibility, and breaches of these covenants could materially adversely affect our business, results of operations and financial condition.

The terms of our current secured and unsecured debt instruments and other indebtedness that we may incur in the future, require or will require us to comply with a number of customary financial and other covenants, such as maintaining leverage ratios, minimum tangible net worth requirements, REIT status and certain levels of debt service coverage. Our continued ability to incur additional debt and to conduct business in general is subject to compliance with these financial and other covenants, which limit our operational flexibility. For example, mortgages on our properties contain customary covenants such as those that limit or restrict our ability, without the consent of the lender, to further encumber or sell the applicable properties, or to replace the applicable tenant or operator. Breaches of certain covenants may result in defaults under the mortgages on our properties and cross-defaults under certain of our other indebtedness, even if we satisfy our payment obligations to the respective obligee. Covenants that limit our operational flexibility as well as defaults resulting from the breach of any of these covenants could materially adversely affect our business, results of operations and financial condition.

23


 

Table of Contents

An increase in interest rates could increase interest cost on new debt and existing variable rate debt and could materially adversely impact our ability to refinance existing debt, sell assets and conduct acquisition, investment and development activities.

Since the most recent recession, the U.S. Federal Reserve has taken actions which have resulted in low interest rates prevailing in the marketplace for a historically long period of time. In December 2016, the U.S. Federal Reserve raised its benchmark interest rate by a quarter of a percentage point. At this point, it is uncertain what impact the December rate increase might have on us. Additionally, market interest rates may continue to increase, and the increase may materially and negatively affect us. If interest rates increase, so could our interest costs for any variable rate debt and for new debt. This increased cost could make the financing of any acquisition and development activity more costly. Rising interest rates could limit our ability to refinance existing debt when it matures, or cause us to pay higher interest rates upon refinancing and increase interest expense on refinanced indebtedness. In addition, an increase in interest rates could decrease the amount third parties are willing to pay for our assets, thereby limiting our ability to reposition our portfolio promptly in response to changes in economic or other conditions.

We manage a portion of our exposure to interest rate risk by accessing debt with staggered maturities and through the use of derivative instruments, primarily interest rate swap agreements. However, no amount of hedging activity can fully insulate us from the risks associated with changes in interest rates. Swap agreements involve risk, including that counterparties may fail to honor their obligations under these arrangements, that these arrangements may not be effective in reducing our exposure to interest rate changes, that the amount of income we earn from hedging transactions may be limited by federal tax provisions governing REITs and that these arrangements may cause us to pay higher interest rates on our debt obligations than would otherwise be the case. Failure to hedge effectively against interest rate risk, if we choose to engage in such activities, could adversely affect our results of operations and financial condition.

Volatility, disruption or uncertainty in the financial markets may impair our ability to raise capital, obtain new financing or refinance existing obligations and fund real estate and development activities.

The global financial markets have experienced and may continue to undergo periods of significant volatility, disruption and uncertainty. While economic conditions have improved since the economic downturn in 2008 and 2009, economic growth has at times been slow and uneven and the strength and sustainability of an economic recovery is challenging and uncertain. Increased or prolonged market disruption, volatility or uncertainty could materially adversely impact our ability to raise capital, obtain new financing or refinance our existing obligations as they mature and fund real estate and development activities.

Market volatility could also lead to significant uncertainty in the valuation of our investments and those of our joint ventures, which may result in a substantial decrease in the value of our properties and those of our joint ventures. As a result, we may be unable to recover the carrying amount of such investments and the associated goodwill, if any, which may require us to recognize impairment charges in earnings.

We may be adversely affected by fluctuations in currency exchange rates.

We may pursue growth opportunities in international markets where the U.S. dollar is not the denominated currency. The ownership of investments located outside of the United States subjects us to risk from fluctuations in exchange rates between foreign currencies and the U.S. dollar. A significant change in the value of the British pound sterling (“GBP”) may have a materially adverse effect on our financial position, debt covenant ratios, results of operations and cash flow.

We may attempt to manage the impact of foreign currency exchange rate changes through the use of derivative contracts or other methods. For example, we currently utilize GBP denominated liabilities as a natural hedge against our GBP denominated assets. Additionally, we executed currency swap contracts to hedge the risk related to a portion of the forecasted interest receipts on these investments. However, no amount of hedging activity can fully insulate us from the risks associated with changes in foreign currency exchange rates, and the failure to hedge effectively against foreign currency exchange rate risk, if we choose to engage in such activities, could materially adversely affect our results of operations and financial condition. In addition, any international currency gain recognized with respect to changes in exchange rates may not qualify under the 75% gross income test or the 95% gross income test that we must satisfy annually in order to qualify and maintain our status as a REIT.

24


 

Table of Contents

 

 

Risks Related to Other Events

We are subject to certain provisions of Maryland law and our charter relating to business combinations which may prevent a transaction that may otherwise be in the interest of our stockholders.

The Maryland Business Combination Act provides that unless exempted, a Maryland corporation may not engage in business combinations, including a merger, consolidation, share exchange or, in circumstances specified in the statute, an asset transfer or issuance or reclassification of equity securities with an “interested stockholder” or an affiliate of an interested stockholder for five years after the most recent date on which the interested stockholder became an interested stockholder, and thereafter unless specified criteria are met. An interested stockholder is generally a person owning or controlling, directly or indirectly, 10% or more of the voting power of the outstanding voting stock of a Maryland corporation. Unless our Board of Directors takes action to exempt us, generally or with respect to certain transactions, from this statute in the future, the Maryland Business Combination Act will be applicable to business combinations between us and other persons.

In addition to the restrictions on business combinations contained in the Maryland Business Combination Act, our charter also contains restrictions on business combinations. Our charter requires that, except in certain circumstances, “business combinations,” including a merger or consolidation, and certain asset transfers and issuances of securities, with a “related person,” including a beneficial owner of 10% or more of our outstanding voting stock, be approved by the affirmative vote of the holders of at least 90% of our outstanding voting stock.

The restrictions on business combinations provided under Maryland law and contained in our charter may delay, defer or prevent a change of control or other transaction even if such transaction involves a premium price for our common stock or our stockholders believe that such transaction is otherwise in their best interests.

Unfavorable resolution of litigation matters and disputes could have a material adverse effect on our financial condition.

From time to time, we are involved in legal proceedings, lawsuits and other claims. We may also be named as defendants in lawsuits arising out of our alleged actions or the alleged actions of our tenants and operators for which such tenants and operators have agreed to indemnify, defend and hold us harmless. An unfavorable resolution of any such litigation may have a materially adverse effect on our business, results of operations and financial condition. Regardless of the outcome, litigation or other legal proceedings may result in substantial costs, disruption of our normal business operations and the diversion of management attention. We may be unable to prevail in, or achieve a favorable settlement of, any pending or future legal action against us. See Item 3—Legal Proceedings of this Annual Report on Form 10-K.

Loss of our key personnel could temporarily disrupt our operations and adversely affect us.

We depend on the efforts of our executive officers, and competition for these individuals is intense. Although they are covered by our Executive Severance Plan and Change in Control Plan, which provide many of the benefits typically found in executive employment agreements, none of our executive chairman, chief executive officer or incoming chief financial officer have employment agreements with us. We cannot assure you that they, or our president who does have an employment agreement with us, will remain employed with us. The loss or limited availability of the services of any of our executive officers, or our inability to recruit and retain qualified personnel in the future, could, at least temporarily, have a materially adverse effect on our business, results of operations and financial condition and the value of our common stock.

We may experience uninsured or underinsured losses, which could result in a significant loss of the capital invested in a property, lower than expected future revenues or unanticipated expense.

We maintain comprehensive insurance coverage on our properties with terms, conditions, limits and deductibles that we believe are adequate and appropriate given the relative risk and costs of such coverage, and we regularly review our insurance coverage. However, a large number of our properties are located in areas exposed to earthquake, windstorm, flood and other natural disasters and may be subject to other losses. In particular, our life science portfolio is concentrated

25


 

Table of Contents

in areas known to be subject to earthquake activity. While we purchase insurance coverage for earthquake, windstorm, flood and other natural disasters that we believe is adequate in light of current industry practice and analyses prepared by outside consultants, such insurance may not fully cover such losses. These losses can result in decreased anticipated revenues from a property and the loss of all or a portion of the capital we have invested in a property. Following these events, we may remain liable for any mortgage debt or other financial obligations related to the property. The insurance market for such exposures can be very volatile, and we may be unable to purchase the limits and terms we desire on a commercially reasonable basis in the future. In addition, there are certain exposures for which we do not purchase insurance because we do not believe it is economically feasible to do so or where there is no viable insurance market.

If one of our properties experiences a loss that is uninsured or that exceeds policy coverage limits, we could lose our investment in the damaged property as well as the anticipated future cash flows from such property. If the damaged property is subject to recourse indebtedness, we could continue to be liable for the indebtedness even if the property is irreparably damaged.

In addition, even if damage to our properties is covered by insurance, a disruption of business caused by a casualty event may result in loss of revenues for us. Any business interruption insurance may not fully compensate them or us for such loss of revenue.

Environmental compliance costs and liabilities associated with our real estate-related investments may be substantial and may materially impair the value of those investments.

Federal, state and local laws, ordinances and regulations may require us, as a current or previous owner of real estate, to investigate and clean up certain hazardous or toxic substances or petroleum released at a property. We may be held liable to a governmental entity or to third parties for property damage and for investigation and cleanup costs incurred by the third parties in connection with the contamination. The costs of cleanup and remediation could be substantial. In addition, some environmental laws create a lien on the contaminated site in favor of the government for damages and the costs it incurs in connection with the contamination.

Although we currently carry environmental insurance on our properties in an amount that we believe is commercially reasonable and generally require our tenants and operators to indemnify us for environmental liabilities they cause, such liabilities could exceed the amount of our insurance, the financial ability of the tenant or operator to indemnify us or the value of the contaminated property. As the owner of a site, we may also be held liable to third parties for damages and injuries resulting from environmental contamination emanating from the site. We may also experience environmental liabilities arising from conditions not known to us. The cost of defending against these claims, complying with environmental regulatory requirements, conducting remediation of any contaminated property, or paying personal injury or other claims or fines could be substantial and could have a materially adverse effect on our business, results of operations and financial condition.

In addition, the presence of contamination or the failure to remediate contamination may materially adversely affect our ability to use, sell or lease the property or to borrow using the property as collateral.

We rely on information technology in our operations, and any material failure, inadequacy, interruption or security failure of that technology could harm our business.

We rely on information technology networks and systems, including the Internet, to process, transmit and store electronic information, and to manage or support a variety of business processes, including financial transactions and records, and maintaining personal identifying information and tenant and lease data. We purchase some of our information technology from vendors, on whom our systems depend. We rely on commercially available systems, software, tools and monitoring to provide security for the processing, transmission and storage of confidential tenant and customer data, including individually identifiable information relating to financial accounts. Although we have taken steps to protect the security of our information systems and the data maintained in those systems, it is possible that our safety and security measures will not prevent the systems’ improper functioning or damage, or the improper access or disclosure of personally identifiable information such as in the event of cyber-attacks. Security breaches, including physical or electronic break-ins, computer viruses, attacks by hackers and similar breaches, can create system disruptions, shutdowns or unauthorized disclosure of confidential information. The risk of security breaches has generally increased as the number, intensity and sophistication

26


 

Table of Contents

of attacks have increased. In some cases, it may be difficult to anticipate or immediately detect such incidents and the damage they cause. Any failure to maintain proper function, security and availability of our information systems could interrupt our operations, damage our reputation, subject us to liability claims or regulatory penalties and could have a materially adverse effect on our business, financial condition and results of operations.

 

Risk Related to Tax, including REIT-Related Risks

Loss of our tax status as a REIT would substantially reduce our available funds and would have materially adverse consequences for us and the value of our common stock.

Qualification as a REIT involves the application of numerous highly technical and complex provisions of the Internal Revenue Code of 1986, as amended (the “Code”), for which there are only limited judicial and administrative interpretations, as well as the determination of various factual matters and circumstances not entirely within our control. We intend to continue to operate in a manner that enables us to qualify as a REIT. However, our qualification and taxation as a REIT depend upon our ability to meet, through actual annual operating results, asset diversification, distribution levels and diversity of stock ownership, the various qualification tests imposed under the Code. For example, to qualify as a REIT, at least 95% of our gross income in any year must be derived from qualifying sources, and we must make distributions to our stockholders aggregating annually at least 90% of our REIT taxable income, excluding net capital gains. In addition, new legislation, regulations, administrative interpretations or court decisions could change the tax laws or interpretations of the tax laws regarding qualification as a REIT, or the federal income tax consequences of that qualification, in a manner that is materially adverse to our stockholders. Accordingly, there is no assurance that we have operated or will continue to operate in a manner so as to qualify or remain qualified as a REIT.

If we lose our REIT status, we will face serious tax consequences that will substantially reduce the funds available to make payments of principal and interest on the debt securities we issue and to make distributions to stockholders. If we fail to qualify as a REIT:

·

we will not be allowed a deduction for distributions to stockholders in computing our taxable income;

·

we will be subject to corporate-level income tax, including any applicable alternative minimum tax, on our taxable income at regular corporate rates;

·

we could be subject to increased state and local income taxes; and

·

unless we are entitled to relief under relevant statutory provisions, we will be disqualified from taxation as a REIT for the four taxable years following the year during which we fail to qualify as a REIT.

As a result of all these factors, our failure to qualify as a REIT could also impair our ability to expand our business and raise capital and could materially adversely affect the value of our common stock.

The present federal income tax treatment of REITs may be modified, possibly with retroactive effect, by legislative, judicial or administrative action at any time, which could affect the federal income tax treatment of an investment in us. The federal income tax rules dealing with REITs constantly are under review by persons involved in the legislative process, the U.S. Internal Revenue Service (the “IRS”) and the U.S. Treasury Department, which results in statutory changes as well as frequent revisions to regulations and interpretations. Revisions in federal tax laws and interpretations thereof could affect or cause us to change our investments and commitments and affect the tax considerations of an investment in us.

We could have potential deferred and contingent tax liabilities from corporate acquisitions that could limit, delay or impede future sales of our properties.

If, during the five-year period beginning on the date we acquire certain companies, we recognize a gain on the disposition of any property acquired, then, to the extent of the excess of (i) the fair market value of such property as of the acquisition date over (ii) our adjusted income tax basis in such property as of that date, we will be required to pay a corporate-level federal income tax on this gain at the highest regular corporate rate. There can be no assurance that these triggering dispositions will not occur, and these requirements could limit, delay or impede future sales of our properties.

27


 

Table of Contents

In addition, the IRS may assert liabilities against us for corporate income taxes for taxable years prior to the time that we acquire certain companies, in which case we will owe these taxes plus interest and penalties, if any.

There are uncertainties relating to the calculation of non-REIT tax earnings and profits (“E&P”) in certain acquisitions, which may require us to distribute E&P.

In order to remain qualified as a REIT, we are required to distribute to our stockholders all of the accumulated non-REIT E&P of certain companies that we acquire, prior to the close of the first taxable year in which the acquisition occurs. Failure to make such E&P distributions would result in our disqualification as a REIT. The determination of the amount to be distributed in such E&P distributions is a complex factual and legal determination. We may have less than complete information at the time we undertake our analysis, or we may interpret the applicable law differently from the IRS. We currently believe that we have satisfied the requirements relating to such E&P distributions. There are, however, substantial uncertainties relating to the determination of E&P, including the possibility that the IRS could successfully assert that the taxable income of the companies acquired should be increased, which would increase our non-REIT E&P. Moreover, an audit of the acquired company following our acquisition could result in an increase in accumulated non-REIT E&P, which could require us to pay an additional taxable distribution to our then-existing stockholders, if we qualify under rules for curing this type of default, or could result in our disqualification as a REIT.

Thus, we might fail to satisfy the requirement that we distribute all of our non-REIT E&P by the close of the first taxable year in which the acquisition occurs. Moreover, although there are procedures available to cure a failure to distribute all of our E&P, we cannot now determine whether we will be able to take advantage of these procedures or the economic impact on us of doing so.

Recent tax legislation impacts certain U.S. federal income tax rules applicable to REITs and could adversely affect our current tax positions.

The Protecting Americans from Tax Hikes Act of 2015 (the “Act”) contains changes to certain aspects of the U.S. federal income tax rules applicable to us. The Act is the most recent example of changes to the REIT rules, and additional legislative changes may occur that could adversely affect our current tax positions. The Act modifies various rules that apply to our ownership of, and business relationship with, our TRSs and reduces the maximum allowable value of our assets attributable to TRSs from 25% to 20% which could impact our ability to enter into future investments. The Act makes permanent the reduction of the recognition period (from ten years to five years) during which an entity that converted from a corporation to a REIT or was acquired by a REIT is subject to a corporate-level tax on built-in gains recognized during such period, which could influence the types of investments we enter into in the future. The Act also makes multiple changes related to the Foreign Investment in Real Property Tax Act, or FIRPTA, expands prohibited transaction safe harbors and qualifying hedges, and repeals the preferential dividend rule for public REITs previously applicable to us. Lastly, the Act adjusts the way we may calculate certain earnings and profits calculations to avoid double taxation at the stockholder level, and expands the types of qualifying assets and income for purposes of the REIT requirements. The provisions enacted by the Act could result in changes in our tax positions or investments, and future legislative changes related to those rules described above could have a materially adverse impact on our results of operations and financial condition.

Our international investments and operations may result in additional tax-related risks.

We have investments and operations in the United Kingdom, and may further expand internationally. International expansion presents tax-related risks that are different from those we face with respect to our domestic properties and operations. These risks include, but are not limited to:  

·

international currency gain recognized with respect to changes in exchange rates may not always qualify under the 75% gross income test or the 95% gross income test that we must satisfy annually in order to qualify and maintain our status as a REIT;

·

challenges with respect to the repatriation of foreign earnings and cash; and

·

challenges of complying with foreign tax rules (including the possible revisions in tax treaties or other laws and regulations, including those governing the taxation of our international income).

28


 

Table of Contents

Our charter contains ownership limits with respect to our common stock and other classes of capital stock.

Our charter contains restrictions on the ownership and transfer of our common stock and preferred stock that are intended to assist us in preserving our qualification as a REIT. Under our charter, subject to certain exceptions, no person or entity may own, actually or constructively, more than 9.8% (by value or by number of shares, whichever is more restrictive) of the outstanding shares of our common stock or any class or series of our preferred stock.

Additionally, our charter has a 9.9% ownership limitation on the direct or indirect ownership of our voting shares, which may include common stock or other classes of capital stock. Our Board of Directors, in its sole discretion, may exempt a proposed transferee from either ownership limit. The ownership limits may delay, defer or prevent a transaction or a change of control that might involve a premium price for our common stock or might otherwise be in the best interests of our stockholders.

ITEM 1B.    Unresolved Staff Comments

None.

ITEM 2.    Properties

We are organized to invest in income-producing healthcare-related facilities. In evaluating potential investments, we consider a multitude of factors, including:

·

location, construction quality, age, condition and design of the property;

·

geographic area, proximity to other healthcare facilities, type of property and demographic profile, including new competitive supply;

·

whether the expected risk-adjusted return exceeds the incremental cost of capital;

·

whether the rent or operating income provides a competitive market return to our investors;

·

duration, rental rates, tenant and operator quality and other attributes of in-place leases, including master lease structures and coverage;

·

current and anticipated cash flow and its adequacy to meet our operational needs;

·

availability of security such as letters of credit, security deposits and guarantees;

·

potential for capital appreciation;

·

expertise and reputation of the tenant or operator;

·

occupancy and demand for similar healthcare facilities in the same or nearby communities;

·

the mix of revenues generated at healthcare facilities between privately paid and government reimbursed;

·

availability of qualified operators or property managers and whether we can manage the property;

·

potential alternative uses of the facilities;

·

the regulatory and reimbursement environment in which the properties operate;

·

tax laws related to REITs;

·

prospects for liquidity through financing or refinancing; and

·

our access to and cost of capital.

 

29


 

Table of Contents

 

Property and Direct Financing Lease Investments

The following table summarizes our consolidated property and DFL investments as of and for the year ended December 31, 2016 (square feet and dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Number of

    

 

 

Gross Asset

    

Rental

 

Operating

 

Facility Location

 

Facilities

 

Capacity

    

Value(1)

 

Revenues(2)

    

Expenses

 

SH NNN—real estate:

 

 

 

(Units)

 

 

 

 

 

 

 

 

 

 

California

 

22

 

2,022

 

$

453,094

 

$

51,312

 

$

(5,494)

 

Texas

 

16

 

1,761

 

 

216,536

 

 

46,071

 

 

(5)

 

Florida

 

14

 

1,776

 

 

275,825

 

 

38,041

 

 

 —

 

Oregon

 

16

 

1,357

 

 

188,626

 

 

26,858

 

 

(317)

 

Virginia

 

10

 

1,228

 

 

270,132

 

 

21,705

 

 

 —

 

Washington

 

17

 

1,199

 

 

212,047

 

 

17,178

 

 

 —

 

Colorado

 

2

 

414

 

 

89,791

 

 

18,043

 

 

 —

 

Other (28 States)

 

86

 

7,776

 

 

1,361,661

 

 

167,855

 

 

(948)

 

 

 

183

 

17,533

 

 

3,067,712

 

 

387,063

 

 

(6,764)

 

Senior housing—DFLs(3):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (12 States)

 

27

 

3,123

 

 

628,698

 

 

36,055

 

 

54

 

Total SH NNN

 

210

 

20,656

 

$

3,696,410

 

$

423,118

 

$

(6,710)

 

SHOP:

 

 

 

(Units)

 

 

 

 

 

 

 

 

 

 

Texas

 

27

 

4,385

 

$

623,258

 

$

137,818

 

$

(91,514)

 

Florida

 

23

 

3,241

 

 

498,329

 

 

128,805

 

 

(85,267)

 

Colorado

 

7

 

1,123

 

 

342,301

 

 

54,052

 

 

(33,174)

 

Illinois

 

8

 

1,434

 

 

275,079

 

 

53,472

 

 

(42,337)

 

California

 

11

 

1,632

 

 

264,306

 

 

93,579

 

 

(72,231)

 

Other (21 States)

 

53

 

5,483

 

 

949,248

 

 

219,096

 

 

(156,347)

 

Total SHOP

 

129

 

17,298

 

$

2,952,521

 

$

686,822

 

$

(480,870)

 

 

30


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Number of

    

 

 

Gross Asset

 

Rental

 

Operating

 

Facility Location

 

Facilities

 

Capacity

 

Value(1)

 

Revenues(2)

 

Expenses

 

Life science:

 

 

 

(Sq. Ft.)

 

 

 

 

 

 

 

 

 

 

California

 

108

 

6,432

 

$

3,176,224

 

$

331,525

 

$

(67,940)

 

Other (2 States)

 

8

 

512

 

 

143,255

 

 

27,012

 

 

(4,538)

 

Total life science

 

116

 

6,944

 

$

3,319,479

 

$

358,537

 

$

(72,478)

 

Medical office:

 

 

 

(Sq. Ft.)

 

 

 

 

 

 

 

 

 

 

Texas

 

60

 

5,606

 

$

917,195

 

$

123,677

 

$

(51,484)

 

California

 

17

 

993

 

 

308,853

 

 

30,958

 

 

(16,305)

 

Pennsylvania

 

4

 

1,282

 

 

285,232

 

 

33,166

 

 

(12,714)

 

Florida

 

24

 

1,328

 

 

235,819

 

 

26,203

 

 

(11,944)

 

Other (26 States)

 

133

 

8,901

 

 

1,601,306

 

 

232,276

 

 

(81,240)

 

Total medical office

 

238

 

18,110

 

$

3,348,405

 

$

446,280

 

$

(173,687)

 

Other(4):

 

 

 

(Beds)

 

 

 

 

 

 

 

 

 

 

Texas

 

4

 

1,035

 

$

231,512

 

$

34,138

 

$

(4,592)

 

California

 

2

 

111

 

 

143,500

 

 

19,360

 

 

(15)

 

Other (9 States)

 

10

 

1,105

 

 

206,798

 

 

39,421

 

 

(47)

 

 

 

16

 

2,251

 

$

581,810

 

$

92,919

 

$

(4,654)

 

Other—U.K.:

 

 

 

(Units)

 

 

 

 

 

 

 

 

 

 

Other (U.K.)

 

61

 

3,198

 

 

307,949

 

 

32,810

 

 

 -

 

Total other non-reportable segments

 

77

 

 

 

$

889,759

 

$

125,729

 

$

(4,654)

 

Total properties

 

770

 

 

 

$

14,206,574

 

$

2,040,486

 

$

(738,399)

 


(1)

Represents gross real estate and the carrying value of DFLs, excluding development properties and assets held for sale. Gross real estate represents the carrying amount of real estate after adding back accumulated depreciation and amortization.

(2)

Represent the combined amount of rental and related revenues, tenant recoveries, resident fees and services and income from DFLs.

(3)

Represents leased properties that are classified as DFLs.

(4)

Represents hospitals and skilled nursing facilities, and includes leased properties that are classified as DFLs.

 

31


 

Table of Contents

 

Occupancy and Annual Rent Trends

The following table summarizes occupancy and average annual rent trends for our consolidated property and DFL investments for the years ended December 31, (square feet in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

2016

    

2015

    

2014

    

2013

    

2012

 

SH NNN(1):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average annual rent per unit(1)

 

$

14,604

 

$

14,544

 

$

13,907

 

$

13,361

 

$

13,593

 

Average capacity (available units)

 

 

28,455

 

 

28,777

 

 

33,917

 

 

35,932

 

 

27,235

 

SHOP:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average annual rent per unit(1)

 

$

42,851

 

$

41,435

 

$

38,017

 

$

32,070

 

$

30,294

 

Average capacity (available units)

 

 

16,028

 

 

12,704

 

 

6,408

 

 

4,620

 

 

4,626

 

Life science:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average occupancy percentage

 

 

98

%  

 

97

%  

 

93

%  

 

92

%  

 

90

%

Average annual rent per square foot(1)

 

$

48

 

$

46

 

$

46

 

$

44

 

$

45

 

Average occupied square feet

 

 

7,332

 

 

7,179

 

 

6,637

 

 

6,480

 

 

6,250

 

Medical office:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average occupancy percentage

 

 

91

%

 

91

%  

 

91

%  

 

91

%  

 

91

%

Average annual rent per square foot(1)

 

$

28

 

$

28

 

$

28

 

$

27

 

$

27

 

Average occupied square feet

 

 

15,697

 

 

14,677

 

 

13,136

 

 

12,767

 

 

12,147

 

Other non-reportable segments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average annual rent per bed - Hospital(1)

 

$

39,076

 

$

39,834

 

$

38,756

 

$

38,089

 

$

37,294

 

Average capacity (available beds) - Hospital

 

 

2,271

 

 

2,187

 

 

2,184

 

 

2,138

 

 

2,050

 

Average annual rent per unit - U.K.(1)

 

 

9,200

 

 

10,048

 

 

11,240

 

 

 —

 

 

 —

 

Average capacity (available units) - U.K.

 

 

3,190

 

 

2,515

 

 

501

 

 

 —

 

 

 —

 

Average annual rent per bed - SNF(1)

 

 

10,803

 

 

8,292

 

 

8,062

 

 

7,537

 

 

7,308

 

Average capacity (available beds) - SNF

 

 

426

 

 

1,047

 

 

1,022

 

 

974

 

 

976

 


(1)

Average annual rent is presented as a ratio of revenues comprised of rental and related revenues, tenant recoveries and income from DFLs divided by the average capacity or average occupied square feet of the facilities and annualized for mergers and acquisitions for the year in which they occurred. Average annual rent for leased properties (including DFLs) excludes termination fees and non-cash revenue adjustments (i.e., straight-line rents, amortization of market lease intangibles and DFL non-cash interest).

 

32


 

Table of Contents

 

Development Properties

The following table sets forth the properties in our consolidated property portfolio at December 31, 2016 that were under development or redevelopment (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

 

 

    

Estimated

 

 

 

 

 

Placed

 

Investment

 

Total at

 

Name of Project

 

Location

 

in Service

 

to Date(1)

 

Completion

 

Life science:

 

 

 

 

 

 

 

 

 

 

 

 

The Cove at Oyster Point - Phase I

 

South San Francisco, CA

 

$

101,179

 

$

64,854

 

$

190,800

 

The Cove at Oyster Point - Phase II

 

South San Francisco, CA

 

 

 —

 

 

112,152

 

 

220,486

 

The Cove at Oyster Point - Phase III

 

South San Francisco, CA

 

 

 —

 

 

24,916

 

 

211,111

 

Ridgeview

 

San Diego, CA

 

 

 —

 

 

31,207

 

 

62,000

 

Medical office:

 

 

 

 

 

 

 

 

 

 

 

 

Pearland II

 

Pearland, TX

 

 

5,400

 

 

9,906

 

 

18,800

 

Sky Ridge

 

Lone Tree, CO

 

 

17,692

 

 

14,015

 

 

37,551

 

Cypress

 

Cypress, TX

 

 

15,968

 

 

13,861

 

 

40,206

 

Woodlands Plaza IV

 

Shenendoah, TX

 

 

 —

 

 

19,550

 

 

37,050

 

Medical City Dallas Garage(2)

 

Dallas, TX

 

 

 —

 

 

5,325

 

 

9,300

 

Yorktown(2)

 

Fairfax, VA

 

 

10

 

 

1,420

 

 

6,208

 

Aurora I and II(2)

 

Aurora, CO

 

 

658

 

 

1,068

 

 

8,888

 

Museum Medical Tower(2)

 

Houston, TX

 

 

161

 

 

1,381

 

 

10,048

 

Sunrise Tower IV(2)

 

Las Vegas, NV

 

 

308

 

 

1,666

 

 

6,500

 

One Fannin(2)

 

Houston, TX

 

 

720

 

 

1,737

 

 

8,000

 

 

 

 

 

$

142,096

 

$

303,058

 

$

866,948

 


(1)

Excludes the portion of the property that has been placed in service.

(2)

Represents redevelopment projects.

At December 31, 2016, we also had $252 million of land held for future development primarily in our life science segment.

 

 

Tenant Lease Expirations

The following table shows tenant lease expirations, including those related to DFLs, for the next 10 years and thereafter at our consolidated properties, assuming that none of the tenants exercise any of their renewal or purchase options, unless otherwise noted below (dollars and square feet in thousands), and excludes properties in our SHOP segment and assets held for sale. See “Tenant Purchase Options” section of Note 12 to the Consolidated Financial Statements for additional information on leases subject to purchase options.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expiration Year

 

Segment

 

Total

 

2017(1)

 

2018

 

2019

 

2020

 

2021

 

2022

 

2023

 

2024

 

2025

 

2026

 

Thereafter

 

SH NNN:

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Properties

 

 

210

 

 

26

 

 

7

 

 

5

 

 

22

 

 

6

 

 

1

 

 

24

 

 

12

 

 

5

 

 

7

 

 

95

 

Base rent(2)

 

$

311,203

 

$

12,035

 

$

25,114

 

$

9,470

 

$

38,574

 

$

9,872

 

$

1,476

 

$

43,368

 

$

13,674

 

$

9,388

 

$

5,599

 

$

142,633

 

% of segment base rent

 

 

100

 

 

4

 

 

8

 

 

3

 

 

12

 

 

3

 

 

 —

 

 

14

 

 

4

 

 

3

 

 

2

 

 

47

 

Life science(3):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Square feet

 

 

6,686

 

 

671

 

 

1,196

 

 

570

 

 

508

 

 

778

 

 

599

 

 

880

 

 

65

 

 

499

 

 

121

 

 

799

 

Base rent(2)

 

$

273,121

 

$

28,922

 

$

60,540

 

$

18,222

 

$

16,331

 

$

44,326

 

$

18,631

 

$

41,204

 

$

3,111

 

$

17,273

 

$

5,439

 

$

19,122

 

% of segment base rent

 

 

100

 

 

11

 

 

22

 

 

7

 

 

6

 

 

16

 

 

7

 

 

15

 

 

1

 

 

6

 

 

2

 

 

7

 

Medical office:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Square feet

 

 

16,666

 

 

2,905

 

 

2,285

 

 

1,984

 

 

2,144

 

 

1,397

 

 

951

 

 

594

 

 

531

 

 

1,821

 

 

749

 

 

1,305

 

Base rent(2)

 

$

376,515

 

$

69,771

 

$

53,416

 

$

47,655

 

$

51,569

 

$

34,879

 

$

23,195

 

$

13,621

 

$

14,014

 

$

28,323

 

$

18,692

 

$

21,380

 

% of segment base rent

 

 

100

 

 

19

 

 

14

 

 

13

 

 

14

 

 

9

 

 

6

 

 

4

 

 

4

 

 

8

 

 

5

 

 

4

 

Other non-reportable segments(4):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Properties

 

 

77

 

 

1

 

 

 —

 

 

5

 

 

1

 

 

1

 

 

4

 

 

 —

 

 

2

 

 

1

 

 

 —

 

 

62

 

Base rent(2)

 

$

110,022

 

$

7,815

 

$

 —

 

$

7,434

 

$

7,815

 

$

1,526

 

$

12,918

 

$

 —

 

$

15,073

 

$

21,857

 

$

 —

 

$

35,584

 

% of segment base rent

 

 

100

 

 

7

 

 

 —

 

 

7

 

 

7

 

 

1

 

 

12

 

 

 —

 

 

14

 

 

20

 

 

 —

 

 

32

 

Total:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Base rent(2)

 

$

1,070,861

 

$

118,543

 

$

139,070

 

$

82,781

 

$

114,289

 

$

90,603

 

$

56,220

 

$

98,193

 

$

45,872

 

$

76,841

 

$

29,730

 

$

218,719

 

% of total base rent

 

 

100

 

 

11

 

 

13

 

 

8

 

 

11

 

 

8

 

 

5

 

 

9

 

 

4

 

 

7

 

 

3

 

 

21

 

33


 

Table of Contents


(1)

Includes month-to-month leases.

(2)

The most recent month’s (or subsequent month’s if acquired in the most recent month) base rent including additional rent floors and cash income from DFLs annualized for 12 months. Base rent does not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e., straight-line rents, amortization of market lease intangibles, DFL non-cash interest and deferred revenues).

(3)

Includes 337,000 sq. ft. and annualized rents of $20 million expiring in 2018 related to the exercise of tenant purchase options in January 2016.

(4)

Includes a hospital with annualized rents of $8 million expiring in 2017 related to the exercise of a tenant purchase option in February 2016.

See Schedule III: Real Estate and Accumulated Depreciation, included in this report, which information is incorporated by reference in this Item 2.

ITEM 3.    Legal Proceedings

We believe that our existing legal proceedings will not have a material adverse impact on our business or financial position, results of operations or cash flows. We record a liability when a loss is considered probable and the amount can be reasonably estimated.

See “Legal Proceedings” section of Note 12 to the Consolidated Financial Statements for information regarding legal proceedings, which information is incorporated by reference in this Item 3.

ITEM 4.    Mine Safety Disclosures

None.

34


 

Table of Contents

PART II

ITEM 5.   Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our common stock is listed on the New York Stock Exchange. It has been our policy to declare quarterly dividends to common stockholders so as to comply with applicable provisions of the Code governing REITs. For the fiscal quarters indicated below are the reported high and low sales prices per share of our common stock on the New York Stock Exchange and the cash dividends paid per common share:

 

 

 

 

 

 

 

 

 

 

 

 

    

High

    

Low

    

Per Share
Distribution

 

2016(1)

 

 

 

 

 

 

 

 

 

 

Fourth Quarter

 

$

38.09

 

$

27.61

 

$

0.370

 

Third Quarter

 

 

40.43

 

 

34.56

 

 

0.575

 

Second Quarter

 

 

36.90

 

 

31.91

 

 

0.575

 

First Quarter

 

 

39.25

 

 

25.11

 

 

0.575

 

2015(1)

 

 

 

 

 

 

 

 

 

 

Fourth Quarter

 

 

39.83

 

 

32.71

 

 

0.565

 

Third Quarter

 

 

40.90

 

 

35.37

 

 

0.565

 

Second Quarter

 

 

44.79

 

 

36.20

 

 

0.565

 

First Quarter

 

 

49.61

 

 

39.88

 

 

0.565

 


(1)

Price as originally traded. Does not give effect to the stock dividend of $6.17 per common share related to the Spin-Off (discussed below).

At January 31, 2017, we had 9,894 stockholders of record, and there were 218,367 beneficial holders of our common stock.

Dividends (Distributions)

Distributions with respect to our common stock can be characterized for federal income tax purposes as taxable ordinary dividends, capital gain dividends, nondividend distributions or a combination thereof. Following is the characterization of our annual common stock distributions per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Ordinary dividends

    

$

1.5561

    

$

2.1184

    

$

1.9992

 

Capital gain dividends

 

 

 —

 

 

0.0316

 

 

0.0890

 

Nondividend distributions

 

 

6.7089

 

 

0.1100

 

 

0.0918

 

 

 

$

8.2650

(1)

$

2.2600

 

$

2.1800

 


(1)

Consists of $2.095 per common share of quarterly cash dividends and $6.17 per common share of stock dividends related to the Spin-Off (discussed below).

HCP common stockholders on October 24, 2016, the record date for the Spin-Off (the “Record Date”), received upon the Spin-Off on October 31, 2016 one share of QCP common stock for every five shares of HCP common stock they held (the “Distributed Shares”) and cash in lieu of fractional shares of QCP. For U.S. federal income tax purposes, HCP reported the fair market value of the QCP common stock distributed per each share of HCP common stock outstanding on the Record Date was $6.17, or $30.85 for each share of QCP common stock. Accordingly, every HCP common stockholder who received a Distributed Share has a tax cost basis of $30.85 per Distributed Share.

On February 2, 2017, we announced that our Board of Directors declared a quarterly common stock cash dividend of $0.37 per share. The common stock dividend will be paid on March 2, 2017 to stockholders of record as of the close of business on February 15, 2017.

35


 

Table of Contents

 

Issuer Purchases of Equity Securities

The table below sets forth the information with respect to purchases of our common stock made by or on our behalf during the quarter ended December 31, 2016.

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Total Number of Shares

    

Maximum Number (or

 

 

 

 

 

 

 

 

Purchased as

 

Approximate Dollar Value)

 

 

 

Total Number

 

 

 

 

Part of Publicly

 

of Shares that May Yet

 

 

 

of Shares

 

Average Price

 

Announced Plans

 

be Purchased Under

 

Period Covered

 

Purchased(1)

 

Paid per Share

 

or Programs

 

the Plans or Programs

 

October 1-31, 2016

 

30

 

$

35.91

 

 —

 

 —

 

November 1-30, 2016

 

 —

 

 

 —

 

 —

 

 —

 

December 1-31, 2016

 

590

 

 

30.30

 

 —

 

 —

 

Total

 

620

 

 

30.57

 

 —

 

 —

 


(1)

Represents restricted shares withheld under our equity incentive plans to offset tax withholding obligations that occur upon vesting of restricted shares. The value of the shares withheld is based on the closing price of our common stock on the last trading day prior to the date the relevant transaction occurred.

 

36


 

Table of Contents

 

Performance Graph

The graph below compares the cumulative total return of HCP, the S&P 500 Index and the Equity REIT Index of NAREIT, from January 1, 2012 to December 31, 2016. Total cumulative return is based on a $100 investment in HCP common stock and in each of the indices on January 1, 2012 and assumes quarterly reinvestment of dividends before consideration of income taxes. Stockholder returns over the indicated periods should not be considered indicative of future stock prices or stockholder returns.

COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN

AMONG S&P 500, EQUITY REITS AND HCP, INC.

RATE OF RETURN TREND COMPARISON

JANUARY 1, 2012–DECEMBER 31, 2016

(JANUARY 1, 2012 = $100)

Performance Graph Total Stockholder Return

Picture 3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

December 31,

 

 

    

2012

    

2013

    

2014

    

2015

    

2016

 

FTSE NAREIT Equity REIT Index

 

$

119.70

 

$

123.12

 

$

157.63

 

$

162.08

 

$

176.07

 

S&P 500

 

 

115.98

 

 

153.51

 

 

174.47

 

 

176.88

 

 

197.98

 

HCP, Inc.

 

 

114.21

 

 

96.33

 

 

122.96

 

 

113.24

 

 

103.02

 

 

 

 

 

37


 

Table of Contents

ITEM 6.    Selected Financial Data

Set forth below is our selected financial data as of and for each of the years in the five-year period ended December 31, (dollars in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

2013

 

2012

 

Statement of operations data:

   

    

 

   

 

    

   

 

    

   

 

    

   

 

    

 

Total revenues

 

$

2,129,294

 

$

1,940,489

 

$

1,636,833

 

$

1,488,786

 

$

1,281,861

 

Income from continuing operations

 

 

374,171

 

 

152,668

 

 

271,315

 

 

253,526

 

 

156,213

 

Net income (loss) applicable to common shares

 

 

626,549

 

 

(560,552)

 

 

919,796

 

 

969,103

 

 

812,289

 

Basic earnings per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

0.77

 

 

0.30

 

 

0.56

 

 

0.52

 

 

0.29

 

Discontinued operations

 

 

0.57

 

 

(1.51)

 

 

1.45

 

 

1.61

 

 

1.61

 

Net income (loss) attributable to common stockholders

 

 

1.34

 

 

(1.21)

 

 

2.01

 

 

2.13

 

 

1.90

 

Diluted earnings per common share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

0.77

 

 

0.30

 

 

0.56

 

 

0.52

 

 

0.29

 

Discontinued operations

 

 

0.57

 

 

(1.51)

 

 

1.44

 

 

1.61

 

 

1.61

 

Net income (loss) attributable to common stockholders

 

 

1.34

 

 

(1.21)

 

 

2.00

 

 

2.13

 

 

1.90

 

Balance sheet data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

 

15,759,265

 

 

21,449,849

 

 

21,331,436

 

 

20,040,310

 

 

19,879,697

 

Debt obligations(1)

 

 

9,189,495

 

 

11,069,003

 

 

9,721,269

 

 

8,626,067

 

 

8,659,691

 

Total equity

 

 

5,941,308

 

 

9,746,317

 

 

10,997,099

 

 

10,931,134

 

 

10,753,777

 

Other data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends paid

 

 

979,542

 

 

1,046,638

 

 

1,001,559

 

 

956,685

 

 

865,306

 

Dividends paid per common share(2)

 

 

2.095

 

 

2.260

 

 

2.180

 

 

2.100

 

 

2.000

 

Funds from operations (“FFO”)(3)

 

 

1,119,153

 

 

(10,841)

 

 

1,381,634

 

 

1,349,264

 

 

1,166,508

 

Diluted FFO per common share(3)

 

 

2.39

 

 

(0.02)

 

 

3.00

 

 

2.95

 

 

2.72

 

FFO as adjusted(3)

 

 

1,282,390

 

 

1,470,167

 

 

1,398,691

 

 

1,382,699

 

 

1,195,799

 

Diluted FFO as adjusted per common share(3)

 

 

2.74

 

 

3.16

 

 

3.04

 

 

3.02

 

 

2.79

 

Funds available for distribution (“FAD”)(3)

 

 

1,215,696

 

 

1,261,849

 

 

1,178,822

 

 

1,158,082

 

 

954,645

 


(1)

Includes bank line of credit, bridge and term loans, senior unsecured notes, mortgage and other secured debt, and other debt.

(2)

Represents cash dividends. Additionally, in October 2016 we issued $6.17 of stock dividends related to the Spin-Off.

(3)

For a more detailed discussion and reconciliation of FFO, FFO as adjusted and FAD, see “Non-GAAP Financial Measure Reconciliations” in Item 7. 

38


 

Table of Contents

ITEM 7.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

The information set forth in this Item 7 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:

·

2016 Transaction Overview

·

Dividends

·

Results of Operations

·

Liquidity and Capital Resources

·

Contractual Obligations

·

Off-Balance Sheet Arrangements

·

Inflation

·

Non-GAAP Financial Measure Reconciliations

·

Critical Accounting Policies

·

Recent Accounting Pronouncements

2016 Transaction Overview

 

Spin-Off of Real Estate Portfolio

On October 31, 2016, we completed our previously announced Spin-Off of QCP. QCP’s assets include 338 properties, primarily comprised of the HCRMC DFL investments and an equity investment in HCRMC. Following the completion of the Spin-Off on October 31, 2016, QCP is an independent, publicly-traded, self-managed and self-administrated REIT. As a result of the Spin-Off, the operations of QCP are now classified as discontinued operations in all periods presented herein.  We entered into a Separation and Distribution Agreement (the “Separation and Distribution Agreement”) with QCP in connection with the Spin-Off. The Separation and Distribution Agreement divides and allocates the assets and liabilities of HCP prior to the Spin-Off between QCP and HCP, governs the rights and obligations of the parties regarding the Spin-Off, and contains other key provisions relating to the separation of QCP’s business from HCP.

In connection with the Spin-Off, we entered into a Transition Services Agreement ("TSA") with QCP. Per the terms of the TSA, we agreed to provide certain administrative and support services to QCP on a transitional basis for established fees, which are expected to approximate the actual cost incurred by us in providing the transition services to QCP for the relevant period. The TSA will terminate on the expiration of the term of the last service provided under the agreement, which will be on or prior to October  30, 2017. The TSA provides that QCP generally has the right to terminate a transition service upon thirty days' notice to us. The TSA contains provisions under which we will, subject to certain limitations, be obligated to indemnify QCP for losses incurred by QCP resulting from our breach of the TSA.

See Notes 1 and 5 to the Consolidated Financial Statements for further information on the Spin-Off.

 

39


 

Table of Contents

 

Investment Transactions

In January 2016, we acquired a portfolio of five private pay senior housing communities with 364 units and a skilled nursing facility with 120 beds for $95 million. All of the communities were developed within the past two years and are triple-net leased to four regional operators.

In July 2016, we acquired two Class A life science buildings totaling 136,000 square feet and a four-acre parcel of land in San Diego, California for $49 million.

In September 2016, we acquired a portfolio of seven private pay senior housing communities for $186 million, including the assumption of $74 million of debt, at a 4.0% interest rate, maturing in 2044. Consisting of 526 assisted living and memory care units, the portfolio is managed by Senior Lifestyle Corporation in a 100% owned RIDEA structure.

In November 2016, we entered into agreements with Maria Mallaband Care Group (“Maria Mallaband”) to acquire a portfolio of predominantly private pay prime care homes located in London/South-East England for $131 million (£105 million). In mid-2017, through the exercise of a call option, subject to certain contingencies, we intend to convert our bridge loan provided to Maria Mallaband in November into fee ownership and enter into a Master Lease with Maria Mallaband.

In December 2016, we acquired a portfolio of 10 MOBs, including nine on-campus MOBs, located throughout the U.S. in a sale-leaseback transaction with Community Health Systems for $163 million. The MOBs have an initial lease term of 15 years.

 

Developments

Through February 13, 2017, we have leased 73% of The Cove Phase I, which consists of two Class A buildings totaling 247,000 square feet and was delivered in the third quarter of 2016. In response to Phase I leasing success and continued strong demand from life science users in South San Francisco, in February 2016, we commenced a $220 million development, The Cove Phase II, which adds two Class A buildings totaling 230,000 square feet and is expected to be delivered by the third quarter of 2017. Through February 13, 2017, we have leased 100% of The Cove Phase II. In response to The Cove Phase I and Phase II leasing success, in October 2016, we commenced the $211 million development of The Cove Phase III, which adds two Class A buildings representing up to 336,000 square feet.

In June 2016, we commenced a $62 million multi-building development project encompassing 301,000 square feet at our Ridgeview Business Park in Poway, California, which is 50% leased. The project includes a $32 million build-to-suit project with an existing tenant for 152,000 square feet and is expected to be completed in 2018 as part of a larger leasing transaction.

 

Disposition Transactions

In January 2017, we sold four life science facilities in Salt Lake City, Utah for $76 million.

In May 2016, we entered into a master contribution agreement with Brookdale to contribute our ownership interest in RIDEA II to an unconsolidated JV owned by HCP and an investor group led by Columbia Pacific Advisors, LLC (“CPA”) (the “HCP/CPA JV”). The members agreed to recapitalize RIDEA II with $602 million of debt, of which $360 million was provided by a third-party and $242 million was provided by HCP. In return, we received $480 million in cash proceeds from the HCP/CPA JV and $242 million in note receivables and retained an approximate 40% beneficial interest in RIDEA II (the note receivable and 40% beneficial interest are herein referred to as the “RIDEA II Investments”). This transaction resulted in HCP deconsolidating the net assets of RIDEA II because it will no longer direct the activities that most significantly impact the venture. The closing of these transactions occurred in January 2017.

In October 2016, we entered into definitive agreements to sell 64 SH NNN assets, currently under triple-net leases with Brookdale, for $1.125 billion to affiliates of Blackstone Real Estate Partners VIII, L.P. The closing of this transaction is expected to occur during 2017 and remains subject to regulatory and third party approvals and other customary closing conditions. Additionally, in October 2016, we entered into definitive agreements for a multi-element transaction with

40


 

Table of Contents

Brookdale to: (i) sell or transition 25 assets currently triple-net leased to Brookdale, for which Brookdale will receive a $10.5 million annual rent reduction upon lease termination, (ii) re-allocate annual rent of $9.6 million from those 25 assets to the remaining Brookdale triple-net lease portfolio (occurred on November 1, 2016) and (iii) transition eight triple-net leased assets into RIDEA structures (seven of which closed in December 2016 and one of which closed in January 2017). The closing of the sale or transition of the 25 assets and corresponding rent reduction is expected to occur throughout 2017 and remain subject to regulatory and third party approvals and other customary closing conditions.

During the year ended December 31, 2016, we sold: (i) a portfolio of five post-acute/skilled nursing and two SH NNN facilities for $130 million, (ii) five life science facilities for $386 million, (iii) seven SH NNN facilities for $88 million, (iv) three MOBs for $20 million and (v) three SHOP facilities for $41 million and recognized total gain on sales of $165 million.

In January 2016, we entered into a definitive agreement for purchase options that were exercised on eight life science facilities in South San Francisco, California, to be sold in two tranches for $311 million (sold in November 2016 and discussed above) and $269 million, respectively. The second tranche is expected to close in the third quarter of 2018.

In June 2016 and September 2016, we received $51 million and $19 million, respectively, from the monetization of three senior housing development loans, recognizing $15 million and $4 million of incremental interest income, respectively, which represents our participation in the appreciation of the underlying real estate assets.

 

Financing Activities

In January 2017, we paid down $440 million on our revolving line of credit facility, primarily using proceeds from our RIDEA II joint venture disposition.

During 2016, we repaid $2.0 billion of senior unsecured notes, $1.1 billion of which was prepaid using proceeds from the Spin-Off. In addition, we settled $388 million of mortgage debt, $108 million of which was prepaid using proceeds from the Spin-Off. As a result of the prepayment of debt using proceeds from the Spin-Off, we incurred aggregate loss on debt extinguishments of $46 million, primarily related to prepayment penalties.

In July 2016, we exercised a one-year extension option on our £137 million ($169 million at December 31, 2016), four-year unsecured term loan that was entered into on July 30, 2012 (the “2012 Term Loan”). Based on our credit ratings at December 31, 2016, the 2012 Term Loan accrues interest at a rate of GBP LIBOR plus 1.40%.

Dividends

Quarterly cash dividends paid during 2016 aggregated to $2.095 per share. On February 2, 2017, our Board of Directors declared a quarterly cash dividend of $0.37 per common share. The dividend will be paid on March 2, 2017 to stockholders of record as of the close of business on February 15, 2017.

Results of Operations

We evaluate our business and allocate resources among our reportable business segments: (i) senior housing triple-net (SH NNN), (ii) senior housing operating portfolio (SHOP), (iii) life science and (iv) medical office. Under the medical office segment, we invest through the acquisition and development of MOBs, which generally require a greater level of property management. Otherwise, we primarily invest, through the acquisition and development of real estate, in single tenant and operator properties. We have other non-reportable segments that are comprised primarily of our U.K. care homes, debt investments and hospitals. We evaluate performance based upon: (i) property net operating income from continuing operations (“NOI”) and (ii) adjusted NOI (cash NOI) of the combined consolidated and unconsolidated investments in each segment. The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the Consolidated Financial Statements).

41


 

Table of Contents

Non-GAAP Financial Measures

Net Operating Income

NOI and adjusted NOI are non-U.S. generally accepted accounting principles (“GAAP”) supplemental financial measures used to evaluate the operating performance of real estate. We include properties from our consolidated portfolio, as well as our pro-rata share of properties owned by our unconsolidated joint ventures in our NOI and adjusted NOI. We believe providing this information assists investors and analysts in estimating the economic interest in our total portfolio of real estate. Our pro-rata share information is prepared on a basis consistent with the comparable consolidated amounts, is intended to reflect our proportionate economic interest in the operating results of properties in our portfolio and is calculated by applying our actual ownership percentage for the period. We do not control the unconsolidated joint ventures, and the pro-rata presentations of revenues and expenses included in NOI (see below) do not represent our legal claim to such items. The joint venture members or partners are entitled to profit or loss allocations and distributions of cash flows according to the joint venture agreements, which provide for such allocations generally according to their invested capital.

The presentation of pro-rata information has limitations, which include, but are not limited to, the following (i) the amounts shown on the individual line items were derived by applying our overall economic ownership interest percentage determined when applying the equity method of accounting and do not necessarily represent our legal claim to the assets and liabilities, or the revenues and expenses and (ii) other companies in our industry may calculate their pro-rata interest differently, limiting the usefulness as a comparative measure. Because of these limitations, the pro-rata financial information should not be considered independently or as a substitute for our financial statements as reported under GAAP. We compensate for these limitations by relying primarily on our GAAP financial statements, using the pro-rata financial information as a supplement.

NOI is defined as rental and related revenues, including tenant recoveries, resident fees and services, and income from DFLs, less property level operating expenses; NOI excludes all other financial statement amounts included in net income (loss) as presented in Note 14 to the Consolidated Financial Statements. Management believes NOI provides relevant and useful information because it reflects only income and operating expense items that are incurred at the property level and presents them on an unleveraged basis. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles, non-refundable entrance fees and lease termination fees (“non-cash adjustments”). Adjusted NOI is oftentimes referred to as “cash NOI.” We use NOI and adjusted NOI to make decisions about resource allocations, to assess and compare property level performance, and to evaluate our same property portfolio (“SPP”), as described below. We believe that net income (loss) is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, our definition of NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating NOI. For a reconciliation of NOI and Adjusted NOI to net income (loss) by segment, refer to Note 14 to the Consolidated Financial Statements.

Operating expenses generally relate to leased medical office and life science properties and senior housing RIDEA properties. We generally recover all or a portion of our leased medical office and life science property expenses through tenant recoveries. We present expenses as operating or general and administrative based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expenses.

Same Property Portfolio

SPP NOI and adjusted NOI information allows us to evaluate the performance of our property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties. We include properties from our consolidated portfolio, as well as properties owned by our unconsolidated joint ventures in our SPP NOI and adjusted NOI (see NOI above for further discussion regarding our use of pro-rata share information and its limitations). We identify our SPP as stabilized properties that remained in operations and were consistently reported as leased properties or RIDEA properties for the duration of the year-over-year comparison periods presented, excluding assets held for sale. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in our SPP. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) control(s) the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly

42


 

Table of Contents

completed developments and redevelopments are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. SPP NOI excludes (i) certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis and (ii) entrance fees and related activity such as deferred expenses, reserves and management fees related to entrance fees. A property is removed from our SPP when it is sold, placed into redevelopment or changes its reporting structure. For a reconciliation of SPP to total portfolio adjusted NOI and other relevant disclosures by segment, refer to our Segment Analysis below.

Funds From Operations

We believe FFO applicable to common shares, diluted FFO applicable to common shares, and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.

FFO, as defined by the National Association of Real Estate Investment Trusts (“NAREIT”), is net income (loss) applicable to common shares (computed in accordance with GAAP), excluding gains or losses from sales of depreciable property, including any current and deferred taxes directly associated with sales of depreciable property, impairments of, or related to, depreciable real estate, plus real estate and other depreciation and amortization, and adjustments to compute our share of FFO and FFO as adjusted (see below) from joint ventures. Adjustments for joint ventures are calculated to reflect our pro-rata share of both our consolidated and unconsolidated joint ventures. We reflect our share of FFO for unconsolidated joint ventures by applying our actual ownership percentage for the period to the applicable reconciling items on an entity by entity basis. We reflect our share for consolidated joint ventures in which we do not own 100% of the equity by adjusting our FFO to remove the third party ownership share of the applicable reconciling items based on actual ownership percentage for the applicable periods. Our pro-rata share information is prepared on a basis consistent with the comparable consolidated amounts, is intended to reflect our proportionate economic interest in the operating results of properties in our portfolio and is calculated by applying our actual ownership percentage for the period. We do not control the unconsolidated joint ventures, and the pro-rata presentations of reconciling items included in FFO (see above) do not represent our legal claim to such items. The joint venture members or partners are entitled to profit or loss allocations and distributions of cash flows according to the joint venture agreements, which provide for such allocations generally according to their invested capital.

The presentation of pro-rata information has limitations which include, but are not limited to, the following: (i) the amounts shown on the individual line items were derived by applying our overall economic ownership interest percentage determined when applying the equity method of accounting or allocating noncontrolling interests, and do not necessarily represent our legal claim to the assets and liabilities, or the revenues and expenses; and (ii) other companies in our industry may calculate their pro-rata interest differently, limiting the usefulness as a comparative measure. Because of these limitations, the pro-rata financial information should not be considered independently or as a substitute for our financial statements as reported under GAAP. We compensate for these limitations by relying primarily on our GAAP financial statements, using the pro-rata financial information as a supplement. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income (loss). We compute FFO in accordance with the current NAREIT definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from ours.

In addition, we present FFO before the impact of non-comparable items including, but not limited to, severance-related charges, litigation provisions, preferred stock redemption charges, impairments (recoveries) of non-depreciable assets, prepayment costs (benefits) associated with early retirement or payment of debt, foreign currency remeasurement losses (gains) and transaction-related items (“FFO as adjusted”). Prepayment costs (benefits) associated with early retirement of debt include the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of debt. Transaction-related items include acquisition and pursuit costs (e.g., due diligence and closing) and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities. Management believes that FFO as adjusted provides a meaningful supplemental measurement of our FFO run-rate and is frequently used by analysts, investors and other

43


 

Table of Contents

interested parties in the evaluation of our performance as a REIT. At the same time that NAREIT created and defined its FFO measure for the REIT industry, it also recognized that “management of each of its member companies has the responsibility and authority to publish financial information that it regards as useful to the financial community.” We believe stockholders, potential investors and financial analysts who review our operating performance are best served by an FFO run-rate earnings measure that includes, in addition to adjustments made to arrive at the NAREIT defined measure of FFO, other adjustments to net income (loss). FFO as adjusted is used by management in analyzing our business and the performance of our properties, and we believe it is important that stockholders, potential investors and financial analysts understand this measure used by management. We use FFO as adjusted to: (i) evaluate our performance in comparison with expected results and results of previous periods, relative to resource allocation decisions, (ii) evaluate the performance of our management, (iii) budget and forecast future results to assist in the allocation of resources, (iv) assess our performance as compared with similar real estate companies and the industry in general and (v) evaluate how a specific potential investment will impact our future results. Other REITs or real estate companies may use different methodologies for calculating an adjusted FFO measure, and accordingly, our FFO as adjusted may not be comparable to those reported by other REITs. For a reconciliation of net income (loss) to FFO and FFO as adjusted and other relevant disclosure, refer to “Non-GAAP Financial Measure Reconciliations” below.

Funds Available for Distribution

FAD is defined as FFO as adjusted after excluding the impact of the following: (i) amortization of acquired market lease intangibles, net, (ii) amortization of deferred compensation expense, (iii) amortization of deferred financing costs, net, (iv) straight-line rents, (v) non-cash interest and depreciation related to DFLs and lease incentive amortization (reduction of straight-line rents) and (vi) deferred revenues, excluding amounts amortized into rental income that are associated with tenant funded improvements owned/recognized by us and up-front cash payments made by tenants to reduce their contractual rents. Also, FAD: (i) is computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements, and (ii) includes lease restructure payments and adjustments to compute our share of FAD from our unconsolidated joint ventures and those related to CCRC non-refundable entrance fees. Adjustments for joint ventures are calculated to reflect our pro-rata share of both our consolidated and unconsolidated joint ventures. We reflect our share of FAD for unconsolidated joint ventures by applying our actual ownership percentage for the period to the applicable reconciling items on an entity by entity basis. We reflect our share for consolidated joint ventures in which we do not own 100% of the equity by adjusting our FAD to remove the third party ownership share of the applicable reconciling items based on actual ownership percentage for the applicable periods (see FFO above for further disclosure regarding our use of pro-rata share information and its limitations). Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, our FAD may not be comparable to those reported by other REITs. Although our FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of our performance and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. We believe FAD is an alternative run-rate earnings measure that improves the understanding of our operating results among investors and makes comparisons with: (i) expected results, (ii) results of previous periods and (iii) results among REITs, more meaningful. FAD does not represent cash generated from operating activities determined in accordance with GAAP and is not necessarily indicative of cash available to fund cash needs as it excludes the following items which generally flow through our cash flows from operating activities: (i) adjustments for changes in working capital or the actual timing of the payment of income or expense items that are accrued in the period, (ii) transaction-related costs, (iii) litigation provision, (iv) severance-related expenses and (v) actual cash receipts from interest income recognized on loans receivable (in contrast to our FAD adjustment to exclude non-cash interest and depreciation related to our investments in direct financing leases). Furthermore, FAD is adjusted for recurring capital expenditures, which are generally not considered when determining cash flows from operations or liquidity. FAD is a non-GAAP supplemental financial measure and should not be considered as an alternative to net income (loss) determined in accordance with GAAP. For a reconciliation of net income (loss) to FAD and other relevant disclosure, refer to “Non-GAAP Financial Measure Reconciliations” below.

44


 

Table of Contents

Comparison of the Year Ended December 31, 2016 to the Year Ended December 31, 2015 and the Year Ended December 31, 2015 to the Year Ended December 31, 2014

 

Overview(1)

2016 and 2015

 

Results for the years ended December 31, 2016 and 2015 (dollars in thousands except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

Year Ended

 

Per

 

 

 

December 31, 2016

 

December 31, 2015

 

Share

 

 

    

Amount

 

Per Diluted Share

 

Amount

 

Per Diluted Share

 

Change

 

Net income (loss) applicable to common shares

 

$

626,549

 

$

1.34

 

$

(560,552)

 

$

(1.21)

 

$

2.55

 

FFO applicable to common shares

 

 

1,119,153

 

 

2.39

 

 

(10,841)

 

 

(0.02)

 

 

2.41

 

FFO as adjusted applicable to common shares

 

 

1,282,390

 

 

2.74

 

 

1,470,167

 

 

3.16

 

 

(0.42)

 

FAD applicable to common shares

 

 

1,215,696

 

 

 

 

 

1,261,849

 

 

 

 

 

 

 


(1)

For the reconciliation of non-GAAP financial measures, see “Non-GAAP Financial Measure Reconciliations” section below.

Earnings per share (“EPS”) increased primarily as a result of the following:

·

impairment charges during 2015 not repeated in 2016;

·

increased NOI from: (i) our 2015 and 2016 acquisitions, (ii) annual rent escalations and (iii) developments placed in service;

·

increased gains on sales of real estate due to a higher volume of disposition activity during 2016;

·

a reduction in interest expense as a result of debt repayments during 2015 and 2016; and

·

a net termination fee expense recognized in 2015 not repeated in 2016.

The increase in EPS was partially offset by the following:

·

a reduction in income from our HCRMC investments as a result of: (i) the HCRMC lease amendment effective April 1, 2015, (ii) the sale of non-strategic assets during the second half of 2015 and 2016, and (iii) a change in income recognition to a cash basis method beginning in January 2016;

·

the impact from the Spin-Off of QCP resulting in: (i) increased transaction costs and (ii) loss on debt extinguishment, representing penalties on the prepayment of debt using proceeds from the Spin-Off;

·

increased income tax expense related to our estimated exposure to state built-in gain tax;

·

a reduction in interest income from placing our Four Seasons senior notes (“Four Seasons Notes”) on cost recovery status in the third quarter of 2015 and loan repayments during 2015 and 2016;

·

increased severance-related charges during 2016 primarily related to the departure of our former President and Chief Executive Officer (“CEO”) in July 2016;

·

increased depreciation and amortization from our 2015 and 2016 acquisitions; and

·

a reduction of foreign currency remeasurement gains recognized as a result of effective hedges designated in September 2015.

FFO increased primarily as a result of the aforementioned events impacting EPS, excluding depreciation and amortization and gains on sales of real estate, both of which are adjustments to our calculation of FFO.

45


 

Table of Contents

FFO as adjusted decreased primarily as a result of the following:

·

a reduction in income from our HCRMC investments as a result of: (i) the HCRMC lease amendment effective April 1, 2015, (ii) the sale of non-strategic assets during the second half of 2015 and 2016 and (iii) a change in income recognition to a cash basis method beginning in January 2016; 

·

decreased income from the QCP assets included in the Spin-Off; and

·

a reduction in interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and loan repayments during 2015 and 2016.

The decrease in FFO as adjusted was partially offset by the following:

·

increased NOI from: (i) our 2015 and 2016 consolidated acquisitions, (ii) annual rent escalations and (iii) developments placed in service; and

·

a reduction in interest expense as a result of debt repayments during 2015 and 2016.

FAD increased primarily as a result of the following:

 

·

increased NOI from: (i) our 2015 and 2016 consolidated acquisitions, (ii) annual rent escalations and (iii) developments placed in service; and

·

increased incremental interest income from the payoff of participating development loans.

The increase in FAD was partially offset by the following:

 

·

decreased income from our HCRMC investments as a result of the HCRMC lease amendment effective April 1, 2015 and the sale of non-strategic assets during the second half of 2015 and the first half of 2016;

·

decreased income from the QCP assets included in the Spin-Off;

·

decreased interest income from placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and loan repayments during 2015 and 2016; and

·

increased leasing costs and second generation capital expenditures.

 

2015 and 2014

 

Results for the years ended December 31, 2015 and 2014 (dollars in thousands except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

Year Ended

 

Per

 

 

 

December 31, 2015

 

December 31, 2014

 

Share

 

 

 

Amount

 

Per Diluted Share

 

Amount

 

Per Diluted Share

 

Change

 

Net (loss) income applicable to common shares

 

$

(560,552)

 

$

(1.21)

 

$

919,796

 

$

2.00

 

$

(3.21)

 

FFO applicable to common shares

 

 

(10,841)

 

 

(0.02)

 

 

1,381,634

 

 

3.00

 

 

(3.02)

 

FFO as adjusted applicable to common shares

 

 

1,470,167

 

 

3.16

 

 

1,398,691

 

 

3.04

 

 

0.12

 

FAD applicable to common shares

 

 

1,261,849

 

 

 

 

 

1,178,822

 

 

 

 

 

 

 

 

EPS and FFO decreased primarily as a result of the following:

·

impairments related to our: (i) HCRMC DFL investments, (ii) investment in Four Seasons Notes and (iii) equity investment in HCRMC;

·

net fees recognized in 2014 for terminating the leases on 49 senior housing properties in a transaction with Brookdale not repeated in 2015;

·

increased transaction-related items as a result of higher levels of transactional activity in 2015; and

46


 

Table of Contents

·

a severance-related charge related to the departure of our former Executive Vice President and Chief Investment Officer in June 2015.

The decreases were partially offset by following:

·

increased NOI from our 2014 and 2015 acquisitions;

·

incremental interest income from the repayments of three development loans resulting from our share in the appreciation of the underlying real estate assets;

·

impairment recovery from a repayment of a loan receivable; and

·

increased foreign currency remeasurement gains.

Additionally, EPS decreased as a result of: (i) decreased gain on sales of real estate and (ii) increased depreciation expense, partially offset by increased equity income from unconsolidated joint venture as a result of gain on sales of real estate from HCP Ventures III, LLC and HCP Ventures IV, LLC.

FFO as adjusted and FAD increased primarily as a result of increased NOI from: (i) our 2014 and 2015 acquisitions and (ii) incremental interest income from the repayments of three development loans resulting from our share in the appreciation of the underlying real estate assets. The increases were partially offset by: (i) the decrease in income from DFLs as a result of the HCRMC Lease Amendment and (ii) placing our Four Seasons Notes on cost recovery status in the third quarter of 2015.

Segment Analysis

The tables below provide selected operating information for our SPP and total property portfolio for each of our business segments. For the year ended December 31, 2016, our consolidated SPP consists of 644 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2015 and that remained in operations under a consistent reporting structure. For the year ended December 31, 2015, our consolidated SPP consisted of 653 properties acquired or placed in service and stabilized on or prior to January 1, 2014 and that remained in operations under a consistent reporting structure. Our total property portfolio consists of 802,  1,205 and 1,196 properties at December 31, 2016, 2015 and 2014, respectively, and excludes properties classified as held for sale and discontinued operations.

 

Senior Housing Triple-Net

2016 and 2015

 

Results as of and for the years ended December 31, 2016 and 2015 (dollars in thousands except per unit data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPP

 

Total Portfolio

 

 

 

2016

 

2015

 

Change

 

2016

 

2015

 

Change

 

Rental revenues(1)

    

$

302,976

    

$

304,442

    

$

(1,466)

    

$

423,118

    

$

428,269

    

$

(5,151)

 

Operating expenses

 

 

(237)

 

 

(637)

 

 

400

 

 

(6,710)

 

 

(3,427)

 

 

(3,283)

 

NOI

 

 

302,739

 

 

303,805

 

 

(1,066)

 

 

416,408

 

 

424,842

 

 

(8,434)

 

Non-cash adjustments to NOI

 

 

(5,282)

 

 

(7,550)

 

 

2,268

 

 

(7,566)

 

 

(9,716)

 

 

2,150

 

Adjusted NOI

 

$

297,457

 

$

296,255

 

$

1,202

 

 

408,842

 

 

415,126

 

 

(6,284)

 

Non-SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

 

(111,385)

 

 

(118,871)

 

 

7,486

 

SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

$

297,457

 

$

296,255

 

$

1,202

 

Adjusted NOI % change

 

 

 

 

 

 

 

 

0.4

%

 

 

 

 

 

 

 

 

 

Property count(2)

 

 

205

 

 

205

 

 

 

 

 

210

 

 

295

 

 

 

 

Average capacity (units)(3)

 

 

20,269

 

 

20,268

 

 

 

 

 

28,455

 

 

28,777

 

 

 

 

Average annual rent per unit

 

$

14,684

 

$

14,645

 

 

 

 

$

14,604

 

$

14,544

 

 

 

 


(1)

Represents rental and related revenues and income from DFLs.

(2)

From our 2015 presentation of SPP, we removed nine SH NNN properties from SPP that were sold, 17 SH NNN properties that were transitioned

47


 

Table of Contents

to a RIDEA structure in our SHOP segment and 64 SH NNN properties that were classified as held for sale.

(3)

Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.

SPP.  SPP NOI decreased primarily as a result of lower rents in our portfolio of assets leased to Sunrise Senior Living (the “Sunrise Portfolio”). SPP adjusted NOI increased primarily as a result of annual rent escalations, partially offset by lower cash rent received from our Sunrise portfolio.

Non-SPP.  Non-SPP NOI and adjusted NOI decreased primarily as a result of: (i) nine SH NNN facilities sold in 2016 and (ii) the transition of 17 SH NNN facilities to a RIDEA structure (reported in our SHOP segment), partially offset by five SH NNN facilities acquired in the first quarter of 2016.

Total Portfolio.  NOI and adjusted NOI decreased based on the combined decrease to non-SPP, partially offset by the increase to SPP adjusted NOI discussed above.  

2015 and 2014

 

Results as of and for the years ended December 31, 2015 and 2014 (dollars in thousands except per unit data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPP

 

Total Portfolio

 

 

 

2015

 

2014

 

Change

 

2015

 

2014

 

Change

 

Rental revenues(1)

    

$

423,719

    

$

426,045

    

$

(2,326)

    

$

428,269

    

$

538,113

    

$

(109,844)

 

Operating expenses

 

 

(1,500)

 

 

(1,586)

 

 

86

 

 

(3,427)

 

 

(3,629)

 

 

202

 

NOI

 

 

422,219

 

 

424,459

 

 

(2,240)

 

 

424,842

 

 

534,484

 

 

(109,642)

 

Non-cash adjustments to NOI

 

 

(10,773)

 

 

(24,169)

 

 

13,396

 

 

(9,716)

 

 

(66,474)

 

 

56,758

 

Adjusted NOI

 

$

411,446

 

$

400,290

 

$

11,156

 

 

415,126

 

 

468,010

 

 

(52,884)

 

Non-SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

 

(3,680)

 

 

(67,720)

 

 

64,040

 

SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

$

411,446

 

$

400,290

 

$

11,156

 

Adjusted NOI % change

 

 

 

 

 

 

 

 

2.8

%

 

 

 

 

 

 

 

 

 

Property count(2)

 

 

293

 

 

293

 

 

 

 

 

295

 

 

296

 

 

 

 

Average capacity (units)(3)

 

 

28,556

 

 

28,626

 

 

 

 

 

28,777

 

 

33,917

 

 

 

 

Average annual rent per unit

 

$

10,207

 

$

9,955

 

 

 

 

$

14,544

 

$

13,907

 

 

 

 


(1)

Represents rental and related revenues and income from DFLs.

(2)

From our 2014 presentation of SPP, we removed 12 senior housing properties that were sold.

(3)

Represents average capacity as reported by the respective tenants or operators for the 12-month period and a quarter in arrears from the periods presented.

 

SPP.    SPP NOI decreased primarily as a result of lower rents in our Sunrise Portfolio. SPP adjusted NOI increased primarily as a result of annual rent escalations.

Non-SPP.  Non-SPP NOI and adjusted NOI decreased primarily as a result of $38 million of net revenues recognized from a 2014 transaction with Brookdale and the transition of RIDEA II properties from SH NNN to SHOP.

Total Portfolio.  NOI and adjusted NOI decreased based on the combined decrease to non-SPP, partially offset by the increase to SPP adjusted NOI discussed above.

48


 

Table of Contents

 

Senior Housing Operating Portfolio

2016 and 2015

 

Results as of and for the years ended December 31, 2016 and 2015 (dollars in thousands, except per unit data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPP

 

Total Portfolio

 

 

 

2016

 

2015

 

Change

 

2016

 

2015

 

Change

 

Resident fees and services

    

$

439,607

    

$

419,217

    

$

20,390

    

$

686,822

    

$

518,264

    

$

168,558

 

HCP share of unconsolidated JV revenues

 

 

174,366

 

 

167,593

 

 

6,773

 

 

204,591

 

 

181,410

 

 

23,181

 

Operating expenses

 

 

(311,278)

 

 

(298,648)

 

 

(12,630)

 

 

(480,870)

 

 

(371,016)

 

 

(109,854)

 

HCP share of unconsolidated JV share of operating expenses

 

 

(150,544)

 

 

(145,448)

 

 

(5,096)

 

 

(166,791)

 

 

(151,962)

 

 

(14,829)

 

NOI

 

 

152,151

 

 

142,714

 

 

9,437

 

 

243,752

 

 

176,696

 

 

67,056

 

Non-cash adjustments to NOI

 

 

 —

 

 

 —

 

 

 —

 

 

20,076

 

 

34,045

 

 

(13,969)

 

Adjusted NOI

 

$

152,151

 

$

142,714

 

$

9,437

 

 

263,828

 

 

210,741

 

 

53,087

 

Non-SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

 

(111,677)

 

 

(68,027)

 

 

(43,650)

 

SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

$

152,151

 

$

142,714

 

$

9,437

 

Adjusted NOI % change

 

 

 

 

 

 

 

 

6.6

%

 

 

 

 

 

 

 

 

 

Property count(1)

 

 

83

 

 

83

 

 

 

 

 

152

 

 

130

 

 

 

 

Average capacity (units)

 

 

16,915

 

 

16,824

 

 

 

 

 

24,728

 

 

20,354

 

 

 

 

Average annual rent per unit

 

$

11,489

 

$

11,010

 

 

 

 

$

11,111

 

$

10,558

 

 

 

 


(1)

From our 2015 presentation of SPP, we removed two SHOP properties from SPP that were sold and a SHOP property that was classified as held for sale.

SPP.  SPP NOI and adjusted NOI increased primarily as a result of increased occupancy and rates for resident fees and services.

Non-SPP.  Non-SPP NOI and adjusted NOI increased as a result of 2015 acquisitions, primarily our RIDEA III acquisition. The increase to non-SPP NOI was partially offset by an $8 million net termination fee related to our RIDEA III acquisition, which was not repeated in 2016.  

Total Portfolio.  NOI and adjusted NOI increased based on the combined increases to SPP and non-SPP discussed above.

49


 

Table of Contents

2015 and 2014

 

Results as of and for the years ended December 31, 2015 and 2014 (dollars in thousands, except per unit data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPP

 

Total Portfolio

 

 

 

2015

 

2014

 

Change

 

2015

 

2014

 

Change

 

Rental revenues

 

$

160,053

 

$

152,841

 

$

7,212

 

$

518,264

 

$

243,612

 

$

274,652

 

HCP share of unconsolidated JV revenues

 

 

 —

 

 

 —

 

 

 —

 

 

181,410

 

 

57,740

 

 

123,670

 

Operating expenses

 

 

(99,815)

 

 

(96,450)

 

 

(3,365)

 

 

(371,016)

 

 

(163,650)

 

 

(207,366)

 

HCP share of unconsolidated JV share of operating expenses

 

 

 —

 

 

 —

 

 

 —

 

 

(151,962)

 

 

(49,571)

 

 

(102,391)

 

NOI

 

 

60,238

 

 

56,391

 

 

3,847

 

 

176,696

 

 

88,131

 

 

88,565

 

Non-cash adjustments to NOI

 

 

 —

 

 

 —

 

 

 —

 

 

34,045

 

 

10,160

 

 

23,885

 

Adjusted NOI

 

$

60,238

 

$

56,391

 

$

3,847

 

 

210,741

 

 

98,291

 

 

112,450

 

Non-SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

 

(150,503)

 

 

(41,900)

 

 

(108,603)

 

SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

$

60,238

 

$

56,391

 

$

3,847

 

Adjusted NOI % change

 

 

 

 

 

 

 

 

6.8

%

 

 

 

 

 

 

 

 

 

Property count(1)

 

 

20

 

 

20

 

 

 

 

 

130

 

 

85

 

 

 

 

Average capacity (units)

 

 

4,612

 

 

4,613

 

 

 

 

 

16,724

 

 

12,177

 

 

 

 

Average annual rent per unit

 

$

8,676

 

$

8,283

 

 

 

 

$

13,227

 

$

6,848

 

 

 

 

SPP.  SPP NOI and adjusted NOI increased primarily as a result of increased occupancy and rates for resident fees and services.

Non-SPP.  Non-SPP NOI and adjusted NOI increased as a result of: (i) acquisitions, primarily the CCRC JV in 2014 and RIDEA III in 2015, (ii) the transition of RIDEA II properties from SH NNN to SHOP and (iii) an $8 million net termination fee related to our RIDEA III acquisition in 2015.  

Total Portfolio.  NOI and adjusted NOI increased based on the combined increases to SPP and non-SPP discussed above.

50


 

Table of Contents

 

Life Science

2016 and 2015

 

Results as of and for the years ended December 31, 2016 and 2015 (dollars and sq. ft. in thousands, except per sq. ft. data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPP

 

Total Portfolio

 

 

 

2016

 

2015

 

Change

 

2016

 

2015

 

Change

 

Rental revenues(1)

    

$

306,317

    

$

295,515

    

$

10,802

    

$

358,537

    

$

342,984

    

$

15,553

 

HCP share of unconsolidated JV revenues

 

 

7,485

 

 

7,030

 

 

455

 

 

7,599

 

 

7,106

 

 

493

 

Operating expenses

 

 

(58,812)

 

 

(58,779)

 

 

(33)

 

 

(72,478)

 

 

(70,217)

 

 

(2,261)

 

HCP share of unconsolidated JV share of operating expenses

 

 

(1,601)

 

 

(1,612)

 

 

11

 

 

(1,601)

 

 

(1,612)

 

 

11

 

NOI

 

 

253,389

 

 

242,154

 

 

11,235

 

 

292,057

 

 

278,261

 

 

13,796

 

Non-cash adjustments to NOI

 

 

505

 

 

(6,630)

 

 

7,135

 

 

(3,003)

 

 

(10,392)

 

 

7,389

 

Adjusted NOI

 

$

253,894

 

$

235,524

 

$

18,370

 

 

289,054

 

 

267,869

 

 

21,185

 

Non-SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

 

(35,160)

 

 

(32,345)

 

 

(2,815)

 

SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

$

253,894

 

$

235,524

 

$

18,370

 

Adjusted NOI % change

 

 

 

 

 

 

 

 

7.8

%

 

 

 

 

 

 

 

 

 

Property count(2)

 

 

111

 

 

111

 

 

 

 

 

120

 

 

122

 

 

 

 

Average occupancy

 

 

97.6

%

 

96.5

%

 

 

 

 

97.4

%

 

96.8

%

 

 

 

Average occupied sq. ft.

 

 

6,639

 

 

6,559

 

 

 

 

 

7,594

 

 

7,423

 

 

 

 

Average annual total revenues per occupied sq. ft.

 

$

47

 

$

45

 

 

 

 

$

48

 

$

46

 

 

 

 

Average annual rental revenues per occupied sq. ft.

 

$

39

 

$

38

 

 

 

 

$

40

 

$

38

 

 

 

 


(1)

Represents rental and related revenues and tenant recoveries.

(2)

From our 2015 presentation of SPP, we removed five life science facilities that were sold and four life science facilities that were classified as held for sale.

SPP.  SPP NOI and adjusted NOI increased primarily as a result of mark-to-market lease renewals, new leasing activity and increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations and a decline in rent abatements.

Non-SPP.  Non-SPP NOI and adjusted NOI increased primarily as a result of life science acquisitions in 2015 and 2016 and increased occupancy in a development placed in operation in 2016, partially offset by five life science facilities sold in 2016.

Total Portfolio.  NOI and adjusted NOI increased based on the combined increases to SPP and non-SPP discussed above.

During the year ended December 31, 2016, 1.4 million square feet of new and renewal leases commenced at an average annual base rent of $32.70 per square foot, including 114,000 square feet related to a development placed in service at an average annual base rent of $55.80 per square foot, compared to 1.3 million square feet of expired and terminated leases with an average annual base rent of $26.25 per square foot. During the year ended December 31, 2016, we classified 324,000 square feet as real estate and related assets held for sale, net with an average annual base rent of $18.81 per square foot, acquired properties with 61,000 occupied square feet with an average annual base rent of $47.79 per square foot and disposed of 535,000 square feet with an average annual base rent of $53.46 per square foot.

 

51


 

Table of Contents

2015 and 2014

 

Results as of and for the years ended December 31, 2015 and 2014 (dollars and sq. ft. in thousands, except per sq. ft. data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPP

 

Total Portfolio

 

 

 

2015

 

2014

 

Change

 

2015

 

2014

 

Change

 

Rental revenues(1)

    

$

317,937

    

$

298,720

    

$

19,217

    

$

342,984

    

$

314,114

    

$

28,870

 

HCP share of unconsolidated JV revenues

 

 

7,030

 

 

6,888

 

 

142

 

 

7,106

 

 

6,888

 

 

218

 

Operating expenses

 

 

(59,053)

 

 

(54,554)

 

 

(4,499)

 

 

(70,217)

 

 

(63,080)

 

 

(7,137)

 

HCP share of unconsolidated JV share of operating expenses

 

 

(1,612)

 

 

(1,749)

 

 

137

 

 

(1,612)

 

 

(1,749)

 

 

137

 

NOI

 

 

264,302

 

 

249,305

 

 

14,997

 

 

278,261

 

 

256,173

 

 

22,088

 

Non-cash adjustments to NOI

 

 

(8,892)

 

 

(9,423)

 

 

531

 

 

(10,392)

 

 

(10,375)

 

 

(17)

 

Adjusted NOI

 

$

255,410

 

$

239,882

 

$

15,528

 

 

267,869

 

 

245,798

 

 

22,071

 

Non-SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

 

(12,459)

 

 

(5,916)

 

 

(6,543)

 

SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

$

255,410

 

$

239,882

 

$

15,528

 

Adjusted NOI % change

 

 

 

 

 

 

 

 

6.5

%

 

 

 

 

 

 

 

 

 

Property count(2)

 

 

111

 

 

111

 

 

 

 

 

122

 

 

115

 

 

 

 

Average occupancy

 

 

96.9

%

 

92.3

 

 

 

 

96.8

%

 

92.5

 

 

 

Average occupied sq. ft.

 

 

6,980

 

 

6,646

 

 

 

 

 

7,423

 

 

6,888

 

 

 

 

Average annual total revenues per occupied sq. ft.

 

$

45

 

$

45

 

 

 

 

$

46

 

$

45

 

 

 

 

Average annual rental revenues per occupied sq. ft.

 

$

37

 

$

37

 

 

 

 

$

38

 

$

38

 

 

 

 


(1)

Represents rental and related revenues and tenant recoveries.

(2)

From our 2014 presentation of SPP, we removed a life science facility that was placed into land held for development, which no longer meets our criteria for SPP as of the date placed into development.

SPP.  SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.

Non-SPP.  Non-SPP NOI and adjusted NOI increased primarily as a result of our life science development projects placed into service during 2014 and life science acquisitions in 2014 and 2015.  

Total Portfolio.  NOI and adjusted NOI increased based on the combined increases to SPP and non-SPP discussed above.

During the year ended December 31, 2015, 694,000 square feet of new and renewal leases commenced at an average annual base rent of $33.52 per square foot compared to 412,000 square feet of expired and terminated leases with an average annual base rent of $33.47 per square foot. During the year ended December 31, 2015, we acquired properties with 158,000 occupied square feet with an average annual base rent of $38.80 per square foot. 

 

52


 

Table of Contents

 

Medical Office

2016 and 2015

 

Results as of and for the years ended December 31, 2016 and 2015 (dollars and sq. ft. in thousands, except per sq. ft. data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPP

 

Total Portfolio

 

 

 

2016

 

2015

 

Change

 

2016

 

2015

 

Change

 

Rental revenues(1)

    

$

376,346

    

$

367,804

    

$

8,542

    

$

446,280

    

$

415,351

    

$

30,929

 

HCP share of unconsolidated JV revenues

 

 

1,876

 

 

1,834

 

 

42

 

 

1,996

 

 

1,870

 

 

126

 

Operating expenses

 

 

(141,897)

 

 

(138,130)

 

 

(3,767)

 

 

(173,687)

 

 

(162,054)

 

 

(11,633)

 

HCP share of unconsolidated JV share of operating expenses

 

 

(595)

 

 

(612)

 

 

17

 

 

(595)

 

 

(612)

 

 

17

 

NOI

 

 

235,730

 

 

230,896

 

 

4,834

 

 

273,994

 

 

254,555

 

 

19,439

 

Non-cash adjustments to NOI

 

 

(463)

 

 

(2,381)

 

 

1,918

 

 

(3,557)

 

 

(4,933)

 

 

1,376

 

Adjusted NOI

 

$

235,267

 

$

228,515

 

$

6,752

 

 

270,437

 

 

249,622

 

 

20,815

 

Non-SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

 

(35,170)

 

 

(21,107)

 

 

(14,063)

 

SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

$

235,267

 

$

228,515

 

$

6,752

 

Adjusted NOI % change

 

 

 

 

 

 

 

 

3.0

%

 

 

 

 

 

 

 

 

 

Property count(2)

 

 

203

 

 

203

 

 

 

 

 

239

 

 

227

 

 

 

 

Average occupancy

 

 

91.9

%

 

91.6

%

 

 

 

 

91.5

%

 

90.7

%

 

 

 

Average occupied sq. ft.

 

 

13,079

 

 

13,008

 

 

 

 

 

15,800

 

 

14,778

 

 

 

 

Average annual total revenues per occupied sq. ft.

 

$

29

 

$

28

 

 

 

 

$

28

 

$

28

 

 

 

 

Average annual rental revenues per occupied sq. ft.

 

$

24

 

$

23

 

 

 

 

$

24

 

$

23

 

 

 

 


(1)

Represents rental and related revenues and tenant recoveries.

(2)

From our 2015 presentation of SPP, we removed three MOBs that were sold and six MOBs that were placed into redevelopment.

SPP.  SPP NOI and adjusted NOI increased primarily as a result of increased occupancy. Additionally, SPP adjusted NOI increased as a result of annual rent escalations.

Non-SPP.  Non-SPP NOI and adjusted NOI increased primarily as a result of increased occupancy in former redevelopment and development properties that have been placed into operations and additional NOI from our MOB acquisitions in 2015 and 2016, partially offset by the sale of three MOBs.

Total Portfolio.  NOI and adjusted NOI increased based on the combined increases to SPP and non-SPP discussed above.

During the year ended December 31, 2016, 2.4 million square feet of new and renewal leases commenced at an average annual base rent of $22.96 per square foot, including 211,000 square feet related to developments and redevelopments placed into service at an average annual base rent of $24.62, compared to 2.1 million square feet of expiring and terminated leases with an average annual base rent of $23.19 per square foot. During the year ended December 31, 2016, we acquired properties with 897,000 square feet with an average annual base rent of $14.70 per square foot, including 756,000 square feet with a triple-net annual base rent of $13.00 per square foot, and disposed of 82,000 square feet with an average annual base rent of $23.94 per square foot.

 

53


 

Table of Contents

2015 and 2014

 

Results as of and for the years ended December 31, 2015 and 2014 (dollars and sq. ft. in thousands, except per sq. ft. data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SPP

 

Total Portfolio

 

 

 

2015

 

2014

 

Change

 

2015

 

2014

 

Change

 

Rental revenues(1)

    

$

358,769

    

$

352,442

    

$

6,327

    

$

415,351

    

$

368,055

    

$

47,296

 

HCP share of unconsolidated JV revenues

 

 

1,834

 

 

1,789

 

 

45

 

 

1,870

 

 

1,825

 

 

45

 

Operating expenses

 

 

(137,411)

 

 

(135,375)

 

 

(2,036)

 

 

(162,054)

 

 

(147,144)

 

 

(14,910)

 

HCP share of unconsolidated JV share of operating expenses

 

 

(612)

 

 

(571)

 

 

(41)

 

 

(612)

 

 

(571)

 

 

(41)

 

NOI

 

 

222,580

 

 

218,285

 

 

4,295

 

 

254,555

 

 

222,165

 

 

32,390

 

Non-cash adjustments to NOI

 

 

(663)

 

 

(846)

 

 

183

 

 

(4,933)

 

 

(1,291)

 

 

(3,642)

 

Adjusted NOI

 

$

221,917

 

$

217,439

 

$

4,478

 

 

249,622

 

 

220,874

 

 

28,748

 

Non-SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

 

(27,705)

 

 

(3,435)

 

 

(24,270)

 

SPP adjusted NOI

 

 

 

 

 

 

 

 

 

 

$

221,917

 

$

217,439

 

$

4,478

 

Adjusted NOI % change

 

 

 

 

 

 

 

 

2.1

%

 

 

 

 

 

 

 

 

 

Property count(2)

 

 

205

 

 

205

 

 

 

 

 

227

 

 

215

 

 

 

 

Average occupancy

 

 

90.5

 

91.2

 

 

 

 

90.7

 

90.8

 

 

 

Average occupied sq. ft.

 

 

12,667

 

 

12,750

 

 

 

 

 

14,778

 

 

13,237

 

 

 

 

Average annual total revenues per occupied sq. ft.

 

$

28

 

$

28

 

 

 

 

$

28

 

$

28

 

 

 

 

Average annual rental revenues per occupied sq. ft.

 

$

24

 

$

23

 

 

 

 

$

23

 

$

23

 

 

 

 


(1)

Represents rental and related revenues and tenant recoveries.

(2)

From our 2014 presentation of SPP, we removed a MOB that was sold.

SPP.  SPP adjusted NOI increased as a result of annual rent escalations.

Non-SPP.  Non-SPP NOI and adjusted NOI increased primarily as a result of our MOB acquisitions in 2014 and 2015.  

Total Portfolio.  NOI and adjusted NOI increased based on the combined increases to SPP and non-SPP discussed above.

During the year ended December 31, 2015, 2.4 million square feet of new and renewal leases commenced at an average annual base rent of $23.82 per square foot compared to 2.4 million square feet of expiring and terminated leases with an average annual base rent of $24.15 per square foot. During the year ended December 31, 2015, we acquired properties with 1.9 million occupied square feet with an average annual base rent of $16.19 per square foot, including 1.2 million square feet with a triple-net annual base rent of $10.74 per square foot, and disposed of 17,000 square feet with an average annual base rent of $17.50 per square foot.

 

54


 

Table of Contents

Other Income and Expense Items

Results for the years ended December 31, 2016, 2015 and 2014 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

2016 vs.

 

2015 vs.

 

 

2016

 

2015

 

2014

 

2015

 

2014

Interest income

 

$

88,808

 

$

112,184

 

$

73,623

 

$

(23,376)

 

$

38,561

Interest expense

 

 

464,403

 

 

479,596

 

 

439,742

 

 

(15,193)

 

 

39,854

Depreciation and amortization

 

 

568,108

 

 

504,905

 

 

455,016

 

 

63,203

 

 

49,889

General and administrative

 

 

103,611

 

 

95,965

 

 

81,765

 

 

7,646

 

 

14,200

Acquisition and pursuit costs

 

 

9,821

 

 

27,309

 

 

17,142

 

 

(17,488)

 

 

10,167

Impairments, net

 

 

 —

 

 

108,349

 

 

 —

 

 

(108,349)

 

 

108,349

Gain on sales of real estate, net

 

 

164,698

 

 

6,377

 

 

3,288

 

 

158,321

 

 

3,089

Loss on debt extinguishments

 

 

(46,020)

 

 

 —

 

 

 —

 

 

(46,020)

 

 

 —

Other income, net

 

 

3,654

 

 

16,208

 

 

9,252

 

 

(12,554)

 

 

6,956

Income tax (expense) benefit

 

 

(4,473)

 

 

9,807

 

 

506

 

 

(14,280)

 

 

9,301

Equity income (loss) from unconsolidated joint ventures

 

 

11,360

 

 

6,590

 

 

(3,605)

 

 

4,770

 

 

10,195

Total discontinued operations

 

 

265,755

 

 

(699,086)

 

 

665,276

 

 

964,841

 

 

(1,364,362)

Noncontrolling interests’ share in earnings

 

 

(12,179)

 

 

(12,817)

 

 

(14,358)

 

 

638

 

 

1,541

Interest income.  The decrease in interest income for the year ended December 31, 2016 was primarily the result of: (i) placing our Four Seasons Notes on cost recovery status in the third quarter of 2015 and (ii) paydowns in our loan portfolio. The decrease in interest income was partially offset by additional interest income from: (i) the Four Seasons senior secured term loan purchased in the fourth quarter of 2015 and (ii) additional fundings in our loan portfolio, including our £105 million ($131 million) loan to Maria Mallaband in November 2016.

The increase in interest income for the year ended December 31, 2015 was primarily the result of: (i) fundings through our U.K. loan facility to HC-One in November 2014 and February 2015, (ii) incremental interest income from the repayments of three development loans resulting from the appreciation of the underlying real estate assets and (iii) additional fundings under our mezzanine loan facility with Tandem in May 2015. The increase in interest income was partially offset by the impact of placing our Four Seasons Notes on cost recovery status in the third quarter of 2015.

Interest expense.  The decrease in interest expense for the year ended December 31, 2016 was primarily the result of: (i) mortgage debt repayments during 2015 and 2016, primarily from mortgage debt secured by properties in our SH NNN, life science and medical office segments, (ii) senior unsecured notes payoffs during 2015 and 2016 and higher capitalized interest. The decrease in interest expense was partially offset by: (i) senior unsecured notes issued during 2015 and (ii) increased borrowings under our line of credit facility.

The increase in interest expense for the year ended December 31, 2015 was primarily the result of: (i) senior unsecured notes issued during 2014 and 2015, (ii) increased borrowings from our term loan originated in 2015, (iii) increased borrowings under our line of credit facility and (iv) lower capitalized interest. The increase in interest expense was partially offset by: (i) repayments of senior unsecured notes and (ii) mortgage debt that matured during 2014 and 2015. The increased borrowings were used to fund our investment activities and to refinance our debt maturities.

55


 

Table of Contents

The table below sets forth information with respect to our debt, excluding premiums, discounts and debt issuance costs (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31,(1)

 

 

 

2016

 

2015

 

2014

 

Balance:

    

 

    

 

 

    

 

 

    

 

Fixed rate

 

$

7,614,473

 

$

10,659,378

 

$

8,841,676

 

Variable rate

 

 

1,545,366

 

 

397,432

 

 

847,016

 

Total

 

$

9,159,839

 

$

11,056,810

 

$

9,688,692

 

Percentage of total debt:

 

 

 

 

 

 

 

 

 

 

Fixed rate

 

 

83.1

%  

 

96.4

%

 

91.3

%

Variable rate

 

 

16.9

 

 

3.6

 

 

8.7

 

Total

 

 

100

%

 

100

%

 

100

%

Weighted average interest rate at end of period:

 

 

 

 

 

 

 

 

 

 

Fixed rate

 

 

4.26

%

 

4.68

%

 

5.01

%

Variable rate

 

 

2.23

%

 

1.72

%

 

1.59

%

Total weighted average rate

 

 

3.91

%

 

4.57

%

 

4.71

%


(1)

At December 31, 2016, 2015 and 2014, excludes $92 million, $94 million and $97 million of other debt, respectively, that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities and demand notes that have no scheduled maturities. At December 31, 2016, 2015 and 2014, principal balances of $46 million, $71 million and $71 million of variable-rate mortgages, respectively, are presented as fixed-rate debt as the interest payments were swapped from variable to fixed. At December 31, 2016, 2015 and 2014, principal balances of £220 million ($272 million), £357 million ($526 million) and £137 million ($214 million) term loans, respectively, are presented as fixed-rate debt as the interest payments were swapped from variable to fixed.

Depreciation and amortization.  The increase in depreciation and amortization expense for the year ended December 31, 2016 was primarily the result of the impact of acquisitions primarily in our SHOP and medical office segments.

The increase in depreciation and amortization expense for the year ended December 31, 2015 was primarily the result of the impact of our acquisitions primarily in our SHOP, life science and medical office segments and redevelopment projects placed in service during 2014 and 2015 primarily in our life science and medical office segments. The increase in depreciation and amortization expense was partially offset by additional depreciation expense recognized in 2014 as a result of a change in estimate of the depreciable life and residual value of certain properties in our SN NNN and medical office segments.

General and administrative expenses.  The increase in general and administrative expenses for the year ended December 31, 2016 was primarily the result of: (i) higher severance-related charges primarily resulting from the departure of our former President and CEO in July 2016 and (ii) higher professional fees in 2016, partially offset by lower compensation related expenses.

The increase in general and administrative expenses for the year ended December 31, 2015 was primarily the result of: (i) a severance-related charge resulting from the resignation of our former Executive Vice President and Chief Investment Officer in June 2015 and (ii) higher compensation related expenses.

Acquisition and pursuit costs.  The decrease in acquisition and pursuit costs for the year ended December 31, 2016 was primarily a result of lower levels of transactional activity in 2016 compared to the same period in 2015. 

The increase in acquisition and pursuit costs for the year ended December 31, 2015 was primarily due to higher levels of transactional activity in 2015, including transactional costs related to the U.K. and RIDEA III investments.

Beginning in the first quarter of 2017, upon the Company’s planned adoption of the Financial Accounting Standards Board’s Accounting Standards Update No. 2017-01, Clarifying the Definition of a Business, the Company expects a decrease in acquisition and pursuit costs recognized within its consolidated statements of operations. See Note 2 to the Consolidated Financial Statements for further information.

56


 

Table of Contents

Impairments, net.  During the year ended December 31, 2015, we recognized the following impairment charges: (i) $112 million related to our investment in Four Seasons Notes and (ii) $3 million related to a MOB. The impairment charges were partially offset by a $6 million impairment recovery related to the repayment of a loan.

Gain on sales of real estate, net.  During the year ended December 31, 2016, we sold a portfolio of five facilities in one of our non-reportable segments and two SH NNN facilities for $130 million, five life science facilities for $386 million, seven SH NNN facilities for $88 million, three MOBs for $20 million and three SHOP facilities for $41 million, recognizing total gain on sales of $165 million.

During the year ended December 31, 2015, we sold the following assets: (i) nine SH NNN facilities for $60 million, resulting from Brookdale’s exercise of its purchase option, (ii) two parcels of land in our life science segment for $51 million and (iii) a MOB for $0.4 million, recognizing total gain on sales of $6 million.

Loss on debt extinguishments.  During the fourth quarter of 2016, using proceeds from the Spin-Off, we repaid $1.1 billion of senior unsecured notes that were due to mature in January 2017 and January 2018 and repaid $108 million of mortgage debt; incurring aggregate loss on debt extinguishments of $46 million, primarily related to prepayment penalties.  

Other income, net.  The decrease in other income, net for the year ended December 31, 2016 was primarily the result of a reduction of foreign currency remeasurement gains from remeasuring assets and liabilities denominated in GBP to U.S. dollars (“USD”) as a result of effective hedges designated in September 2015.

The increase in other income, net for the year ended December 31, 2015 was primarily the result of the impact from remeasuring assets and liabilities denominated in GBP to USD.

Income tax (expense) benefit.  The increase in income taxes for the year ended December 31, 2016 was primarily the result of recognizing tax liabilities representing our estimated exposure to state built-in gain tax.

The decrease in income taxes for the year ended December 31, 2015 was primarily the result of the tax benefit related to our share of operating losses from our RIDEA joint ventures formed as part of the 2014 Brookdale transaction and related to our U.K. real estate investments in 2015.

Equity income (loss) from unconsolidated joint ventures.  The increase in equity income from unconsolidated joint ventures for the year ended December 31, 2016 was primarily the result of increased income from our share of gains on sales of real estate.

The increase in equity income from unconsolidated joint ventures for the year ended December 31, 2015 was primarily the result of our share of gains on sales of real estate from HCP Ventures III, LLC and HCP Ventures IV, LLC, partially offset by our share of operating losses recognized from the CCRC JV.

Total discontinued operations.  Discontinued operations for the years ended December 31, 2016, 2015 and 2014 resulted in income of $266 million, loss of $699 million and income of $665 million, respectively. Income and loss from discontinued operations primarily relates to the operations of QCP. Income from discontinued operations increased during the year ended December 31, 2016 as a result of impairment charges during 2015 not repeated in 2016. The increase in discontinued operations was partially offset by the following: (i) a reduction in income from our HCRMC investments as a result of the HCRMC lease amendment effective April 1, 2015, the sale of non-strategic assets during the second half of 2015 and the first half of 2016, and a change in income recognition to a cash basis method beginning in January 2016, (ii) transaction costs of $87 million related to the Spin-Off and (iii) increased income tax expense related to our estimated exposure to state built-in gain tax. During the years ended December 31, 2015 and 2014, we recognized impairments of $1.3 billion and $36 million, respectively, related to our HCRMC portfolio.

57


 

Table of Contents

Liquidity and Capital Resources

We anticipate: (i) funding recurring operating expenses, (ii) meeting debt service requirements including principal payments and maturities, and (iii) satisfying our distributions to our stockholders and non-controlling interest members, for the next 12 months primarily by using cash flow from operations, available cash balances and cash from our various sources of financing.  

Our principal investing liquidity needs for the next 12 months are to:

·

fund capital expenditures, including tenant improvements and leasing costs; and

·

fund future acquisition, transactional and development activities.

We anticipate satisfying these future investing needs using one or more of the following:

·

issuance of common or preferred stock;

·

issuance of additional debt, including unsecured notes and mortgage debt;

·

draws on our credit facilities; and/or

·

sale or exchange of ownership interests in properties.

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, as noted below, our revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our credit ratings. We also pay a facility fee on the entire revolving commitment that depends upon our credit ratings. As of January 31, 2017, we had a credit rating of BBB from Fitch, Baa2 from Moody’s and BBB from S&P Global on our senior unsecured debt securities.

 

Cash Flow Summary

The following summary discussion of our cash flows is based on the Consolidated Statements of Cash Flows and is not meant to be an all-inclusive discussion of the changes in our cash flows for the periods presented below.

Cash and cash equivalents were $95 million and $340 million at December 31, 2016 and 2015, respectively, reflecting a decrease of $245 million. The following table sets forth changes in cash flows (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

Change

 

Net cash provided by operating activities

    

$

1,214,131

    

$

1,222,145

    

$

(8,014)

 

Net cash used in investing activities

 

 

(410,617)

 

 

(1,672,005)

 

 

1,261,388

 

Net cash (used in) provided by financing activities

 

 

(1,054,265)

 

 

614,087

 

 

(1,668,352)

 

The decrease in operating cash flow is primarily the result of increased transaction costs and decreased income related to the Spin-Off, partially offset by our 2015 and 2016 acquisitions, annual rent increases and increased working capital. Our cash flow from operations is dependent upon the occupancy levels of our buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.

The following are significant investing and financing activities for the year ended December 31, 2016:

·

made investments of $1.3 billion (development, leasing and acquisition of real estate, investments in unconsolidated joint ventures and loans, and purchases of securities) and received proceeds of $908 million primarily from real estate and DFL sales;

·

paid cash dividends on common stock of $980 million, which were generally funded by cash provided by our operating activities and cash on hand; and

·

received net proceeds of $1.7 billion from the Spin-Off of QCP, raised proceeds of $1.2 billion primarily from our net

58


 

Table of Contents

borrowings under our bank line of credit, and repaid $2.9 billion under our bank line of credit, senior unsecured notes and mortgage debt.

 

Debt

Bank line of credit and Term Loans.  Our $2.0 billion unsecured revolving line of credit facility (the “Facility”) matures on March 31, 2018 and contains a one-year extension option. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends on our credit ratings. We pay a facility fee on the entire revolving commitment that depends on our credit ratings. Based on our credit ratings at January 31, 2017, the margin on the Facility was 1.05%, and the facility fee was 0.20%. The Facility also includes a feature that allows us to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At December 31, 2016, we had $900 million, including £372 million ($460 million), outstanding under the Facility with a weighted average effective interest rate of 1.821%. In January 2017, we paid down $440 million on the Facility primarily using proceeds from our RIDEA II transaction.

On July 30, 2012, we entered into a credit agreement with a syndicate of banks for a £137 million ($169 million at December 31, 2016) unsecured term loan, which matures in 2017. Based on our credit ratings at January 31, 2017, the 2012 Term Loan accrues interest at a rate of GBP LIBOR plus 1.40%. 

On January 12, 2015, we entered into a credit agreement with a syndicate of banks for a £220 million ($272 million at December 31, 2016) four-year unsecured term loan (the “2015 Term Loan”) that accrues interest at a rate of GBP LIBOR plus 1.15%, subject to adjustments based on our credit ratings (the 2012 and 2015 Term Loans are collectively, the “Term Loans”). Proceeds from the 2015 Term Loan were used to repay a £220 million draw on the Facility that partially funded the November 2014 HC-One Facility (see Note 7 to the Consolidated Financial Statements). Concurrently, we entered into a three-year interest rate swap agreement that effectively fixes the interest rate of the 2015 Term Loan (1.97% at December 31, 2016). The 2015 Term Loan contains a one-year committed extension option.

The Facility and Term Loans contain certain financial restrictions and other customary requirements, including cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60% and (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times. The Facility and Term Loans also require a Minimum Consolidated Tangible Net Worth of $6.5 billion at December 31, 2016, which requirement was reduced, via an amendment to the Facility, effective upon the completion of the Spin-Off of QCP on October 31, 2016. At December 31, 2016, we were in compliance with each of these restrictions and requirements of the Facility and Term Loans.

Senior unsecured notes.  At December 31, 2016, we had senior unsecured notes outstanding with an aggregate principal balance of $7.2 billion. Interest rates on the notes ranged from 2.79% to 6.88%, with a weighted average effective interest rate of 4.34% and a weighted average maturity of six years at December 31, 2016. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. At December 31, 2016, we believe we were in compliance with these covenants.

Mortgage debt.  At December 31, 2016, we had $619 million in aggregate principal amount of mortgage debt outstanding that is secured by 36 healthcare facilities (including redevelopment properties) with a carrying value of $899 million. Interest rates on the mortgage debt ranged from 3.02% to 7.50%, with a weighted average effective interest rate of 3.40% and a weighted average maturity of six years at December 31, 2016.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets, and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

59


 

Table of Contents

 

Equity

At December 31, 2016, we had 468 million shares of common stock outstanding, equity totaled $5.9 billion, and our equity securities had a market value of $14.1 billion.

At December 31, 2016, non-managing members held an aggregate of 4 million units in five limited liability companies (“DownREITs”) for which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).

At-The-Market Program.  In June 2015, we established an at-the-market program, in connection with the renewal of our Shelf Registration Statement. Under this program, we may sell shares of our common stock from time to time having an aggregate gross sales price of up to $750 million through a consortium of banks acting as sales agents or directly to the banks acting as principals. There was no activity during the year ended December 31, 2016 and, as of December 31, 2016, shares of our common stock having an aggregate gross sales price of $676 million were available for sale under the at-the-market program. Actual future sales will depend upon a variety of factors, including but not limited to market conditions, the trading price of our common stock and our capital needs. We have no obligation to sell the remaining shares available for sale under our program.

 

Shelf Registration

We filed a prospectus with the SEC as part of a registration statement on Form S-3ASR, using a shelf registration process, which expires in June 2018. Under the “shelf” process, we may sell any combination of the securities described in the prospectus through one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities and warrants.

 

Contractual Obligations

The following table summarizes our material contractual payment obligations and commitments at December 31, 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

 

    

 

 

    

 

 

    

More than

 

 

 

Total(1)

 

2017

 

2018-2019

 

2020-2021

 

Five Years

 

Bank line of credit(2)

 

$

899,718

 

$

 —

 

$

899,718

 

$

 —

 

$

 —

 

Term loans(3)

 

 

441,181

 

 

169,305

 

 

271,876

 

 

 —

 

 

 —

 

Senior unsecured notes

 

 

7,200,000

 

 

250,000

 

 

450,000

 

 

2,000,000

 

 

4,500,000

 

Mortgage debt

 

 

618,940

 

 

479,795

 

 

7,480

 

 

15,184

 

 

116,481

 

U.K. loan commitments(4)

 

 

43,107

 

 

39,946

 

 

3,161

 

 

 —

 

 

 —

 

Construction loan commitments(5)

 

 

124

 

 

124

 

 

 —

 

 

 —

 

 

 —

 

Development commitments(6)

 

 

117,019

 

 

114,229

 

 

2,790

 

 

 —

 

 

 —

 

Ground and other operating leases

 

 

412,055

 

 

7,294

 

 

14,751

 

 

13,706

 

 

376,304

 

Interest(7)

 

 

2,265,501

 

 

337,433

 

 

584,054

 

 

485,911

 

 

858,103

 

Total

 

$

11,997,645

 

$

1,398,126

 

$

2,233,830

 

$

2,514,801

 

$

5,850,888

 


(1)

Excludes $92 million of other debt that represents life care bonds and demand notes that have no scheduled maturities. Additionally, excludes a  $100 million unsecured revolving credit facility commitment to QCP,  which is available to be drawn upon by QCP through the fourth quarter of 2017 and matures in the fourth quarter of 2018. The unsecured revolving credit facility will automatically and permanently decrease each calendar month by an amount equal to 50% of QCP's and its restricted subsidiaries’ retained cash flow for the prior calendar month. All borrowings under the unsecured revolving credit facility will be subject to the satisfaction of certain conditions (see Note 1 to the Consolidated Financial Statements).

(2)

Includes £372 million ($460 million) translated into USD.

(3)

Represents £357 million translated into USD.

(4)

Represents £35 million translated into USD for commitments to fund our U.K. loan facilities.

(5)

Represents commitments to finance development projects and related working capital financings.

(6)

Represents construction and other commitments for developments in progress.

(7)

Interest on variable-rate debt is calculated using rates in effect at December 31, 2016.

60


 

Table of Contents

Off-Balance Sheet Arrangements

We own interests in certain unconsolidated joint ventures as described under Note 8 to the Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable. In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities, as described under Note 12 to the Consolidated Financial Statements. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described above under “Contractual Obligations”.

Inflation

Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Most of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, and remaining other leases require the tenant or operator to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the tenant or operator expense reimbursements and contractual rent increases described above.

61


 

Table of Contents

Non-GAAP Financial Measure Reconciliations

Funds From Operations and Funds Available for Distribution

The following is a reconciliation from net income (loss) applicable to common shares, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO, FFO as adjusted and FAD (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

2013

 

2012

 

Net income (loss) applicable to common shares

    

$

626,549

    

$

(560,552)

    

$

919,796

    

$

969,103

    

$

812,289

 

Depreciation and amortization of real estate, in-place lease and other intangibles

 

 

572,998

 

 

510,785

 

 

459,995

 

 

429,174

 

 

366,512

 

Other depreciation and amortization

 

 

11,919

 

 

22,223

 

 

18,864

 

 

14,326

 

 

12,756

 

Gain on sales of real estate, net

 

 

(164,698)

 

 

(6,377)

 

 

(31,298)

 

 

(69,866)

 

 

(31,454)

 

Taxes associated with real estate dispositions

 

 

60,451

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

Impairments of real estate

 

 

 —

 

 

2,948

 

 

 —

 

 

1,372

 

 

 —

 

Equity income from unconsolidated joint ventures 

 

 

(11,360)

 

 

(57,313)

 

 

(49,570)

 

 

(64,433)

 

 

(54,455)

 

FFO from unconsolidated joint ventures

 

 

44,071

 

 

90,498

 

 

70,873

 

 

74,324

 

 

64,933

 

Noncontrolling interests’ and participating securities’ share in earnings

 

 

13,377

 

 

14,134

 

 

16,795

 

 

15,903

 

 

17,547

 

Noncontrolling interests’ and participating securities’ share in FFO

 

 

(34,154)

 

 

(27,187)

 

 

(23,821)

 

 

(20,639)

 

 

(21,620)

 

FFO applicable to common shares

 

$

1,119,153

 

$

(10,841)

 

$

1,381,634

 

$

1,349,264

 

$

1,166,508

 

Distributions on dilutive convertible units

 

 

8,732

 

 

 —

 

 

13,799

 

 

13,276

 

 

13,028

 

Diluted FFO applicable to common shares

 

$

1,127,885

 

$

(10,841)

 

$

1,395,433

 

$

1,362,540

 

$

1,179,536

 

Weighted average shares used to calculate diluted FFO per common share

 

 

471,566

 

 

462,795

 

 

464,845

 

 

461,710

 

 

434,328

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impact of adjustments to FFO:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related items(1)

 

$

96,586

 

$

32,932

 

$

(18,856)

 

$

6,191

 

$

5,339

 

Other impairments, net(2)

 

 

 —

 

 

1,446,800

 

 

35,913

 

 

 —

 

 

7,878

 

Loss on debt extinguishment(3)

 

 

46,020

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

Severance-related charges(4)

 

 

16,965

 

 

6,713

 

 

 —

 

 

27,244

 

 

5,642

 

Foreign currency remeasurement losses (gains)

 

 

585

 

 

(5,437)

 

 

 —

 

 

 —

 

 

 —

 

Litigation provision

 

 

3,081

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

Preferred stock redemption charge

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

10,432

 

 

 

$

163,237

 

$

1,481,008

 

$

17,057

 

$

33,435

 

$

29,291

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FFO as adjusted applicable to common shares

 

$

1,282,390

 

$

1,470,167

 

$

1,398,691

 

$

1,382,699

 

$

1,195,799

 

Distributions on dilutive convertible units and other

 

 

12,849

 

 

13,597

 

 

13,766

 

 

13,220

 

 

12,957

 

Diluted FFO as adjusted applicable to common shares

 

$

1,295,239

 

$

1,483,764

 

$

1,412,457

 

$

1,395,919

 

$

1,208,756

 

Weighted average shares used to calculate diluted FFO as adjusted per common share(5)

 

 

473,340

 

 

469,064

 

 

464,845

 

 

461,710

 

 

433,607

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per common share

 

$

1.34

 

$

(1.21)

 

$

2.00

 

$

2.13

 

$

1.90

 

Depreciation and amortization

 

 

1.21

 

 

1.10

 

 

1.00

 

 

0.93

 

 

0.85

 

Impairments on real estate and DFL depreciation

 

 

0.03

 

 

0.06

 

 

0.04

 

 

0.03

 

 

0.03

 

Taxes related to real estate dispositions and gain on sales of real estate, net

 

 

(0.22)

 

 

(0.01)

 

 

(0.07)

 

 

(0.15)

 

 

(0.07)

 

Joint venture and participating securities FFO adjustments

 

 

0.03

 

 

0.04

 

 

0.03

 

 

0.01

 

 

0.01

 

Diluted FFO per common share

 

$

2.39

 

$

(0.02)

 

$

3.00

 

$

2.95

 

$

2.72

 

Transaction-related items(1)

 

 

0.20

 

 

0.07

 

 

(0.04)

 

 

0.01

 

 

0.01

 

Other impairments, net(2)

 

 

 —

 

 

3.11

 

 

0.08

 

 

 —

 

 

0.02

 

Loss on debt extinguishment(3)

 

 

0.10

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

Severance-related charges(4)

 

 

0.04

 

 

0.01

 

 

 —

 

 

0.06

 

 

0.01

 

Foreign currency remeasurement losses (gains)

 

 

 —

 

 

(0.01)

 

 

 —

 

 

 —

 

 

 —

 

Litigation provision

 

 

0.01

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

Preferred stock redemption charge

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

0.03

 

FFO as adjusted applicable to common shares

 

$

2.74

 

$

3.16

 

$

3.04

 

$

3.02

 

$

2.79

 

 

62


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

2013

 

2012

 

FFO as adjusted applicable to common shares

    

$

1,282,390

    

$

1,470,167

    

$

1,398,691

    

$

1,382,699

    

$

1,195,799

 

Amortization of market lease intangibles, net

 

 

(1,197)

 

 

(1,295)

 

 

(949)

 

 

(6,646)

 

 

(2,232)

 

Amortization of deferred compensation(6)

 

 

15,581

 

 

23,233

 

 

21,885

 

 

23,327

 

 

23,277

 

Amortization of deferred financing costs

 

 

20,014

 

 

20,222

 

 

19,260

 

 

18,541

 

 

16,501

 

Straight-line rents

 

 

(18,003)

 

 

(28,859)

 

 

(41,032)

 

 

(39,587)

 

 

(47,311)

 

DFL non-cash interest(7)

 

 

2,600

 

 

(87,861)

 

 

(77,568)

 

 

(86,055)

 

 

(94,240)

 

Other depreciation and amortization

 

 

(11,919)

 

 

(22,223)

 

 

(18,864)

 

 

(14,326)

 

 

(12,756)

 

Deferred revenues – tenant improvement related

 

 

(1,883)

 

 

(2,594)

 

 

(2,306)

 

 

(2,906)

 

 

(1,570)

 

Deferred revenues – additional rents

 

 

(76)

 

 

(219)

 

 

422

 

 

63

 

 

(85)

 

Leasing costs and tenant and capital improvements

 

 

(88,953)

 

 

(82,072)

 

 

(74,464)

 

 

(64,557)

 

 

(61,440)

 

Lease restructure payments

 

 

16,604

 

 

22,657

 

 

9,425

 

 

 —

 

 

 —

 

Joint venture adjustments – CCRC entrance fees

 

 

29,998

 

 

30,918

 

 

11,443

 

 

 —

 

 

 —

 

Joint venture and other FAD adjustments(7)

 

 

(29,460)

 

 

(80,225)

 

 

(67,121)

 

 

(52,471)

 

 

(61,298)

 

FAD applicable to common shares

 

$

1,215,696

 

$

1,261,849

 

$

1,178,822

 

$

1,158,082

 

$

954,645

 

Distributions on dilutive convertible units

 

 

13,088

 

 

14,230

 

 

13,799

 

 

13,276

 

 

7,714

 

Diluted FAD applicable to common shares

 

$

1,228,784

 

$

1,276,079

 

$

1,192,621

 

$

1,171,358

 

$

962,359

 


(1)

For the year ended December 31, 2016, transaction-related items primarily relate to the Spin-Off. For the year ended December 31, 2015, transaction-related items primarily relate to acquisition and pursuit costs. For the year ended December 31, 2014, transaction-related items include a net benefit from the 2014 Brookdale transaction, partially offset by acquisition and pursuit costs. For the years ended December 31, 2013 and 2012, transaction-related items primarily relate to acquisition and pursuit costs.

(2)

For the year ended December 31, 2015, other impairments, net include impairment charges of: (i) $1.3 billion related to our HCRMC DFL investments, (ii) $112 million related to our Four Seasons Notes and (iii) $46 million related to our equity investment in HCRMC, partially offset by an impairment recovery of $6 million related to a loan payoff. For the year ended December 31, 2014, the other impairment relates to our equity investment in HCRMC. 

(3)

Represents penalties of $46 million from the prepayment of $1.1 billion of senior unsecured notes and $108 million of mortgage debt using proceeds from the Spin-Off.

(4)

For the year ended December 31, 2016, severance-related charges primarily relate to the departure of our former President and CEO. For the year ended December 31, 2015, the severance-related charge relates to the departure of our former Executive Vice President and Chief Investment Officer. For the year ended December 31, 2013, the severance-related charge relates to the departure of our former Chairman, CEO and President.

(5)

Our weighted average shares for the year ended December 31, 2012 used to calculate diluted FFO as adjusted eliminate the impact of 22 million shares from our common stock offering completed on October 19, 2012; proceeds from this offering were used to fund the Blackstone JV acquisition.

(6)

Excludes $7 million primarily related to the acceleration of deferred compensation for restricted stock units that vested upon the departure of our former President and CEO, which is included in the severance-related charges for the year ended December 31, 2016. Excludes $3 million related to the acceleration of deferred compensation for restricted stock units and stock options that vested upon the departure of our former Executive Vice President and Chief Investment Officer, which is included in the severance-related charge for year ended December 31, 2015. Excludes $17 million related to the acceleration of deferred compensation for restricted stock units and options that vested upon the departure of our former CEO, which is included in severance-related charges for the year ended December 31, 2013.

(7)

Our equity investment in HCRMC was accounted for using the equity method, which required an elimination of DFL income that is proportional to our ownership in HCRMC. Further, our share of earnings from HCRMC (equity income) increased for the corresponding elimination of related lease expense recognized at the HCRMC entity level, which we presented as a non-cash joint venture FAD adjustment. Beginning in January 2016, as a result of placing our equity investment in HCRMC on a cash basis method of accounting, we no longer eliminated our proportional ownership share of income from DFLs to equity income (loss) from unconsolidated joint ventures. See Note 5 to the Consolidated Financial Statements for additional discussion.

63


 

Table of Contents

Critical Accounting Policies

The preparation of financial statements in conformity with U.S. GAAP requires our management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. For a more detailed discussion of our significant accounting policies, see Note 2 to the Consolidated Financial Statements. Below is a discussion of accounting policies that we consider critical in that they may require complex judgment in their application or require estimates about matters that are inherently uncertain.

 

Principles of Consolidation

The consolidated financial statements include the accounts of HCP, Inc., our wholly-owned subsidiaries and joint ventures that we control, through voting rights or other means. We consolidate investments in variable interest entities (“VIEs”) when we are the primary beneficiary of the VIE. A variable interest holder is considered to be the primary beneficiary of a VIE if it has the power to direct the activities that most significantly impact the entity’s economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to the VIE.

We make judgments about which entities are VIEs based on an assessment of whether: (i) the equity investors as a group, do not have a controlling financial interest, (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support, or (iii) substantially all of the entity’s activities involve or are performed on behalf of an equity investor that holds disproportionately few voting rights. We make judgments with respect to our level of influence or control over an entity and whether we are (or are not) the primary beneficiary of a VIE. Consideration of various factors includes, but is not limited to, our ability to direct the activities that most significantly impact the entity’s economic performance, our form of ownership interest, our representation on the entity’s governing body, the size and seniority of our investment, and our ability and the rights of other investors to participate in policy making decisions, replace the manager and/or liquidate the entity, if applicable. Our ability to correctly assess our influence or control over an entity when determining the primary beneficiary of a VIE affects the presentation of these entities in our consolidated financial statements. When we perform a re-analysis of the primary beneficiary at a date other than at inception of the VIE, our assumptions may be different and may result in the identification of a different primary beneficiary.

If we determine that we are the primary beneficiary of a VIE, our consolidated financial statements would include the operating results of the VIE rather than the results of the variable interest in the VIE. We would require the VIE to provide us timely financial information and would review the internal controls of the VIE to determine if we could rely on the financial information it provides. If the VIE has deficiencies in its internal controls over financial reporting, or does not provide us with timely financial information, this may adversely impact the quality and/or timing of our financial reporting and our internal controls over financial reporting.

 

Revenue Recognition

At the inception of a new lease arrangement, including new leases that arise from amendments, we assess the terms and conditions to determine the proper lease classification. A lease arrangement is classified as an operating lease if none of the following criteria are met: (i) transfer of ownership to the lessee prior to or shortly after the end of the lease term, (ii) lessee has a bargain purchase option during or at the end of the lease term, (iii) the lease term is equal to 75% or more of the underlying property’s economic life, or (iv) the present value of future minimum lease payments (excluding executory costs) is equal to 90% or more of the excess estimated fair value (over retained tax credits) of the leased asset. If one of the four criteria is met and the minimum lease payments are determined to be reasonably predictable and collectible, the lease arrangement is generally accounted for as a direct financing lease. If the assumptions utilized in the above classifications assessments were different, our lease classification for accounting purposes may have been different; thus

64


 

Table of Contents

the timing and amount of our revenue recognized would have been impacted, which may be material to our consolidated financial statements.

We recognize rental revenue for operating leases on a straight-line basis over the lease term when collectibility of all minimum lease payments is reasonably assured and the tenant has taken possession or controls the physical use of a leased asset. If the lease provides for tenant improvements, we determine whether the tenant improvements are owned by the tenant or us. When we are the owner of the tenant improvements, the tenant is not considered to have taken physical possession or have control of the leased asset until the tenant improvements are substantially complete. When the tenant is the owner of the tenant improvements, any tenant improvement allowance funded is treated as a lease incentive and amortized as a reduction of revenue over the lease term. The determination of ownership of a tenant improvement is subject to significant judgment. If our assessment of the owner of the tenant improvements was different, the timing and amount of our revenue recognized would be impacted.

Certain leases provide for additional rents that are contingent upon a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the base amount or other thresholds. The recognition of additional rents requires us to make estimates of amounts owed and, to a certain extent, is dependent on the accuracy of the facility results reported to us. Our estimates may differ from actual results, which could be material to our consolidated financial statements.

We maintain an allowance for doubtful accounts, including an allowance for operating lease straight-line rent receivables, for estimated losses resulting from tenant defaults or the inability of tenants to make contractual rent and tenant recovery payments. We monitor the liquidity and creditworthiness of our tenants and operators on a continuous basis. This evaluation considers industry and economic conditions, property performance, credit enhancements and other factors. For straight-line rent receivable amounts, our assessment is based on income recoverable over the term of the lease. We exercise judgment in establishing allowances and consider payment history and current credit status in developing these estimates. These estimates may differ from actual results, which could be material to our consolidated financial statements.

We use the direct finance method of accounting to record income from DFLs. For leases accounted for as DFLs, the net investment in the DFL represents receivables for the sum of future minimum lease payments receivable and the estimated residual values of the leased properties, less the unamortized unearned income. Unearned income is deferred and amortized to income over the lease terms to provide a constant yield when collectibility of the lease payments is reasonably assured. The determination of estimated useful lives and residual values are subject to significant judgment. If these assessments were to change, the timing and amount of our revenue recognized would be impacted.

Loans receivable are classified as held-for-investment based on management’s intent and ability to hold the loans for the foreseeable future or to maturity. We recognize interest income on loans, including the amortization of discounts and premiums, using the interest method applied on a loan-by-loan basis when collectibility of the future payments is reasonably assured. Premiums, discounts and related costs are recognized as yield adjustments over the term of the related loans. If management determined that certain loans should no longer be classified as held-for-investment, the timing and amount of our interest income recognized would be impacted.

Loans receivable and DFLs (collectively, “Finance Receivables”), are reviewed and assigned an internal rating of Performing, Watch List or Workout. Finance Receivables that are deemed Performing meet all present contractual obligations, and collection and timing, of all amounts owed is reasonably assured. Watch List Finance Receivables are defined as Finance Receivables that do not meet the definition of Performing or Workout. Workout Finance Receivables are defined as Finance Receivables in which we have determined, based on current information and events, that: (i) it is probable we will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the tenant, operator, or borrower is delinquent on making payments under the contractual terms of the agreement (iii) and we have commenced action or anticipate pursuing action in the near term to seek recovery of our investment.

65


 

Table of Contents

Finance Receivables are placed on nonaccrual status when management determines that the collectibility of contractual amounts is not reasonably assured (the asset will have an internal rating of either Watch List or Workout). Further, we perform a credit analysis to support the tenant’s, operator’s, borrower’s and/or guarantor’s repayment capacity and the underlying collateral values. We use the cash basis method of accounting for Finance Receivables placed on nonaccrual status unless one of the following conditions exist whereby we utilize the cost recovery method of accounting: (i) if we determine that it is probable that we will only recover the recorded investment in the Finance Receivable, net of associated allowances or charge-offs (if any), or (ii) we cannot reasonably estimate the amount of an impaired Finance Receivable. For cash basis method of accounting we apply payments received, excluding principal paydowns, to interest income so long as that amount does not exceed the amount that would have been earned under the original contractual terms. For cost recovery method of accounting any payment received is applied to reduce the recorded investment. Generally, we return a Finance Receivable to accrual status when all delinquent payments become current under the terms of the loan or lease agreements and collectibility of the remaining contractual loan or lease payments is reasonably assured.

Allowances are established for Finance Receivables on an individual basis utilizing an estimate of probable losses, if they are determined to be impaired. Finance Receivables are impaired when it is deemed probable that we will be unable to collect all amounts due in accordance with the contractual terms of the loan or lease. An allowance is based upon our assessment of the lessee’s or borrower’s overall financial condition, economic resources, payment record, the prospects for support from any financially responsible guarantors and, if appropriate, the net realizable value of any collateral. These estimates consider all available evidence, including the expected future cash flows discounted at the Finance Receivable’s effective interest rate, fair value of collateral, general economic conditions and trends, historical and industry loss experience, and other relevant factors, as appropriate. Should a Finance Receivable be deemed partially or wholly uncollectible, the uncollectible balance is charged off against the allowance in the period in which the uncollectible determination has been made.

 

Real Estate

We make estimates as part of our process for allocating a purchase price to the various identifiable assets of an acquisition based upon the relative fair value of each asset. The most significant components of our allocations are typically buildings as-if-vacant, land and in-place leases. In the case of allocating fair value to buildings and intangibles, our fair value estimates will affect the amount of depreciation and amortization we record over the estimated useful life of each asset acquired or the remaining lease term. In the case of allocating fair value to in-place leases, we make our best estimates based on our evaluation of the specific characteristics of each tenant’s lease. Factors considered include estimates of carrying costs during hypothetical expected lease-up periods, market conditions and costs to execute similar leases. Our assumptions affect the amount of future revenue that we will recognize over the remaining lease term for the acquired in-place leases.

A variety of costs are incurred in the development and leasing of properties. After determination is made to capitalize a cost, it is allocated to the specific component of a project that is benefited. Determination of when a development project is substantially complete and capitalization must cease involves a degree of judgment. The costs of land and buildings under development include specifically identifiable costs. The capitalized costs include pre-construction costs essential to the development of the property, development costs, construction costs, interest costs, real estate taxes and other costs incurred during the period of development. We consider a construction project to be considered substantially complete and available for occupancy and cease capitalization of costs upon the completion of the related tenant improvements.

66


 

Table of Contents

 

Impairment of Long-Lived Assets

We assess the carrying value of our real estate assets and related intangibles (“real estate assets”) when events or changes in circumstances indicate that the carrying amount of the real estate assets may not be recoverable, but at least annually. Recoverability of real estate assets is measured by comparing the carrying amount of the real estate assets to the respective estimated future undiscounted cash flows. The estimated future undiscounted cash flows are calculated utilizing the lowest level of identifiable cash flows that are largely independent of the cash flows of other assets and liabilities. In order to review our real estate assets for recoverability, we consider market conditions, as well as our intent with respect to holding or disposing of the asset. If our analysis indicates that the carrying value of the real estate assets is not recoverable on an undiscounted cash flow basis, we recognize an impairment charge for the amount by which the carrying value exceeds the fair value of the real estate asset.

The determination of the fair value of real estate assets involves significant judgment. This judgment is based on our analysis and estimates of fair value of real estate assets, future operating results and resulting cash flows of each real estate asset whose carrying amount may not be recoverable. Our ability to accurately predict future operating results, resulting cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While we believe our assumptions are reasonable, changes in these assumptions may have a material impact on our financial results.

 

Investments in Unconsolidated Joint Ventures

The initial carrying value of investments in unconsolidated joint ventures is based on the amount paid to purchase the joint venture interest or the carrying value of the assets prior to the sale or contribution of the interests to the joint venture. We evaluate our equity method investments for impairment indicators based upon a comparison of the fair value of the equity method investment to our carrying value. If we determine there is a decline in the fair value of our investment in an unconsolidated joint venture below its carrying value and it is other-than-temporary, an impairment is recorded. The determination of the fair value of investments in unconsolidated joint ventures and as to whether a deficiency in fair value is “other-than-temporary” involves significant judgment. Our estimates consider all available evidence including, as appropriate, the present value of the expected future cash flows discounted at market rates, general economic conditions and trends, severity and duration of a fair value deficiency, and other relevant factors. Capitalization rates, discount rates and credit spreads utilized in our valuation models are based upon rates that we believe to be within a reasonable range of current market rates for the respective investments. While we believe our assumptions are reasonable, changes in these assumptions may have a material impact on our financial results.

 

Income Taxes

As part of the process of preparing our consolidated financial statements, significant management judgment is required to evaluate our compliance with REIT requirements. Our determinations are based on interpretation of tax laws, and our conclusions may have an impact on the income tax expense recognized. Adjustments to income tax expense may be required as a result of: (i) audits conducted by federal, state and local tax authorities, (ii) our ability to qualify as a REIT, (iii) the potential for built-in gain recognition, and (iv) changes in tax laws. Adjustments required in any given period are included within the income tax provision.

Recent Accounting Pronouncements

See Note 2 to the Consolidated Financial Statements for the impact of new accounting standards.

ITEM 7A.    Quantitative and Qualitative Disclosures About Market Risk

We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates, specifically the GBP. We use derivative financial instruments in the normal course of business to mitigate interest rate and foreign currency risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the consolidated balance sheets at fair value (see Note 24 to the Consolidated Financial Statements).

67


 

Table of Contents

To illustrate the effect of movements in the interest rate and foreign currency markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the change in fair value. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $3 million.

 

Interest Rate Risk

At December 31, 2016, we are exposed to market risks related to fluctuations in interest rates primarily on variable rate debt. As of December 31, 2016, $317 million of our variable-rate debt was hedged by interest rate swap transactions. The interest rate swaps are designated as cash flow hedges, with the objective of managing the exposure to interest rate risk by converting the interest rates on our variable-rate debt to fixed interest rates.

Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets until their maturity or earlier prepayment and refinancing. If interest rates have risen at the time we seek to refinance our fixed rate debt, whether at maturity or otherwise, our future earnings and cash flows could adversely be affected by additional borrowing costs. Conversely, lower interest rates at the time of refinancing may reduce our overall borrowing costs. However, interest rate changes will affect the fair value of our fixed rate instruments. Assuming a one percentage point change in interest rates would change the fair value of our fixed rate debt and investments by approximately $56 million and $8 million, respectively, and would not materially impact earnings or cash flows. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not materially impact the fair value of those instruments. Assuming a one percentage point change in the interest rate related to our variable-rate debt and variable-rate investments, and assuming no other changes in the outstanding balance as of December 31, 2016, our annual interest expense and interest income would change by approximately $15 million and $1 million, respectively.

 

 

Foreign Currency Exchange Rate Risk

At December 31, 2016, our exposure to foreign currencies primarily relates to U.K. investments in leased real estate, senior notes and related GBP denominated cash flows. Our foreign currency exposure is partially mitigated through the use of GBP denominated borrowings and foreign currency swap contracts. Based solely on our operating results for the year ended December 31, 2016, including the impact of existing hedging arrangements, if the value of the GBP relative to the U.S. dollar were to increase or decrease by 10% compared to the average exchange rate during the year ended December 31, 2016, our cash flows would have decreased or increased, as applicable, by less than $1 million.

 

Market Risk

We have investments in marketable debt securities classified as held-to-maturity because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At December 31, 2016, both the fair value and carrying value of marketable debt securities were $69 million.

 

 

 

 

68


 

Table of Contents

ITEM 8.Financial Statements and Supplementary Data

HCP, Inc.

Index to Consolidated Financial Statements

 

 

 

 

Report of Independent Registered Public Accounting Firm 

   

70 

 

 

 

 

 

Consolidated Balance Sheets—December 31, 2016 and 2015 

 

71 

 

Consolidated Statements of Operations—for the years ended December 31, 2016, 2015 and 2014 

 

72 

 

Consolidated Statements of Comprehensive Income (Loss)—for the years ended December 31, 2016, 2015 and 2014 

 

73 

 

Consolidated Statements of Equity—for the years ended December 31, 2016, 2015 and 2014 

 

74 

 

Consolidated Statements of Cash Flows—for the years ended December 31, 2016, 2015 and 2014 

 

75 

 

Notes to Consolidated Financial Statements 

 

76 

 

 

69


 

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders of HCP, Inc.

Irvine, California

We have audited the accompanying consolidated balance sheets of HCP, Inc. and subsidiaries (the “Company”) as of December 31, 2016 and 2015, and the related consolidated statements of operations, comprehensive income (loss), equity, and cash flows for each of the three years in the period ended December 31, 2016. Our audits also included the financial statement schedules listed in the Index at Item 15. These financial statements and financial statement schedules are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and financial statement schedules based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of HCP, Inc. and subsidiaries as of December 31, 2016 and 2015, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly, in all material respects, the information set forth therein.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company’s internal control over financial reporting as of December 31, 2016, based on the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 13, 2017 expressed an unqualified opinion on the Company’s internal control over financial reporting.

 

 

 

 

/s/ Deloitte & Touche LLP

 

Los Angeles, California

February 13, 2017

 

 

70


 

Table of Contents

HCP, Inc.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2016

 

2015

 

ASSETS

 

    

 

    

 

    

 

Real estate:

 

 

 

 

 

 

 

Buildings and improvements

 

$

11,692,654

 

$

12,007,071

 

Development costs and construction in progress

 

 

400,619

 

 

388,576

 

Land

 

 

1,881,487

 

 

1,934,610

 

Accumulated depreciation and amortization

 

 

(2,648,930)

 

 

(2,476,015)

 

Net real estate

 

 

11,325,830

 

 

11,854,242

 

Net investment in direct financing leases

 

 

752,589

 

 

750,693

 

Loans receivable, net

 

 

807,954

 

 

768,743

 

Investments in and advances to unconsolidated joint ventures

 

 

571,491

 

 

605,244

 

Accounts receivable, net of allowance of $4,459 and $3,261, respectively

 

 

45,116

 

 

48,929

 

Cash and cash equivalents

 

 

94,730

 

 

340,442

 

Restricted cash

 

 

42,260

 

 

46,090

 

Intangible assets, net

 

 

479,805

 

 

586,657

 

Assets held for sale and discontinued operations, net

 

 

927,866

 

 

5,654,326

 

Other assets, net

 

 

711,624

 

 

794,483

 

Total assets(1)

 

$

15,759,265

 

$

21,449,849

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

Bank line of credit

 

$

899,718

 

$

397,432

 

Term loans

 

 

440,062

 

 

524,807

 

Senior unsecured notes

 

 

7,133,538

 

 

9,120,107

 

Mortgage debt

 

 

623,792

 

 

932,212

 

Other debt

 

 

92,385

 

 

94,445

 

Intangible liabilities, net

 

 

58,145

 

 

56,147

 

Liabilities of assets held for sale and discontinued operations, net

 

 

3,776

 

 

25,266

 

Accounts payable and accrued liabilities

 

 

417,360

 

 

430,786

 

Deferred revenue

 

 

149,181

 

 

122,330

 

Total liabilities(1)

 

 

9,817,957

 

 

11,703,532

 

Commitments and contingencies

 

 

 

 

 

 

 

Common stock, $1.00 par value: 750,000,000 shares authorized; 468,081,489 and 465,488,492 shares issued and outstanding, respectively

 

 

468,081

 

 

465,488

 

Additional paid-in capital

 

 

8,198,890

 

 

11,647,039

 

Cumulative dividends in excess of earnings

 

 

(3,089,734)

 

 

(2,738,414)

 

Accumulated other comprehensive loss

 

 

(29,642)

 

 

(30,470)

 

Total stockholders’ equity

 

 

5,547,595

 

 

9,343,643

 

Joint venture partners

 

 

214,377

 

 

217,066

 

Non-managing member unitholders

 

 

179,336

 

 

185,608

 

Total noncontrolling interests

 

 

393,713

 

 

402,674

 

Total equity

 

 

5,941,308

 

 

9,746,317

 

Total liabilities and equity

 

$

15,759,265

 

$

21,449,849

 


(1)

The Company’s consolidated total assets and total liabilities at December 31, 2016 and 2015 include certain assets of variable interest entities (“VIEs”) that can only be used to settle the liabilities of the related VIE. The VIE creditors do not have recourse to HCP, Inc. Total assets at December 31, 2016 include VIE assets as follows: buildings and improvements $3.5 billion; developments in process $32 million; land $327 million; accumulated depreciation and amortization $676 million; accounts receivable, net  $20 million; cash $36 million; restricted cash $23 million; intangible assets, net $169 million; and other assets, net  $70 million. Total assets at December 31, 2015 include VIE assets as follows: buildings and improvements $791 million; land $125 million; accumulated depreciation and amortization $135 million; accounts receivable, net $16 million; cash $35 million; restricted cash $18 million; and other assets, net of $20 million. Total liabilities at December 31, 2016 include mortgage debt of $521 million; intangible liabilities, net of $9 million; accounts payable and accrued liabilities of $121 million and deferred revenue of $23 million from VIEs. Total liabilities at December 31, 2015 include accounts payable and accrued liabilities of $60 million and deferred revenue of $14 million of from VIEs. See Note 21 to the Consolidated Financial Statements for additional details.

See accompanying Notes to Consolidated Financial Statements.

71


 

Table of Contents

HCP, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Revenues:

    

 

 

    

 

    

    

 

    

 

Rental and related revenues

 

$

1,159,791

 

$

1,116,830

 

$

1,147,145

 

Tenant recoveries

 

 

134,280

 

 

125,022

 

 

109,659

 

Resident fees and services

 

 

686,835

 

 

525,453

 

 

241,965

 

Income from direct financing leases

 

 

59,580

 

 

61,000

 

 

64,441

 

Interest income

 

 

88,808

 

 

112,184

 

 

73,623

 

Total revenues

 

 

2,129,294

 

 

1,940,489

 

 

1,636,833

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

464,403

 

 

479,596

 

 

439,742

 

Depreciation and amortization

 

 

568,108

 

 

504,905

 

 

455,016

 

Operating

 

 

738,399

 

 

610,679

 

 

381,294

 

General and administrative

 

 

103,611

 

 

95,965

 

 

81,765

 

Acquisition and pursuit costs

 

 

9,821

 

 

27,309

 

 

17,142

 

Impairments, net

 

 

 —

 

 

108,349

 

 

 —

 

Total costs and expenses

 

 

1,884,342

 

 

1,826,803

 

 

1,374,959

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

Gain on sales of real estate, net

 

 

164,698

 

 

6,377

 

 

3,288

 

Loss on debt extinguishments

 

 

(46,020)

 

 

 —

 

 

 —

 

Other income, net

 

 

3,654

 

 

16,208

 

 

9,252

 

Total other income, net

 

 

122,332

 

 

22,585

 

 

12,540

 

Income before income taxes and equity income from unconsolidated joint ventures

 

 

367,284

 

 

136,271

 

 

274,414

 

Income tax (expense) benefit

 

 

(4,473)

 

 

9,807

 

 

506

 

Equity income (loss) from unconsolidated joint ventures

 

 

11,360

 

 

6,590

 

 

(3,605)

 

Income from continuing operations

 

 

374,171

 

 

152,668

 

 

271,315

 

Discontinued operations:

 

 

 

 

 

 

 

 

 

 

Income before impairments, transaction costs, gain on sales of real estate and income taxes

 

 

400,701

 

 

643,109

 

 

673,935

 

Impairments, net

 

 

 —

 

 

(1,341,399)

 

 

(35,913)

 

Transaction costs

 

 

(86,765)

 

 

 —

 

 

 —

 

Gain on sales of real estate, net of income taxes

 

 

 —

 

 

 —

 

 

28,010

 

Income tax expense

 

 

(48,181)

 

 

(796)

 

 

(756)

 

Total discontinued operations

 

 

265,755

 

 

(699,086)

 

 

665,276

 

Net income (loss)

 

 

639,926

 

 

(546,418)

 

 

936,591

 

Noncontrolling interests’ share in earnings

 

 

(12,179)

 

 

(12,817)

 

 

(14,358)

 

Net income (loss) attributable to HCP, Inc.

 

 

627,747

 

 

(559,235)

 

 

922,233

 

Participating securities’ share in earnings

 

 

(1,198)

 

 

(1,317)

 

 

(2,437)

 

Net income (loss) applicable to common shares

 

$

626,549

 

$

(560,552)

 

$

919,796

 

Basic earnings per common share:

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.77

 

$

0.30

 

$

0.56

 

Discontinued operations

 

 

0.57

 

 

(1.51)

 

 

1.45

 

Net income (loss) applicable to common shares

 

$

1.34

 

$

(1.21)

 

$

2.01

 

Diluted earnings per common share:

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.77

 

$

0.30

 

$

0.56

 

Discontinued operations

 

 

0.57

 

 

(1.51)

 

 

1.44

 

Net income (loss) applicable to common shares

 

$

1.34

 

$

(1.21)

 

$

2.00

 

Weighted average shares used to calculate earnings per common share:

 

 

 

 

 

 

 

 

 

 

Basic

 

 

467,195

 

 

462,795

 

 

458,425

 

Diluted

 

 

467,403

 

 

462,795

 

 

458,796

 

 

See accompanying Notes to Consolidated Financial Statements.

72


 

Table of Contents

HCP, Inc.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Net income (loss)

    

$

639,926

    

$

(546,418)

    

$

936,591

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

Change in net unrealized (losses) gains on securities:

 

 

 

 

 

 

 

 

 

 

Unrealized (losses) gains

 

 

(62)

 

 

(5)

 

 

13

 

Change in net unrealized gains on cash flow hedges:

 

 

 

 

 

 

 

 

 

 

Unrealized gains

 

 

3,233

 

 

1,894

 

 

2,258

 

Reclassification adjustment realized in net income

 

 

707

 

 

148

 

 

(1,085)

 

Change in Supplemental Executive Retirement Plan obligation

 

 

282

 

 

126

 

 

(627)

 

Foreign currency translation adjustment

 

 

(3,332)

 

 

(8,738)

 

 

(9,967)

 

Total other comprehensive income (loss)

 

 

828

 

 

(6,575)

 

 

(9,408)

 

Total comprehensive income (loss)

 

 

640,754

 

 

(552,993)

 

 

927,183

 

Total comprehensive income attributable to noncontrolling interests

 

 

(12,179)

 

 

(12,817)

 

 

(14,358)

 

Total comprehensive income (loss) attributable to HCP, Inc.

 

$

628,575

 

$

(565,810)

 

$

912,825

 

 

See accompanying Notes to Consolidated Financial Statements.

 

 

 

73


 

Table of Contents

HCP, Inc.

CONSOLIDATED STATEMENTS OF EQUITY

(In thousands, except per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

Dividends

 

Other

 

Total

 

 

 

 

 

 

 

 

 

Common Stock

 

Paid-In

 

In Excess

 

Comprehensive

 

Stockholders’

 

Noncontrolling

 

 Total

 

 

    

Shares

    

Amount

    

Capital

    

Of Earnings

    

Income (Loss)

    

Equity

    

Interests

    

Equity

 

January 1, 2014

 

456,961

 

$

456,961

 

$

11,334,041

 

$

(1,053,215)

 

$

(14,487)

 

$

10,723,300

 

$

207,834

 

$

10,931,134

 

Net income

 

 —

 

 

 —

 

 

 —

 

 

922,233

 

 

 —

 

 

922,233

 

 

14,358

 

 

936,591

 

Other comprehensive income

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(9,408)

 

 

(9,408)

 

 

 —

 

 

(9,408)

 

Issuance of common stock, net

 

2,939

 

 

2,939

 

 

89,749

 

 

 —

 

 

 —

 

 

92,688

 

 

(557)

 

 

92,131

 

Repurchase of common stock

 

(323)

 

 

(323)

 

 

(12,380)

 

 

 —

 

 

 —

 

 

(12,703)

 

 

 —

 

 

(12,703)

 

Exercise of stock options

 

169

 

 

169

 

 

4,292

 

 

 —

 

 

 —

 

 

4,461

 

 

 —

 

 

4,461

 

Amortization of deferred compensation

 

 —

 

 

 —

 

 

21,885

 

 

 —

 

 

 —

 

 

21,885

 

 

 —

 

 

21,885

 

Common dividends ($2.18 per share)

 

 —

 

 

 —

 

 

 —

 

 

(1,001,559)

 

 

 —

 

 

(1,001,559)

 

 

 —

 

 

(1,001,559)

 

Distributions to noncontrolling interests

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(15,611)

 

 

(15,611)

 

Issuance of noncontrolling interests

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

57,746

 

 

57,746

 

Purchase of noncontrolling interests

 

 —

 

 

 —

 

 

(5,600)

 

 

 —

 

 

 —

 

 

(5,600)

 

 

(1,968)

 

 

(7,568)

 

December 31, 2014

 

459,746

 

 

459,746

 

 

11,431,987

 

 

(1,132,541)

 

 

(23,895)

 

 

10,735,297

 

 

261,802

 

 

10,997,099

 

Net (loss) income

 

 —

 

 

 —

 

 

 —

 

 

(559,235)

 

 

 —

 

 

(559,235)

 

 

12,817

 

 

(546,418)

 

Other comprehensive loss

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(6,575)

 

 

(6,575)

 

 

 —

 

 

(6,575)

 

Issuance of common stock, net

 

5,117

 

 

5,117

 

 

176,950

 

 

 —

 

 

 —

 

 

182,067

 

 

(3,183)

 

 

178,884

 

Repurchase of common stock

 

(198)

 

 

(198)

 

 

(8,540)

 

 

 —

 

 

 —

 

 

(8,738)

 

 

 —

 

 

(8,738)

 

Exercise of stock options

 

823

 

 

823

 

 

26,764

 

 

 —

 

 

 —

 

 

27,587

 

 

 —

 

 

27,587

 

Amortization of deferred compensation

 

 —

 

 

 —

 

 

26,127

 

 

 —

 

 

 —

 

 

26,127

 

 

 —

 

 

26,127

 

Common dividends ($2.26 per share)

 

 —

 

 

 —

 

 

 —

 

 

(1,046,638)

 

 

 —

 

 

(1,046,638)

 

 

 —

 

 

(1,046,638)

 

Distributions to noncontrolling interests

 

 —

 

 

 —

 

 

(263)

 

 

 —

 

 

 —

 

 

(263)

 

 

(18,884)

 

 

(19,147)

 

Issuance of noncontrolling interests

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

151,185

 

 

151,185

 

Purchase of noncontrolling interests

 

 —

 

 

 —

 

 

(5,986)

 

 

 —

 

 

 —

 

 

(5,986)

 

 

(1,063)

 

 

(7,049)

 

December 31, 2015

 

465,488

 

$

465,488

 

$

11,647,039

 

$

(2,738,414)

 

$

(30,470)

 

$

9,343,643

 

$

402,674

 

$

9,746,317

 

Net income

 

 —

 

 

 —

 

 

 —

 

 

627,747

 

 

 —

 

 

627,747

 

 

12,179

 

 

639,926

 

Other comprehensive loss

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

828

 

 

828

 

 

 —

 

 

828

 

Issuance of common stock, net

 

2,552

 

 

2,552

 

 

61,625

 

 

 —

 

 

 —

 

 

64,177

 

 

 —

 

 

64,177

 

Conversion of DownREIT units to common stock

 

145

 

 

145

 

 

5,948

 

 

 —

 

 

 —

 

 

6,093

 

 

(6,093)

 

 

 —

 

Repurchase of common stock

 

(237)

 

 

(237)

 

 

(8,448)

 

 

 —

 

 

 —

 

 

(8,685)

 

 

 —

 

 

(8,685)

 

Exercise of stock options

 

133

 

 

133

 

 

3,340

 

 

 —

 

 

 —

 

 

3,473

 

 

 —

 

 

3,473

 

Amortization of deferred compensation

 

 —

 

 

 —

 

 

22,884

 

 

 —

 

 

 —

 

 

22,884

 

 

 —

 

 

22,884

 

Common dividends ($2.095 per share)

 

 —

 

 

 —

 

 

 —

 

 

(979,542)

 

 

 —

 

 

(979,542)

 

 

 —

 

 

(979,542)

 

Distribution of QCP, Inc.

 

 —

 

 

 —

 

 

(3,532,763)

 

 

 —

 

 

 —

 

 

(3,532,763)

 

 

 —

 

 

(3,532,763)

 

Distributions to noncontrolling interests

 

 —

 

 

 —

 

 

(36)

 

 

 —

 

 

 —

 

 

(36)

 

 

(26,311)

 

 

(26,347)

 

Issuance of noncontrolling interests

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

11,834

 

 

11,834

 

Deconsolidation of noncontrolling interests

 

 —

 

 

 —

 

 

(36)

 

 

475

 

 

 —

 

 

439

 

 

67

 

 

506

 

Purchase of noncontrolling interests

 

 —

 

 

 —

 

 

(663)

 

 

 —

 

 

 —

 

 

(663)

 

 

(637)

 

 

(1,300)

 

December 31, 2016

 

468,081

 

$

468,081

 

$

8,198,890

 

$

(3,089,734)

 

$

(29,642)

 

$

5,547,595

 

$

393,713

 

$

5,941,308

 

 

See accompanying Notes to Consolidated Financial Statements.

 

74


 

Table of Contents

HCP, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Cash flows from operating activities:

    

 

    

    

 

    

    

 

    

 

Net income (loss)

 

$

639,926

 

$

(546,418)

 

$

936,591

 

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization of real estate, in-place lease and other intangibles:

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

568,108

 

 

504,905

 

 

455,016

 

Discontinued operations

 

 

4,890

 

 

5,880

 

 

4,979

 

Amortization of market lease intangibles, net

 

 

(1,197)

 

 

(1,295)

 

 

(949)

 

Amortization of deferred compensation

 

 

22,884

 

 

26,127

 

 

21,885

 

Amortization of deferred financing costs

 

 

20,014

 

 

20,222

 

 

19,260

 

Straight-line rents

 

 

(18,003)

 

 

(28,859)

 

 

(41,032)

 

Loan and direct financing lease non-cash interest:

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

599

 

 

(5,648)

 

 

1,063

 

Discontinued operations

 

 

 —

 

 

(90,065)

 

 

(79,349)

 

Deferred rental revenues

 

 

(1,959)

 

 

(2,813)

 

 

(1,884)

 

Equity income from unconsolidated joint ventures

 

 

(11,360)

 

 

(57,313)

 

 

(49,570)

 

Distributions of earnings from unconsolidated joint ventures

 

 

26,492

 

 

15,111

 

 

5,045

 

Lease termination income, net

 

 

 —

 

 

(1,103)

 

 

(38,001)

 

Gain on sales of real estate, net

 

 

(164,698)

 

 

(6,377)

 

 

(31,298)

 

Deferred income tax expense

 

 

47,195

 

 

 —

 

 

 —

 

Loss on debt extinguishment

 

 

46,020

 

 

 —

 

 

 —

 

Foreign exchange and other losses (gains), net

 

 

188

 

 

(7,178)

 

 

(2,270)

 

Impairments, net

 

 

 —

 

 

1,449,748

 

 

35,913

 

Changes in:

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

3,813

 

 

(9,569)

 

 

(8,845)

 

Other assets, net

 

 

(10,805)

 

 

(19,453)

 

 

(6,287)

 

Accounts payable and other accrued liabilities

 

 

42,024

 

 

(23,757)

 

 

28,354

 

Net cash provided by operating activities

 

 

1,214,131

 

 

1,222,145

 

 

1,248,621

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

Acquisition of RIDEA III, net

 

 

 —

 

 

(770,325)

 

 

 —

 

Acquisition of the CCRC unconsolidated joint venture interest, net

 

 

 —

 

 

 —

 

 

(370,186)

 

Acquisitions of other real estate

 

 

(467,162)

 

 

(613,252)

 

 

(503,470)

 

Development of real estate

 

 

(421,322)

 

 

(281,017)

 

 

(178,513)

 

Leasing costs and tenant and capital improvements

 

 

(91,442)

 

 

(84,282)

 

 

(71,734)

 

Proceeds from sales of real estate, net

 

 

647,754

 

 

58,623

 

 

104,557

 

Contributions to unconsolidated joint ventures

 

 

(10,186)

 

 

(69,936)

 

 

(2,935)

 

Distributions in excess of earnings from unconsolidated joint ventures

 

 

28,366

 

 

30,989

 

 

2,657

 

Proceeds from sales of marketable securities

 

 

 —

 

 

2,348

 

 

 —

 

Principal repayments on loans receivable, direct financing leases and other

 

 

231,990

 

 

625,701

 

 

119,511

 

Investments in loans receivable and other

 

 

(273,693)

 

 

(575,652)

 

 

(600,019)

 

Purchase of securities for debt defeasance

 

 

(73,278)

 

 

 —

 

 

 —

 

Decrease (increase) in restricted cash

 

 

18,356

 

 

4,798

 

 

(11,747)

 

Net cash used in investing activities

 

 

(410,617)

 

 

(1,672,005)

 

 

(1,511,879)

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

Net borrowings under bank line of credit

 

 

1,108,417

 

 

98,743

 

 

845,190

 

Repayments under bank line of credit

 

 

(540,000)

 

 

(511,521)

 

 

 —

 

Proceeds related to QCP Spin-Off, net

 

 

1,691,268

 

 

 —

 

 

 —

 

Cash impact of QCP Spin-Off

 

 

(6,096)

 

 

 —

 

 

 —

 

Borrowings under term loan

 

 

 —

 

 

333,014

 

 

 —

 

Issuance of senior unsecured notes

 

 

 —

 

 

1,936,017

 

 

1,150,000

 

Repayments of senior unsecured notes

 

 

(2,000,000)

 

 

(400,000)

 

 

(487,000)

 

Issuance of mortgage and other debt

 

 

 —

 

 

 —

 

 

35,445

 

Debt extinguishment costs

 

 

(45,406)

 

 

 —

 

 

 —

 

Repayments of mortgage and other debt

 

 

(316,774)

 

 

(57,845)

 

 

(447,784)

 

Deferred financing costs

 

 

(9,450)

 

 

(19,995)

 

 

(16,550)

 

Issuance of common stock and exercise of options

 

 

67,650

 

 

206,471

 

 

96,592

 

Repurchase of common stock

 

 

(8,685)

 

 

(8,738)

 

 

(12,703)

 

Dividends paid on common stock

 

 

(979,542)

 

 

(1,046,638)

 

 

(1,001,559)

 

Issuance of noncontrolling interests

 

 

11,834

 

 

110,775

 

 

4,674

 

Purchase of noncontrolling interests

 

 

(1,300)

 

 

(7,049)

 

 

(5,897)

 

Distributions to noncontrolling interests

 

 

(26,181)

 

 

(19,147)

 

 

(15,611)

 

Net cash (used in) provided by financing activities

 

 

(1,054,265)

 

 

614,087

 

 

144,797

 

Effect of foreign exchange on cash and cash equivalents

 

 

(1,019)

 

 

(1,537)

 

 

1,715

 

Net (decrease) increase in cash and cash equivalents

 

 

(251,770)

 

 

162,690

 

 

(116,746)

 

Cash and cash equivalents, beginning of year

 

 

346,500

 

 

183,810

 

 

300,556

 

Cash and cash equivalents, end of year

 

$

94,730

 

$

346,500

 

$

183,810

 

Less: cash and cash equivalents of discontinued operations

 

 

 —

 

 

(6,058)

 

 

(1,894)

 

Cash and cash equivalents of continuing operations, end of year

 

$

94,730

 

$

340,442

 

$

181,916

 

See accompanying Notes to Consolidated Financial Statements.

 

75


 

Table of Contents

HCP, Inc.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1.    Business

Overview

HCP, Inc., an S&P 500 company, is a Maryland corporation that is organized to qualify as a real estate investment trust (“REIT”) which, together with its consolidated entities (collectively, “HCP” or the “Company”), invests primarily in real estate serving the healthcare industry in the United States (“U.S.”). The Company acquires, develops, leases, manages and disposes of healthcare real estate and provides financing to healthcare providers. The Company’s diverse portfolio is comprised of investments in the following reportable healthcare segments: (i) senior housing triple-net (“SH NNN”), (ii) senior housing operating portfolio (“SHOP”), (iii) life science and (iv) medical office.

 

Quality Care Properties, Inc.

On October 31, 2016, the Company completed the spin-off (the “Spin-Off”) of its subsidiary, Quality Care Properties, Inc. (“QCP”) (NYSE:QCP). The Spin-Off assets included 338 properties, primarily comprised of the HCR ManorCare, Inc. (“HCRMC”) direct financing lease (“DFL”) investments and an equity investment in HCRMC. QCP is an independent, publicly-traded, self-managed and self-administrated REIT. As a result of the Spin-Off, the operations of QCP are now classified as discontinued operations in all periods presented herein. See Note 5 for further information on the Spin-Off.

On October 17, 2016, subsidiaries of QCP issued $750 million in aggregate principal amount of senior secured notes due 2023 (the “QCP Notes”), the gross proceeds of which were deposited in escrow until they were released in connection with the consummation of the Spin-Off on October 31, 2016. The QCP Notes bear interest at a rate of 8.125% per annum, payable semiannually. From October 17, 2016 until the completion of the Spin-Off, QCP (a then wholly-owned subsidiary of HCP) incurred $2 million in interest expense. In addition, immediately prior to the effectiveness of the Spin-Off, subsidiaries of QCP received $1.0 billion of proceeds from their borrowings under a senior secured term loan, bearing interest at a rate at QCP’s option of either: (i) LIBOR plus 5.25%, subject to a 1% floor or (ii) a base rate specified in the first lien credit and guaranty agreement plus 4.25%, bringing the total gross proceeds raised by QCP and its subsidiaries under those financings to $1.75 billion. In connection with the consummation of the Spin-Off, QCP and its subsidiaries transferred $1.69 billion in cash and 94 million shares of QCP common stock to HCP and certain of its other subsidiaries, and HCP and its applicable subsidiaries transferred the assets comprising the QCP portfolio to QCP and its subsidiaries. HCP then distributed substantially all of the outstanding shares of QCP common stock to its stockholders, based on the distribution ratio of one share of QCP common stock for every five shares of HCP common stock held by HCP stockholders as of the October 24, 2016 record date for the distribution. The Company recorded the distribution of the assets and liabilities of QCP from its consolidated balance sheet on a historical cost basis as a dividend from stockholders’ equity of $3.5 billion, and no gain or loss was recognized. The Company primarily used the $1.69 billion proceeds of the cash distribution it received from QCP upon consummation of the Spin-Off to pay down certain of the Company’s existing debt obligations.

 

The Company entered into a Separation and Distribution Agreement (the “Separation and Distribution Agreement”) with QCP in connection with the Spin-Off. The Separation and Distribution Agreement divides and allocates the assets and liabilities of the Company prior to the Spin-Off between QCP and HCP, governs the rights and obligations of the parties regarding the Spin-Off, and contains other key provisions relating to the separation of QCP’s business from HCP.

 

In connection with the Spin-Off, the Company entered into a Transition Services Agreement ("TSA") with QCP. Per the terms of the TSA, the Company agreed to provide certain administrative and support services to QCP on a transitional basis for established fees. The TSA will terminate on the expiration of the term of the last service provided under the agreement, which will be on or prior to October 30, 2017. The TSA provides that QCP generally has the right to terminate a transition service upon thirty days’ notice to the Company. The TSA contains provisions under which the Company will, subject to certain limitations, be obligated to indemnify QCP for losses incurred by QCP resulting from the Company’s breach of the TSA.

76


 

Table of Contents

Following completion of the Spin-Off, which occurred on October 31, 2016, HCP is the sole lender to QCP of a $100 million unsecured revolving credit facility maturing in 2018 (the "Unsecured Revolving Credit Facility"). Commitments under the Unsecured Revolving Credit Facility will automatically and permanently decrease each calendar month by an amount equal to 50% of QCP's and its restricted subsidiaries’ retained cash flow for the prior calendar month. All borrowings under the Unsecured Revolving Credit Facility will be subject to the satisfaction of certain conditions, including (i) QCP’s senior secured revolving credit facility being unavailable, (ii) the failure of HCRMC to pay rent and (iii) other customary conditions, including the absence of a default and the accuracy of representations and warranties. QCP may only draw on the Unsecured Revolving Credit Facility prior to the one-year anniversary of the completion of the Spin-Off. Borrowings under the Unsecured Revolving Credit Facility bear interest at a rate equal to LIBOR, subject to a 1.00% floor, plus an applicable margin of 6.25%. In addition to paying interest on outstanding principal under the Unsecured Revolving Credit Facility, QCP is required to pay a facility fee equal to 0.50% per annum of the unused capacity under the Unsecured Revolving Credit Facility to HCP, payable quarterly. At December 31, 2016, no amounts were drawn on the Unsecured Revolving Credit Facility.

 

NOTE 2.    Summary of Significant Accounting Policies

Use of Estimates

Management is required to make estimates and assumptions in the preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”). These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from management’s estimates.

Principles of Consolidation

 

The consolidated financial statements include the accounts of HCP, Inc., its wholly-owned subsidiaries, joint ventures and variable interest entities that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation.

The Company is required to continually evaluate its VIE relationships and consolidate these entities when it is determined to be the primary beneficiary of their operations. A VIE is broadly defined as an entity where either: (i) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support, (ii) substantially all of an entity’s activities either involve or are conducted on behalf of an investor that has disproportionately few voting rights, or (iii) the equity investors as a group lack any of the following: (a) the power through voting or similar rights to direct the activities of an entity that most significantly impact the entity’s economic performance, (b) the obligation to absorb the expected losses of an entity, or (c) the right to receive the expected residual returns of an entity.

A variable interest holder is considered to be the primary beneficiary of a VIE if it has the power to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to the VIE. The Company qualitatively assesses whether it is (or is not) the primary beneficiary of a VIE. Consideration of various factors includes, but is not limited to, its form of ownership interest, its representation on the VIE’s governing body, the size and seniority of its investment, its ability and the rights of other investors to participate in policy making decisions and its ability to replace the VIE manager and/or liquidate the entity.

For its investments in joint ventures that are not considered to be VIEs, the Company evaluates the type of ownership rights held by the limited partner(s) that may preclude consolidation in circumstances in which the sole general partner would otherwise consolidate the limited partnership. The assessment of limited partners’ rights and their impact on the presumption of control over a limited partnership by the sole general partner should be made when an investor becomes the sole general partner and should be reassessed if (i) there is a change to the terms or in the exercisability of the limited partner rights, (ii) the sole general partner increases or decreases its ownership interest in the limited partnership, or (iii) there is an increase or decrease in the number of outstanding limited partnership interests. The Company similarly evaluates the rights of managing members of limited liability companies.

77


 

Table of Contents

Revenue Recognition

At the inception of a new lease arrangement, including new leases that arise from amendments, the Company assesses its terms and conditions to determine the proper lease classification. A lease arrangement is classified as an operating lease if none of the following criteria are met: (i) transfer of ownership to the lessee prior to or shortly after the end of the lease term, (ii) lessee has a bargain purchase option during or at the end of the lease term, (iii) the lease term is equal to 75% or more of the underlying property’s economic life, or (iv) the present value of future minimum lease payments (excluding executory costs) is equal to 90% or more of the excess fair value (over retained tax credits) of the leased property. If one of the four criteria is met and the minimum lease payments are determined to be reasonably predictable and collectible, the lease arrangement is generally accounted for as a direct financing lease (“DFL”).

The Company utilizes the direct finance method of accounting to record DFL income. For a lease accounted for as a DFL, the net investment in the DFL represents receivables for the sum of future minimum lease payments and the estimated residual value of the leased property, less the unamortized unearned income. Unearned income is deferred and amortized to income over the lease term to provide a constant yield when collectibility of the lease payments is reasonably assured.

The Company commences recognition of rental revenue for operating lease arrangements when the tenant has taken possession or controls the physical use of a leased asset; the tenant is not considered to have taken physical possession or have control of the leased asset until the Company-owned tenant improvements are substantially completed. If a lease arrangement provides for tenant improvements, the Company determines whether the tenant improvements are owned by the tenant or the Company. When the Company is the owner of the tenant improvements, any tenant improvements funded by the tenant are treated as lease payments which are deferred and amortized into income over the lease term. When the tenant is the owner of the tenant improvements, any tenant improvement allowance that is funded by the Company is treated as a lease incentive and amortized as a reduction of revenue over the lease term. Ownership of tenant improvements is determined based on various factors including, but not limited to, the following criteria:

·

lease stipulations of how and on what a tenant improvement allowance may be spent;

·

which party to the arrangement retains legal title to the tenant improvements upon lease expiration;

·

whether the tenant improvements are unique to the tenant or general purpose in nature; and

·

if the tenant improvements are expected to have significant residual value at the end of the lease term.

Certain leases provide for additional rents that are contingent upon a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the base amount or other thresholds, and only after any contingency has been removed (when the related thresholds are achieved). This may result in the recognition of rental revenue in periods subsequent to when such payments are received.

Tenant recoveries subject to operating leases generally relate to the reimbursement of real estate taxes, insurance and repairs and maintenance expense. These expenses are recognized as revenue in the period they are incurred. The reimbursements of these expenses are recognized and presented gross, as the Company is generally the primary obligor and, with respect to purchasing goods and services from third party suppliers, has discretion in selecting the supplier and bears the associated credit risk.

For operating leases with minimum scheduled rent increases, the Company recognizes income on a straight line basis over the lease term when collectibility is reasonably assured. Recognizing rental income on a straight line basis results in a difference in the timing of revenue amounts from what is contractually due from tenants. If the Company determines that collectibility of straight line rents is not reasonably assured, future revenue recognition is limited to amounts contractually owed and paid, and, when appropriate, an allowance for estimated losses is established.

Resident fee revenue is recorded when services are rendered and includes resident room and care charges, community fees and other resident charges. Residency agreements are generally for a term of 30 days to one year, with resident fees billed monthly. Revenue for certain care related services is recognized as services are provided and is billed monthly in arrears.

78


 

Table of Contents

Loans receivable are classified as held-for-investment based on management’s intent and ability to hold the loans for the foreseeable future or to maturity. Loans held-for-investment are carried at amortized cost and are reduced by a valuation allowance for estimated credit losses as necessary. The Company recognizes interest income on loans, including the amortization of discounts and premiums, loan fees paid and received, using the interest method. The interest method is applied on a loan-by-loan basis when collectibility of the future payments is reasonably assured. Premiums and discounts are recognized as yield adjustments over the term of the related loans. Loans are transferred from held-for-investment to held-for-sale when management’s intent is to no longer hold the loans for the foreseeable future. Loans held-for-sale are recorded at the lower of cost or fair value.

The Company recognizes a gain on sales of real estate upon the closing of a transaction with the purchaser. Gains on real estate sold are recognized using the full accrual method when collectibility of the sales price is reasonably assured, the Company is not obligated to perform additional activities that may be considered significant, the initial investment from the buyer is sufficient and other profit recognition criteria have been satisfied. Gain on sales of real estate may be deferred in whole or in part until the requirements for gain recognition have been met.

Allowance for Doubtful Accounts

The Company evaluates the liquidity and creditworthiness of its tenants, operators and borrowers on a monthly and quarterly basis. The Company’s evaluation considers industry and economic conditions, individual and portfolio property performance, credit enhancements, liquidity and other factors. The Company’s tenants, borrowers and operators furnish property, portfolio and guarantor/operator-level financial statements, among other information, on a monthly or quarterly basis; the Company utilizes this financial information to calculate the lease or debt service coverages that it uses as a primary credit quality indicator. Lease and debt service coverage information is evaluated together with other property, portfolio and operator performance information, including revenue, expense, net operating income, occupancy, rental rate, reimbursement trends, capital expenditures and EBITDA (defined as earnings before interest, tax, and depreciation and amortization), along with other liquidity measures. The Company evaluates, on a monthly basis or immediately upon a significant change in circumstance, its tenants’, operators’ and borrowers’ ability to service their obligations with the Company.

The Company maintains an allowance for doubtful accounts for straight-line rent receivables resulting from tenants’ inability to make contractual rent and tenant recovery payments or lease defaults. For straight-line rent receivables, the Company’s assessment is based on amounts estimated to be recoverable over the lease term.

In connection with the Company’s quarterly review process or upon the occurrence of a significant event, loans receivable and DFLs (collectively, “Finance Receivables”), are reviewed and assigned an internal rating of Performing, Watch List or Workout. Finance Receivables that are deemed Performing meet all present contractual obligations, and collection and timing, of all amounts owed is reasonably assured. Watch List Finance Receivables are defined as Finance Receivables that do not meet the definition of Performing or Workout. Workout Finance Receivables are defined as Finance Receivables in which the Company has determined, based on current information and events, that: (i) it is probable it will be unable to collect all amounts due according to the contractual terms of the agreement, (ii) the tenant, operator, or borrower is delinquent on making payments under the contractual terms of the agreement and (iii) the Company has commenced action or anticipates pursuing action in the near term to seek recovery of its investment.

Finance Receivables are placed on nonaccrual status when management determines that the collectibility of contractual amounts is not reasonably assured (the asset will have an internal rating of either Watch List or Workout). Further, the Company performs a credit analysis to support the tenant’s, operator’s, borrower’s and/or guarantor’s repayment capacity and the underlying collateral values. The Company uses the cash basis method of accounting for Finance Receivables placed on nonaccrual status unless one of the following conditions exist whereby it utilizes the cost recovery method of accounting: (i) if the Company determines that it is probable that it will only recover the recorded investment in the Finance Receivable, net of associated allowances or charge-offs (if any), or (ii) the Company cannot reasonably estimate the amount of an impaired Finance Receivable. For cash basis method of accounting the Company applies payments received, excluding principal paydowns, to interest income so long as that amount does not exceed the amount that would have been earned under the original contractual terms. For cost recovery method of accounting any payment received is applied to reduce the recorded investment. Generally, the Company returns a Finance Receivable to accrual status when all delinquent payments become current under the terms of the loan or lease agreements and collectibility of the remaining contractual loan or lease payments is reasonably assured.

79


 

Table of Contents

Allowances are established for Finance Receivables on an individual basis utilizing an estimate of probable losses, if they are determined to be impaired. Finance Receivables are impaired when it is deemed probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the loan or lease. An allowance is based upon the Company’s assessment of the lessee’s or borrower’s overall financial condition, economic resources, payment record, the prospects for support from any financially responsible guarantors and, if appropriate, the net realizable value of any collateral. These estimates consider all available evidence, including the expected future cash flows discounted at the Finance Receivable’s effective interest rate, fair value of collateral, general economic conditions and trends, historical and industry loss experience, and other relevant factors, as appropriate. Should a Finance Receivable be deemed partially or wholly uncollectible, the uncollectible balance is charged off against the allowance in the period in which the uncollectible determination has been made.

Real Estate

The Company’s real estate assets, consisting of land, buildings and improvements are recorded at fair value upon acquisition and/or consolidation. Any assumed liabilities, other acquired tangible assets or identifiable intangibles are also recorded at fair value upon acquisition and/or consolidation. The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate appropriate discount and/or capitalization rates or other available market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant. Transaction costs related to acquisitions of businesses, including properties, are expensed as incurred.

The Company records acquired “above and below market” leases at fair value using discount rates which reflect the risks associated with the leases acquired. The amount recorded is based on the present value of the difference between (i) the contractual amounts paid pursuant to each in-place lease and (ii) management’s estimate of fair market lease rates for each in-place lease, measured over a period equal to the remaining term of the lease for above market leases and the initial term plus the extended term for any leases with bargain renewal options. Other intangible assets acquired include amounts for in-place lease values that are based on an evaluation of the specific characteristics of each property and the acquired tenant lease(s). Factors considered include estimates of carrying costs during hypothetical expected lease-up periods, market conditions and costs to execute similar leases. In estimating carrying costs, the Company includes estimates of lost rents at market rates during the hypothetical expected lease-up periods, which are dependent on local market conditions and expected trends. In estimating costs to execute similar leases, the Company considers leasing commissions, legal and other related costs.

The Company capitalizes direct construction and development costs, including predevelopment costs, interest, property taxes, insurance and other costs directly related and essential to the development or construction of a real estate asset. The Company capitalizes construction and development costs while substantive activities are ongoing to prepare an asset for its intended use. The Company considers a construction project as substantially complete and held available for occupancy upon the completion of Company-owned tenant improvements, but no later than one year from cessation of significant construction activity. Costs incurred after a project is substantially complete and ready for its intended use, or after development activities have ceased, are expensed as incurred. For redevelopment of existing operating properties, the Company capitalizes the cost for the construction and improvement incurred in connection with the redevelopment.

Costs previously capitalized related to abandoned developments/redevelopments are charged to earnings. Expenditures for repairs and maintenance are expensed as incurred. The Company considers costs incurred in conjunction with re-leasing properties, including tenant improvements and lease commissions, to represent the acquisition of productive assets and, accordingly, such costs are reflected as investing activities in the Company’s consolidated statement of cash flows.

The Company computes depreciation on properties using the straight-line method over the assets’ estimated useful lives. Depreciation is discontinued when a property is identified as held for sale. Buildings and improvements are depreciated over useful lives ranging up to 60 years. Market lease intangibles are amortized primarily to revenue over the remaining noncancellable lease terms and bargain renewal periods, if any. In-place lease intangibles are amortized to expense over the remaining noncancellable lease term and bargain renewal periods, if any.

80


 

Table of Contents

Impairment of Long-Lived Assets and Goodwill

The Company assesses the carrying value of real estate assets and related intangibles (“real estate assets”) when events or changes in circumstances indicate that the carrying value may not be recoverable. The Company tests its real estate assets for impairment by comparing the sum of the expected future undiscounted cash flows to the carrying value of the real estate assets. The expected future undiscounted cash flows are calculated utilizing the lowest level of identifiable cash flows that are largely independent of the cash flows of other assets and liabilities. If the carrying value exceeds the expected future undiscounted cash flows, an impairment loss will be recognized to the extent that the carrying value of the real estate assets is greater than their fair value. If an asset is classified as held for sale, it is reported at the lower of its carrying value or fair value less costs to sell and no longer depreciated.

Goodwill is tested for impairment at least annually based on certain qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value. Potential impairment indicators include a significant decline in real estate values, significant restructuring plans, current macroeconomic conditions, state of the equity and capital markets or a significant decline in the Company’s market capitalization. If the Company determines that it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company applies the required two-step quantitative approach. The quantitative procedures of the two-step approach (i) compare the fair value of a reporting unit with its carrying value, including goodwill, and, if necessary, (ii) compare the implied fair value of reporting unit goodwill with the carrying value as if it had been acquired in a business combination at the date of the impairment test. The excess fair value of the reporting unit over the fair value of assets and liabilities, excluding goodwill, is the implied value of goodwill and is used to determine the impairment amount, if any. The Company has selected the fourth quarter of each fiscal year to perform its annual impairment test.

Assets Held for Sale and Discontinued Operations

Prior to the Company’s adoption of Accounting Standards Update (“ASU”) No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”), a discontinued operation was a component of an entity that had either been disposed of or was deemed to be held for sale and, (i) the operations and cash flows of the component had been or was to be eliminated from ongoing operations as a result of the disposal transaction, and (ii) the entity was not to have any significant continuing involvement in the operations of the component after the disposal transaction. Subsequent to the Company’s adoption of ASU 2014-08 on April 1, 2014, a discontinued operation must further represent that a disposal is a strategic shift that has (or will have) a major effect on the Company’s operations and financial results.

Investments in Unconsolidated Joint Ventures

Investments in entities which the Company does not consolidate, but has the ability to exercise significant influence over the operating and financial policies of, are reported under the equity method of accounting. Under the equity method of accounting, the Company’s share of the investee’s earnings or losses is included in the Company’s consolidated results of operations.

The initial carrying value of investments in unconsolidated joint ventures is based on the amount paid to purchase the joint venture interest or the fair value of the assets prior to the sale of interests in the joint venture. To the extent that the Company’s cost basis is different from the basis reflected at the joint venture level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of equity in earnings of the joint venture. The Company evaluates its equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value. When the Company determines a decline in the fair value of an investment in an unconsolidated joint venture below its carrying value is other-than-temporary, an impairment is recorded. The Company recognizes gains on the sale of interests in joint ventures to the extent the economic substance of the transaction is a sale.

The Company’s fair values of its equity method investments are determined based on discounted cash flow models that include all estimated cash inflows and outflows over a specified holding period and, where applicable, any estimated debt premiums or discounts. Capitalization rates, discount rates and credit spreads utilized in these valuation models are based upon assumptions that the Company believes to be within a reasonable range of current market rates for the respective investments.

81


 

Table of Contents

Share-Based Compensation

Compensation expense for share-based awards granted to employees, including grants of employee stock options, are recognized in the consolidated statements of operations based on their grant date fair market value. Compensation expense for awards with graded vesting schedules is generally recognized on a straight-line basis over the vesting period. Forfeitures of share-based awards are recognized as they occur.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash on hand and short-term investments with original maturities of three months or less when purchased.

Restricted Cash

Restricted cash primarily consists of amounts held by mortgage lenders to provide for (i) real estate tax expenditures, tenant improvements and capital expenditures, (ii) security deposits, and (iii) net proceeds from property sales that were executed as tax-deferred dispositions.

Derivatives and Hedging

During its normal course of business, the Company uses certain types of derivative instruments for the purpose of managing interest rate and foreign currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company’s related assertions.

The Company recognizes all derivative instruments, including embedded derivatives that are required to be bifurcated, as assets or liabilities in the consolidated balance sheets at fair value. Changes in fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in earnings. For derivative instruments designated in qualifying cash flow hedging relationships, changes in fair value related to the effective portion of the derivative instruments are recognized in accumulated other comprehensive income (loss), whereas changes in fair value of the ineffective portion are recognized in earnings.

Using certain of its British pound sterling (“GBP”) denominated debt, the Company applies net investment hedge accounting to hedge the foreign currency exposure from its net investment in GBP-functional subsidiaries. The variability of the GBP-denominated debt due to changes in the GBP to U.S. dollar (“USD”) exchange rate (“remeasurement value”) is recognized as part of the cumulative translation adjustment component of accumulated other comprehensive income (loss).

The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivative instruments that are part of a hedging relationship to specific forecasted transactions as well as recognized obligations or assets in the consolidated balance sheets. The Company also assesses and documents, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivative instruments are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative instrument ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, the Company discontinues its cash flow hedge accounting prospectively and records the appropriate adjustment to earnings based on the current fair value of the derivative instrument. For net investment hedge accounting, upon sale or liquidation of the hedged investment, the cumulative balance of the remeasurement value is reclassified to earnings.

Income Taxes

HCP, Inc. elected REIT status and believes it has always operated so as to continue to qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986, as amended (the “Code”). Accordingly, HCP, Inc. will not be subject to U.S. federal income tax, provided that it continues to qualify as a REIT and makes distributions to stockholders equal to or in excess of its taxable income. In addition, the Company has formed several consolidated subsidiaries, which have elected REIT status. HCP, Inc. and its consolidated REIT subsidiaries are each subject to the REIT qualification requirements under the Code. If any REIT fails to qualify as a REIT in any taxable year, it will be subject to federal income taxes at regular corporate rates and may be ineligible to qualify as a REIT for four subsequent tax years.

82


 

Table of Contents

HCP, Inc. and its consolidated REIT subsidiaries are subject to state, local and foreign income taxes in some jurisdictions, and in certain circumstances each REIT may also be subject to federal excise taxes on undistributed income. In addition, certain activities that the Company undertakes may be conducted by entities which have elected to be treated as taxable REIT subsidiaries (“TRSs”). TRSs are subject to both federal and state income taxes. The Company recognizes tax penalties relating to unrecognized tax benefits as additional income tax expense. Interest relating to unrecognized tax benefits is recognized as interest expense.

Marketable Securities

The Company classifies its marketable equity securities as available for sale. These securities are carried at fair value with unrealized gains and losses recognized in stockholders’ equity as a component of accumulated other comprehensive income (loss). Gains or losses on securities sold are determined based on the specific identification method. The Company classifies its marketable debt securities as held to maturity, because the Company has the positive intent and ability to hold the securities to maturity. Held to maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. When the Company determines declines in fair value of marketable securities are other-than-temporary, a loss is recognized in earnings.

Capital Raising Issuance Costs

Costs incurred in connection with the issuance of common shares are recorded as a reduction of additional paid-in capital. Debt issuance costs related to debt instruments excluding line of credit arrangements are deferred, recorded as a reduction of the related debt liability, and amortized to interest expense over the remaining term of the related debt liability utilizing the interest method. Debt issuance costs related to line of credit arrangements are deferred, included in other assets, and amortized to interest expense over the remaining term of the related line of credit arrangement utilizing the interest method.

Penalties incurred to extinguish debt and any remaining unamortized debt issuance costs, discounts and premiums are recognized as income or expense in the consolidated statements of operations at the time of extinguishment.

Segment Reporting

The Company’s reportable segments, based on how it evaluates its business and allocates resources, are as follows: (i) SH NNN, (ii) SHOP, (iii) life science and (iv) medical office.

Prior to the third quarter of 2016, the Company operated through five reportable segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. During the third quarter of 2016, primarily as a result of the planned spin-off of QCP, the Company revised its operating analysis structure. The Company believes the change to its reportable segments is appropriate and consistent with how its chief operating decision makers review the Company’s operating results and determine resource allocations. Accordingly, all prior period segment information has been reclassified to conform to the current period presentation.

Noncontrolling Interests

Arrangements with noncontrolling interest holders are reported as a component of equity separate from the Company’s equity. Net income attributable to a noncontrolling interest is included in net income on the consolidated statements of operations and, upon a gain or loss of control, the interest purchased or sold, and any interest retained, is recorded at fair value with any gain or loss recognized in earnings. The Company accounts for purchases or sales of equity interests that do not result in a change in control as equity transactions.

The Company consolidates non-managing member limited liability companies (“DownREITs”) because it exercises control, and the noncontrolling interests in these entities are carried at cost. The non-managing member limited liability company (“LLC”) units (“DownREIT units”) are exchangeable for an amount of cash approximating the then-current market value of shares of the Company’s common stock or, at the Company’s option, shares of the Company’s common stock (subject to certain adjustments, such as stock splits and reclassifications). Upon exchange of DownREIT units for the Company’s common stock, the carrying amount of the DownREIT units is reclassified to stockholders’ equity.

Foreign Currency Translation and Transactions

Assets and liabilities denominated in foreign currencies that are translated into U.S. dollars use exchange rates in effect at the end of the period, and revenues and expenses denominated in foreign currencies that are translated into U.S. dollars

83


 

Table of Contents

use average rates of exchange in effect during the related period. Gains or losses resulting from translation are included in accumulated other comprehensive income (loss), a component of stockholders’ equity on the consolidated balance sheets. Gains or losses resulting from foreign currency transactions are translated into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of transaction gains or losses are included in other income, net in the consolidated statements of operations.

Life Care Bonds Payable

Certain of the Company’s continuing care retirement communities (“CCRCs”) issue non-interest bearing life care bonds payable to certain residents of the CCRCs. Generally, the bonds are refundable to the resident or to the resident’s estate upon termination or cancellation of the CCRC agreement or upon the successful resale of the unit. Proceeds from the issuance of new bonds are used to retire existing bonds, and since the maturity of the obligations for the facilities is not determinable, no interest is imputed. These amounts are included in other debt in the Company’s consolidated balance sheets.

Fair Value Measurement

The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:

·

Level 1—quoted prices for identical instruments in active markets;

·

Level 2—quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

·

Level 3—fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The Company measures fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at fair value. When available, the Company utilizes quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1. In instances where a market price is available, but the instrument is in an inactive or over-the-counter market, the Company consistently applies the dealer (market maker) pricing estimate and classifies the asset or liability in Level 2.

If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads and/or market capitalization rates. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or Level 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by the Company include discounted cash flow and Black-Scholes valuation models. The Company also considers its counterparty’s and own credit risk for derivative instruments and other liabilities measured at fair value. The Company has elected the mid-market pricing expedient when determining fair value.

Earnings per Share

Basic earnings per common share is computed by dividing net income applicable to common shares by the weighted average number of shares of common stock outstanding during the period. The Company accounts for unvested share-based payment awards that contain non-forfeitable dividend rights or dividend equivalents (whether paid or unpaid) as participating securities, which are included in the computation of earnings per share pursuant to the two-class method. Diluted earnings per common share is calculated by including the effect of dilutive securities.

Recent Accounting Pronouncements

In March 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”). ASU 2016-09 is intended

84


 

Table of Contents

to simplify accounting for share-based payment transactions. The areas for simplification in this update involve several aspects of accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities and classification on the statements of cash flows. ASU 2016-09 is effective for fiscal years, and interim periods within, beginning after December 15, 2016. Early adoption is permitted. The transition method required by ASU 2016-09 varies based on the specific amendment being adopted. The Company adopted ASU 2016-09 on October 1, 2016; the adoption of which did not have a material impact to its consolidated financial position, results of operations or statements of cash flows. As a result of the new guidance, the Company formally disclosed its policy regarding the treatment of forfeitures of stock compensation awards (see Share-Based Compensation above).

In September 2015, the FASB issued ASU No. 2015-16, Simplifying the Accounting for Measurement-Period Adjustments (“ASU 2015-16”). ASU 2015-16 simplifies the accounting for adjustments made to provisional amounts recognized in a business combination by requiring the acquirer to (i) recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amount is determined, (ii) record, in the same period, the effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date and (iii) present separately or disclose the portion of the amount recorded in current-period earnings by line item that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. ASU 2015-16 is effective for fiscal years, and interim periods within, beginning after December 15, 2015. Early adoption is permitted. The Company adopted ASU 2015-16 on January 1, 2016; the adoption of which did not have a material impact on its consolidated financial position or results of operations.

In February 2015, the FASB issued ASU No. 2015-02, Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 requires amendments to both the VIE and voting consolidation accounting models. The amendments (i) rescind the indefinite deferral of certain aspects of accounting standards relating to consolidations and provide a permanent scope exception for registered money market funds and similar unregistered money market funds, (ii) modify (a) the identification of variable interests (fees paid to a decision maker or service provider), (b) the VIE characteristics for a limited partnership or similar entity and (c) the primary beneficiary determination under the VIE model and (iii) eliminate the presumption within the current voting model that a general partner controls a limited partnership or similar entity. ASU 2015-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2015. Early adoption is permitted. A reporting entity may apply the amendments in ASU 2015-02 using either a modified retrospective or retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The Company adopted ASU 2015-02 on January 1, 2016; the adoption of which did not have a material impact to its consolidated financial position or results of operations.

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). The amendments in ASU 2017-04 eliminate the current two-step approach used to test goodwill for impairment and require an entity to apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit's carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. ASU 2017-04 is effective for fiscal years, including interim periods within, beginning after December 15, 2019 (upon the first goodwill impairment test performed during that fiscal year). Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. A reporting entity must apply the amendments in ASU 2017-04 using a prospective approach. The Company does not expect the adoption of ASU 2017-04 to have a material impact to its consolidated financial position or results of operations.

In January 2017, the FASB issued ASU No. 2017-01, Clarifying the Definition of a Business (“ASU 2017-01”). The amendments in ASU 2017-01 provide an initial screen to determine if substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single identifiable asset or a group of similar identifiable assets, in which case, the transaction would be accounted for as an asset acquisition. In addition, ASU 2017-01 clarifies the requirements for a set of activities to be considered a business and narrows the definition of an output. ASU 2017-01 is effective for fiscal years, and interim periods within, beginning after December 15, 2017. Early adoption is permitted. A reporting entity must apply the amendments in ASU 2017-01 using a prospective approach. The Company plans to adopt ASU 2017-01 during the first quarter of 2017. Upon adoption of ASU 2017-01, the Company expects to recognize a majority of its real estate acquisitions and dispositions as asset transactions rather than business combinations which will result in the capitalization of related third party transaction costs.

85


 

Table of Contents

In November 2016, the FASB issued ASU No. 2016-18, Restricted Cash (“ASU 2016-18”). The amendments in ASU 2016-18 require an entity to reconcile and explain the period-over-period change in total cash, cash equivalents and restricted cash within its statements of cash flows. ASU 2016-18 is effective for fiscal years, and interim periods within, beginning after December 15, 2017. Early adoption is permitted. A reporting entity must apply the amendments in ASU 2016-18 using a full retrospective approach. The Company does not expect the adoption of ASU 2016-18 to have a material impact to its consolidated statements of cash flows as the Company does not have material restricted cash activity.

In August 2016, the FASB issued ASU No. 2016-15, Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). The amendments in ASU 2016-15 are intended to clarify current guidance on the classification of certain cash receipts and cash payments in the statement of cash flows. ASU 2016-15 is effective for fiscal years, and interim periods within, beginning after December 15, 2017. Early adoption is permitted. A reporting entity must apply the amendments in ASU 2016-18 using a full retrospective approach. The Company is currently in compliance with substantially all of the clarifications in ASU 2016-15 and as such, the Company does not expect the adoption of ASU 2016-15 to have a material impact to its consolidated statements of cash flows.

In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. This update also simplifies the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment at each reporting period. ASU 2016-01 is effective for fiscal years, and interim periods within, beginning after December 15, 2017. Early adoption is permitted only for updates to certain disclosure requirements. A reporting entity is required to apply the amendments in ASU 2016-01 using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The Company does not have any material equity investments, other than those that are accounted for using the equity method of accounting, and as such, does not expect the adoption of ASU 2016-01 to have a material impact to its consolidated financial position or results of operations.

In October 2016, the FASB issued ASU No. 2016-16, Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”). The amendments in ASU 2016-16 require an entity to recognize the income tax consequences of intra-entity transfers of assets other than inventory at the time that the transfer occurs. Current guidance does not require recognition of tax consequences until the asset is eventually sold to a third party. ASU 2016-16 is effective for fiscal years, and interim periods within, beginning after December 15, 2017. Early adoption is permitted as of the first interim period presented in a year. A reporting entity must apply the amendments in ASU 2016-16 using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. The Company is evaluating the impact of the adoption of ASU 2016-16 on January 1, 2018 to its consolidated financial position and results of operations. The Company does not expect the adoption of ASU 2016-16 to have a material impact to its consolidated financial position or results of operations.

In June 2016, the FASB issued ASU No. 2016-13, Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 is intended to improve financial reporting by requiring timelier recognition of credit losses on loans and other financial instruments held by financial institutions and other organizations. The amendments in ASU 2016-13 eliminate the “probable” initial threshold for recognition of credit losses in current accounting guidance and, instead, reflect an entity’s current estimate of all expected credit losses. Previously, when credit losses were measured under current accounting guidance, an entity generally only considered past events and current conditions in measuring the incurred loss. The amendments in ASU 2016-13 broaden the information that an entity must consider in developing its expected credit loss estimate for assets measured either collectively or individually. The use of forecasted information incorporates more timely information in the estimate of expected credit loss. ASU 2016-13 is effective for fiscal years, and interim periods within, beginning after December 15, 2019. Early adoption is permitted for fiscal years, and interim periods within, beginning after December 15, 2018. A reporting entity is required to apply the amendments in ASU 2016-13 using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption. A prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. Upon adoption of ASU 2016-13, the Company is required to reassess its financing receivables, including direct finance leases and loans receivable, and expects that application of ASU 2016-13 may result in the Company recognizing credit losses at an earlier date than would otherwise be recognized under

86


 

Table of Contents

current accounting guidance. As such, the Company is still evaluating the impact of the adoption of ASU 2016-13 on January 1, 2020 to its consolidated financial position and results of operations.

In February 2016, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02”). ASU 2016-02 amends the current accounting for leases to (i) require lessees to put most leases on their balance sheets, but continue recognizing expenses on their income statements in a manner similar to requirements under current accounting guidance, (ii) eliminate current real estate specific lease provisions and (iii) modify the classification criteria and accounting for sales-type leases for lessors. ASU 2016-02 is effective for fiscal years, and interim periods within, beginning after December 15, 2018. Early adoption is permitted. The transition method required by ASU 2016-02 varies based on the specific amendment being adopted. As a result of adopting ASU 2016-02, the Company will recognize all of its operating leases for which it is the lessee, including corporate office leases and ground leases, on its consolidated balance sheets and will capitalize fewer legal costs related to the drafting and execution of its lease agreements. The Company is evaluating the impact of the adoption of ASU 2016-02 on January 1, 2019 to its consolidated financial position and results of operations.

Between May 2014 and May 2016, the FASB issued three ASUs changing the requirements for recognizing and reporting revenue (together, herein referred to as the “Revenue ASUs”): (i) ASU No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), (ii) ASU No. 2016-08, Principal versus Agent Considerations (Reporting Revenue Gross versus Net) (“ASU 2016-08”) and (iii) ASU No. 2016-12, Narrow-Scope Improvements and Practical Expedients (“ASU 2016-12”). ASU 2014-09 provides guidance for revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2016-08 is intended to improve the operability and understandability of the implementation guidance on principal versus agent considerations. ASU 2016-12 provides practical expedients and improvements on the previously narrow scope of ASU 2014-09. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date (“ASU 2015-14”). ASU 2015-14 defers the effective date of ASU 2014-09 by one year to fiscal years, and interim periods within, beginning after December 15, 2017. All subsequent ASUs related to ASU 2014-09, including ASU 2016-08 and ASU 2016-12, assumed the deferred effective date enforced by ASU 2015-14. Early adoption of the Revenue ASUs is permitted for annual periods, and interim periods within, beginning after December 15, 2016. A reporting entity may apply the amendments in the Revenue ASUs using either a modified retrospective approach, by recording a cumulative-effect adjustment to equity as of the beginning of the fiscal year of adoption or full retrospective approach. The Company is evaluating the complete impact of the adoption of the Revenue ASUs on January 1, 2018 to its consolidated financial position and results of operations. As the primary source of revenue for the Company is generated through leasing arrangements, which are excluded from the Revenue ASUs, the Company expects that it will be impacted in its recognition of non-lease revenue, such as certain resident fees in its RIDEA structures (a portion of which are not generated through leasing arrangements) and its recognition of real estate sale transactions. Under ASU 2014-09, revenue recognition for real estate sales is largely based on the transfer of control versus continuing involvement under current guidance. As a result, the Company generally expects that the new guidance will result in more transactions qualifying as sales of real estate and revenue being recognized at an earlier date than under current accounting guidance. 

Reclassifications

Certain amounts in the Company’s consolidated financial statements have been reclassified for prior periods to conform to the current period presentation. Certain prior period amounts have been reclassified on the consolidated balance sheets and consolidated statements of operations for discontinued operations (see Note 5). See Segment Reporting above for additional reclassifications. 

 

NOTE 3.     Brookdale Lease Amendments and Terminations and the Formation of Two RIDEA Joint Ventures (“Brookdale Transaction”)

On July 31, 2014, Brookdale Senior Living (“Brookdale”) completed its acquisition of Emeritus Corporation (“Emeritus”). On August 29, 2014, the Company and Brookdale completed a multiple-element transaction with three major components:

·

amended existing lease agreements on 153 HCP-owned senior housing communities previously leased and operated by Emeritus, that included the termination of embedded purchase options in the leases relating to 30 properties and future rent reductions;

87


 

Table of Contents

·

terminated existing lease agreements on 49 HCP-owned senior housing properties previously leased and operated by Emeritus, that included the termination of embedded purchase options in these leases relating to 19 properties. At closing, the Company contributed 48 of these properties to newly formed consolidated partnerships that are operated under a structure permitted by the Housing and Economic Recovery Act of 2008 (commonly referred to as “RIDEA”) (“RIDEA II”); the 49th property was contributed on January 1, 2015. Brookdale owns a 20% noncontrolling equity interest in the RIDEA II entities (“SH PropCo” and “SH OpCo”) and manages the facilities on behalf of the partnership (see Note 5 for the disposition of a portion of our interest in RIDEA II in January 2017); and

·

entered into new unconsolidated joint ventures that own 14 campuses of continuing care retirement communities (“CCRC”) in a RIDEA structure (collectively, the “CCRC JV”) with the Company owning a 49% equity interest and Brookdale owning a 51% equity interest. Brookdale manages these communities on behalf of this partnership. 

Leases Amended on 153 Properties (“NNN Lease Restructuring”)

Effectively, the Company paid consideration of $129 million to terminate the existing purchase options and received consideration of: (i) $76 million for lower rent payments and escalators and (ii) $53 million to settle the amount that the Company owed to Brookdale for the RIDEA II transaction.

The Company amortizes the $53 million of net consideration paid to Brookdale for the NNN Lease Restructuring as a reduction in rental income on a straight-line basis over the term of the new leases. Additionally, the lease-related intangibles, initial direct costs and straight-line rent receivables associated with the previous leases will be amortized prospectively over the new (or amended) lease terms.

Lease Terminations of 49 Properties that were contributed to a RIDEA Structure (RIDEA II)

The net value of the terminated leases and forfeited purchase options was $108 million ($131 million for the value of the terminated leases, less $23 million for the value of the forfeited purchase options).

As consideration for the net value of $108 million for the terminated leases and the $47 million sale to Brookdale of the 20% noncontrolling interest in RIDEA II, the Company received the following: (i) a $34 million short-term receivable recorded in other assets (repaid in June 2016); (ii) a $68 million note from Brookdale (the “Brookdale Receivable”) recorded in loans receivable that was repaid in November 2014; and (iii) an effective offset for the $53 million associated with the additional consideration owed by the Company to Brookdale for the NNN Lease Restructuring transaction discussed above. The fair values of the short-term receivable and Brookdale Receivable were estimated based on similar instruments available in the marketplace and are considered to be Level 2 measurements within the fair value hierarchy.

As a result of terminating these leases, the Company recognized a net gain of $38 million consisting of: (i) $108 million gain based on the fair value of the net consideration received; less (ii) $70 million to write-off the direct leasing costs and straight-line rent receivables related to the former in-place leases.

Fair Value Measurement Techniques and Quantitative Information

The fair values of the forfeited rental payments and purchase option rights related to the NNN Lease Restructuring and the RIDEA II were based on the income approach and are considered Level 3 measurements within the fair value hierarchy. The Company utilized discounted cash flow models with observable and unobservable valuation inputs. These fair value measurements, or valuation techniques, were based on current market participant expectations and information available as of the close of the transaction on August 29, 2014.

88


 

Table of Contents

The following table summarizes the quantitative information about fair value measurements for the NNN Lease Restructuring and RIDEA II transactions (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

    

Fair Value

    

Valuation Technique

    

Valuation Inputs

    

Input Average or Range

 

NNN Lease Restructuring

 

 

 

 

 

 

 

 

 

 

Rental payment concessions by HCP

 

$

76,000

 

Discounted Cash Flow

 

NNN Rent Coverage Ratio

 

1.20x

 

(benefiting Brookdale)

 

 

 

 

 

 

NNN Rent Growth Rate

 

3.0%

 

 

 

 

 

 

 

 

Discount Rate

 

8.00%-8.50%

 

Forfeited purchase options by

 

$

(129,000)

 

Discounted Cash Flow

 

Capitalization Rates

 

7.50%-9.25%

 

Brookdale (benefiting HCP)

 

 

 

 

 

 

Discount Rate

 

10.50%-11.00%

 

 

 

 

 

 

 

 

Exercise Probability

 

100.00%

 

RIDEA II

 

 

 

 

 

 

 

 

 

 

Forfeited rental payments by HCP

 

$

131,000

 

Discounted Cash Flow

 

NNN Rent Coverage Ratio

 

1.20x

 

(benefiting Brookdale)

 

 

 

 

 

 

NNN Rent Growth Rate

 

3.0%

 

 

 

 

 

 

 

 

EBITDAR Growth Rate

 

5.5%

 

 

 

 

 

 

 

 

Discount Rate

 

8.00%-11.00%

 

Forfeited purchase options by

 

$

(23,000)

 

Discounted Cash Flow

 

Capitalization Rates

 

7.50%-9.25%

 

Brookdale (benefiting HCP)

 

 

 

 

 

 

Discount Rate

 

10.50%-11.00%

 

 

 

 

 

 

 

 

Exercise Probability

 

100.00%

 

 

In determining which valuation technique would be utilized to calculate fair value for the multiple elements of this transaction, the Company considered the market approach, obtaining published investor survey and sales transaction data, where available. The information obtained was consistent with the valuation inputs and assumptions utilized by the selected income approach that was applied to this transaction. Investor survey and sales transaction data reviewed for similar transactions in similar marketplaces, included, but were not limited to, sales price per unit, rent coverage ratios, rental rate growth as well as capitalization and discount rates.

Rental Payment Concessions.  The fair value of the rental payment concessions related to the NNN Lease Restructuring Transaction was determined as the present value of the difference between (i) the remaining contractual rental payments of the in-place leases, limited to the first purchase option date (where available) and market rents to complete the initial lease term of the amended Brookdale leases thereafter and (ii) the contractual rental payments under the amended Brookdale leases.

Forfeited Rental Payments.  The fair value of the forfeited rental payments related to the RIDEA II transaction was calculated as the present value of the difference between (i) the remaining contractual rental payments of the terminated in-place leases, limited to first purchase option date, where available and (ii) the forecasted cash flows of the facility-level operating results of the RIDEA II.

Forfeited Purchase Option Rights.  The fair value of the forfeited purchase option rights was determined as the present value of the difference between (i) the fair value of the underlying property as of the initial exercise date and (ii) the exercise price for purchase option rights as defined in the lease agreement. To determine the fair value of the underlying property as of the initial exercise date, the Company utilized a cash flow model that incorporated growth rates to forecast the underlying property’s operating results and applied capitalization rates to establish its expected fair value.  The Company utilized an appropriate risk-adjusted discount rate to estimate the present value as of the closing date of the transaction.

89


 

Table of Contents

NOTE 4.    Other Real Estate Property Investments

2016 Real Estate Acquisitions

The following table summarizes real estate acquisitions for the year ended December 31, 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consideration

 

Assets Acquired(1)

 

 

 

 

 

Liabilities

 

 

 

 

Net

 

Segment

    

Cash Paid

    

Assumed

    

Real Estate

    

Intangibles

 

SH NNN

 

$

76,362

 

$

1,200

 

$

71,875

    

$

5,687

 

SHOP

 

 

113,971

 

 

76,931

 

 

177,551

 

 

13,351

 

Life science

 

 

49,000

 

 

 —

 

 

47,400

 

 

1,600

 

Medical office 

 

 

209,920

 

 

4,854

 

 

209,178

 

 

5,596

 

Other

 

 

17,909

 

 

 —

 

 

16,596

 

 

1,313

 

 

 

$

467,162

 

$

82,985

 

$

522,600

 

$

27,547

 


(1)

The purchase price allocations are preliminary and may be subject to change. Revenues and earnings since the acquisition dates, as well as the supplementary pro forma information, assuming these acquisitions occurred as of the beginning of the prior periods, were not material.

 

2015 Acquisition of Private Pay Senior Housing Portfolio (“RIDEA III”)

On June 30, 2015, the Company and Brookdale acquired a portfolio of 35 private pay senior housing communities from Chartwell Retirement Residences, including two leasehold interests, representing 5,025 units. The portfolio was acquired in a RIDEA structure (“RIDEA III”), with Brookdale owning a 10% noncontrolling interest. Brookdale has operated these communities since 2011 and continues to manage the communities under a long-term management agreement, which is cancellable under certain conditions (subject to a fee if terminated within seven years from the acquisition date). The Company paid $770 million in cash consideration, net of cash assumed, and assumed $32 million of net liabilities and $29 million of noncontrolling interests to acquire: (i) real estate with a fair value of $771 million, (ii) lease-up intangible assets with a fair value of $53 million and (iii) working capital of $7 million. As a result of the acquisition, the Company recognized a net termination fee of $8 million in rental and related revenues, which represents the termination value of the two leasehold interests. The lease-up intangible assets recognized were attributable to the value of the acquired underlying operating resident leases of the senior housing communities that were stabilized or nearly stabilized (i.e., resident occupancy above 80%). From the acquisition date to December 31, 2015, the Company recognized revenues and earnings of $94 million and $1 million, respectively, from RIDEA III. For the year ended December 31, 2016, the Company recognized revenues and earnings of $187 million and $3 million, respectively, from RIDEA III.

Pro Forma Results of Operations (Unaudited)

The following unaudited pro forma consolidated results of operations assume that the RIDEA III acquisition was completed as of January 1, 2014 (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

    

December 31, 2015

    

December 31, 2014

 

Revenues

 

$

2,034,369

 

$

1,824,593

 

Net (loss) income

 

 

(531,464)

 

 

954,540

 

Net (loss) income applicable to HCP, Inc.

 

 

(545,776)

 

 

938,387

 

Basic earnings per common share

 

$

(1.18)

 

$

2.04

 

Diluted earnings per common share

 

 

(1.18)

 

 

2.04

 

 

90


 

Table of Contents

2015 Other Real Estate Acquisitions 

In addition to the RIDEA III acquisition discussed above, the following table summarizes other real estate acquisitions for the year ended December 31, 2015 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consideration

 

Assets Acquired(1)

 

 

 

Cash Paid/

 

Liabilities

 

Noncontrolling

 

 

 

 

Net

 

Segment

    

Debt Settled

    

Assumed

    

Interest

    

Real Estate

    

Intangibles

 

SH NNN

 

$

208

 

$

 —

 

$

 —

 

$

208

    

$

 —

 

SHOP

 

 

151,054

 

 

1,443

 

 

4,255

 

 

147,296

 

 

9,456

 

Life science

 

 

80,946

 

 

2,054

 

 

 —

 

 

68,988

 

 

14,012

 

Medical office(2)

 

 

384,114

 

 

12,866

 

 

 —

 

 

305,091

 

 

91,889

 

Other(3)

 

 

296,227

 

 

6,855

 

 

 —

 

 

248,826

 

 

54,256

 

 

 

$

912,549

 

$

23,218

 

$

4,255

 

$

770,409

 

$

169,613

 


(1)

Revenues and earnings since the acquisition dates, as well as the supplementary pro forma information, assuming these acquisitions occurred as of the beginning of the prior periods, were not material.

(2)

Includes $225 million for a medical office building (“MOB”) portfolio acquisition completed in June 2015 and placed in HCP Ventures V, LLC (“HCP Ventures V”), of which in October 2015 the Company issued a 49% noncontrolling interest in HCP Ventures V for $110 million (see Note 13).

(3)

Includes £174 million ($254 million) of the Company’s HC-One Facility (see Note 7) converted to fee ownership in a portfolio of 36 care homes located throughout the United Kingdom (“U.K.”) and includes £27 million ($42 million) of a loan originated in May 2015 converted to fee ownership in two U.K. care homes.

 

Construction, Tenant and Other Capital Improvements

The following table summarizes the Company’s funding for construction, tenant and other capital improvements (in thousands):

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

Segment

    

2016

    

2015

 

SH NNN

 

$

49,109

 

$

53,980

 

SHOP

 

 

74,158

 

 

77,425

 

Life science

 

 

200,122

 

 

122,319

 

Medical office

 

 

128,308

 

 

131,021

 

Other

 

 

7,203

 

 

37

 

 

 

$

458,900

 

$

384,782

 

 

 

91


 

Table of Contents

 

NOTE 5.    Discontinued Operations and Dispositions of Real Estate

Discontinued Operations - Quality Care Properties, Inc.

On October 31, 2016, the Company completed the Spin-Off of its subsidiary, QCP.

The following is a summary of the assets and liabilities transferred to QCP at the Spin-Off date (in thousands):

 

 

 

 

 

 

 

 

 

October 31,

 

December 31,

 

 

2016

 

2015

ASSETS

 

    

 

    

 

    

Real estate:

 

 

 

 

 

 

Buildings and improvements

 

$

191,633

 

$

191,633

Land

 

 

14,147

 

 

14,147

Accumulated depreciation and amortization

 

 

(71,845)

 

 

(65,319)

Net real estate

 

 

133,935

 

 

140,461

Net investment in direct financing leases

 

 

5,107,180

 

 

5,154,316

Cash and cash equivalents

 

 

6,096

 

 

6,058

Restricted cash

 

 

 —

 

 

14,526

Intangible assets, net

 

 

18,517

 

 

17,049

Other assets, net

 

 

6,620

 

 

7,790

Total assets

 

$

5,272,348

 

$

5,340,200

LIABILITIES

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

46,925

 

$

5,453

Deferred revenue

 

 

667

 

 

687

Total liabilities

 

 

47,592

 

 

6,140

Net assets

 

$

5,224,756

 

$

5,334,060

 

The results of discontinued operations through October 31, 2016, the Spin-Off date, are included in the consolidated results for the years ended December 31, 2016, 2015 and 2014. Summarized financial information for discontinued operations for the years ended December 31, 2016, 2015, and 2014 is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Revenues:

 

 

 

 

 

 

 

 

 

 

Rental and related revenues

    

 $

22,971

    

$

27,651

    

$

27,111

 

Tenant recoveries

 

 

1,233

 

 

1,464

 

 

1,029

 

Income from direct financing leases

 

 

384,752

 

 

572,835

 

 

598,629

 

Interest income

 

 

 —

 

 

 —

 

 

868

 

Total revenues

 

 

408,956

 

 

601,950

 

 

627,637

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

(4,892)

 

 

(5,880)

 

 

(4,979)

 

Operating

 

 

(3,367)

 

 

(3,697)

 

 

(3,309)

 

General and administrative

 

 

(67)

 

 

(57)

 

 

(410)

 

Transaction costs

 

 

(86,765)

 

 

 —

 

 

 —

 

Impairments

 

 

 —

 

 

(1,295,504)

 

 

 —

 

Other income, net

 

 

71

 

 

70

 

 

85

 

Income (loss) before income taxes and income from and impairments of equity method investment

 

 

313,936

 

 

(703,118)

 

 

619,024

 

Income tax expense

 

 

(48,181)

 

 

(796)

 

 

(756)

 

Income from equity method investment

 

 

 —

 

 

50,723

 

 

53,175

 

Impairments of equity method investment

 

 

 —

 

 

(45,895)

 

 

(35,913)

 

Net income (loss) from discontinued operations

 

 $

265,755

 

$

(699,086)

 

$

635,530

 

 

92


 

Table of Contents

During the fourth quarter of 2016, using proceeds from the Spin-Off, the Company repaid $500 million of 6.0% senior unsecured notes that were due to mature in January 2017, $600 million of 6.7% senior unsecured notes that were due to mature in January 2018 and $108 million of mortgage debt; incurring aggregate loss on debt extinguishments of $46 million.

HCR ManorCare, Inc. 

Discontinued operations is primarily comprised of QCP’s HCRMC DFL investments and equity investment in HCRMC. During the years ended December 31, 2016, 2015 and 2014, the Company recognized DFL income of $385 million, $573 million and $599 million, respectively, and received cash payments of $385 million, $483 million and $519 million, respectively, from the HCRMC DFL investments. The carrying value of the HCRMC DFL investments was $5.2 billion at December 31, 2015.

The following summarizes the significant transactions and impairments related to HCRMC:

2014

During the year ended December 31, 2014, the Company concluded that its equity investment in HCRMC was other-than-temporarily impaired and recorded an impairment charge of $36 million. The impairment charge reduced the carrying amount of the Company’s equity investment in HCRMC from $75 million to its fair value of $39 million. The fair value of the Company’s equity investment was based on an income approach utilizing a discounted cash flow valuation model and inputs were considered to be Level 3 measurements within the fair value hierarchy.

The following is a summary of the quantitative information about fair value measurements for the impairment related to the Company’s equity ownership interest in HCRMC using a discounted cash flow valuation model:

 

 

 

 

Description of Input(s) to the Valuation

    

Valuation Inputs

 

Range of revenue growth rates(1)

 

(0.2%)-3.5%

 

Range of occupancy growth rates(1)

 

(0.3%)-0.2%

 

Range of operating expense growth rates(1)

 

0.6%-2.8%

 

Discount rate

 

13.7%

 

Range of earnings multiples

 

6.0x-7.0x

 


(1)

For growth rates, the value ranges provided represent the highest and lowest input utilized in the valuation model for any forecasted period.

 

2015

During the three months ended March 31, 2015, the Company and HCRMC agreed to market for sale the real estate and operations associated with 50 non-strategic facilities that were under the Master Lease. During the year ended December 31, 2015, the Company completed sales of 22 non-strategic HCRMC facilities for $219 million. During the year ended December 31, 2016, the Company sold an additional 11 facilities for $62 million, bringing the total facilities sold to 33 at the time of the Spin-Off.

On March 29, 2015, certain subsidiaries of the Company entered into an amendment to the Master Lease (the “HCRMC Lease Amendment”) effective April 1, 2015. The HCRMC Lease Amendment reduced initial annual rent by a net $68 million and reset the minimum rent escalation to 3.0% for each lease year through the expiration of the initial term. The initial term was extended five years to an average of 16 years. As consideration for the rent reduction, the Company received a Deferred Rent Obligation (“DRO”) from the Lessee equal to an aggregate amount of $525 million. As a result of the HCRMC Lease Amendment, the Company recorded an impairment charge of $478 million related to its HCRMC DFL investments. The impairment charge reduced the carrying value of the HCRMC DFL investments from $6.6 billion to $6.1 billion, based on the present value of the future lease payments effective April 1, 2015 under the Amended Master Lease discounted at the original DFL investments’ effective lease rate. Additionally, HCRMC agreed to sell, and HCP agreed to purchase, nine post-acute facilities for an aggregate purchase price of $275 million. Through December 31, 2015, HCRMC and HCP completed seven of the nine facility purchases for $184 million. Through Spin-Off, HCRMC and HCP completed the remaining two facility purchases for $91 million, bringing the nine facility purchases to an aggregate $275 million, the proceeds of which were used to settle a portion of the DRO discussed above.

93


 

Table of Contents

As of September 30, 2015, the Company concluded that its equity investment in HCRMC was other-than-temporarily impaired and recorded an impairment charge of $27 million. The impairment charge reduced the carrying amount of the Company’s equity investment in HCRMC from $48 million to its fair value of $21 million.

The fair value of the Company’s equity investment in HCRMC was based on a discounted cash flow valuation model and inputs were considered to be Level 3 measurements within the fair value hierarchy. The following is a summary of the quantitative information about fair value measurements for the impairment related to the Company’s equity ownership interest in HCRMC using a discounted cash flow valuation model:

 

 

 

 

Description of Input(s) to the Valuation

    

Valuation Inputs

 

Range of revenue growth rates(1)

 

(1.8%)-3.0%

 

Range of occupancy growth rates(1)

 

(0.8%)-0.2%

 

Range of operating expense growth rates(1)

 

(1.1%)-3.1%

 

Discount rate

 

15.20%

 

Range of earnings multiples

 

6.0x-7.0x

 


(1)

For growth rates, the value ranges provided represent the highest and lowest input utilized in the valuation model for any forecasted period.

 

As part of the Company’s fourth quarter 2015 review process, including its internal rating evaluation, it assessed the collectibility of all contractual rent payments under the Amended Master Lease, as discussed below and assigned an internal rating of “Watch List” as of December 31, 2015. Further, the Company placed the HCRMC DFL investments on nonaccrual status and began utilizing a cash basis method of accounting in accordance with its policies (see Note 2).

As a result of assigning an internal rating of “Watch List” to its HCRMC DFL investments during the quarterly review process, the Company further evaluated the carrying amount of its HCRMC DFL investments and determined that it was probable that its HCRMC DFL investments were impaired. As a result of the significant decline in HCRMC’s fixed charge coverage ratio in the fourth quarter of 2015, combined with a lower growth outlook for the post-acute/skilled nursing business, the Company determined that it was probable that its HCRMC DFL investments were impaired. In the fourth quarter of 2015, the Company recorded an allowance for DFL losses (impairment charge) of $817 million, reducing the carrying amount of its HCRMC DFL investments from $6.0 billion to $5.2 billion. The allowance for credit losses was determined as the present value of expected future (i) in-place lease payments under the HCRMC Amended Master Lease and (ii) estimated market rate lease payments, each discounted at the original HCRMC DFL investments’ effective lease rate. Impairments related to an allowance for credit losses are included in impairments, net.

The market rate lease payments were based on an income approach utilizing a discounted cash flow valuation model. The significant inputs to this valuation model included forecasted EBITDAR (defined as earnings before interest, taxes, depreciation and amortization, and rent), rent coverage ratios and real estate capitalization rates and are summarized as follows (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Post-acute/

 

 

 

Senior Housing

 

 

Skilled nursing

 

Description of Input(s) to the Valuation

    

DFL Valuation Inputs

 

    

DFL Valuation Inputs

 

Range of EBITDAR

 

$75,000-$85,000

 

 

$385,000-$435,000

 

Range of rent coverage ratio

 

1.05x-1.15x

 

 

1.25x-1.35x

 

Range of real estate capitalization rate

 

6.25%-7.25%

 

 

7.50%-8.50%

 

 

In December 2015, the Company concluded that its equity investment in HCRMC was other-than-temporarily impaired and recorded an impairment charge of $19 million, reducing its carrying value to zero. Beginning in January 2016, income was recognized only if cash distributions were received from HCRMC.

2016

The Company’s acquisition of the HCRMC DFL investments in 2011 was subject to federal and state built-in gain tax of up to $2 billion if all the assets were sold within 10 years. At the time of acquisition, the Company intended to hold the assets for at least 10 years, at which time the assets would no longer be subject to the built-in gain tax. In December 2015, the U.S. Federal Government passed legislation which permanently reduced the holding period, for federal tax purposes,

94


 

Table of Contents

to five years. The Company satisfied the five year holding period requirement in April 2016. This legislation was not extended to certain states, which maintain a 10 year requirement.

During the year ended December 31, 2016, the Company determined that it may sell assets during the next five years and, therefore, recorded a deferred tax liability of $47 million, representing its estimated exposure to state built-in gain tax.

Dispositions of Real Estate

Held for Sale

At December 31, 2016, 64 SH NNN facilities, four life science facilities and a SHOP facility were classified as held for sale, with an aggregate carrying value of $928 million, primarily comprised of real estate assets of $809 million. At December 31, 2015, four life science facilities were classified as held for sale, with an aggregate carrying value of $314 million, primarily comprised of real estate assets of $288 million. Liabilities of assets held for sale is primarily comprised of intangible liabilities at both December 31, 2016 and 2015.

 

2016 Dispositions

During the year ended December 31, 2016, the Company sold the following: (i) a portfolio of five post-acute/skilled nursing facilities and two SH NNN facilities for $130 million, (ii) five life science facilities for $386 million, (iii) seven  SH NNN facilities for $88 million, (iv) three MOBs for $20 million and (v) three SHOP facilities for $41 million.

2015 Dispositions

During the year ended December 31, 2015, the Company sold the following: (i) nine SH NNN facilities for $60 million resulting from Brookdale’s exercise of its purchase option received as part of the Brookdale Transaction, (ii) two parcels of land in its life science segment for $51 million and (iii) a MOB for $400,000.  

2014 Dispositions

During the year ended December 31, 2014, the Company sold the following: (i) two post-acute/skilled nursing facilities for $22 million, (ii) a hospital for $17 million, (iii) a senior housing facility for $16 million and (iv) a MOB for $145,000.

On August 29, 2014, in conjunction with the Brookdale Transaction, the Company contributed three senior housing facilities with a carrying value of $92 million into the CCRC JV (an unconsolidated joint venture with Brookdale discussed in Note 3). The Company recorded its investment in the CCRC JV for the contribution of these properties at their carrying value (carryover basis) and therefore did not recognize either a gain or loss upon the contribution.

Pending Dispositions

In October 2016, the Company entered into definitive agreements to sell 64 SH NNN assets (classified as held for sale as of December 31, 2016), currently under triple-net leases with Brookdale, for $1.125 billion to affiliates of Blackstone Real Estate Partners VIII L.P. The closing of this transaction is expected to occur in the first quarter of 2017 and remains subject to regulatory and third party approvals and other customary closing conditions. Additionally, in October 2016, the Company entered into definitive agreements for a multi-element transaction with Brookdale to: (i) sell or transition 25 assets currently triple-net leased to Brookdale, for which Brookdale will receive a $10.5 million annual rent reduction upon lease termination, (ii) re-allocate annual rent of $9.6 million from those 25 assets to the remaining Brookdale triple-net lease portfolio (occurred on November 1, 2016) and (iii) transition eight triple-net leased assets into RIDEA structures (seven of which closed in December 2016 and one of which closed in January 2017). The closing of the sale or transition of the 25 assets and corresponding rent reduction is expected to occur throughout 2017 and remains subject to regulatory and third party approvals and other customary closing conditions.

 

In January 2016, the Company entered into a definitive agreement for purchase options that were exercised on eight life science facilities in South San Francisco, California, to be sold in two tranches for $311 million (sold in November 2016 and discussed above) and $269 million, respectively. The second tranche is expected to close in the third quarter of 2018.

 

Subsequent Events

In January 2017, the Company sold four life science facilities in Salt Lake City, Utah for $76 million.

95


 

Table of Contents

In May 2016, the Company entered into a master contribution agreement with Brookdale to contribute its ownership interest in RIDEA II to an unconsolidated JV owned by HCP and an investor group led by Columbia Pacific Advisors, LLC (“CPA”) (the “HCP/CPA JV”). The members agreed to recapitalize RIDEA II with $602 million of debt, of which $360 million was provided by a third-party and $242 million was provided by HCP. In return, the Company received $480 million in cash proceeds from the HCP/CPA JV and $242 million in note receivables and retained an approximately 40% beneficial interest in RIDEA II (the note receivable and 40% beneficial interest are herein referred to as the “RIDEA II Investments”). The Company’s RIDEA II Investments are recognized and accounted for as equity method investments. This transaction resulted in the Company deconsolidating the net assets of RIDEA II because it will not direct the activities that most significantly impact the venture. These transactions closed in January 2017.

NOTE 6.    Net Investment in Direct Financing Leases

The components of net investment in DFLs consisted of the following (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2016

 

2015

 

Minimum lease payments receivable

    

$

1,108,237

    

$

1,155,215

 

Estimated residual values

 

 

539,656

 

 

535,161

 

Less unearned income

 

 

(895,304)

 

 

(939,683)

 

Net investment in direct financing leases

 

$

752,589

 

$

750,693

 

Properties subject to direct financing leases

 

 

30

 

 

30

 

 

Certain DFLs contain provisions that allow the tenants to elect to purchase the properties during or at the end of the lease terms for the aggregate initial investment amount plus adjustments, if any, as defined in the lease agreements. Certain leases also permit the Company to require the tenants to purchase the properties at the end of the lease terms.

The following table summarizes future minimum lease payments contractually due under DFLs at December 31, 2016 (in thousands):

 

 

 

 

 

Year

    

Amount

 

2017

 

$

91,770

 

2018

 

 

66,121

 

2019

 

 

67,526

 

2020

 

 

62,234

 

2021

 

 

62,641

 

Thereafter

 

 

757,945

 

 

 

$

1,108,237

 

 

Direct Financing Lease Internal Ratings

 

The following table summarizes the Company’s internal ratings for net investment in DFLs at December 31, 2016 (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying

 

Percentage of

 

Internal Ratings

 

Segment

    

Amount

    

DFL Portfolio

    

Performing DFLs

    

Watch List DFLs

    

Workout DFLs

 

SH NNN

 

$

628,698

 

84

 

$

267,897

 

$

360,801

 

$

 —

 

Other

 

 

123,891

 

16

 

 

123,891

 

 

 —

 

 

 —

 

 

 

$

752,589

 

100

 

$

391,788

 

$

360,801

 

$

 —

 

 

Beginning September 30, 2013, the Company placed a 14 property senior housing DFL (the “DFL Portfolio”) on nonaccrual status and classified the DFL Portfolio on “Watch List” status. The Company determined that the collection of all rental payments was and continues to be no longer reasonably assured; therefore, rental revenue for the DFL Portfolio has been recognized on a cash basis. The Company re-assessed the DFL Portfolio for impairment on December 31, 2016 and determined that the DFL Portfolio was not impaired based on its belief that: (i) it was not probable that it will not collect all of the rental payments under the terms of the lease; and (ii) the fair value of the underlying collateral exceeded

96


 

Table of Contents

the DFL Portfolio’s carrying amount. The fair value of the DFL Portfolio was estimated based on a discounted cash flow model, the inputs to which are considered to be a Level 3 measurement within the fair value hierarchy. Inputs to this valuation model include real estate capitalization rates, industry growth rates and operating margins, some of which influence the Company’s expectation of future cash flows from the DFL Portfolio and, accordingly, the fair value of its investment. During the years ended December 31, 2016, 2015 and 2014, the Company recognized DFL income of $13 million, $15 million and $19 million, respectively, and received cash payments of $18 million, $20 million and $24 million, respectively, from the DFL Portfolio. The carrying value of the DFL Portfolio was $361 million and $366 million at December 31, 2016 and 2015, respectively.

 

 

 

NOTE 7.    Loans Receivable

The following table summarizes the Company’s loans receivable (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2016

 

2015

 

 

 

Real Estate

 

Other

 

 

 

 

Real Estate

 

Other

 

 

 

 

 

 

Secured

 

Secured

 

Total

 

Secured

 

Secured

 

Total

 

Mezzanine(1)(2)

    

$

 —

    

$

615,188

    

$

615,188

    

$

    

$

660,138

    

$

660,138

 

Other

 

 

195,946

 

 

 —

 

 

195,946

 

 

114,322

 

 

 

 

114,322

 

Unamortized premiums (discounts), fees and costs, net

 

 

413

 

 

(3,593)

 

 

(3,180)

 

 

961

 

 

(6,678)

 

 

(5,717)

 

Allowance for loan losses

 

 

 —

 

 

 —

 

 

 —

 

 

 

 

 —

 

 

 —

 

 

 

$

196,359

 

$

611,595

 

$

807,954

 

$

115,283

 

$

653,460

 

$

768,743

 


(1)

At December 31, 2016, included £282 million ($348 million) outstanding and £2 million ($3 million) of associated unamortized discounts, fees and costs both related to the HC-One Facility. At December 31, 2015, included £273 million ($403 million) outstanding and £4 million ($5 million) of associated unamortized discounts, fees and costs both related to the HC-One Facility.

(2)

At December 31, 2016, the Company had £35 million ($43 million) remaining under its commitments to fund development projects and capital expenditures under it U.K. development projects.

 

The following table summarizes the Company’s internal ratings for loans receivable at December 31, 2016 (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

    

 

    

Percentage

    

Internal Ratings

 

 

 

Carrying

 

of Loan

 

Performing

    

Watch List

    

Workout

 

Investment Type

    

Amount

    

Portfolio

    

Loans

 

 Loans

 

Loans

 

Real estate secured

 

$

196,359

 

24

 

$

196,359

 

$

 —

 

$

 —

 

Other secured

 

 

611,595

 

76

 

 

355,130

 

 

256,465

 

 

 —

 

 

 

$

807,954

 

100

 

$

551,489

 

$

256,465

 

$

 —

 

97


 

Table of Contents

Real Estate Secured Loans

The following table summarizes the Company’s loans receivable secured by real estate at December 31, 2016 (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Final

 

Number

 

 

 

 

 

 

 

 

 

Maturity

 

of

 

 

 

Principal

 

Carrying

 

Date

 

Loans

 

Payment Terms

 

Amount(1)

 

Amount

 

2017

    

1

 

monthly interest-only payments, accrues interest at LIBOR plus 6.0%, and secured by, among other things, the issuer’s real estate assets

    

$

34,602

    

$

35,015

 

2018

 

1

 

monthly interest-only payments, accrues interest at 8.0% and secured by a senior housing facility in Pennsylvania(2)

 

 

21,473

 

 

21,566

 

2021

 

2

 

aggregate monthly interest-only payments, accrues interest at 8.0% and 9.75% and secured by two senior housing facility in the U.K.(3)

 

 

9,008

 

 

9,339

 

2023

 

1

 

monthly interest-only payments, accrues interest at 7.0% and secured by seven senior housing facilities in the U.K.

 

 

130,439

 

 

130,439

 

 

 

5

 

 

 

$

195,522

 

$

196,359

 


(1)

Represents future contractual principal payments to be received on loans receivable secured by real estate.

(2)

Represents commitments to fund an aggregate of $0.1 million for a development project that is at or near completion as of December 31, 2016.

(3)

Represents commitments to fund an aggregate of £12 million ($15 million) for two development projects as of December 31, 2016.

 

During the year ended December 31, 2016, the Company recognized $26 million in interest income related to loans secured by real estate.

In December 2015, the Company purchased £28 million ($42 million) of Four Seasons Health Care’s (“Four Seasons”) £40 million senior secured term loan. The loan is secured by, among other things, the real estate assets of Four Seasons, and represents the most senior debt tranche. The loan bears interest at a rate of LIBOR plus 6.0% per annum and matures in December 2017.

Other Secured Loans

HC-One Facility

In November 2014, the Company was the lead investor in the financing for Formation Capital and Safanad’s acquisition of NHP, a company that, at closing, owned 273 nursing and residential care homes representing over 12,500 beds in the U.K. principally operated by HC-One. The Company provided a loan facility (the “HC-One Facility”), secured by substantially all of NHP’s assets, totaling £395 million, with £363 million ($574 million) drawn at closing. The HC-One Facility has a five-year term and was funded by a £355 million draw on the Company’s revolving line of credit facility that is discussed in Note 11. In February 2015, the Company increased the HC-One Facility by £108 million ($164 million) to £502 million ($795 million), in conjunction with HC-One’s acquisition of Meridian Healthcare. In April 2015, the Company converted £174 million of the HC-One Facility into a sale-leaseback transaction for 36 nursing and residential care homes located throughout the U.K. (see Note 4). In September 2015, the Company amended and increased its commitment under the HC-One Facility by £11 million primarily for the funding of capital expenditures and a development project. As part of the amendments, the Company shortened the non-call period by 17 months and provided consent for (i) the pay down of £34 million from disposition proceeds without a prepayment premium and (ii) the spin-off of 36 properties into a separate joint venture. In return, the Company retained security over the spin-off properties for a period of two years. Through the year ended December 31, 2015, the Company received paydowns of £34 million ($52 million). At December 31, 2016, the HC-One Facility had an outstanding balance of $345 million.

Tandem Health Care Loan

On July 31, 2012, the Company closed a mezzanine loan facility to lend up to $205 million to Tandem Health Care (“Tandem”), as part of the recapitalization of a post-acute/skilled nursing portfolio. The Company funded $100 million (the “First Tranche”) at closing and funded an additional $102 million (the “Second Tranche”) in June 2013. In May 2015, the Company increased and extended the mezzanine loan facility with Tandem to (i) fund $50 million (the “Third Tranche”) and $5 million (the “Fourth Tranche”), which proceeds were used to repay a portion of Tandem’s existing senior

98


 

Table of Contents

and mortgage debt, respectively; (ii) extend its maturity to October 2018; and (iii) extend the prepayment penalty period to January 2017. The loans bear interest at fixed rates of 12%, 14%,  6% and 6% per annum for the First, Second, Third and Fourth Tranches, respectively.

Due to a decline in Tandem’s operating performance, as of September 30, 2016, the Company assigned an internal rating of “Watch List” to its Tandem Health Care Loan. Although Tandem continues to remain current on its payment obligations, the collection and timing of all future amounts owed is no longer reasonably assured. During the year ended December 31, 2016, 2015 and 2014, the Company recognized interest income of $31 million, $29 million and $27 million, respectively, and received cash payments of $30 million, $29 million and $27 million, respectively, from Tandem. At December 31, 2016, the facility had an outstanding balance of $256 million at an 11.5% blended interest rate and was subordinate to $374 million of senior mortgage debt.

 

 

NOTE 8.    Investments in and Advances to Unconsolidated Joint Ventures

The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying Amount

 

 

 

 

 

 

 

December 31,

 

Entity(1)

    

Segment

    

Ownership %

    

2016

 

2015

 

CCRC JV(2)

 

SHOP

 

49

 

$

439,449

 

$

465,179

 

MBK JV(3)

 

SHOP

 

50

 

 

38,909

 

 

34,131

 

HCP Ventures III, LLC

 

Medical office

 

30

 

 

1,533

 

 

9,241

 

HCP Ventures IV, LLC

 

Medical office

 

20

 

 

7,277

 

 

11,884

 

HCP Life Science(4)

 

Life science

 

50-63

 

 

67,879

 

 

68,582

 

Vintage Park

 

SHOP

 

85

 

 

7,486

 

 

8,729

 

MBK Development JV(3)

 

SHOP

 

50

 

 

2,463

 

 

2,224

 

Suburban Properties, LLC

 

Medical office

 

67

 

 

4,628

 

 

4,621

 

K&Y(5)

 

Other

 

80

 

 

1,342

 

 

 —

 

Advances to unconsolidated joint ventures, net and other

 

 

 

 

 

 

525

 

 

653

 

 

 

 

 

 

 

$

571,491

 

$

605,244

 


(1)

These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.

(2)

Includes two unconsolidated joint ventures in a RIDEA structure (CCRC PropCo and CCRC OpCo).

(3)

Includes two unconsolidated joint ventures in a RIDEA structure (PropCo and OpCo).

(4)

Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).

(5)

Includes three unconsolidated joint ventures.

 

MBK JV

On March 30, 2015, the Company and MBK Senior Living (“MBK”), a subsidiary of Mitsui & Co. Ltd, formed a new RIDEA joint venture (“MBK JV”) that owns three senior housing facilities with the Company and MBK each owning a 50% equity interest. MBK manages these communities on behalf of the joint venture. The Company contributed $27 million of cash and MBK contributed the three senior housing facilities with a fair value of $126 million, which were encumbered by $78 million of mortgage debt at closing.

HCP Ventures III, LLC and HCP Ventures IV, LLC

On December 30, 2015, HCP Ventures III, LLC (“HCP Ventures III”) and HCP Ventures IV, LLC (“HCP Ventures IV”) sold 61 MOBs, three hospitals and a re-development property for total proceeds of $634 million, recognizing gains on sales of real estate of $59 million, of which the Company’s share was $15 million. As part of these sales, the Company received aggregate distributions of $45 million, including repayment of its loan receivable. During the quarter ended December 31, 2016, HCP Ventures III sold the remaining three assets in its portfolio for $31 million, recognizing gains on sales of real estate of $4.9 million, of which the Company’s share was $1.3 million. As part of this sale, the Company received aggregate distributions of $8 million.

99


 

Table of Contents

NOTE 9.    Intangibles

The following table summarizes the Company’s intangible lease assets (in thousands):

 

 

 

 

 

 

 

 

 

 

December 31,

 

Intangible lease assets

 

2016

 

2015

 

Lease-up intangibles

    

$

719,788

    

$

765,861

 

Above market tenant lease intangibles

 

 

147,409

 

 

154,928

 

Below market ground lease intangibles

 

 

44,500

 

 

44,051

 

Gross intangible lease assets

 

 

911,697

 

 

964,840

 

Accumulated depreciation and amortization

 

 

(431,892)

 

 

(378,183)

 

Net intangible lease assets

 

$

479,805

 

$

586,657

 

The remaining weighted average amortization period of intangible lease assets was 13 years at both December 31, 2016 and 2015.

The following table summarizes the Company’s intangible lease liabilities (in thousands):

 

 

 

 

 

 

 

 

 

 

December 31,

 

Intangible lease liabilities

 

2016

 

2015

 

Below market lease intangibles

    

$

161,595

    

$

149,762

 

Above market ground lease intangibles

 

 

2,329

 

 

6,121

 

Gross intangible lease liabilities

 

 

163,924

 

 

155,883

 

Accumulated depreciation and amortization

 

 

(105,779)

 

 

(99,736)

 

Net intangible lease liabilities

 

$

58,145

 

$

56,147

 

The remaining weighted average amortization period of intangible lease liabilities was 11 and 10 years at December 31, 2016 and 2015, respectively.

For the years ended December 31, 2016, 2015 and 2014, rental income includes additional revenues of $4 million, $4 million and $3 million, respectively, from the amortization of net below market lease intangibles. For the years ended December 31, 2016, 2015 and 2014, operating expenses include additional expense of $1 million each year from the amortization of net below market ground lease intangibles. For the years ended December 31, 2016, 2015 and 2014, depreciation and amortization expense includes additional expense of $85 million, $76 million and $60 million, respectively, from the amortization of lease-up and non-compete agreement intangibles.

The following table summarizes the estimated aggregate amortization of intangible assets and liabilities for each of the five succeeding fiscal years and thereafter (in thousands):

 

 

 

 

 

 

 

 

 

    

Intangible

    

Intangible

 

 

 

Assets

 

Liabilities

 

2017

 

$

86,113

 

$

11,686

 

2018

 

 

69,805

 

 

9,018

 

2019

 

 

51,710

 

 

6,558

 

2020

 

 

43,763

 

 

5,142

 

2021

 

 

37,255

 

 

3,636

 

Thereafter

 

 

191,159

 

 

22,105

 

 

 

$

479,805

 

$

58,145

 

 

100


 

Table of Contents

 

NOTE 10.    Other Assets

The following table summarizes the Company’s other assets (in thousands):

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2016

 

2015

 

Straight-line rent receivables, net of allowance of $25,059 and $32,918, respectively

    

$

311,776

    

$

366,951

 

Marketable debt securities, net 

 

 

68,630

 

 

102,958

 

Leasing costs and inducements, net 

 

 

156,820

 

 

158,708

 

Goodwill

 

 

42,386

 

 

47,019

 

Other

 

 

132,012

 

 

118,847

 

Total other assets

 

$

711,624

 

$

794,483

 

 

Four Seasons Health Care Senior Unsecured Notes

Marketable debt securities, net are classified as held-to-maturity debt securities and primarily represent senior notes issued by Elli Investments Limited (“Elli”), a company beneficially owned by funds or limited partnerships managed by Terra Firma, as part of the financing for Elli’s acquisition of Four Seasons Health Care (the “Four Seasons Notes”). The Four Seasons Notes mature in June 2020, are non-callable through June 2016 and bear interest on their par value at a fixed rate of 12.25% per annum. The Company purchased an aggregate par value of £138.5 million of the Four Seasons Notes at a discount for £136.8 million ($215 million) in June 2012, representing 79% of the total £175 million issued and outstanding Four Seasons Notes. In June 2015 and September 2015, the Company determined that the Four Seasons Notes were other-than-temporarily impaired (see Note 17).

 

Elli remains obligated to repay the aggregate par value at maturity and interest payments due June 15 and December 15 each year. When the remaining semi-annual interest payments are received, the Company expects to reduce the carrying value of the Four Seasons Notes during the related fiscal period. Accordingly, the Company applied the contractual interest payments received in December 2015 (£8 million or $13 million), June 2016 (£8 million or $13 million) and December 2016 (£8 million or $11 million) against the principal balance. This treatment reduced the carrying value of the Four Seasons Notes to £58 million ($85 million) and £42 million ($50 million) at December 31, 2015 and 2016, respectively.

 

NOTE 11.    Debt

Bank Line of Credit and Term Loans

The Company’s $2.0 billion unsecured revolving line of credit facility (the “Facility”) matures on March 31, 2018 and contains a one-year extension option. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends upon the Company’s credit ratings. The Company pays a facility fee on the entire revolving commitment that depends on its credit ratings. Based on the Company’s credit ratings at December 31, 2016, the margin on the Facility was 1.05%, and the facility fee was 0.20%. The Facility also includes a feature that allows the Company to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At December 31, 2016, the Company had $900 million, including £372 million ($460 million), outstanding under the Facility with a weighted average effective interest rate of 1.82%.

On July 30, 2012, the Company entered into a credit agreement with a syndicate of banks for a £137 million ($169 million at December 31, 2016) four-year unsecured term loan (the “2012 Term Loan”). In July 2016, the Company exercised a one-year extension option on the 2012 Term Loan. Based on the Company’s credit ratings at December 31, 2016, the 2012 Term Loan accrues interest at a rate of GBP LIBOR plus 1.40%.  

On January 12, 2015, the Company entered into a credit agreement with a syndicate of banks for a £220 million ($272 million at December 31, 2016) four-year unsecured term loan (the “2015 Term Loan”) that accrues interest at a rate of GBP LIBOR plus 1.15%, subject to adjustments based on the Company’s credit ratings (the 2012 and 2015 Term Loans are collectively, the “Term Loans”). Concurrently, the Company entered into a three-year interest rate swap contract that fixes the interest rate of the 2015 Term Loan (1.97% at December 31, 2016). Proceeds from the 2015 Term Loan were used to repay £220 million that partially funded the November 2014 HC-One Facility (see Note 7). The 2015 Term Loan contains a one-year committed extension option.

101


 

Table of Contents

The Facility and Term Loans contain certain financial restrictions and other customary requirements, including cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60% and (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times. The Facility and Term Loans also require a Minimum Consolidated Tangible Net Worth of $6.5 billion at December 31, 2016, which requirement was reduced, via an amendment to the Facility, effective upon the completion of the Spin-Off of QCP on October 31, 2016. At December 31, 2016, the Company was in compliance with each of these restrictions and requirements of the Facility and Term Loans.

Senior Unsecured Notes

At December 31, 2016, the Company had senior unsecured notes outstanding with an aggregate principal balance of $7.2 billion. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. The Company believes it was in compliance with these covenants at December 31, 2016.

The following table summarizes the Company’s senior unsecured notes issuances for the periods presented (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issuance

 

 

 

 

 

 

 

 

Period

    

Amount

    

Coupon Rate

    

Maturity Date

    

Net Proceeds

 

Year ended December 31, 2015:

 

 

 

 

 

 

 

 

 

 

 

 

 

January 21, 2015

 

$

600,000

 

 

3.400

%

 

2025

 

$

591,000

 

May 20, 2015

 

$

750,000

 

 

4.000

%

 

2025

 

$

739,000

 

December 1, 2015

 

$

600,000

 

 

4.000

%

 

2022

 

$

594,000

 

 

The following table summarizes the Company’s senior unsecured notes payoffs for the periods presented (dollars in thousands):

 

 

 

 

 

 

 

 

Period

    

Amount

    

Coupon Rate

 

Year ended December 31, 2016:

 

 

 

 

 

 

 

February 1, 2016

 

$

500,000

 

 

3.750

%

September 15, 2016

 

$

400,000

 

 

6.300

%

November 30, 2016

 

$

500,000

 

 

6.000

%

November 30, 2016

 

$

600,000

 

 

6.700

%

Year ended December 31, 2015:

 

 

 

 

 

 

 

March 1, 2015

 

$

200,000

 

 

6.000

%

June 8, 2015

 

$

200,000

 

 

7.072

%

 

Mortgage Debt

At December 31, 2016, the Company had $619 million in aggregate principal of mortgage debt outstanding, which is secured by 36 healthcare facilities (including redevelopment properties) with a carrying value of $899 million.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

102


 

Table of Contents

Debt Maturities

The following table summarizes the Company’s stated debt maturities and scheduled principal repayments at December 31, 2016 (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

 

 

    

Senior Unsecured Notes(3)

    

    

Mortgage Debt(4)

    

    

 

 

 

 

 

Line of

 

 

 

 

 

 

Interest

 

 

 

 

Interest

 

 

 

 

 

Year

 

Credit(1)

 

Term Loans(2)

 

Amount

 

Rate

 

 

Amount

 

Rate

 

 

Total(5)

 

2017

 

$

 —

 

$

169,305

 

$

250,000

 

5.72

%

 

$

479,795

 

3.14

%

 

$

899,100

 

2018

 

 

899,718

 

 

 —

 

 

 —

 

 —

%

 

 

3,641

 

 —

%

 

 

903,359

 

2019

 

 

 —

 

 

271,876

 

 

450,000

 

3.95

%

 

 

3,839

 

 —

%

 

 

725,715

 

2020

 

 

 —

 

 

 —

 

 

800,000

 

2.81

%

 

 

3,907

 

5.11

%

 

 

803,907

 

2021

 

 

 —

 

 

 —

 

 

1,200,000

 

5.54

%

 

 

11,277

 

5.38

%

 

 

1,211,277

 

Thereafter

 

 

 —

 

 

 —

 

 

4,500,000

 

4.27

%

 

 

116,481

 

4.13

%

 

 

4,616,481

 

 

 

 

899,718

 

 

441,181

 

 

7,200,000

 

4.34

%

 

 

618,940

 

3.40

%

 

 

9,159,839

 

Discounts and debt costs, net

 

 

 —

 

 

(1,119)

 

 

(66,462)

 

 

 

 

 

4,852

 

 

 

 

 

(62,729)

 

 

 

$

899,718

 

$

440,062

 

$

7,133,538

 

 

 

 

$

623,792

 

 

 

 

$

9,097,110

 


(1)

Includes £372 million translated into USD. 

(2)

Represents £357 million translated into USD.

(3)

Interest rates on the notes ranged from 2.79% to 6.88% with a weighted average effective rate of 4.34% and a weighted average maturity of six years.

(4)

Interest rates on the mortgage debt ranged from 3.02% to 7.50% with a weighted average effective interest rate of 3.40% and a weighted average maturity of six years.

(5)

Excludes $92 million of other debt that represents Life Care Bonds and Demand Notes that have no scheduled maturities.

 

Other Debt

At December 31, 2016, the Company had $64 million of non-interest bearing life care bonds at two of its continuing care retirement communities and non-interest bearing occupancy fee deposits at three of its senior housing facilities, all of which are payable to certain residents of the facilities (collectively, “Life Care Bonds”). The Life Care Bonds are generally refundable to the residents upon the termination of the contract or upon the successful resale of the unit.

At December 31, 2016, the Company had $28 million of on-demand notes (“Demand Notes”) from the CCRC JV. The Demand Notes bear interest at a rate of 4.5%.  

Subsequent Events

In January 2017, the Company repaid $440 million on the Facility primarily using proceeds from the RIDEA II joint venture disposition.

NOTE 12.    Commitments and Contingencies

Legal Proceedings

From time to time, the Company is a party to legal proceedings, lawsuits and other claims. Except as described below, the Company is not aware of any other legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company’s financial condition, results of operations or cash flows. The Company’s policy is to expense legal costs as they are incurred.

On May 9, 2016, a purported stockholder of the Company filed a putative class action complaint, Boynton Beach Firefighters’ Pension Fund v. HCP, Inc., et al., Case No. 3:16-cv-01106-JJH, in the U.S. District Court for the Northern District of Ohio against the Company and certain of its officers, and HCRMC and certain of its officers, asserting violations of the federal securities laws. The suit asserts claims under sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and alleges that the Company made certain false or misleading statements relating to the value of and risks concerning its investment in HCRMC by allegedly failing to disclose that HCRMC had engaged in billing fraud, as alleged by the U.S. Department of Justice in a pending suit against HCRMC arising from the False Claims Act. The plaintiff in the suit demands compensatory damages (in an unspecified amount), costs and expenses (including attorneys’ fees and expert fees), and equitable, injunctive, or other relief as the Court deems just and proper. As the Boynton Beach action is in its

103


 

Table of Contents

early stages and a lead plaintiff has not yet been named, the defendants have not yet responded to the complaint. The Company believes the suit to be without merit and intends to vigorously defend against it.

On June 16, 2016 and July 5, 2016, purported stockholders of the Company filed two derivative actions, respectively Subodh v. HCR ManorCare Inc., et al., Case No. 30-2016-00858497-CU-PT-CXC and Stearns v. HCR ManorCare, Inc., et al., Case No. 30-2016-00861646-CU-MC-CJC, in the Superior Court of California, County of Orange, against certain of the Company’s current and former directors and officers and HCRMC. The Stearns action was subsequently consolidated by the Court with the Subodh action. The Company is named as a nominal defendant. The consolidated derivative action alleges that the defendants engaged in various acts of wrongdoing, including, among other things, breaching fiduciary duties by publicly making false or misleading statements of fact regarding HCRMC’s finances and prospects, and failing to maintain adequate internal controls. The plaintiffs demand damages (in an unspecified amount), pre-judgment and post-judgment interest, a directive that the Company and the individual defendants improve the Company's corporate governance and internal procedures (including putting resolutions to amend the bylaws or charter to a stockholder vote), restitution from the individual defendants, costs (including attorneys’ fees, experts’ fees, costs, and expenses), and further relief as the Court deems just and proper. As the Subodh action is in the early stages, the defendants are in the process of evaluating the suit and have not yet responded to the complaint.

 

On June 9, 2016, and on August 25, 2016, the Company received letters from a private law firm, acting on behalf of its clients, purported stockholders of the Company, each asserting substantially the same allegations made in the Subodh and Stearns matters discussed above. Each letter demands that the Company’s Board of Directors take action to assert the Company’s rights. The Board of Directors is in the process of evaluating the demand letters.

The Company is unable to estimate the ultimate individual or aggregate amount of monetary liability or financial impact with respect to matters discussed above as of December 31, 2016.

 

DownREIT LLCs

In connection with the formation of certain DownREIT LLCs, members may contribute appreciated real estate to a DownREIT LLC in exchange for DownREIT units. These contributions are generally tax-deferred, so that the pre-contribution gain related to the property is not taxed to the member. However, if a contributed property is later sold by the DownREIT LLC, the unamortized pre-contribution gain that exists at the date of sale is specifically allocated and taxed to the contributing members. In many of the DownREITs, the Company has entered into indemnification agreements with those members who contributed appreciated property into the DownREIT LLC. Under these indemnification agreements, if any of the appreciated real estate contributed by the members is sold by the DownREIT LLC in a taxable transaction within a specified number of years, the Company will reimburse the affected members for the federal and state income taxes associated with the pre-contribution gain that is specially allocated to the affected member under the Code (“make-whole payments”). These make-whole payments include a tax gross-up provision. These indemnification agreements have expiration terms that range through 2033.

Commitments

The following table summarizes the Company’s material commitments, excluding debt servicing obligations (see Note 11), at December 31, 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

 

    

 

    

 

 

    

 

 

    

More than

 

 

 

Total(1)

 

2017

 

2018-2019

 

2020-2021

 

Five Years

 

U.K. loan commitments(2)

 

 

43,107

 

 

39,946

 

 

3,161

 

 

 —

 

 

 —

 

Construction loan commitments(3)

 

 

124

 

 

124

 

 

 —

 

 

 —

 

 

 —

 

Development commitments(4)

 

 

117,019

 

 

114,229

 

 

2,790

 

 

 —

 

 

 —

 

Ground and other operating leases

 

 

412,055

 

 

7,294

 

 

14,751

 

 

13,706

 

 

376,304

 

Total

 

$

572,305

 

$

161,593

 

$

20,702

 

$

13,706

 

$

376,304

 


(1)

Excludes the $100 million Unsecured Revolving Credit Facility commitment to QCP, which is available to be drawn on by QCP through the fourth quarter of 2017 and matures in the fourth quarter of 2018. The Unsecured Revolving Credit Facility will automatically and permanently decrease each calendar month by an amount equal to 50% of QCP’s and its restricted subsidiaries’ retained cash flow for the prior calendar month. All borrowings under the Unsecured Revolving Credit Facility will be subject to the satisfaction of certain conditions (see Note 1).

(2)

Represents £35 million translated into USD for commitments to fund the Company’s U.K. loan facilities.

104


 

Table of Contents

(3)

Represents commitments to finance development projects and related working capital financings.

(4)

Represents construction and other commitments for developments in progress.

Credit Enhancement Guarantee

Certain of the Company’s senior housing facilities serve as collateral for $91 million of debt (maturing May 1, 2025) that is owed by a previous owner of the facilities. This indebtedness is guaranteed by the previous owner who has an investment grade credit rating. These senior housing facilities, which are classified as DFLs, had a carrying value of $629 million as of December 31, 2016.

Environmental Costs

The Company monitors its properties for the presence of hazardous or toxic substances. The Company is not aware of any environmental liability with respect to the properties that would have a material adverse effect on the Company’s business, financial condition or results of operations. The Company carries environmental insurance and believes that the policy terms, conditions, limitations and deductibles are adequate and appropriate under the circumstances, given the relative risk of loss, the cost of such coverage and current industry practice.

General Uninsured Losses

The Company obtains various types of insurance to mitigate the impact of property, business interruption, liability, flood, windstorm, earthquake, environmental and terrorism related losses. The Company attempts to obtain appropriate policy terms, conditions, limits and deductibles considering the relative risk of loss, the cost of such coverage and current industry practice. There are, however, certain types of extraordinary losses, such as those due to acts of war or other events that may be either uninsurable or not economically insurable. In addition, the Company has a large number of properties that are exposed to earthquake, flood and windstorm occurrences for which the related insurances carry high deductibles.

Tenant Purchase Options

Certain leases, including DFLs contain purchase options whereby the tenant may elect to acquire the underlying real estate. Annualized base rent from leases subject to purchase options, summarized by the year the purchase options are exercisable, are as follows (dollars in thousands):

 

 

 

 

 

 

 

 

    

Annualized

    

Number of

 

Year

 

Base Rent(1)

 

Properties

 

2017

 

$

16,202

 

9

 

2018

 

 

20,028

 

4

 

2019

 

 

14,411

 

2

 

2020

 

 

13,869

 

4

 

Thereafter

 

 

56,405

 

32

 

 

 

$

120,915

 

51

 


(1)

Represents the most recent month’s base rent including additional rent floors and cash income from DFLs annualized for 12 months. Base rent does not include tenant recoveries, additional rents in excess of floors and non-cash revenue adjustments (i.e., straight- line rents, amortization of market lease intangibles, DFL non-cash and deferred revenues).

 

105


 

Table of Contents

Rental Expense

The Company’s rental expense attributable to continuing operations for the years ended December 31, 2016, 2015 and 2014 was $10 million, $10 million and $8 million, respectively. These rental expense amounts include ground rent and other leases. Ground leases generally require fixed annual rent payments and may also include escalation clauses and renewal options. These leases have terms that are up to 99 years, excluding extension options. Future minimum lease obligations under non-cancelable ground and other operating leases as of December 31, 2016 were as follows (in thousands):

 

 

 

 

 

Year

    

Amount

 

2017

 

$

7,294

 

2018

 

 

7,303

 

2019

 

 

7,448

 

2020

 

 

7,018

 

2021

 

 

6,688

 

Thereafter

 

 

376,304

 

 

 

$

412,055

 

 

 

 

NOTE 13.     Equity

Common Stock

On February 2, 2017, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.37 per share. The common stock cash dividend will be paid on March 2, 2017 to stockholders of record as of the close of business on February 15, 2017.

During the years ended December 31, 2016, 2015 and 2014, the Company declared and paid common stock cash dividends of $2.095,  $2.26 and $2.18 per share, respectively. 

In June 2015, the Company established an at-the-market equity offering program (“ATM Program”). Under this program, the Company may sell shares of its common stock from time to time having an aggregate gross sales price of up to $750 million through a consortium of banks acting as sales agents or directly to the banks acting as principals. During the year ended December 31, 2015, the Company issued 1.8 million shares of common stock at a weighted average price of $40.14 for proceeds of $73 million, net of fees and commissions of $1 million. There was no activity during the year ended December 31, 2016.

The following table summarizes the Company’s other common stock activities (shares in thousands):

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

December 31,

 

 

 

2016

 

2015

 

2014

 

Dividend Reinvestment and Stock Purchase Plan

    

2,021

    

2,762

    

2,299

 

Conversion of DownREIT units

 

145

 

104

 

27

 

Exercise of stock options

 

133

 

823

 

169

 

Vesting of restricted stock units

 

529

 

409

 

614

 

Repurchase of common stock

 

237

 

198

 

323

 

 

106


 

Table of Contents

Accumulated Other Comprehensive Loss

The following table summarizes the Company’s accumulated other comprehensive loss (in thousands):

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2016

 

2015

 

Cumulative foreign currency translation adjustment

 

$

(22,817)

 

$

(19,485)

 

Unrealized losses on cash flow hedges, net

 

 

(3,642)

 

 

(7,582)

 

Supplemental Executive Retirement Plan minimum liability

 

 

(3,129)

 

 

(3,411)

 

Unrealized (losses) gains on available for sale securities

    

 

(54)

    

 

8

 

Total accumulated other comprehensive loss

 

$

(29,642)

 

$

(30,470)

 

 

Noncontrolling Interests

On October 7, 2015, the Company issued a 49% noncontrolling interest in HCP Ventures V to an institutional capital investor for $110 million. HCP Ventures V owns a portfolio of 11 on-campus MOBs located in Texas and acquired through a sale-leaseback transaction with Memorial Hermann in June 2015.

At December 31, 2016, there were 4 million non-managing member units (7 million shares of HCP common stock are issuable upon conversion) outstanding in five DownREIT LLCs, all of which the Company is the managing member of. At December 31, 2016, the carrying and market values of the four million DownREIT units were $179 million and $199 million, respectively.

See Note 20 for the supplemental schedule of non-cash financing activities.

NOTE 14.    Segment Disclosures

The Company evaluates its business and allocates resources based on its reportable business segments: (i) SH NNN, (ii) SHOP, (iii) life science and (iv) medical office. Under the medical office segment, the Company invests through the acquisition and development of medical office buildings (“MOBs”), which generally require a greater level of property management. Otherwise, the Company primarily invests, through the acquisition and development of real estate, in single tenant and operator properties. The Company has non-reportable segments that are comprised primarily of the Company’s debt investments, hospital properties and U.K. care homes. The accounting policies of the segments are the same as those described under Summary of Significant Accounting Policies (see Note 2). During the year ended December 31, 2016, 17 SH NNN facilities were transitioned to a RIDEA structure (reported in the Company’s SHOP segment). There were no intersegment sales or transfers during the years ended December 31, 2015 and 2014. The Company evaluates performance based upon: (i) property net operating income from continuing operations (“NOI”) and (ii) adjusted NOI (cash NOI) of the combined consolidated and unconsolidated investments in each segment.

Non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, marketable equity securities and, if any, real estate held for sale. Interest expense, depreciation and amortization, and non-property specific revenues and expenses are not allocated to individual segments in evaluating the Company’s segment-level performance.

107


 

Table of Contents

The following tables summarize information for the reportable segments (in thousands):

For the year ended December 31, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life

 

Medical

 

Other

 

Corporate

 

 

 

 

Segments

    

SH NNN

    

SHOP

    

Science

    

Office

    

Non-reportable

    

Non-segment

    

Total

 

Rental revenues(1)

 

$

423,118

 

$

686,822

 

$

358,537

 

$

446,280

 

$

125,729

 

$

 —

 

$

2,040,486

 

HCP share of unconsolidated JV revenues

 

 

 —

 

 

204,591

 

 

7,599

 

 

1,996

 

 

1,618

 

 

 —

 

 

215,804

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

(6,710)

 

 

(480,870)

 

 

(72,478)

 

 

(173,687)

 

 

(4,654)

 

 

 —

 

 

(738,399)

 

HCP share of unconsolidated JV operating expenses

 

 

 —

 

 

(166,791)

 

 

(1,601)

 

 

(595)

 

 

(48)

 

 

 —

 

 

(169,035)

 

NOI

 

 

416,408

 

 

243,752

 

 

292,057

 

 

273,994

 

 

122,645

 

 

 —

 

 

1,348,856

 

Non-cash adjustments to NOI(2)

 

 

(7,566)

 

 

20,076

 

 

(3,003)

 

 

(3,557)

 

 

(3,019)

 

 

 —

 

 

2,931

 

Adjusted NOI

 

 

408,842

 

 

263,828

 

 

289,054

 

 

270,437

 

 

119,626

 

 

 —

 

 

1,351,787

 

Addback non-cash adjustments

 

 

7,566

 

 

(20,076)

 

 

3,003

 

 

3,557

 

 

3,019

 

 

 —

 

 

(2,931)

 

Interest income

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

88,808

 

 

 —

 

 

88,808

 

Interest expense

 

 

(9,499)

 

 

(29,745)

 

 

(2,357)

 

 

(5,895)

 

 

(9,153)

 

 

(407,754)

 

 

(464,403)

 

Depreciation and amortization

 

 

(136,146)

 

 

(108,806)

 

 

(130,829)

 

 

(161,790)

 

 

(30,537)

 

 

 —

 

 

(568,108)

 

General and administrative

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(103,611)

 

 

(103,611)

 

Acquisition and pursuit costs

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(9,821)

 

 

(9,821)

 

Gain on sales of real estate, net

 

 

48,744

 

 

675

 

 

49,042

 

 

8,333

 

 

57,904

 

 

 —

 

 

164,698

 

Loss on debt extinguishments

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(46,020)

 

 

(46,020)

 

Other income, net

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

3,654

 

 

3,654

 

Income tax expense

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(4,473)

 

 

(4,473)

 

Less: HCP share of unconsolidated JV NOI

 

 

 —

 

 

(37,800)

 

 

(5,998)

 

 

(1,401)

 

 

(1,570)

 

 

 —

 

 

(46,769)

 

Equity income from unconsolidated joint ventures

 

 

 —

 

 

4,226

 

 

2,927

 

 

3,350

 

 

857

 

 

 —

 

 

11,360

 

Total discontinued operations

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

265,755

 

 

265,755

 

Net income (loss)

 

$

319,507

 

$

72,302

 

$

204,842

 

$

116,591

 

$

228,954

 

$

(302,270)

 

$

639,926

 

 

108


 

Table of Contents

For the year ended December 31, 2015:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life

 

Medical

 

Other

 

Corporate

 

 

 

 

Segments

    

SH NNN

    

SHOP

    

Science

    

Office

    

Non-reportable

    

Non-segment

    

Total

 

Rental revenues(1)

 

$

428,269

 

$

518,264

 

$

342,984

 

$

415,351

 

$

123,437

 

$

 —

 

$

1,828,305

 

HCP share of unconsolidated JV revenues

 

 

 —

 

 

181,410

 

 

7,106

 

 

1,870

 

 

1,600

 

 

 —

 

 

191,986

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 —

 

Operating expenses

 

 

(3,427)

 

 

(371,016)

 

 

(70,217)

 

 

(162,054)

 

 

(3,965)

 

 

 —

 

 

(610,679)

 

HCP share of unconsolidated JV operating expenses

 

 

 —

 

 

(151,962)

 

 

(1,612)

 

 

(612)

 

 

(73)

 

 

 —

 

 

(154,259)

 

NOI

 

 

424,842

 

 

176,696

 

 

278,261

 

 

254,555

 

 

120,999

 

 

 —

 

 

1,255,353

 

Non-cash adjustments to NOI(2)

 

 

(9,716)

 

 

34,045

 

 

(10,392)

 

 

(4,933)

 

 

(2,356)

 

 

 —

 

 

6,648

 

Adjusted NOI

 

 

415,126

 

 

210,741

 

 

267,869

 

 

249,622

 

 

118,643

 

 

 —

 

 

1,262,001

 

Addback non-cash adjustments

 

 

9,716

 

 

(34,045)

 

 

10,392

 

 

4,933

 

 

2,356

 

 

 —

 

 

(6,648)

 

Interest income

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

112,184

 

 

 —

 

 

112,184

 

Interest expense

 

 

(16,899)

 

 

(31,869)

 

 

(2,878)

 

 

(9,603)

 

 

(9,745)

 

 

(408,602)

 

 

(479,596)

 

Depreciation and amortization

 

 

(125,538)

 

 

(80,981)

 

 

(126,241)

 

 

(143,682)

 

 

(28,463)

 

 

 —

 

 

(504,905)

 

General and administrative

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(95,965)

 

 

(95,965)

 

Acquisition and pursuit costs

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(27,309)

 

 

(27,309)

 

Impairments, net

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(108,349)

 

 

 —

 

 

(108,349)

 

Gain on sales of real estate, net

 

 

6,325

 

 

 —

 

 

 —

 

 

52

 

 

 —

 

 

 —

 

 

6,377

 

Other income, net

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

16,208

 

 

16,208

 

Income tax benefit

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

9,807

 

 

9,807

 

Less: HCP share of unconsolidated JV NOI

 

 

 —

 

 

(29,448)

 

 

(5,494)

 

 

(1,258)

 

 

(1,527)

 

 

 —

 

 

(37,727)

 

Equity (loss) income from unconsolidated joint ventures

 

 

 —

 

 

(9,032)

 

 

2,718

 

 

12,904

 

 

 —

 

 

 —

 

 

6,590

 

Total discontinued operations

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(699,086)

 

 

(699,086)

 

Net income (loss)

 

$

288,730

 

$

25,366

 

$

146,366

 

$

112,968

 

$

85,099

 

$

(1,204,947)

 

$

(546,418)

 

109


 

Table of Contents

For the year ended December 31, 2014:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life

 

Medical

 

Other

 

Corporate

 

 

 

 

Segments

    

SH NNN

    

SHOP

    

Science

    

Office

    

Non-reportable

    

Non-segment

    

Total

 

Rental revenues(1)

 

$

538,113

 

$

243,612

 

$

314,114

 

$

368,055

 

$

99,316

 

$

 —

 

$

1,563,210

 

HCP share of unconsolidated JV revenues

 

 

 —

 

 

57,740

 

 

6,888

 

 

1,825

 

 

 —

 

 

 —

 

 

66,453

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

(3,629)

 

 

(163,650)

 

 

(63,080)

 

 

(147,144)

 

 

(3,791)

 

 

 —

 

 

(381,294)

 

HCP share of unconsolidated JV operating expenses

 

 

 —

 

 

(49,571)

 

 

(1,749)

 

 

(571)

 

 

 —

 

 

 —

 

 

(51,891)

 

NOI

 

 

534,484

 

 

88,131

 

 

256,173

 

 

222,165

 

 

95,525

 

 

 —

 

 

1,196,478

 

Non-cash adjustments to NOI(2)

 

 

(66,474)

 

 

10,160

 

 

(10,375)

 

 

(1,291)

 

 

(805)

 

 

 —

 

 

(68,785)

 

Adjusted NOI

 

 

468,010

 

 

98,291

 

 

245,798

 

 

220,874

 

 

94,720

 

 

 —

 

 

1,127,693

 

Addback non-cash adjustments

 

 

66,474

 

 

(10,160)

 

 

10,375

 

 

1,291

 

 

805

 

 

 —

 

 

68,785

 

Interest income

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

73,623

 

 

 —

 

 

73,623

 

Interest expense

 

 

(32,866)

 

 

(31,648)

 

 

(3,141)

 

 

(9,396)

 

 

(4,441)

 

 

(358,250)

 

 

(439,742)

 

Depreciation and amortization

 

 

(158,881)

 

 

(42,153)

 

 

(111,552)

 

 

(124,141)

 

 

(18,284)

 

 

(5)

 

 

(455,016)

 

General and administrative

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(81,765)

 

 

(81,765)

 

Acquisition and pursuit costs

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

(17,142)

 

 

(17,142)

 

Gain on sales of real estate, net

 

 

3,288

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

3,288

 

Other income, net

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

9,252

 

 

9,252

 

Income tax benefit

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

506

 

 

506

 

Less: HCP share of unconsolidated JV NOI

 

 

 —

 

 

(8,169)

 

 

(5,139)

 

 

(1,254)

 

 

 —

 

 

 —

 

 

(14,562)

 

Equity (loss) income from unconsolidated joint ventures

 

 

 —

 

 

(4,110)

 

 

2,834

 

 

(2,329)

 

 

 —

 

 

 —

 

 

(3,605)

 

Total discontinued operations

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

665,276

 

 

665,276

 

Net income

 

$

346,025

 

$

2,051

 

$

139,175

 

$

85,045

 

$

146,423

 

$

217,872

 

$

936,591

 


(1)

Represents rental and related revenues, tenant recoveries, resident fees and services, and income from DFLs.

(2)

Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees.

 

110


 

Table of Contents

The following table summarizes the Company’s revenues by segment (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

December 31,

Segments

    

2016

  

2015

  

2014

SH NNN

 

$

423,118

 

$

428,269

 

$

538,113

SHOP

 

 

686,822

 

 

518,264

 

 

243,612

Life science 

 

 

358,537

 

 

342,984

 

 

314,114

Medical office 

 

 

446,280

 

 

415,351

 

 

368,055

Other non-reportable segments

 

 

214,537

 

 

235,621

 

 

172,939

Total revenues

 

$

2,129,294

 

$

1,940,489

 

$

1,636,833

The following table summarizes the Company’s total assets by segment (in thousands):

 

 

 

 

 

 

 

 

 

 

December 31,

 

Segments

 

2016

 

2015

 

SH NNN

    

$

3,871,720

    

$

5,092,443

 

SHOP

 

 

3,623,931

 

 

3,195,384

 

Life science 

 

 

4,029,500

 

 

3,682,308

 

Medical office 

 

 

3,737,939

 

 

3,436,884

 

Gross reportable segment assets 

 

 

15,263,090

 

 

15,407,019

 

Accumulated depreciation and amortization

 

 

(2,900,060)

 

 

(2,704,425)

 

Net reportable segment assets 

 

 

12,363,030

 

 

12,702,594

 

Other non-reportable segment assets

 

 

1,685,563

 

 

1,787,579

 

Assets held for sale and discontinued operations, net

 

 

927,866

 

 

5,654,326

 

Other non-segment assets

 

 

782,806

 

 

1,305,350

 

Total assets

 

$

15,759,265

 

$

21,449,849

 

 

As a result of a change in reportable segments, the Company allocated goodwill to the new reporting units using a relative fair value approach. The Company completed a goodwill impairment assessment for all reporting units immediately prior to the reallocation and determined that no impairment existed at September 30, 2016. Additionally, the Company completed the required annual impairment test during the fourth quarter of 2016 and no impairment was recognized. At December 31, 2016, goodwill of $42 million was allocated to segment assets as follows: (i) SH NNN—$16 million, (ii) SHOP—$9 million, (iii) medical office—$11 million and (iv) other—$6 million. At December 31, 2015, goodwill of $47 million was allocated to segment assets as follows: (i) SH NNN—$21 million, (ii) SHOP—$9 million, (iii) medical office—$11 million and (iv) other—$6 million.

 

NOTE 15.    Future Minimum Rents

The following table summarizes future minimum lease payments to be received, excluding operating expense reimbursements, from tenants under non-cancelable operating leases as of December 31, 2016 (in thousands):

 

 

 

 

 

Year

    

Amount

 

2017

 

$

1,068,698

 

2018

 

 

995,723

 

2019

 

 

899,038

 

2020

 

 

825,614

 

2021

 

 

750,635

 

Thereafter

 

 

3,546,462

 

 

 

$

8,086,170

 

 

 

 

111


 

Table of Contents

NOTE 16.    Compensation Plans

Stock Based Compensation

On May 11, 2006, the Company’s stockholders approved the 2006 Performance Incentive Plan, which was amended and restated in 2009 (“the 2006 Plan”). On May 1, 2014, the Company’s stockholders approved the 2014 Performance Incentive Plan (“the 2014 Plan”) (collectively, “the Plans”). Following the adoption of the 2014 Plan, no new awards will be issued under the 2006 Plan. The Plans provide for the granting of stock-based compensation, including stock options, restricted stock and restricted stock units to officers, employees and directors in connection with their employment with or services provided to the Company. The maximum number of shares reserved for awards under the 2014 Plan is 33 million shares, and as of December 31, 2016, 31 million of the reserved shares under the 2014 Plan are available for future awards of which 21 million shares may be issued as restricted stock and restricted stock units.

Total share-based compensation expense recognized during the years ended December 31, 2016, 2015 and 2014 was $23 million, $26 million and $22 million, respectively. The year ended December 31, 2016 includes a $7 million charge recognized in general and administrative expenses primarily resulting from the termination of the Company’s former chief executive officer (“CEO”) that was comprised of the accelerated vesting of restricted stock units in accordance with the terms of the former CEO’s employment agreement. As of December 31, 2016 and 2015, there was $14 million and $19 million, respectively, of deferred compensation cost associated with future employee services, related to unvested share-based compensation arrangements granted under the Company’s incentive plans, which is expected to be recognized over a weighted average period of three years.

Conversion of Equity Awards at the Spin-Off Date

The Plans were established with anti-dilution provisions, such that in the event of an equity restructuring of the Company (including spin-off transactions), equity awards would preserve their value post-transaction. In order to achieve an equitable modification of the existing awards following the Spin-Off, the Company converted pre-spin awards to their post-spin value, resulting in grants to remaining employees denominated solely in the Company’s common stock. The modification assumed a conversion ratio on all awards calculated as the final pre-spin closing price of the Company’s common stock divided by the five trading day average post-spin closing price (“Five Day Average Price”) of the Company’s common stock. The conversion impacted 133 participants, resulted in additional awards being granted and incremental fair value of unvested awards due to the difference between the Five Day Average Price and the pre-spin closing price on the Spin-Off date. The vesting periods were unchanged for unvested grants at the Spin-Off date. The incremental fair value of unvested awards was immaterial.

Stock Options

Stock options are granted with an exercise price per share equal to the closing market price of the Company’s common stock on the grant date. Stock options generally vest ratably over a three- to five-year period and have a 10-year contractual term. Vesting of certain stock options may accelerate, as provided in the Plans or in the applicable award agreement, upon retirement, a change in control or other specified events. Upon exercise, a participant is required to pay the exercise price of the stock options being exercised and the related tax withholding obligation.

There have been no grants of stock options since 2014. Stock options outstanding and exercisable were 1.3 million and 1.2 million at December 31, 2016, respectively, and 1.7 million and 1.4 million at December 31, 2015, respectively. Proceeds received from stock options exercised under the Plans for the years ended December 31, 2016, 2015 and 2014 were $4 million, $28 million and $5 million, respectively. Compensation expense related to stock options was immaterial for all periods presented.

 

Restricted Stock Awards

Under the Plans, restricted stock awards, including restricted stock units and performance stock units are granted subject to certain restrictions. Conditions of vesting are determined at the time of grant.  Restrictions on certain awards generally lapse, as provided in the Plans or in the applicable award agreement, upon retirement, a change in control or other specified events. The fair market value of restricted stock awards, both time vesting and those subject to specific performance criteria, are expensed over the period of vesting. Restricted stock units, which vest based solely upon passage of time generally vest over a period of one to four years. The fair value of restricted stock units is determined based on the closing market price of the Company's shares on the grant date. Performance stock units, which are restricted stock awards that

112


 

Table of Contents

vest dependent upon attainment of various levels of performance that equal or exceed targeted levels, generally vest in their entirety at the end of a three year performance period. The number of shares that ultimately vest can vary from 0% to 200% of target depending on the level of achievement of the performance criteria. The fair value of performance stock units is determined based on the Monte Carlo valuation model. The compensation expense recognized for all restricted stock awards is net of forfeitures.

Upon vesting of restricted stock awards, the participant is required to pay the related tax withholding obligation. Participants can generally elect to have the Company reduce the number of common stock shares delivered to pay the employee tax withholding obligation. The value of the shares withheld is dependent on the closing market price of the Company’s common stock on the trading date prior to the relevant transaction occurring. During the years ended December 31, 2016, 2015 and 2014, the Company withheld 237,000, 200,000 and 323,000 shares, respectively, to offset tax withholding obligations with respect to the vesting of the restricted stock and performance restricted stock unit awards.

Holders of restricted stock awards, including restricted stock units and performance stock units, are generally entitled to receive dividends equal to the amount that would be paid on an equivalent number of shares of common stock.

The following table summarizes restricted stock award activity, including performance stock units, for the year ended December 31, 2016 (units and shares in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Weighted

    

 

    

Weighted

 

 

 

Restricted

 

Average

 

 

 

Average

 

 

 

Stock

 

Grant Date

 

Restricted

 

Grant Date

 

 

 

Units

 

Fair Value

 

Shares

 

Fair Value

 

Unvested at January 1, 2016

 

867

 

$

43.34

 

36

 

$

41.77

 

Granted

 

790

 

 

34.86

 

 —

 

 

 —

 

Vested

 

(528)

 

 

42.07

 

(36)

 

 

41.77

 

Forfeited

 

(167)

 

 

41.48

 

 —

 

 

 —

 

Unvested at December 31, 2016

 

962

 

 

37.39

 

 —

 

 

 —

 

 

At December 31, 2016, the weighted average remaining vesting period of restricted stock and performance based units was one year. The total fair value (at vesting) of restricted stock and performance based units which vested for the years ended December 31, 2016, 2015 and 2014 was $24 million, $21 million and $24 million, respectively.

NOTE 17.    Impairments

In June 2015 and September 2015, the Company determined that its Four Seasons Notes (see Note 10) were other-than-temporarily impaired resulting from a continued decrease in the fair value of its investment. Although the Company does not intend to sell and does not believe it will be required to sell the Four Seasons Notes before their maturity, the Company determined that a credit loss existed resulting from several factors including: (i) deterioration in Four Seasons’ operating performance since the fourth quarter of 2014 and (ii) credit downgrades to Four Seasons received during the first half of 2015. Accordingly, the Company recorded impairment charges during the three months ended June 30, 2015 and September 30, 2015 of $42 million and $70 million, respectively, reducing the carrying value of the Four Seasons Notes at September 30, 2015 to $100 million (£66 million).

The fair value of the Four Seasons Notes used to calculate the impairment charge was based on quoted market prices. However, because the Four Seasons Notes are not actively traded, these prices are considered to be Level 2 measurements within the fair value hierarchy. When calculating the fair value and determining whether a credit loss existed, the Company also evaluated Four Season’s ability to repay the Four Seasons Notes according to their contractual terms based on its estimate of future cash flows. The estimated future cash flow inputs included forecasted revenues, capital expenditures, operating expenses, care home occupancy and continued implementation of Four Seasons’ business plan which includes executing on its business line segmentation and continuing to invest in its core real estate portfolio. This information was consistent with the results of the valuation technique used by the Company to determine if a credit loss existed and to calculate the fair value of the Four Seasons Notes during its impairment review.

In June 2015, the Company determined a MOB was impaired and recognized an impairment charge of $3 million, which reduced the carrying value of the Company’s investment to $400,000. The fair value of the MOB was based on its projected

113


 

Table of Contents

sales prices, which was considered to be a Level 2 measurement within the fair value hierarchy. In July 2015, the Company sold the MOB for $400,000 (see Note 5).

Through October 2015, the Company held a secured term loan made to Delphis Operations, L.P. (“Delphis”). In October 2015, the Company received $23 million in cash proceeds from the sale of Delphis’ collateral and recognized an impairment recovery of $6 million for the amount received in excess of the loan’s carrying value.

NOTE 18.    Income Taxes

The Company has elected to be taxed as a REIT under the applicable provisions of the Code for every year beginning with the year ended December 31, 1985. The Company has also elected for certain of its subsidiaries to be treated as taxable REIT subsidiaries (“TRS” or “TRS entities”) which are subject to federal and state income taxes. All entities other than the TRS entities are collectively referred to as the “REIT” within this Note 18. Certain REIT entities are also subject to state, local and foreign income taxes. 

The TRS entities subject to tax reported losses before income taxes from continuing operations of $9 million, $22 million and $2 million for the years ended December 31, 2016, 2015 and 2014, respectively. The REIT’s losses from continuing operations before income taxes from the U.K. were $4 million, $15 million and $4 million for the years ended December 31, 2016, 2015 and 2014, respectively.

The total income tax expense (benefit) from continuing operations consists of the following components (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Current

    

 

    

    

 

    

    

 

    

 

Federal

 

$

8,525

 

$

4,948

 

$

1,833

 

State

 

 

8,307

 

 

1,988

 

 

2,018

 

Foreign

 

 

1,332

 

 

828

 

 

223

 

Total current

 

$

18,164

 

$

7,764

 

$

4,074

 

 

 

 

 

 

 

 

 

 

 

 

Deferred

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(10,241)

 

$

(11,317)

 

$

(3,278)

 

State

 

 

(1,401)

 

 

(1,382)

 

 

(347)

 

Foreign

 

 

(2,049)

 

 

(4,872)

 

 

(955)

 

Total deferred

 

$

(13,691)

 

$

(17,571)

 

$

(4,580)

 

 

 

 

 

 

 

 

 

 

 

 

Total income tax expense (benefit)

 

$

4,473

 

$

(9,807)

 

$

(506)

 

 

The Company’s income tax expense from discontinued operations was $48 million, $1 million and $1 million for the years ended December 31, 2016, 2015 and 2014, respectively (see Note 5).

The following table reconciles the income tax expense (benefit) from continuing operations at statutory rates to the actual income tax expense recorded (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

    

2016

    

2015

    

2014

 

Tax benefit at U.S. federal statutory income tax rate on income or loss subject to tax

    

$

(4,581)

 

$

(12,630)

 

$

(2,131)

 

State income tax expense, net of federal tax

 

 

6,081

 

 

(606)

 

 

134

 

Gross receipts and margin taxes

 

 

1,847

 

 

1,383

 

 

1,573

 

Foreign rate differential

 

 

647

 

 

2,269

 

 

554

 

Effect of permanent differences

 

 

(280)

 

 

(298)

 

 

(196)

 

Return to provision adjustments

 

 

287

 

 

(368)

 

 

(528)

 

Increase in valuation allowance

 

 

472

 

 

443

 

 

88

 

Total income tax expense (benefit)

 

$

4,473

 

$

(9,807)

 

$

(506)

 

 

114


 

Table of Contents

Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of the assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table summarizes the significant components of the Company’s deferred tax assets and liabilities from continuing operations (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

    

2016

    

2015

    

2014

 

Property, primarily differences in depreciation and amortization, the basis of land, and the treatment of interest and certain costs

 

$

28,940

 

$

19,862

 

$

3,418

 

Net operating loss carryforward

 

 

8,784

 

 

3,703

 

 

484

 

Expense accruals and other

 

 

(847)

 

 

(753)

 

 

462

 

Valuation allowance

 

 

(606)

 

 

(531)

 

 

(88)

 

Net deferred tax assets

 

$

36,271

 

$

22,281

 

$

4,276

 

 

Deferred tax assets and liabilities are included in other assets, net and accounts payable and accrued liabilities.

At December 31, 2016 the Company had a net operating loss (“NOL”) carryforward of $24 million related to the TRS entities. These amounts can be used to offset future taxable income, if any. The NOL carryforwards begin to expire in 2033 with respect to the TRS entities.

The Company records a valuation allowance against deferred tax assets in certain jurisdictions when it cannot sustain a conclusion that it is more likely than not that it can realize the deferred tax assets during the periods in which these temporary differences become deductible. The deferred tax asset valuation allowance is adequate to reduce the total deferred tax assets to an amount that the Company estimates will “more-likely-than-not” be realized.

The Company files numerous U.S. federal, state and local income and franchise tax returns. With a few exceptions, the Company is no longer subject to U.S. federal, state, or local tax examinations by taxing authorities for years prior to 2013.

For the year ended December 31, 2016, the tax basis of the Company’s net assets was less than the reported amounts by $2.0 billion. The difference between the reported amounts and the tax basis was primarily related to the Slough Estates USA, Inc. (“SEUSA”) acquisition, which occurred in 2007. For each of the years ended December 31, 2015 and 2014, the tax basis of the Company’s net assets was less than the reported amounts by $6.5 billion. The difference between the reported amounts and the tax basis was primarily related to the SEUSA and HCRMC acquisitions which occurred in 2007 and 2011, respectively. Both SEUSA and HCRMC were corporations subject to federal and state income taxes. As a result of these acquisitions, the Company succeeded to the tax attributes of SEUSA and HCRMC, including the tax basis in the acquired company’s assets and liabilities.

The Company is no longer subject to federal corporate-level tax on the taxable disposition of SEUSA pre-acquisition assets. However, the Company may be subject to corporate-level tax in some states on any taxable disposition that occurs within ten years after the August 1, 2007 acquisition, only to the extent of the built-in gain that existed on the date of the acquisition, based on the fair market value of the assets.

In connection with the HCRMC acquisition, the Company assumed unrecognized tax benefits of $2 million. For the year ended December 31, 2014, the Company had a decrease in unrecognized tax benefits of $1 million. There were no unrecognized tax benefits balances at December 31, 2016 and 2015.

During the year ended December 31, 2014, the Company reversed the entire balance of the interest expense associated with the unrecognized tax benefits assumed in connection with the acquisition of HCRMC. The amount reversed was insignificant and it was due to the lapse in the statute of limitations.

 

115


 

Table of Contents

 

NOTE 19.    Earnings Per Common Share

The following table illustrates the computation of basic and diluted earnings per share (dollars in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Numerator

    

 

    

    

 

    

    

 

    

 

Income from continuing operations

 

$

374,171

 

$

152,668

 

$

271,315

 

Noncontrolling interests’ share in continuing operations

 

 

(12,179)

 

 

(12,817)

 

 

(13,181)

 

Income from continuing operations applicable to HCP, Inc.

 

 

361,992

 

 

139,851

 

 

258,134

 

Participating securities’ share in continuing operations

 

 

(1,198)

 

 

(1,317)

 

 

(2,437)

 

Income from continuing operations applicable to common shares

 

 

360,794

 

 

138,534

 

 

255,697

 

Discontinued operations

 

 

265,755

 

 

(699,086)

 

 

665,276

 

Noncontrolling interests’ share in discontinued operations

 

 

 —

 

 

 —

 

 

(1,177)

 

Net income (loss) applicable to common shares

 

$

626,549

 

$

(560,552)

 

$

919,796

 

Denominator

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares

 

 

467,195

 

 

462,795

 

 

458,425

 

Dilutive potential common shares

 

 

208

 

 

 —

 

 

371

 

Diluted weighted average common shares

 

 

467,403

 

 

462,795

 

 

458,796

 

Basic earnings per common share

 

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

$

0.77

 

$

0.30

 

$

0.56

 

Discontinued operations

 

 

0.57

 

 

(1.51)

 

 

1.45

 

Net income (loss) applicable to common shares

 

$

1.34

 

$

(1.21)

 

$

2.01

 

Diluted earnings per common share

 

 

 

 

 

 

 

 

 

 

Income from continuing operations

 

$

0.77

 

$

0.30

 

$

0.56

 

Discontinued operations

 

 

0.57

 

 

(1.51)

 

 

1.44

 

Net income (loss) applicable to common shares

 

$

1.34

 

$

(1.21)

 

$

2.00

 

 

Restricted stock and certain performance restricted stock units are considered participating securities, because dividend payments are not forfeited even if the underlying share-based award does not vest, and require the use of the two-class method when computing basic and diluted earnings per share.

Options to purchase 1.1 million and  1.4 million shares of common stock that had exercise prices in excess of the average market price of the common stock during the years ended December 31, 2016 and 2014, respectively, were not included because they are anti-dilutive. Additionally, 7 million shares, issuable upon conversion of 4 million DownREIT units during the year ended December 31, 2016 were not included because they are anti-dilutive. For the year ended December 31, 2015, the Company generated a net loss. The weighted-average basic shares outstanding was used in calculating diluted loss per share from continuing operations, as using diluted shares would be anti-dilutive to loss per share.

 

116


 

Table of Contents

NOTE 20.    Supplemental Cash Flow Information

The following table summarizes supplemental cash flow information (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Supplemental cash flow information:

    

 

    

    

 

    

    

 

    

 

Interest paid, net of capitalized interest

 

$

489,453

 

$

451,615

 

$

410,286

 

Income taxes paid

 

 

13,727

 

 

6,959

 

 

5,071

 

Capitalized interest

 

 

11,108

 

 

8,798

 

 

10,314

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

 

 

 

 

 

 

 

Accrued construction costs

 

 

49,999

 

 

52,511

 

 

37,178

 

Non-cash impact of QCP Spin-Off, net

 

 

3,539,584

 

 

 —

 

 

 —

 

Securities transferred for debt defeasance

 

 

73,278

 

 

 —

 

 

 —

 

Settlement of loans receivable as consideration for real estate acquisition

 

 

 —

 

 

299,297

 

 

 —

 

Loan originated in connection with Brookdale Transaction

 

 

 —

 

 

 —

 

 

67,640

 

Real estate contributed to CCRC JV

 

 

 —

 

 

 —

 

 

91,603

 

Fair value of real estate acquired in exchange for sale of real estate

 

 

 —

 

 

 —

 

 

32,000

 

Tenant funded tenant improvements owned by HCP

 

 

27,014

 

 

28,850

 

 

21,863

 

Vesting of restricted stock units

 

 

529

 

 

409

 

 

614

 

Conversion of non-managing member units into common stock

 

 

6,093

 

 

2,979

 

 

473

 

Noncontrolling interest and other liabilities, net assumed in connection with the RIDEA III acquisition

 

 

 —

 

 

61,219

 

 

 —

 

Noncontrolling interest issued in connection with Brookdale Transaction

 

 

 —

 

 

 —

 

 

46,751

 

Noncontrolling interests issued in connection with real estate and other acquisitions

 

 

 —

 

 

10,971

 

 

6,321

 

Noncontrolling interest assumed in connection with real estate disposition

 

 

 —

 

 

 —

 

 

1,671

 

Mortgages and other liabilities assumed with real estate acquisitions

 

 

82,985

 

 

23,218

 

 

37,149

 

Foreign currency translation adjustment

 

 

(3,332)

 

 

(8,738)

 

 

(9,967)

 

Unrealized gains on available-for-sale securities and derivatives designated as cash flow hedges, net

 

 

3,171

 

 

1,889

 

 

2,271

 

 

See discussions related to the Brookdale Transaction in Note 3 and the Spin-Off in Note 5.

NOTE 21.    Variable Interest Entities

On January 1, 2016, the Company adopted ASU 2015-02 using the modified retrospective method as permitted by the ASU. As a result of the adoption, the Company identified additional assets and liabilities of certain VIEs in its consolidated total assets and total liabilities at December 31, 2015 of $543 million and $651 million, respectively. Refer to the specific VIE descriptions below for detail on which entities were classified as consolidated VIEs subsequent to the adoption of ASU 2015-02. Additionally, the Company deconsolidated three JVs and recognized $0.5 million as a cumulative-effect adjustment to cumulative dividends in excess of earnings.

Unconsolidated Variable Interest Entities

At December 31, 2016, the Company had investments in: (i) three unconsolidated VIE joint ventures; (ii) 48 properties leased to VIE tenants; (iii) marketable debt securities of two VIEs and (iv) two loans to VIE borrowers. The Company has determined that it is not the primary beneficiary of and therefore does not consolidate these VIEs because it does not have the ability to control the activities that most significantly impact their economic performance. Except for the Company’s equity interest in the unconsolidated JVs (CCRC OpCo, Vintage Park Development JV and the LLC investment discussed below), it has no formal involvement in these VIEs beyond its investments.

The Company holds a 49% ownership interest in CCRC OpCo, a joint venture entity formed in August 2014 that operates senior housing properties in a RIDEA structure and has been identified as a VIE (see Notes 3 and 8). The equity members of CCRC OpCo “lack power” because they share certain operating rights with Brookdale, as manager of the CCRCs. The assets of CCRC OpCo primarily consist of the CCRCs that it owns and leases, resident fees receivable, notes receivable,

117


 

Table of Contents

and cash and cash equivalents; its obligations primarily consist of operating lease obligations to CCRC PropCo, debt service payments and capital expenditures for the properties, and accounts payable and expense accruals associated with the cost of its CCRCs’ operations. Assets generated by the CCRC operations (primarily rents from CCRC residents) of CCRC OpCo may only be used to settle its contractual obligations (primarily from debt service payments, capital expenditures, and rental costs and operating expenses incurred to manage such facilities).

The Company holds an 85% ownership interest in Vintage Park Development JV (see Note 8), which has been identified as a VIE as power is shared with a member that does not have a substantive equity investment at risk. The assets of Vintage Park Development JV primarily consist of an in-progress independent living facility development project that it owns and cash and cash equivalents; its obligations primarily consist of accounts payable and expense accruals associated with the cost of its development obligations. Any assets generated by Vintage Park Development JV may only be used to settle its contractual obligations (primarily development expenses and debt service payments).

The Company holds a limited partner ownership interest in an unconsolidated LLC that has been identified as a VIE. The Company’s involvement in the entity is limited to its equity investment as a limited partner, and it does not have any substantive participating rights or kick-out rights over the managing member. The assets and liabilities of the entity primarily consist of those associated with its senior housing real estate and development activities. Any assets generated by the entity may only be used to settle its contractual obligations (primarily development expenses and debt service payments).

The Company leases 48 properties to a total of seven tenants that have also been identified as VIEs (“VIE tenants”). These VIE tenants are “thinly capitalized” entities that rely on the operating cash flows generated from the senior housing facilities to pay operating expenses, including the rent obligations under their leases.

The Company holds commercial mortgage-backed securities (“CMBS”) issued by Federal Home Loan Mortgage Corporation (commonly referred to as Freddie MAC) through a special purpose entity that has been identified as a VIE because it is “thinly capitalized.” The CMBS issued by the VIE are backed by mortgage debt obligations on real estate assets.

The Company holds Four Seasons Notes (see Note 10) and a portion of Four Seasons’ senior secured term loan (see Note 6). In the second quarter of 2015, upon the occurrence of a reconsideration event, it was determined that the issuer of the Four Seasons Notes is a VIE because this entity is “thinly capitalized” (see Note 17).

The Company provided a £105 million ($131 million) bridge loan to Maria Mallaband Care Group Ltd. (“MMCG”) to fund the acquisition of a portfolio of care homes in the U.K. MMCG created a special purpose entity to acquire the portfolio and funded it entirely using the Company’s bridge loan. As such, the special purpose entity has been identified as a VIE because it is “thinly capitalized.” The Company retains a three-year call option to acquire all the shares of the special purpose entity, which it can only exercise upon the occurrence of certain events.

The Company provided seller financing of $10 million related to its sale of seven SH NNN facilities. The financing was provided in the form of a secured five-year mezzanine loan to a “thinly capitalized” borrower created to acquire the facilities.

118


 

Table of Contents

The classification of the related assets and liabilities and their maximum loss exposure as a result of the Company’s involvement with these VIEs at December 31, 2016 are presented below (in thousands):

 

 

 

 

 

 

 

 

 

 

 

    

Maximum Loss

    

 

    

Carrying

 

VIE Type

 

Exposure(1)

 

Asset/Liability Type

 

Amount

 

VIE tenants—DFLs(2)

 

$

601,132

 

Net investment in DFLs

 

$

601,132

 

VIE tenants—operating leases(2)

 

 

7,628

 

Lease intangibles, net and straight-line rent receivables

 

 

7,628

 

CCRC OpCo

 

 

103,315

 

Investments in unconsolidated JVs

 

 

103,315

 

Vintage Park Development JV

 

 

7,486

 

Investments in unconsolidated JVs

 

 

7,486

 

Four Seasons

 

 

85,430

 

Loans and marketable debt securities

 

 

85,430

 

Loan—senior secured

 

 

131,215

 

Loans receivable, net

 

 

131,215

 

Loan—seller financing

 

 

10,000

 

Loans receivable, net

 

 

10,000

 

CMBS and LLC investment

 

 

33,275

 

Marketable debt and cost method investment

 

 

33,275

 


(1)

The Company’s maximum loss exposure represents the aggregate carrying amount of such investments (including accrued interest).

(2)

The Company’s maximum loss exposure may be mitigated by re-leasing the underlying properties to new tenants upon an event of default.

As of December 31, 2016, the Company has not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash shortfalls). See Notes 3, 6, 7, 8 and 10 for additional descriptions of the nature, purpose and operating activities of the Company’s unconsolidated VIEs and interests therein.

Consolidated Variable Interest Entities

RIDEA I.  The Company holds a 90% ownership interest in JV entities formed in September 2011 that own and operate senior housing properties in a RIDEA structure (“RIDEA I”). The Company has historically classified RIDEA I OpCo as a VIE and, as a result of the adoption of ASU 2015-02, also classifies RIDEA I PropCo as a VIE due to the non-managing member lacking substantive participation rights in the management of RIDEA I PropCo or kick-out rights over the managing member. The Company consolidates RIDEA I PropCo and RIDEA I OpCo as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of RIDEA I PropCo primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of notes payable to a non-VIE consolidated subsidiary of the Company. The assets of RIDEA I OpCo primarily consist of leasehold interests in senior housing facilities (operating leases), resident fees receivable, and cash and cash equivalents; its obligations primarily consist of lease payments to RIDEA I PropCo and operating expenses of its senior housing facilities (accounts payable and accrued expenses). Assets generated by the senior housing operations (primarily from senior housing resident rents) of the RIDEA I structure may only be used to settle its contractual obligations (primarily from the rental costs, operating expenses incurred to manage such facilities and debt costs).

RIDEA II.  The Company holds an 80% ownership interest in JV entities formed in August 2014 that own and operate senior housing properties in a RIDEA structure (“RIDEA II”). The Company consolidates RIDEA II (“SH PropCo” and “SH OpCo”) as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of SH PropCo primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of a note payable to a non-VIE consolidated subsidiary of the Company. The assets of SH OpCo primarily consist of leasehold interests in senior housing facilities (operating leases), resident fees receivable, and cash and cash equivalents; its obligations primarily consist of lease payments to SH PropCo and operating expenses of its senior housing facilities (accounts payable and accrued expenses). Assets generated by the senior housing operations (primarily from senior housing resident rents) of the RIDEA II structure may only be used to settle its contractual obligations (primarily from the rental costs, operating expenses incurred to manage such facilities and debt costs). See Note 4 for additional discussion of pending RIDEA II transactions.

RIDEA III.  The Company holds a 90% ownership interest in JV entities formed in June 2015 that own and operate senior housing properties in a RIDEA structure. The Company has historically classified RIDEA III OpCo as a VIE and, as a result of the adoption of ASU 2015-02, also classifies RIDEA III PropCo as a VIE due to the non-managing member lacking substantive participation rights in the management of RIDEA III PropCo or kick-out rights over the managing

119


 

Table of Contents

member. The Company consolidates RIDEA III PropCo and RIDEA III OpCo as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of RIDEA III PropCo primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of a note payable to a non-VIE consolidated subsidiary of the Company. The assets of RIDEA III OpCo primarily consist of leasehold interests in senior housing facilities (operating leases), resident fees receivable, and cash and cash equivalents; its obligations primarily consist of lease payments to RIDEA III PropCo and operating expenses of its senior housing facilities (accounts payable and accrued expenses). Assets generated by the senior housing operations (primarily from senior housing resident rents) of the RIDEA III structure may only be used to settle its contractual obligations (primarily from the rental costs, operating expenses incurred to manage such facilities and debt costs).

HCP Ventures V, LLC.  The Company holds a 51% ownership interest in and is the managing member of a JV entity formed in October 2015 that owns and leases MOBs (HCP Ventures V). Upon adoption of ASU 2015-02, the Company classified HCP Ventures V as a VIE due to the non-managing member lacking substantive participation rights in the management of HCP Ventures V or kick-out rights over the managing member. The Company consolidates HCP Ventures V as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE’s economic performance. The assets of HCP Ventures V primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the properties. Assets generated by HCP Ventures V may only be used to settle its contractual obligations (primarily from capital expenditures).

Vintage Park JV.  The Company holds a 90% ownership interest in a JV entity formed in January 2015 that owns an 85% interest in an unconsolidated development VIE (“Vintage Park JV”). Upon adoption of ASU 2015-02, the Company classified Vintage Park JV as a VIE due to the non-managing member lacking substantive participation rights in the management of the Vintage Park JV or kick-out rights over the managing member. The Company consolidates Vintage Park JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIE’s economic performance. The assets of Vintage Park JV primarily consist of an investment in the Vintage Park Development JV and cash and cash equivalents; its obligations primarily consist of funding the ongoing development of the Vintage Park Development JV. Assets generated by the Vintage Park JV may only be used to settle its contractual obligations (primarily from the funding of the Vintage Park Development JV).

DownREITs.  The Company holds a controlling ownership interest in and is the managing member of five DownREITs (see Note 12). Upon adoption of ASU 2015-02, the Company classified the DownREITs as VIEs due to the non-managing members lacking substantive participation rights in the management of the DownREITs or kick-out rights over the managing member. The Company consolidates the DownREITs as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of the DownREITs primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the DownREITs (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).

Other Consolidated Real Estate Partnerships.  The Company holds a controlling ownership interest in and is the general partner (or managing member) of multiple partnerships that own and lease real estate assets (the “Partnerships”). Upon adoption of ASU 2015-02, the Company classified the Partnerships as VIEs due to the limited partners (non-managing members) lacking substantive participation rights in the management of the Partnerships or kick-out rights over the general partner (managing member). The Company consolidates the Partnerships as the primary beneficiary because it has the ability to control the activities that most significantly impact these VIEs’ economic performance. The assets of the Partnerships primarily consist of leased properties (net real estate), rents receivable, and cash and cash equivalents; their obligations primarily consist of debt service payments and capital expenditures for the properties. Assets generated by the Partnerships (primarily from resident rents) may only be used to settle their contractual obligations (primarily from debt service and capital expenditures).

Other consolidated VIEs.  The Company made a loan to an entity that entered into a tax credit structure (“Tax Credit Subsidiary”) and a loan to an entity that made an investment in a development JV (“Development JV”) both of which are considered VIEs. The Company consolidates the Tax Credit Subsidiary and Development JV as the primary beneficiary because it has the ability to control the activities that most significantly impact the VIEs’ economic performance. The assets and liabilities of the Tax Credit Subsidiary and Development JV substantially consist of a development in progress, notes receivable, prepaid expenses, notes payable, and accounts payable and accrued liabilities generated from their

120


 

Table of Contents

operating activities. Any assets generated by the operating activities of the Tax Credit Subsidiary and Development JV may only be used to settle their contractual obligations.

Exchange Accommodation TitleholderDuring the year ended December 31, 2016, the Company acquired a MOB (the "acquired property") using a reverse like-kind exchange structure pursuant to Section 1031 of the Internal Revenue Code (a "reverse 1031 exchange"). As of December 31, 2016, the Company had not completed the reverse 1031 exchange and as such, the acquired property remained in the possession of an Exchange Accommodation Titleholder ("EAT"). The EAT is classified as a VIE as it is a “thinly capitalized” entity. The Company consolidates the EAT because it is the primary beneficiary as it has the ability to control the activities that most significantly impact the EAT's economic performance. The property held by the EAT is reflected as real estate with a carrying value of $37 million as of December 31, 2016. The assets of the EAT primarily consist of a leased property (net real estate), rents receivable, and cash and cash equivalents; its obligations primarily consist of capital expenditures for the property. Assets generated by the EAT may only be used to settle its contractual obligations (primarily from capital expenditures).

 

NOTE 22.    Fair Value Measurements

Financial assets and liabilities measured at fair value on a recurring basis at December 31, 2016 in the consolidated balance sheets are immaterial.

The table below summarizes the carrying amounts and fair values of the Company’s financial instruments (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

 

2016(4)

 

2015

 

 

 

Carrying

 

 

 

 

Carrying

 

 

 

 

 

 

Amount

 

Fair Value

 

Amount

 

Fair Value

 

Loans receivable, net(2)

 

$

807,954

 

$

807,505

 

$

768,743

 

$

770,052

 

Marketable debt securities(2)

 

 

68,630

 

 

68,630

 

 

102,958

 

 

102,958

 

Marketable equity securities(1)

 

 

76

 

 

76

 

 

39

 

 

39

 

Warrants(3)

 

 

19

 

 

19

 

 

55

 

 

55

 

Bank line of credit(2)

 

 

899,718

 

 

899,718

 

 

397,432

 

 

397,432

 

Term loans(2)

 

 

440,062

 

 

440,062

 

 

524,807

 

 

524,807

 

Senior unsecured notes(1)

 

 

7,133,538

 

 

7,386,149

 

 

9,120,107

 

 

9,390,668

 

Mortgage debt(2)

 

 

623,792

 

 

609,374

 

 

932,212

 

 

963,786

 

Other debt(2)

 

 

92,385

 

 

92,385

 

 

94,445

 

 

94,445

 

Interest-rate swap asset(2)

 

 

 —

 

 

 —

 

 

196

 

 

196

 

Interest-rate swap liabilities(2)

 

 

4,857

 

 

4,857

 

 

6,251

 

 

6,251

 

Currency swap assets(2)

 

 

2,920

 

 

2,920

 

 

1,551

 

 

1,551

 


(1)

Level 1: Fair value calculated based on quoted prices in active markets.  

(2)

Level 2: Fair value based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) or for loans receivable, net, mortgage debt, and swaps, calculated utilizing standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit, term loans and other debt, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company’s credit rating.

(3)

Level 3: Fair value determined based on significant unobservable market inputs using standardized derivative pricing models.

(4)

During the years ended December 31, 2016 and 2015, there were no material transfers of financial assets or liabilities within the fair value hierarchy.

 

NOTE 23.    Concentration of Credit Risk

Concentrations of credit risk arise when one or more tenants, operators or obligors related to the Company’s investments are engaged in similar business activities, or activities in the same geographic region, or have similar economic features that would cause their ability to meet contractual obligations, including those to the Company, to be similarly affected by changes in economic conditions. The Company regularly monitors various segments of its portfolio to assess potential concentrations of credit risks. The Company does not have significant foreign operations.

121


 

Table of Contents

The following table provides information regarding the Company’s concentrations with respect to Brookdale as a tenant as of and for the periods presented:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage of Gross Assets

 

Percentage of Revenues

 

 

 

Total Company

 

SH NNN

 

Total Company

 

SH NNN

 

 

 

December 31,

 

December 31,

 

Year Ended December 31,

 

Year Ended December 31,

 

Tenant

 

2016

 

2015

 

2016

 

2015

 

2016

 

2015

 

2014

 

2016

 

2015

 

2014

 

Brookdale(1)

    

17

    

13

    

69

    

53

    

12

    

13

    

19

    

59

    

58

    

59

 


(1)

Includes revenues from 64 SH NNN facilities that were classified as held for sale at December 31, 2016. On July 31, 2014, Brookdale completed its acquisition of Emeritus. These percentages of segment gross assets, total gross assets, segment revenues and total revenues, for the year ended December 31, 2014 are prepared on a pro forma basis to reflect the combined concentration for Brookdale and Emeritus, as if the merger had occurred as of January 1, 2014. Excludes senior housing facilities operated by Brookdale in the Company’s SHOP segment, as discussed below.

 

As of December 31, 2016 and 2015, Brookdale managed or operated, in the Company’s SHOP segment, approximately 18% and 17%, respectively, of the Company’s real estate investments based on gross assets. Because an operator manages the Company’s facilities in exchange for the receipt of a management fee, the Company is not directly exposed to the credit risk of its operators in the same manner or to the same extent as its triple-net tenants. As of December 31, 2016, Brookdale provided comprehensive facility management and accounting services with respect to 108 of the Company’s senior housing facilities and 16 SHOP facilities owned by its unconsolidated joint ventures, for which the Company or joint venture pay annual management fees pursuant to long-term management agreements. Most of the management agreements have terms ranging from 10 to 15 years, with three to four 5-year renewals. The base management fees are 4.5% to 5.0% of gross revenues (as defined) generated by the RIDEA facilities. In addition, there are incentive management fees payable to Brookdale if operating results of the RIDEA properties exceed pre-established EBITDAR (as defined) thresholds.

Brookdale is subject to the registration and reporting requirements of the U.S. Securities and Exchange Commission (“SEC”) and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. The information related to Brookdale contained or referred to in this report has been derived from SEC filings made by Brookdale or other publicly available information, or was provided to the Company by Brookdale, and the Company has not verified this information through an independent investigation or otherwise. The Company has no reason to believe that this information is inaccurate in any material respect, but the Company cannot assure the reader of its accuracy. The Company is providing this data for informational purposes only, and encourages the reader to obtain Brookdale’s publicly available filings, which can be found at the SEC’s website at www.sec.gov.

To mitigate the credit risk of leasing properties to certain senior housing and post-acute/skilled nursing operators, leases with operators are often combined into portfolios that contain cross-default terms, so that if a tenant of any of the properties in a portfolio defaults on its obligations under its lease, the Company may pursue its remedies under the lease with respect to any of the properties in the portfolio. Certain portfolios also contain terms whereby the net operating profits of the properties are combined for the purpose of securing the funding of rental payments due under each lease.

The following table provides information regarding the Company’s concentrations with respect to certain states; the information provided is presented for the gross assets and revenues that are associated with certain real estate assets as percentages of total Company’s gross assets and revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

Percentage of Total

 

Percentage of

 

 

Company Gross Assets

 

Total Company Revenues

 

 

December 31,

 

Year Ended December 31,

State

 

2016

 

2015

 

2016

 

2015

 

2014

California

 

29

    

30

    

26

    

27

    

30

Texas

 

14

    

14

    

17

    

16

    

15

 

 

122


 

Table of Contents

 

NOTE 24.    Derivative Financial Instruments

The following table summarizes the Company’s outstanding interest-rate and foreign currency swap contracts as of December 31, 2016 (dollars and GBP in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

   

 

   

Fixed

   

 

   

 

 

   

 

 

 

 

 

 

 

Hedge

 

Rate/Buy

 

 

 

Notional/Sell

 

 

 

 

Date Entered

 

Maturity Date

 

Designation

 

Amount

 

Floating/Exchange Rate Index

 

Amount

 

Fair Value (1)

 

Interest rate:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

July 2005(2)

 

July 2020

 

Cash Flow

 

 

3.82

BMA Swap Index

 

$

44,500

 

$

(3,662)

 

January 2015(3)

 

October 2017

 

Cash Flow

 

 

1.79

%  

1 Month GBP LIBOR+0.975%

 

£

220,000

 

 

(1,195)

 

Foreign currency:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

January 2015(4)

 

October 2017

 

Cash Flow

 

$

16,000

 

Buy USD/Sell GBP

 

£

10,500

 

 

2,920

 


(1)

Derivative assets are recorded in other assets, net and derivative liabilities are recorded in accounts payable and accrued liabilities on the consolidated balance sheets.

(2)

Represents three interest-rate swap contracts, which hedge fluctuations in interest payments on variable-rate secured debt due to overall changes in hedged cash flows.

(3)

Hedges fluctuations in interest payments on variable-rate unsecured debt due to fluctuations in the underlying benchmark interest rate.

(4)

Currency swap contract (buy USD/sell GBP) hedges the foreign currency exchange risk related to the Company’s forecasted GBP denominated interest receipts on its HC-One Facility. Represents a currency swap to sell £1.0 million monthly at a rate of 1.5149 through October 2017.

 

The Company uses derivative instruments to mitigate the effects of interest rate and foreign currency fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest and foreign currency rates related to the potential impact these changes could have on future earnings and forecasted cash flows. The Company does not use derivative instruments for speculative or trading purposes. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $3 million.

As of December 31, 2016, £268 million of the Company’s GBP-denominated borrowings under the Facility and 2012 term loan are designated as a hedge of a portion of the Company’s net investment in GBP-functional subsidiaries to mitigate its exposure to fluctuations in the GBP to USD exchange rate. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to USD exchange rate of the instrument is recorded as part of the cumulative translation adjustment component of accumulated other comprehensive income (loss). Accordingly, the remeasurement value of the designated £268 million GBP-denominated borrowings due to fluctuations in the GBP to USD exchange rate are reported in accumulated other comprehensive income (loss) as the hedging relationship is considered to be effective. The cumulative balance of the remeasurement value will be reclassified to earnings when the hedged investment is sold or substantially liquidated.

 

NOTE 25.    Selected Quarterly Financial Data (Unaudited)

The following table summarizes selected quarterly information for the years ended December 31, 2016 and 2015 (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended 2016

 

 

 

March 31

 

June 30

 

September 30

 

December 31

 

Total revenues

    

$

520,457

    

$

538,332

    

$

530,555

    

$

539,950

 

Total discontinued operations

 

 

68,408

 

 

107,378

 

 

108,215

 

 

(18,246)

 

Income before income taxes and equity income from investments in unconsolidated joint ventures

 

 

55,949

 

 

196,352

 

 

47,453

 

 

67,530

 

Net income

 

 

119,745

 

 

304,842

 

 

154,039

 

 

61,300

 

Net income applicable to HCP, Inc.

 

 

116,119

 

 

301,717

 

 

151,250

 

 

58,661

 

Basic earnings per common share

 

 

0.25

 

 

0.65

 

 

0.32

 

 

0.12

 

Diluted earnings per common share

 

 

0.25

 

 

0.64

 

 

0.32

 

 

0.12

 

 

123


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended 2015

 

 

 

March 31

 

June 30

 

September 30

 

December 31

 

Total revenues

    

$

451,458

    

$

459,806

    

$

508,900

    

$

520,325

 

Total discontinued operations

 

 

(308,028)

 

 

158,479

 

 

130,210

 

 

(679,765)

 

Income (loss) before income taxes and equity income from investments in unconsolidated joint ventures

 

 

70,806

 

 

6,320

 

 

(11,263)

 

 

70,408

 

Net (loss) income

 

 

(237,503)

 

 

167,748

 

 

117,954

 

 

(594,617)

 

Net (loss) income applicable to HCP, Inc.

 

 

(240,614)

 

 

164,885

 

 

115,362

 

 

(598,868)

 

Basic earnings per common share

 

 

(0.52)

 

 

0.36

 

 

0.25

 

 

(1.29)

 

Diluted earnings per common share

 

 

(0.52)

 

 

0.36

 

 

0.25

 

 

(1.29)

 

 

The above selected quarterly financial data includes the following significant transactions:

·

The quarter ended December 31, 2016 includes the following related to the Spin-Off: (i) $46 million of loss on debt extinguishment and (ii) $58 million of transaction costs.

·

The quarter ended June 30, 2016 includes $120 million of gain on sales from real estate dispositions.

·

The quarter ended March 31, 2016 includes $53 million of income tax expense associated with state built-in gain tax payable upon the disposition of specific real estate assets,  of which $49 million relates to the HCRMC real estate portfolio.

·

During the quarter ended December 31, 2015, the Company recorded net impairment charges of: (i) $817 million related to its DFL investments with HCRMC and (ii) $19 million related to its equity investment in HCRMC, both of which are included in discontinued operations.

·

During the quarter ended September 30, 2015, the Company recorded impairment charges of: (i) $70 million related to its Four Seasons Notes and (ii) $27 million related to its equity investment in HCRMC that is included in discontinued operations.

·

During the quarter ended June 30, 2015, the Company recorded an impairment charge of $42 million related to its Four Seasons Notes.

·

During the quarter ended March 31, 2015, the Company recorded a net impairment charge of $478 million related to its DFL investments with HCRMC that is included in discontinued operations.

 

 

124


 

Table of Contents

ITEM 9.   Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

ITEM 9A.    Controls and Procedures

Disclosure Controls and Procedures.    We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rules 13a-15(b) and 15d-15(b) of the Exchange Act, we carried out an evaluation, under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2016. Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective, as of December 31, 2016, at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting.  There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fourth quarter of 2016 to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Management’s Annual Report on Internal Control over Financial Reporting.    Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control—Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective as of December 31, 2016.

The effectiveness of our internal control over financial reporting as of December 31, 2016 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report, which is included herein.

125


 

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders of HCP, Inc.

Irvine, California

We have audited the internal control over financial reporting of HCP, Inc. and subsidiaries (the ‘‘Company’’) as of December 31, 2016, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed by, or under the supervision of, the company’s principal executive and principal financial officers, or persons performing similar functions, and effected by the company’s board of directors, management, and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2016, based on the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated financial statements and financial statement schedules as of and for the year ended December 31, 2016, of the Company and our report dated February 13, 2017 expressed an unqualified opinion on those financial statements and financial statement schedules.

 

/s/ Deloitte & Touche LLP

 

Los Angeles, California

February 13, 2017

126


 

Table of Contents

ITEM 9B.    Other Information

None.

PART III

ITEM 10.   Directors, Executive Officers and Corporate Governance

We have adopted a Code of Business Conduct and Ethics that applies to all of our directors and employees, including our Chief Executive Officer and all senior financial officers, including our principal financial officer, principal accounting officer and controller. We have also adopted a Vendor Code of Business Conduct and Ethics applicable to our vendors and business partners. Current copies of our Code of Business Conduct and Ethics and Vendor Code of Business Conduct and Ethics are posted on our website at www.hcpi.com/codeofconduct. In addition, waivers from, and amendments to, our Code of Business Conduct and Ethics that apply to our directors and executive officers, including our principal executive officer, principal financial officer, principal accounting officer or persons performing similar functions, will be timely posted in the Investor Relations section of our website at www.hcpi.com.

We hereby incorporate by reference the information appearing under the captions “Proposal No. 1 Election of Directors,” “Our Executive Officers,” “Board of Directors and Corporate Governance” and “Section 16(a) Beneficial Ownership Reporting Compliance” in the Registrant’s definitive proxy statement relating to its 2017 Annual Meeting of Stockholders to be held on April 27, 2017.

ITEM 11.   Executive Compensation

We hereby incorporate by reference the information under the caption “Executive Compensation” in the Registrant’s definitive proxy statement relating to its 2017 Annual Meeting of Stockholders to be held on April 27, 2017.

ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

We hereby incorporate by reference the information under the captions “Security Ownership of Principal Stockholders, Directors and Management” and “Equity Compensation Plan Information” in the Registrant’s definitive proxy statement relating to its 2017 Annual Meeting of Stockholders to be held on April 27, 2017.

ITEM 13.    Certain Relationships and Related Transactions, and Director Independence

We hereby incorporate by reference the information under the caption “Board of Directors and Corporate Governance” in the Registrant’s definitive proxy statement relating to its 2017 Annual Meeting of Stockholders to be held on April 27, 2017.

ITEM 14.    Principal Accounting Fees and Services

We hereby incorporate by reference under the caption “Audit and Non-Audit Fees” in the Registrant’s definitive proxy statement relating to its 2017 Annual Meeting of Stockholders to be held on April 27, 2017.

127


 

Table of Contents

PART IV

ITEM 15.   Exhibits, Financial Statement Schedules

(a) 1.  Financial Statement Schedules

Schedule II: Valuation and Qualifying Accounts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance Accounts(1)

 

 

 

 

Additions

 

Deductions

 

 

 

 

 

    

 

 

    

Amounts

    

 

 

    

 

 

    

 

 

    

 

 

 

 

 

Balance at

 

Charged

 

 

 

 

Uncollectible

 

 

 

 

 

 

 

Year Ended

 

Beginning of

 

Against

 

Acquired

 

Accounts

 

Disposed

 

Balance at

 

December 31,

 

Year

 

Operations, net

 

Properties

 

Written-off

 

Properties

 

End of Year

 

2016

 

$

36,180

 

$

1,177

 

$

 —

 

$

(2,843)

 

$

(4,996)

 

$

29,518

 

2015

 

 

50,531

 

 

3,174

 

 

 —

 

 

(17,209)

 

 

(316)

 

 

36,180

 

2014

 

 

48,136

 

 

5,600

 

 

 —

 

 

(2,512)

 

 

(693)

 

 

50,531

 


(1)

Includes allowance for doubtful accounts, straight-line rent reserves, and allowances for loan and direct financing lease losses and excludes discontinued operations of $818 million and $1 million for the years ended December 31, 2015 and 2014, respectively.

 

 

 

128


 

Table of Contents

Schedule III: Real Estate and Accumulated Depreciation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent 

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

 

    

Encumbrances at

    

 

 

    

Buildings and

    

to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

State

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

Senior housing triple-net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1107

 

Huntsville              

 

AL

 

$

 —

 

$

307

 

$

5,813

 

$

307

 

$

307

 

$

5,453

 

$

5,760

 

$

(1,397)

 

2006

 

40

 

0786

 

Douglas                 

 

AZ

 

 

 —

 

 

110

 

 

703

 

 

110

 

 

110

 

 

703

 

 

813

 

 

(345)

 

2005

 

35

 

0518

 

Tucson                  

 

AZ

 

 

 —

 

 

2,350

 

 

24,037

 

 

2,350

 

 

2,350

 

 

24,037

 

 

26,387

 

 

(10,616)

 

2002

 

30

 

1238

 

Beverly Hills           

 

CA

 

 

 —

 

 

9,872

 

 

32,590

 

 

9,872

 

 

9,872

 

 

37,584

 

 

47,456

 

 

(10,270)

 

2006

 

40

 

0883

 

Carmichael              

 

CA

 

 

 —

 

 

4,270

 

 

13,846

 

 

4,270

 

 

4,270

 

 

13,236

 

 

17,506

 

 

(3,337)

 

2006

 

40

 

2204

 

Chino Hills

 

CA

 

 

 —

 

 

3,720

 

 

41,183

 

 

3,720

 

 

3,720

 

 

41,183

 

 

44,903

 

 

(3,555)

 

2014

 

35

 

0851

 

Citrus Heights          

 

CA

 

 

 —

 

 

1,180

 

 

8,367

 

 

1,180

 

 

1,180

 

 

8,037

 

 

9,217

 

 

(2,834)

 

2006

 

29

 

2092

 

Clearlake

 

CA

 

 

 —

 

 

354

 

 

4,799

 

 

354

 

 

354

 

 

5,086

 

 

5,440

 

 

(699)

 

2012

 

45

 

0790

 

Concord                 

 

CA

 

 

25,000

 

 

6,010

 

 

39,601

 

 

6,010

 

 

6,010

 

 

38,301

 

 

44,311

 

 

(10,918)

 

2005

 

40

 

0787

 

Dana Point              

 

CA

 

 

 —

 

 

1,960

 

 

15,946

 

 

1,960

 

 

1,960

 

 

15,466

 

 

17,426

 

 

(4,414)

 

2005

 

39

 

0798

 

Escondido               

 

CA

 

 

14,340

 

 

5,090

 

 

24,253

 

 

5,090

 

 

5,090

 

 

23,353

 

 

28,443

 

 

(6,666)

 

2005

 

40

 

2054

 

Fortuna

 

CA

 

 

 —

 

 

818

 

 

3,295

 

 

818

 

 

818

 

 

3,309

 

 

4,127

 

 

(1,249)

 

2012

 

50

 

2079

 

Fortuna

 

CA

 

 

 —

 

 

1,346

 

 

11,856

 

 

1,346

 

 

1,346

 

 

11,954

 

 

13,300

 

 

(3,231)

 

2012

 

45

 

0791

 

Fremont                 

 

CA

 

 

 —

 

 

2,360

 

 

11,672

 

 

2,360

 

 

2,360

 

 

11,192

 

 

13,552

 

 

(3,195)

 

2005

 

40

 

0788

 

Granada Hills           

 

CA

 

 

 —

 

 

2,200

 

 

18,257

 

 

2,200

 

 

2,200

 

 

17,637

 

 

19,837

 

 

(5,034)

 

2005

 

39

 

0227

 

Lodi                    

 

CA

 

 

 —

 

 

732

 

 

5,453

 

 

278

 

 

732

 

 

5,453

 

 

6,185

 

 

(2,852)

 

1997

 

35

 

0226

 

Murietta                

 

CA

 

 

 —

 

 

435

 

 

5,729

 

 

230

 

 

435

 

 

5,729

 

 

6,164

 

 

(2,929)

 

1997

 

35

 

1165

 

Northridge              

 

CA

 

 

 —

 

 

6,718

 

 

26,309

 

 

6,752

 

 

6,752

 

 

28,058

 

 

34,810

 

 

(7,305)

 

2006

 

40

 

1168

 

Palm Springs            

 

CA

 

 

 —

 

 

1,005

 

 

5,183

 

 

1,005

 

 

1,005

 

 

5,344

 

 

6,349

 

 

(1,590)

 

2006

 

40

 

0789

 

Pleasant Hill           

 

CA

 

 

6,270

 

 

2,480

 

 

21,333

 

 

2,480

 

 

2,480

 

 

20,633

 

 

23,113

 

 

(5,889)

 

2005

 

40

 

2205

 

Roseville

 

CA

 

 

 —

 

 

3,844

 

 

33,527

 

 

3,844

 

 

3,844

 

 

33,527

 

 

37,371

 

 

(2,839)

 

2014

 

35

 

1167

 

Santa Rosa              

 

CA

 

 

 —

 

 

3,582

 

 

21,113

 

 

3,627

 

 

3,627

 

 

22,008

 

 

25,635

 

 

(5,853)

 

2006

 

40

 

0793

 

South San Francisco

 

CA

 

 

 —

 

 

3,000

 

 

16,586

 

 

3,000

 

 

3,000

 

 

16,056

 

 

19,056

 

 

(4,577)

 

2005

 

40

 

0792

 

Ventura                 

 

CA

 

 

 —

 

 

2,030

 

 

17,379

 

 

2,030

 

 

2,030

 

 

16,749

 

 

18,779

 

 

(4,781)

 

2005

 

40

 

2055

 

Yreka

 

CA

 

 

 —

 

 

565

 

 

9,184

 

 

565

 

 

565

 

 

9,549

 

 

10,114

 

 

(1,324)

 

2012

 

45

 

0512

 

Denver                  

 

CO

 

 

 —

 

 

2,810

 

 

36,021

 

 

2,810

 

 

2,810

 

 

37,906

 

 

40,716

 

 

(16,469)

 

2002

 

30

 

1000

 

Greenwood Village       

 

CO

 

 

 —

 

 

3,367

 

 

43,610

 

 

3,367

 

 

3,367

 

 

45,708

 

 

49,075

 

 

(10,783)

 

2006

 

40

 

2144

 

Glastonbury

 

CT

 

 

 —

 

 

1,658

 

 

16,046

 

 

1,658

 

 

1,658

 

 

16,355

 

 

18,013

 

 

(2,059)

 

2012

 

45

 

0730

 

Torrington              

 

CT

 

 

 —

 

 

166

 

 

11,001

 

 

166

 

 

166

 

 

12,106

 

 

12,272

 

 

(3,348)

 

2005

 

40

 

0861

 

Apopka                  

 

FL

 

 

 —

 

 

920

 

 

4,816

 

 

920

 

 

920

 

 

5,470

 

 

6,390

 

 

(1,501)

 

2006

 

35

 

0852

 

Boca Raton              

 

FL

 

 

 —

 

 

4,730

 

 

17,532

 

 

4,730

 

 

4,730

 

 

22,390

 

 

27,120

 

 

(6,765)

 

2006

 

30

 

1002

 

Coconut Creek           

 

FL

 

 

 —

 

 

2,461

 

 

16,006

 

 

2,461

 

 

2,461

 

 

15,620

 

 

18,081

 

 

(3,793)

 

2006

 

40

 

2467

 

Ft Myers

 

FL

 

 

 —

 

 

2,782

 

 

21,827

 

 

2,782

 

 

2,782

 

 

21,827

 

 

24,609

 

 

(754)

 

2016

 

40

 

1095

 

Gainesville             

 

FL

 

 

 —

 

 

1,221

 

 

12,226

 

 

1,221

 

 

1,221

 

 

12,001

 

 

13,222

 

 

(3,075)

 

2006

 

40

 

0490

 

Jacksonville            

 

FL

 

 

 —

 

 

3,250

 

 

25,936

 

 

2,400

 

 

3,250

 

 

32,106

 

 

35,356

 

 

(11,767)

 

2002

 

35

 

1096

 

Jacksonville            

 

FL

 

 

 —

 

 

1,587

 

 

15,616

 

 

1,587

 

 

1,587

 

 

15,298

 

 

16,885

 

 

(3,920)

 

2006

 

40

 

1017

 

Palm Harbor             

 

FL

 

 

 —

 

 

1,462

 

 

16,774

 

 

1,462

 

 

1,462

 

 

16,888

 

 

18,350

 

 

(4,408)

 

2006

 

40

 

0732

 

Port Orange             

 

FL

 

 

 —

 

 

2,340

 

 

9,898

 

 

2,340

 

 

2,340

 

 

10,270

 

 

12,610

 

 

(2,885)

 

2005

 

40

 

2194

 

Springtree

 

FL

 

 

 —

 

 

1,066

 

 

15,874

 

 

1,066

 

 

1,066

 

 

17,058

 

 

18,124

 

 

(2,342)

 

2013

 

45

 

0802

 

St. Augustine

 

FL

 

 

 —

 

 

830

 

 

11,627

 

 

830

 

 

830

 

 

12,369

 

 

13,199

 

 

(3,799)

 

2005

 

35

 

1097

 

Tallahassee             

 

FL

 

 

 —

 

 

1,331

 

 

19,039

 

 

1,331

 

 

1,331

 

 

18,695

 

 

20,026

 

 

(4,791)

 

2006

 

40

 

1605

 

Vero Beach

 

FL

 

 

 —

 

 

700

 

 

16,234

 

 

700

 

 

700

 

 

15,484

 

 

16,184

 

 

(2,654)

 

2010

 

35

 

1257

 

Vero Beach              

 

FL

 

 

 —

 

 

2,035

 

 

34,993

 

 

2,035

 

 

2,035

 

 

33,634

 

 

35,669

 

 

(8,616)

 

2006

 

40

 

1098

 

Alpharetta              

 

GA

 

 

 —

 

 

793

 

 

8,761

 

 

793

 

 

793

 

 

9,529

 

 

10,322

 

 

(2,351)

 

2006

 

40

 

1099

 

Atlanta                 

 

GA

 

 

 —

 

 

687

 

 

5,507

 

 

687

 

 

687

 

 

6,242

 

 

6,929

 

 

(1,520)

 

2006

 

40

 

2108

 

Buford

 

GA

 

 

 —

 

 

562

 

 

3,604

 

 

562

 

 

562

 

 

4,029

 

 

4,591

 

 

(586)

 

2012

 

45

 

2109

 

Buford

 

GA

 

 

 —

 

 

536

 

 

3,142

 

 

536

 

 

536

 

 

3,374

 

 

3,910

 

 

(483)

 

2012

 

45

 

2053

 

Canton

 

GA

 

 

 —

 

 

401

 

 

17,888

 

 

401

 

 

401

 

 

18,263

 

 

18,664

 

 

(1,859)

 

2012

 

50

 

2165

 

Hartwell

 

GA

 

 

 —

 

 

368

 

 

6,337

 

 

368

 

 

368

 

 

6,611

 

 

6,979

 

 

(786)

 

2012

 

45

 

2066

 

Lawrenceville

 

GA

 

 

 —

 

 

581

 

 

2,669

 

 

581

 

 

581

 

 

2,914

 

 

3,495

 

 

(496)

 

2012

 

45

 

1241

 

Lilburn                 

 

GA

 

 

 —

 

 

907

 

 

17,340

 

 

907

 

 

907

 

 

17,017

 

 

17,924

 

 

(4,372)

 

2006

 

40

 

1112

 

Marietta                

 

GA

 

 

 —

 

 

894

 

 

6,944

 

 

904

 

 

904

 

 

7,330

 

 

8,234

 

 

(1,963)

 

2006

 

40

 

2086

 

Newnan

 

GA

 

 

 —

 

 

1,227

 

 

4,202

 

 

1,227

 

 

1,227

 

 

4,486

 

 

5,713

 

 

(706)

 

2012

 

45

 

1005

 

Oak Park                

 

IL

 

 

 —

 

 

3,476

 

 

35,259

 

 

3,476

 

 

3,476

 

 

36,575

 

 

40,051

 

 

(8,604)

 

2006

 

40

 

1162

 

Orland Park             

 

IL

 

 

 —

 

 

2,623

 

 

23,154

 

 

2,623

 

 

2,623

 

 

23,731

 

 

26,354

 

 

(6,039)

 

2006

 

40

 

1237

 

Wilmette                

 

IL

 

 

 —

 

 

1,100

 

 

9,373

 

 

1,100

 

 

1,100

 

 

9,333

 

 

10,433

 

 

(2,357)

 

2006

 

40

 

1105

 

Louisville

 

KY

 

 

 —

 

 

1,499

 

 

26,252

 

 

1,513

 

 

1,513

 

 

25,813

 

 

27,326

 

 

(6,712)

 

2006

 

40

 

2115

 

Murray

 

KY

 

 

 —

 

 

288

 

 

7,400

 

 

288

 

 

288

 

 

7,533

 

 

7,821

 

 

(1,021)

 

2012

 

45

 

1158

 

Plymouth                

 

MA

 

 

 —

 

 

2,434

 

 

9,027

 

 

2,438

 

 

2,438

 

 

9,308

 

 

11,746

 

 

(2,531)

 

2006

 

40

 

1249

 

Frederick               

 

MD

 

 

 —

 

 

609

 

 

9,158

 

 

609

 

 

609

 

 

9,307

 

 

9,916

 

 

(2,505)

 

2006

 

40

 

0281

 

Westminster             

 

MD

 

 

 —

 

 

768

 

 

5,251

 

 

400

 

 

768

 

 

6,555

 

 

7,323

 

 

(2,204)

 

1998

 

45

 

0546

 

Cape Elizabeth          

 

ME

 

 

 —

 

 

630

 

 

3,524

 

 

290

 

 

630

 

 

3,617

 

 

4,247

 

 

(1,247)

 

2003

 

40

 

0545

 

Saco                    

 

ME

 

 

 —

 

 

80

 

 

2,363

 

 

(90)

 

 

80

 

 

2,518

 

 

2,598

 

 

(864)

 

2003

 

40

 

1258

 

Auburn Hills            

 

MI

 

 

 —

 

 

2,281

 

 

10,692

 

 

2,161

 

 

2,281

 

 

10,692

 

 

12,973

 

 

(2,740)

 

2006

 

40

 

1248

 

Farmington Hills        

 

MI

 

 

 —

 

 

1,013

 

 

12,119

 

 

1,013

 

 

1,013

 

 

12,522

 

 

13,535

 

 

(3,324)

 

2006

 

40

 

1259

 

Sterling Heights        

 

MI

 

 

 —

 

 

1,593

 

 

11,500

 

 

1,593

 

 

1,593

 

 

11,181

 

 

12,774

 

 

(2,865)

 

2006

 

40

 

1235

 

Des Peres               

 

MO

 

 

 —

 

 

4,361

 

 

20,664

 

 

4,361

 

 

4,361

 

 

20,510

 

 

24,871

 

 

(5,166)

 

2006

 

40

 

1236

 

Richmond Heights        

 

MO

 

 

 —

 

 

1,744

 

 

24,232

 

 

1,744

 

 

1,744

 

 

23,838

 

 

25,582

 

 

(6,055)

 

2006

 

40

 

0853

 

St. Louis               

 

MO

 

 

 —

 

 

2,500

 

 

20,343

 

 

2,500

 

 

2,500

 

 

19,853

 

 

22,353

 

 

(7,004)

 

2006

 

30

 

2074

 

Oxford

 

MS

 

 

 —

 

 

2,003

 

 

14,140

 

 

2,003

 

 

2,003

 

 

14,315

 

 

16,318

 

 

(1,663)

 

2012

 

45

 

0878

 

Charlotte               

 

NC

 

 

 —

 

 

710

 

 

9,559

 

 

710

 

 

710

 

 

9,159

 

 

9,869

 

 

(2,309)

 

2006

 

40

 

2465

 

Charlotte

 

NC

 

 

 —

 

 

1,373

 

 

10,774

 

 

1,373

 

 

1,373

 

 

10,774

 

 

12,147

 

 

(372)

 

2016

 

40

 

1119

 

Concord                 

 

NC

 

 

 —

 

 

601

 

 

7,615

 

 

612

 

 

612

 

 

7,484

 

 

8,096

 

 

(1,973)

 

2006

 

40

 

2468

 

Franklin

 

NC

 

 

 —

 

 

1,082

 

 

8,489

 

 

1,082

 

 

1,082

 

 

8,489

 

 

9,571

 

 

(293)

 

2016

 

40

 

2126

 

Mooresville

 

NC

 

 

 —

 

 

2,538

 

 

37,617

 

 

2,538

 

 

2,538

 

 

38,653

 

 

41,191

 

 

(4,162)

 

2012

 

50

 

2466

 

Raeford

 

NC

 

 

 —

 

 

1,304

 

 

10,230

 

 

1,304

 

 

1,304

 

 

10,230

 

 

11,534

 

 

(354)

 

2016

 

40

 

1254

 

Raleigh                 

 

NC

 

 

 —

 

 

1,191

 

 

11,532

 

 

1,191

 

 

1,191

 

 

11,617

 

 

12,808

 

 

(3,069)

 

2006

 

40

 

2127

 

Minot

 

ND

 

 

 —

 

 

685

 

 

16,047

 

 

685

 

 

685

 

 

16,656

 

 

17,341

 

 

(1,936)

 

2012

 

45

 

2169

 

Lexington

 

NE

 

 

 —

 

 

474

 

 

8,405

 

 

474

 

 

474

 

 

8,484

 

 

8,958

 

 

(1,345)

 

2012

 

40

 

1599

 

Cherry Hill

 

NJ

 

 

 —

 

 

2,420

 

 

11,042

 

 

2,420

 

 

2,420

 

 

12,633

 

 

15,053

 

 

(3,020)

 

2010

 

25

 

1239

 

Cresskill               

 

NJ

 

 

 —

 

 

4,684

 

 

53,927

 

 

4,684

 

 

4,684

 

 

53,320

 

 

58,004

 

 

(13,676)

 

2006

 

40

 

0734

 

Hillsborough            

 

NJ

 

 

 —

 

 

1,042

 

 

10,042

 

 

1,042

 

 

1,042

 

 

9,819

 

 

10,861

 

 

(2,831)

 

2005

 

40

 

1242

 

Madison                 

 

NJ

 

 

 —

 

 

3,157

 

 

19,909

 

 

3,157

 

 

3,157

 

 

19,391

 

 

22,548

 

 

(4,982)

 

2006

 

40

 

0733

 

Manahawkin              

 

NJ

 

 

 —

 

 

921

 

 

9,927

 

 

921

 

 

921

 

 

10,001

 

 

10,922

 

 

(2,849)

 

2005

 

40

 

1231

 

Saddle River            

 

NJ

 

 

 —

 

 

1,784

 

 

15,625

 

 

1,784

 

 

1,784

 

 

15,515

 

 

17,299

 

 

(4,085)

 

2006

 

40

 

0245

 

Voorhees Township

 

NJ

 

 

 —

 

 

900

 

 

7,629

 

 

561

 

 

900

 

 

8,003

 

 

8,903

 

 

(3,043)

 

1998

 

45

 

2161

 

Rio Rancho

 

NM

 

 

 —

 

 

1,154

 

 

13,726

 

 

1,154

 

 

1,154

 

 

13,951

 

 

15,105

 

 

(1,780)

 

2012

 

40

 

2121

 

Roswell

 

NM

 

 

 —

 

 

618

 

 

7,038

 

 

618

 

 

618

 

 

7,878

 

 

8,496

 

 

(1,186)

 

2012

 

45

 

2150

 

Roswell

 

NM

 

 

 —

 

 

837

 

 

8,614

 

 

837

 

 

837

 

 

9,524

 

 

10,361

 

 

(1,503)

 

2012

 

45

 

0796

 

Las Vegas               

 

NV

 

 

 —

 

 

1,960

 

 

5,816

 

 

1,960

 

 

1,960

 

 

5,426

 

 

7,386

 

 

(1,549)

 

2005

 

40

 

2110

 

Las Vegas

 

NV

 

 

 —

 

 

667

 

 

14,469

 

 

667

 

 

667

 

 

14,935

 

 

15,602

 

 

(2,063)

 

2012

 

45

 

1252

 

Brooklyn                

 

NY

 

 

 —

 

 

8,117

 

 

23,627

 

 

8,117

 

 

8,117

 

 

23,467

 

 

31,584

 

 

(6,136)

 

2006

 

40

 

1256

 

Brooklyn                

 

NY

 

 

 —

 

 

5,215

 

 

39,052

 

 

5,215

 

 

5,215

 

 

38,966

 

 

44,181

 

 

(10,067)

 

2006

 

40

 

2177

 

Clifton Park

 

NY

 

 

 —

 

 

2,257

 

 

11,470

 

 

2,257

 

 

2,257

 

 

11,470

 

 

13,727

 

 

(1,535)

 

2012

 

50

 

2174

 

Orchard Park

 

NY

 

 

 —

 

 

726

 

 

17,735

 

 

726

 

 

726

 

 

17,735

 

 

18,461

 

 

(2,385)

 

2012

 

45

 

2175

 

Orchard Park

 

NY

 

 

 —

 

 

478

 

 

11,961

 

 

478

 

 

478

 

 

11,961

 

 

12,439

 

 

(1,603)

 

2012

 

45

 

1386

 

Marietta                

 

OH

 

 

 —

 

 

1,069

 

 

11,435

 

 

1,069

 

 

1,069

 

 

11,438

 

 

12,507

 

 

(3,998)

 

2007

 

40

 

1253

 

Youngstown

 

OH

 

 

 —

 

 

695

 

 

10,444

 

 

695

 

 

695

 

 

10,518

 

 

11,213

 

 

(2,727)

 

2006

 

40

 

2083

 

Oklahoma City

 

OK

 

 

 —

 

 

2,116

 

 

28,007

 

 

2,116

 

 

2,116

 

 

29,756

 

 

31,872

 

 

(3,511)

 

2012

 

45

 

2139

 

Gresham

 

OR

 

 

 —

 

 

465

 

 

6,403

 

 

465

 

 

465

 

 

6,605

 

 

7,070

 

 

(874)

 

2012

 

50

 

2182

 

Hermiston

 

OR

 

 

2,496

 

 

582

 

 

8,087

 

 

582

 

 

582

 

 

8,087

 

 

8,669

 

 

(919)

 

2013

 

45

 

2131

 

Keizer

 

OR

 

 

2,593

 

 

551

 

 

6,454

 

 

551

 

 

551

 

 

6,454

 

 

7,005

 

 

(741)

 

2013

 

45

 

2152

 

McMinnville

 

OR

 

 

 —

 

 

3,203

 

 

24,909

 

 

3,203

 

 

3,203

 

 

28,606

 

 

31,809

 

 

(4,833)

 

2012

 

45

 

2089

 

Newberg

 

OR

 

 

 —

 

 

1,889

 

 

16,855

 

 

1,889

 

 

1,889

 

 

17,162

 

 

19,051

 

 

(1,898)

 

2012

 

50

 

2133

 

Portland

 

OR

 

 

 —

 

 

1,615

 

 

12,030

 

 

1,615

 

 

1,615

 

 

12,096

 

 

13,711

 

 

(1,271)

 

2012

 

50

 

2151

 

Portland

 

OR

 

 

 —

 

 

1,677

 

 

9,469

 

 

1,677

 

 

1,677

 

 

9,783

 

 

11,460

 

 

(1,449)

 

2012

 

45

 

2171

 

Portland

 

OR

 

 

 —

 

 

 —

 

 

16,087

 

 

 —

 

 

 —

 

 

16,338

 

 

16,338

 

 

(1,636)

 

2012

 

50

 

2050

 

Redmond

 

OR

 

 

 —

 

 

1,229

 

 

21,921

 

 

1,229

 

 

1,229

 

 

22,590

 

 

23,819

 

 

(2,294)

 

2012

 

50

 

129


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent 

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

 

    

Encumbrances at

    

 

 

    

Buildings and

    

to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

State

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

2084

 

Roseburg

 

OR

 

 

 —

 

 

1,042

 

 

12,090

 

 

1,042

 

 

1,042

 

 

12,199

 

 

13,241

 

 

(1,534)

 

2012

 

45

 

2134

 

Scappoose

 

OR

 

 

 —

 

 

353

 

 

1,258

 

 

353

 

 

353

 

 

1,271

 

 

1,624

 

 

(212)

 

2012

 

50

 

2153

 

Scappoose

 

OR

 

 

 —

 

 

971

 

 

7,116

 

 

971

 

 

971

 

 

7,224

 

 

8,195

 

 

(1,045)

 

2012

 

45

 

2056

 

Stayton

 

OR

 

 

 —

 

 

48

 

 

569

 

 

48

 

 

48

 

 

587

 

 

635

 

 

(127)

 

2012

 

45

 

2058

 

Stayton

 

OR

 

 

 —

 

 

253

 

 

8,621

 

 

253

 

 

253

 

 

8,724

 

 

8,977

 

 

(1,091)

 

2012

 

45

 

2088

 

Tualatin

 

OR

 

 

 —

 

 

 —

 

 

6,326

 

 

 —

 

 

 —

 

 

6,625

 

 

6,625

 

 

(1,073)

 

2012

 

45

 

2180

 

Windfield Village

 

OR

 

 

2,975

 

 

580

 

 

9,817

 

 

580

 

 

580

 

 

9,817

 

 

10,397

 

 

(1,124)

 

2013

 

45

 

1163

 

Haverford               

 

PA

 

 

 —

 

 

16,461

 

 

108,816

 

 

16,461

 

 

16,461

 

 

115,370

 

 

131,831

 

 

(30,593)

 

2006

 

40

 

2063

 

Selinsgrove

 

PA

 

 

 —

 

 

529

 

 

9,111

 

 

529

 

 

529

 

 

9,264

 

 

9,793

 

 

(1,289)

 

2012

 

45

 

1967

 

Cumberland

 

RI

 

 

 —

 

 

2,630

 

 

19,050

 

 

2,630

 

 

2,630

 

 

19,473

 

 

22,103

 

 

(4,179)

 

2011

 

30

 

1972

 

Smithfield

 

RI

 

 

 —

 

 

1,250

 

 

17,816

 

 

1,250

 

 

1,250

 

 

18,134

 

 

19,384

 

 

(4,047)

 

2011

 

30

 

1973

 

South Kingstown

 

RI

 

 

 —

 

 

1,390

 

 

12,551

 

 

1,390

 

 

1,390

 

 

12,918

 

 

14,308

 

 

(2,713)

 

2011

 

30

 

1975

 

Tiverton

 

RI

 

 

 —

 

 

3,240

 

 

25,735

 

 

3,240

 

 

3,240

 

 

25,955

 

 

29,195

 

 

(5,347)

 

2011

 

30

 

1104

 

Aiken                   

 

SC

 

 

 —

 

 

357

 

 

14,832

 

 

363

 

 

363

 

 

14,395

 

 

14,758

 

 

(3,716)

 

2006

 

40

 

1100

 

Charleston              

 

SC

 

 

 —

 

 

885

 

 

14,124

 

 

896

 

 

896

 

 

14,031

 

 

14,927

 

 

(3,710)

 

2006

 

40

 

1109

 

Columbia                

 

SC

 

 

 —

 

 

408

 

 

7,527

 

 

412

 

 

412

 

 

7,414

 

 

7,826

 

 

(1,930)

 

2006

 

40

 

2154

 

Florence

 

SC

 

 

 —

 

 

255

 

 

4,052

 

 

255

 

 

255

 

 

4,757

 

 

5,012

 

 

(760)

 

2012

 

45

 

0306

 

Georgetown              

 

SC

 

 

 —

 

 

239

 

 

3,008

 

 

111

 

 

239

 

 

3,008

 

 

3,247

 

 

(1,169)

 

1998

 

45

 

0879

 

Greenville              

 

SC

 

 

 —

 

 

1,090

 

 

12,558

 

 

1,090

 

 

1,090

 

 

12,058

 

 

13,148

 

 

(3,039)

 

2006

 

40

 

0305

 

Lancaster               

 

SC

 

 

 —

 

 

84

 

 

2,982

 

 

(54)

 

 

84

 

 

2,982

 

 

3,066

 

 

(1,076)

 

1998

 

45

 

0880

 

Myrtle Beach            

 

SC

 

 

 —

 

 

900

 

 

10,913

 

 

900

 

 

900

 

 

10,513

 

 

11,413

 

 

(2,650)

 

2006

 

40

 

0312

 

Rock Hill               

 

SC

 

 

 —

 

 

203

 

 

2,671

 

 

(34)

 

 

203

 

 

2,671

 

 

2,874

 

 

(1,018)

 

1998

 

45

 

1113

 

Rock Hill               

 

SC

 

 

 —

 

 

695

 

 

4,119

 

 

795

 

 

795

 

 

4,074

 

 

4,869

 

 

(1,186)

 

2006

 

40

 

0313

 

Sumter                  

 

SC

 

 

 —

 

 

196

 

 

2,623

 

 

(47)

 

 

196

 

 

2,623

 

 

2,819

 

 

(1,020)

 

1998

 

45

 

2067

 

West Columbia

 

SC

 

 

 —

 

 

220

 

 

2,662

 

 

220

 

 

220

 

 

3,345

 

 

3,565

 

 

(575)

 

2012

 

45

 

2132

 

Cordova

 

TN

 

 

 —

 

 

2,167

 

 

5,829

 

 

2,167

 

 

2,167

 

 

6,309

 

 

8,476

 

 

(927)

 

2012

 

45

 

2060

 

Franklin

 

TN

 

 

 —

 

 

2,475

 

 

27,337

 

 

2,475

 

 

2,475

 

 

28,456

 

 

30,931

 

 

(3,200)

 

2012

 

45

 

2073

 

Kingsport

 

TN

 

 

 —

 

 

1,113

 

 

8,625

 

 

1,113

 

 

1,113

 

 

8,873

 

 

9,986

 

 

(1,114)

 

2012

 

45

 

1003

 

Nashville               

 

TN

 

 

 —

 

 

812

 

 

16,983

 

 

812

 

 

812

 

 

18,759

 

 

19,571

 

 

(4,201)

 

2006

 

40

 

0843

 

Abilene                 

 

TX

 

 

 —

 

 

300

 

 

2,830

 

 

300

 

 

300

 

 

2,710

 

 

3,010

 

 

(717)

 

2006

 

39

 

2107

 

Amarillo

 

TX

 

 

 —

 

 

1,315

 

 

26,838

 

 

1,315

 

 

1,315

 

 

27,256

 

 

28,571

 

 

(3,006)

 

2012

 

45

 

1116

 

Arlington               

 

TX

 

 

 —

 

 

2,494

 

 

12,192

 

 

2,540

 

 

2,540

 

 

11,847

 

 

14,387

 

 

(3,151)

 

2006

 

40

 

0511

 

Austin                  

 

TX

 

 

 —

 

 

2,960

 

 

41,645

 

 

2,960

 

 

2,960

 

 

41,645

 

 

44,605

 

 

(18,393)

 

2002

 

30

 

2075

 

Bedford

 

TX

 

 

 —

 

 

1,204

 

 

26,845

 

 

1,204

 

 

1,204

 

 

28,184

 

 

29,388

 

 

(3,187)

 

2012

 

45

 

0844

 

Burleson                

 

TX

 

 

 —

 

 

1,050

 

 

5,242

 

 

1,050

 

 

1,050

 

 

4,902

 

 

5,952

 

 

(1,297)

 

2006

 

40

 

0848

 

Cedar Hill              

 

TX

 

 

 —

 

 

1,070

 

 

11,554

 

 

1,070

 

 

1,070

 

 

11,104

 

 

12,174

 

 

(2,938)

 

2006

 

40

 

1325

 

Cedar Hill              

 

TX

 

 

 —

 

 

440

 

 

7,494

 

 

440

 

 

440

 

 

6,974

 

 

7,414

 

 

(1,700)

 

2007

 

40

 

0506

 

Friendswood             

 

TX

 

 

 —

 

 

400

 

 

7,354

 

 

79

 

 

400

 

 

7,493

 

 

7,893

 

 

(2,392)

 

2002

 

45

 

0217

 

Houston                 

 

TX

 

 

 —

 

 

835

 

 

7,195

 

 

835

 

 

835

 

 

7,344

 

 

8,179

 

 

(3,083)

 

1997

 

45

 

1106

 

Houston                 

 

TX

 

 

 —

 

 

1,008

 

 

15,333

 

 

1,020

 

 

1,020

 

 

15,052

 

 

16,072

 

 

(3,923)

 

2006

 

40

 

0845

 

North Richland Hills       

 

TX

 

 

 —

 

 

520

 

 

5,117

 

 

520

 

 

520

 

 

4,807

 

 

5,327

 

 

(1,272)

 

2006

 

40

 

0846

 

North Richland Hills       

 

TX

 

 

 —

 

 

870

 

 

9,259

 

 

870

 

 

870

 

 

8,819

 

 

9,689

 

 

(2,667)

 

2006

 

35

 

2162

 

Portland

 

TX

 

 

 —

 

 

1,233

 

 

14,001

 

 

1,233

 

 

1,233

 

 

14,768

 

 

16,001

 

 

(1,901)

 

2012

 

45

 

2116

 

Sherman

 

TX

 

 

 —

 

 

209

 

 

3,492

 

 

209

 

 

209

 

 

3,616

 

 

3,825

 

 

(506)

 

2012

 

45

 

0847

 

Waxahachie              

 

TX

 

 

 —

 

 

390

 

 

3,879

 

 

390

 

 

390

 

 

3,659

 

 

4,049

 

 

(968)

 

2006

 

40

 

2470

 

Abingdon

 

VA

 

 

 —

 

 

1,584

 

 

12,431

 

 

1,584

 

 

1,584

 

 

12,431

 

 

14,015

 

 

(430)

 

2016

 

40

 

1244

 

Arlington               

 

VA

 

 

 —

 

 

3,833

 

 

7,076

 

 

3,833

 

 

3,833

 

 

7,643

 

 

11,476

 

 

(1,990)

 

2006

 

40

 

1245

 

Arlington               

 

VA

 

 

 —

 

 

7,278

 

 

37,407

 

 

7,278

 

 

7,278

 

 

38,069

 

 

45,347

 

 

(9,606)

 

2006

 

40

 

0881

 

Chesapeake              

 

VA

 

 

 —

 

 

1,090

 

 

12,444

 

 

1,090

 

 

1,090

 

 

11,944

 

 

13,034

 

 

(3,011)

 

2006

 

40

 

1247

 

Falls Church            

 

VA

 

 

 —

 

 

2,228

 

 

8,887

 

 

2,228

 

 

2,228

 

 

9,221

 

 

11,449

 

 

(2,416)

 

2006

 

40

 

1164

 

Fort Belvoir            

 

VA

 

 

 —

 

 

11,594

 

 

99,528

 

 

11,594

 

 

11,594

 

 

107,339

 

 

118,933

 

 

(28,542)

 

2006

 

40

 

1250

 

Leesburg                

 

VA

 

 

 —

 

 

607

 

 

3,236

 

 

607

 

 

607

 

 

3,210

 

 

3,817

 

 

(2,926)

 

2006

 

35

 

1246

 

Sterling                

 

VA

 

 

 —

 

 

2,360

 

 

22,932

 

 

2,360

 

 

2,360

 

 

23,162

 

 

25,522

 

 

(6,030)

 

2006

 

40

 

2077

 

Sterling

 

VA

 

 

 —

 

 

1,046

 

 

15,788

 

 

1,046

 

 

1,046

 

 

16,102

 

 

17,148

 

 

(1,748)

 

2012

 

45

 

0225

 

Woodbridge              

 

VA

 

 

 —

 

 

950

 

 

6,983

 

 

775

 

 

950

 

 

8,441

 

 

9,391

 

 

(3,118)

 

1997

 

45

 

1173

 

Bellevue                

 

WA

 

 

 —

 

 

3,734

 

 

16,171

 

 

3,737

 

 

3,737

 

 

16,168

 

 

19,905

 

 

(4,199)

 

2006

 

40

 

2095

 

College Place

 

WA

 

 

 —

 

 

758

 

 

8,051

 

 

758

 

 

758

 

 

8,341

 

 

9,099

 

 

(1,096)

 

2012

 

45

 

1240

 

Edmonds                 

 

WA

 

 

 —

 

 

1,418

 

 

16,502

 

 

1,418

 

 

1,418

 

 

16,106

 

 

17,524

 

 

(4,144)

 

2006

 

40

 

2160

 

Kenmore

 

WA

 

 

 —

 

 

3,284

 

 

16,641

 

 

3,284

 

 

3,284

 

 

16,949

 

 

20,233

 

 

(1,864)

 

2012

 

45

 

0797

 

Kirkland                

 

WA

 

 

 —

 

 

1,000

 

 

13,403

 

 

1,000

 

 

1,000

 

 

13,043

 

 

14,043

 

 

(3,723)

 

2005

 

40

 

1251

 

Mercer Island           

 

WA

 

 

 —

 

 

4,209

 

 

8,123

 

 

4,209

 

 

4,209

 

 

8,201

 

 

12,410

 

 

(2,086)

 

2006

 

40

 

2141

 

Moses Lake

 

WA

 

 

 —

 

 

429

 

 

4,417

 

 

429

 

 

429

 

 

4,569

 

 

4,998

 

 

(868)

 

2012

 

50

 

2096

 

Poulsbo

 

WA

 

 

 —

 

 

1,801

 

 

18,068

 

 

1,801

 

 

1,801

 

 

18,236

 

 

20,037

 

 

(2,186)

 

2012

 

45

 

2102

 

Richland

 

WA

 

 

 —

 

 

249

 

 

5,067

 

 

249

 

 

249

 

 

5,186

 

 

5,435

 

 

(603)

 

2012

 

45

 

0794

 

Shoreline               

 

WA

 

 

 —

 

 

1,590

 

 

10,671

 

 

1,590

 

 

1,590

 

 

10,261

 

 

11,851

 

 

(2,929)

 

2005

 

40

 

0795

 

Shoreline               

 

WA

 

 

 —

 

 

4,030

 

 

26,421

 

 

4,030

 

 

4,030

 

 

25,651

 

 

29,681

 

 

(7,254)

 

2005

 

39

 

2097

 

Spokane

 

WA

 

 

 —

 

 

903

 

 

5,363

 

 

903

 

 

903

 

 

5,509

 

 

6,412

 

 

(849)

 

2012

 

45

 

2061

 

Vancouver

 

WA

 

 

 —

 

 

513

 

 

4,556

 

 

513

 

 

513

 

 

4,710

 

 

5,223

 

 

(696)

 

2012

 

45

 

2062

 

Vancouver

 

WA

 

 

 —

 

 

1,498

 

 

9,997

 

 

1,498

 

 

1,498

 

 

10,127

 

 

11,625

 

 

(1,173)

 

2012

 

45

 

2052

 

Yakima

 

WA

 

 

 —

 

 

557

 

 

5,897

 

 

557

 

 

557

 

 

6,035

 

 

6,592

 

 

(732)

 

2012

 

50

 

2078

 

Yakima

 

WA

 

 

 —

 

 

353

 

 

5,668

 

 

353

 

 

353

 

 

5,685

 

 

6,038

 

 

(628)

 

2012

 

45

 

2114

 

Yakima

 

WA

 

 

 —

 

 

721

 

 

8,872

 

 

721

 

 

721

 

 

10,218

 

 

10,939

 

 

(1,498)

 

2012

 

45

 

2170

 

Madison

 

WI

 

 

 —

 

 

834

 

 

10,050

 

 

834

 

 

834

 

 

10,408

 

 

11,242

 

 

(1,356)

 

2012

 

40

 

2117

 

Bridgeport

 

WV

 

 

 —

 

 

3,174

 

 

15,437

 

 

3,174

 

 

3,174

 

 

15,815

 

 

18,989

 

 

(2,397)

 

2012

 

45

 

2148

 

Sheridan

 

WY

 

 

 —

 

 

915

 

 

12,047

 

 

915

 

 

915

 

 

13,147

 

 

14,062

 

 

(1,599)

 

2012

 

45

 

 

 

 

 

 

 

$

53,674

 

$

320,682

 

$

2,686,038

 

$

316,894

 

$

320,982

 

$

2,746,728

 

$

3,067,710

 

$

(624,171)

 

 

 

 

 

Senior housing operating portfolio

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2366

 

Little Rock

 

AR

 

 

 —

 

 

1,922

 

 

14,140

 

 

2,046

 

 

2,046

 

 

15,630

 

 

17,676

 

 

(4,097)

 

2006

 

45

 

2384

 

Prescott

 

AZ

 

 

 —

 

 

1,276

 

 

8,660

 

 

1,276

 

 

1,276

 

 

10,870

 

 

12,146

 

 

(1,730)

 

2006

 

45

 

1974

 

Sun City

 

AZ

 

 

25,940

 

 

2,640

 

 

33,223

 

 

2,640

 

 

2,640

 

 

35,006

 

 

37,646

 

 

(7,517)

 

2011

 

30

 

2362

 

Camarillo

 

CA

 

 

 —

 

 

5,798

 

 

19,427

 

 

5,822

 

 

5,822

 

 

19,655

 

 

25,477

 

 

(5,271)

 

2006

 

45

 

2352

 

Carlsbad

 

CA

 

 

 —

 

 

7,897

 

 

14,255

 

 

7,897

 

 

7,897

 

 

15,452

 

 

23,349

 

 

(3,890)

 

2006

 

45

 

2399

 

Corona

 

CA

 

 

 —

 

 

2,637

 

 

10,134

 

 

2,637

 

 

2,637

 

 

10,522

 

 

13,159

 

 

(1,408)

 

2012

 

45

 

2364

 

Elk Grove

 

CA

 

 

 —

 

 

2,235

 

 

6,339

 

 

2,235

 

 

2,235

 

 

7,398

 

 

9,633

 

 

(1,873)

 

2006

 

45

 

1965

 

Fresno

 

CA

 

 

17,994

 

 

1,730

 

 

31,918

 

 

1,730

 

 

1,730

 

 

33,445

 

 

35,175

 

 

(7,009)

 

2011

 

30

 

2593

 

Irvine

 

CA

 

 

 —

 

 

8,220

 

 

14,104

 

 

8,220

 

 

8,220

 

 

13,685

 

 

21,905

 

 

(3,141)

 

2006

 

45

 

2369

 

Rancho Mirage

 

CA

 

 

 —

 

 

1,798

 

 

24,053

 

 

1,811

 

 

1,811

 

 

25,460

 

 

27,271

 

 

(6,281)

 

2006

 

45

 

2380

 

Roseville

 

CA

 

 

 —

 

 

692

 

 

21,662

 

 

692

 

 

692

 

 

22,374

 

 

23,066

 

 

(2,380)

 

2012

 

45

 

2353

 

San Diego

 

CA

 

 

 —

 

 

6,384

 

 

32,072

 

 

6,384

 

 

6,384

 

 

32,886

 

 

39,270

 

 

(8,306)

 

2006

 

45

 

2354

 

San Juan Capistrano

 

CA

 

 

 —

 

 

5,983

 

 

9,614

 

 

5,983

 

 

5,983

 

 

11,357

 

 

17,340

 

 

(2,827)

 

2006

 

45

 

1966

 

Sun City

 

CA

 

 

13,623

 

 

2,650

 

 

22,709

 

 

2,650

 

 

2,650

 

 

26,011

 

 

28,661

 

 

(5,960)

 

2011

 

30

 

130


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent 

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

 

    

Encumbrances at

    

 

 

    

Buildings and

    

to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

State

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

2505

 

Arvada

 

CO

 

 

 —

 

 

1,788

 

 

29,896

 

 

1,788

 

 

1,788

 

 

30,553

 

 

32,341

 

 

(1,575)

 

2015

 

35

 

2506

 

Boulder

 

CO

 

 

 —

 

 

2,424

 

 

36,746

 

 

2,424

 

 

2,424

 

 

37,056

 

 

39,480

 

 

(1,471)

 

2015

 

35

 

2373

 

Colorado Springs

 

CO

 

 

 —

 

 

1,910

 

 

24,479

 

 

1,910

 

 

1,910

 

 

25,601

 

 

27,511

 

 

(6,526)

 

2006

 

45

 

2515

 

Denver

 

CO

 

 

 —

 

 

2,311

 

 

18,645

 

 

2,311

 

 

2,311

 

 

20,118

 

 

22,429

 

 

(1,443)

 

2015

 

35

 

2507

 

Englewood

 

CO

 

 

 —

 

 

6,857

 

 

102,524

 

 

6,857

 

 

6,857

 

 

106,438

 

 

113,295

 

 

(4,376)

 

2015

 

35

 

2508

 

Lakewood

 

CO

 

 

 —

 

 

4,384

 

 

60,795

 

 

4,384

 

 

4,384

 

 

62,227

 

 

66,611

 

 

(2,872)

 

2015

 

35

 

2509

 

Lakewood

 

CO

 

 

 —

 

 

2,296

 

 

37,236

 

 

2,296

 

 

2,296

 

 

38,337

 

 

40,633

 

 

(1,464)

 

2015

 

35

 

2355

 

Woodbridge

 

CT

 

 

 —

 

 

2,352

 

 

9,929

 

 

2,363

 

 

2,363

 

 

11,259

 

 

13,622

 

 

(2,828)

 

2006

 

45

 

2519

 

Altamonte Springs

 

FL

 

 

 —

 

 

2,537

 

 

19,186

 

 

2,537

 

 

2,537

 

 

18,806

 

 

21,343

 

 

(3,104)

 

2015

 

35

 

2521

 

Altamonte Springs

 

FL

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

 

2,036

 

 

2,036

 

 

(71)

 

2015

 

35

 

2603

 

Boca Raton

 

FL

 

 

 —

 

 

2,415

 

 

17,923

 

 

2,415

 

 

2,415

 

 

17,561

 

 

19,976

 

 

(4,264)

 

2006

 

40

 

1963

 

Boynton Beach

 

FL

 

 

26,735

 

 

2,550

 

 

31,521

 

 

2,550

 

 

2,550

 

 

34,419

 

 

36,969

 

 

(7,488)

 

2011

 

30

 

1964

 

Boynton Beach

 

FL

 

 

3,743

 

 

570

 

 

5,649

 

 

570

 

 

570

 

 

7,543

 

 

8,113

 

 

(2,131)

 

2011

 

30

 

2602

 

Boynton Beach

 

FL

 

 

 —

 

 

1,270

 

 

4,773

 

 

1,270

 

 

1,270

 

 

4,855

 

 

6,125

 

 

(1,652)

 

2003

 

40

 

2520

 

Clearwater

 

FL

 

 

 —

 

 

2,250

 

 

2,627

 

 

2,250

 

 

2,250

 

 

2,835

 

 

5,085

 

 

(950)

 

2015

 

35

 

2601

 

Delray Beach

 

FL

 

 

 —

 

 

850

 

 

6,637

 

 

850

 

 

850

 

 

6,688

 

 

7,538

 

 

(2,065)

 

2002

 

43

 

2517

 

Ft Lauderdale

 

FL

 

 

 —

 

 

2,867

 

 

43,126

 

 

2,867

 

 

2,867

 

 

45,056

 

 

47,923

 

 

(2,647)

 

2015

 

35

 

2351

 

Gainesville

 

FL

 

 

 —

 

 

1,020

 

 

13,490

 

 

1,020

 

 

1,020

 

 

13,879

 

 

14,899

 

 

(3,510)

 

2015

 

50

 

2518

 

Lake Worth

 

FL

 

 

 —

 

 

1,669

 

 

13,267

 

 

1,669

 

 

1,669

 

 

14,224

 

 

15,893

 

 

(1,102)

 

2015

 

35

 

2592

 

Lantana

 

FL

 

 

 —

 

 

3,520

 

 

26,452

 

 

3,520

 

 

3,520

 

 

25,802

 

 

29,322

 

 

(8,910)

 

2006

 

30

 

1968

 

Largo

 

FL

 

 

46,893

 

 

2,920

 

 

64,988

 

 

2,920

 

 

2,920

 

 

74,115

 

 

77,035

 

 

(16,631)

 

2011

 

30

 

2522

 

Lutz

 

FL

 

 

 —

 

 

902

 

 

15,169

 

 

 —

 

 

902

 

 

16,066

 

 

16,968

 

 

(689)

 

2015

 

35

 

2523

 

Orange City

 

FL

 

 

 —

 

 

912

 

 

9,724

 

 

912

 

 

912

 

 

10,398

 

 

11,310

 

 

(615)

 

2015

 

35

 

1970

 

Palm Beach Gardens

 

FL

 

 

25,822

 

 

4,820

 

 

24,937

 

 

4,820

 

 

4,820

 

 

42,405

 

 

47,225

 

 

(8,592)

 

2011

 

30

 

2524

 

Port St Lucie

 

FL

 

 

 —

 

 

893

 

 

10,333

 

 

893

 

 

893

 

 

11,079

 

 

11,972

 

 

(718)

 

2015

 

35

 

1971

 

Sarasota

 

FL

 

 

21,620

 

 

3,050

 

 

29,516

 

 

3,050

 

 

3,050

 

 

34,272

 

 

37,322

 

 

(7,659)

 

2011

 

30

 

2525

 

Sarasota

 

FL

 

 

 —

 

 

1,426

 

 

16,079

 

 

1,426

 

 

1,426

 

 

16,657

 

 

18,083

 

 

(1,081)

 

2015

 

35

 

2526

 

Tamarac

 

FL

 

 

 —

 

 

970

 

 

16,037

 

 

970

 

 

970

 

 

16,720

 

 

17,690

 

 

(757)

 

2015

 

35

 

2513

 

Venice

 

FL

 

 

 —

 

 

1,140

 

 

20,662

 

 

1,140

 

 

1,140

 

 

22,176

 

 

23,316

 

 

(1,042)

 

2015

 

35

 

2527

 

Vero Beach

 

FL

 

 

 —

 

 

1,048

 

 

17,392

 

 

1,048

 

 

1,048

 

 

18,269

 

 

19,317

 

 

(811)

 

2015

 

35

 

1976

 

West Palm Beach

 

FL

 

 

 —

 

 

390

 

 

2,241

 

 

390

 

 

390

 

 

2,479

 

 

2,869

 

 

(593)

 

2011

 

30

 

2370

 

Atlanta

 

GA

 

 

 —

 

 

2,665

 

 

5,911

 

 

2,669

 

 

2,669

 

 

6,723

 

 

9,392

 

 

(1,882)

 

2006

 

45

 

2388

 

Buford

 

GA

 

 

 —

 

 

1,987

 

 

6,561

 

 

1,987

 

 

1,987

 

 

7,122

 

 

9,109

 

 

(1,024)

 

2012

 

45

 

2395

 

Marietta

 

GA

 

 

 —

 

 

987

 

 

4,818

 

 

987

 

 

987

 

 

5,008

 

 

5,995

 

 

(736)

 

2012

 

45

 

2397

 

Sioux City

 

IA

 

 

 —

 

 

197

 

 

8,078

 

 

197

 

 

197

 

 

8,637

 

 

8,834

 

 

(1,177)

 

2012

 

45

 

2375

 

Burr Ridge

 

IL

 

 

 —

 

 

2,640

 

 

23,901

 

 

2,704

 

 

2,704

 

 

27,326

 

 

30,030

 

 

(6,556)

 

2006

 

45

 

2200

 

Deer Park

 

IL

 

 

 —

 

 

4,172

 

 

2,417

 

 

1,803

 

 

4,220

 

 

44,775

 

 

48,995

 

 

(916)

 

2014

 

*

 

2594

 

Mount Vernon

 

IL

 

 

 —

 

 

296

 

 

15,935

 

 

512

 

 

512

 

 

19,347

 

 

19,859

 

 

(4,584)

 

2006

 

40

 

1969

 

Niles

 

IL

 

 

24,749

 

 

3,790

 

 

32,912

 

 

3,790

 

 

3,790

 

 

37,624

 

 

41,414

 

 

(8,837)

 

2011

 

30

 

1961

 

Olympia Fields

 

IL

 

 

27,968

 

 

4,120

 

 

29,400

 

 

4,120

 

 

4,120

 

 

32,403

 

 

36,523

 

 

(6,976)

 

2011

 

30

 

2376

 

Prospect Heights

 

IL

 

 

 —

 

 

2,680

 

 

20,299

 

 

2,725

 

 

2,725

 

 

23,432

 

 

26,157

 

 

(5,579)

 

2010

 

45

 

2367

 

Schaumburg

 

IL

 

 

 —

 

 

1,701

 

 

12,037

 

 

1,704

 

 

1,704

 

 

14,565

 

 

16,269

 

 

(3,238)

 

2006

 

45

 

1952

 

Vernon Hills

 

IL

 

 

41,043

 

 

4,900

 

 

45,854

 

 

4,900

 

 

4,900

 

 

50,932

 

 

55,832

 

 

(10,808)

 

2011

 

30

 

2595

 

Indianapolis

 

IN

 

 

 —

 

 

1,197

 

 

7,718

 

 

1,197

 

 

1,197

 

 

7,546

 

 

8,743

 

 

(1,918)

 

2006

 

40

 

2596

 

W Lafayette

 

IN

 

 

 —

 

 

813

 

 

10,876

 

 

813

 

 

813

 

 

10,706

 

 

11,519

 

 

(2,723)

 

2006

 

40

 

2371

 

Edgewood

 

KY

 

 

 —

 

 

1,868

 

 

4,934

 

 

1,915

 

 

1,915

 

 

7,328

 

 

9,243

 

 

(1,628)

 

2006

 

45

 

2358

 

Danvers

 

MA

 

 

 —

 

 

4,616

 

 

30,692

 

 

4,621

 

 

4,621

 

 

31,418

 

 

36,039

 

 

(8,045)

 

2006

 

45

 

2363

 

Dartmouth

 

MA

 

 

 —

 

 

3,145

 

 

6,880

 

 

3,176

 

 

3,176

 

 

8,183

 

 

11,359

 

 

(2,067)

 

2006

 

45

 

2357

 

Dedham

 

MA

 

 

 —

 

 

3,930

 

 

21,340

 

 

3,930

 

 

3,930

 

 

22,032

 

 

25,962

 

 

(5,662)

 

2006

 

45

 

2365

 

Baltimore

 

MD

 

 

 —

 

 

1,684

 

 

18,889

 

 

1,696

 

 

1,696

 

 

19,603

 

 

21,299

 

 

(5,036)

 

2006

 

45

 

2583

 

Ellicott City

 

MD

 

 

19,772

 

 

3,607

 

 

31,720

 

 

3,607

 

 

3,607

 

 

31,724

 

 

35,331

 

 

(247)

 

2016

 

42

 

2584

 

Hanover

 

MD

 

 

9,216

 

 

4,513

 

 

25,625

 

 

4,513

 

 

4,513

 

 

25,629

 

 

30,142

 

 

(196)

 

2016

 

42

 

2585

 

Laurel

 

MD

 

 

5,985

 

 

3,895

 

 

13,331

 

 

3,895

 

 

3,895

 

 

13,340

 

 

17,235

 

 

(135)

 

2016

 

42

 

2541

 

Olney

 

MD

 

 

 —

 

 

1,580

 

 

33,802

 

 

1,580

 

 

1,580

 

 

33,887

 

 

35,467

 

 

(1,201)

 

2015

 

40

 

2586

 

Parkville

 

MD

 

 

21,333

 

 

3,854

 

 

29,061

 

 

3,854

 

 

3,854

 

 

29,065

 

 

32,919

 

 

(266)

 

2016

 

42

 

2356

 

Pikesville

 

MD

 

 

 —

 

 

1,416

 

 

8,854

 

 

1,416

 

 

1,416

 

 

9,510

 

 

10,926

 

 

(2,300)

 

2006

 

45

 

2587

 

Waldorf

 

MD

 

 

8,644

 

 

392

 

 

20,514

 

 

392

 

 

392

 

 

20,517

 

 

20,909

 

 

(155)

 

2016

 

42

 

2590

 

Sterling Heights

 

MI

 

 

 —

 

 

920

 

 

7,326

 

 

920

 

 

920

 

 

7,390

 

 

8,310

 

 

(3,211)

 

2001

 

35

 

2374

 

Charlotte

 

NC

 

 

 —

 

 

2,051

 

 

6,529

 

 

2,051

 

 

2,051

 

 

7,678

 

 

9,729

 

 

(1,492)

 

2010

 

45

 

2359

 

Paramus

 

NJ

 

 

 —

 

 

4,280

 

 

31,684

 

 

4,280

 

 

4,280

 

 

32,516

 

 

36,796

 

 

(8,284)

 

2006

 

45

 

2387

 

Albuquerque

 

NM

 

 

 —

 

 

2,223

 

 

8,049

 

 

2,223

 

 

2,223

 

 

8,160

 

 

10,383

 

 

(1,084)

 

2012

 

45

 

2589

 

Albuquerque

 

NM

 

 

 —

 

 

767

 

 

9,324

 

 

767

 

 

767

 

 

9,005

 

 

9,772

 

 

(3,840)

 

1996

 

45

 

2516

 

Centerville

 

OH

 

 

 —

 

 

1,065

 

 

10,901

 

 

1,065

 

 

1,065

 

 

12,240

 

 

13,305

 

 

(929)

 

2015

 

35

 

2512

 

Cincinnati

 

OH

 

 

 —

 

 

1,180

 

 

6,157

 

 

1,180

 

 

1,180

 

 

7,244

 

 

8,424

 

 

(822)

 

2015

 

35

 

2591

 

Cincinnati

 

OH

 

 

 —

 

 

600

 

 

4,428

 

 

600

 

 

600

 

 

4,458

 

 

5,058

 

 

(1,940)

 

2001

 

35

 

2597

 

Fairborn

 

OH

 

 

 —

 

 

298

 

 

10,704

 

 

298

 

 

298

 

 

13,676

 

 

13,974

 

 

(3,350)

 

2006

 

40

 

2372

 

Oklahoma City

 

OK

 

 

 —

 

 

801

 

 

4,904

 

 

811

 

 

811

 

 

5,147

 

 

5,958

 

 

(1,422)

 

2006

 

45

 

2383

 

Oklahoma City

 

OK

 

 

 —

 

 

1,345

 

 

3,943

 

 

1,345

 

 

1,345

 

 

4,193

 

 

5,538

 

 

(654)

 

2012

 

45

 

2390

 

Grants Pass

 

OR

 

 

 —

 

 

430

 

 

3,267

 

 

430

 

 

430

 

 

3,306

 

 

3,736

 

 

(485)

 

2012

 

45

 

2391

 

Grants Pass

 

OR

 

 

 —

 

 

1,064

 

 

16,124

 

 

1,064

 

 

1,064

 

 

16,358

 

 

17,422

 

 

(1,679)

 

2012

 

45

 

2392

 

Grants Pass

 

OR

 

 

 —

 

 

618

 

 

2,932

 

 

618

 

 

618

 

 

3,179

 

 

3,797

 

 

(688)

 

2012

 

45

 

2393

 

Grants Pass

 

OR

 

 

 —

 

 

774

 

 

13,230

 

 

774

 

 

774

 

 

13,447

 

 

14,221

 

 

(1,476)

 

2012

 

45

 

1959

 

East Providence

 

RI

 

 

14,186

 

 

1,890

 

 

13,989

 

 

1,890

 

 

1,890

 

 

15,057

 

 

16,947

 

 

(3,439)

 

2011

 

30

 

1960

 

Greenwich

 

RI

 

 

7,769

 

 

450

 

 

11,845

 

 

450

 

 

450

 

 

13,292

 

 

13,742

 

 

(3,143)

 

2011

 

30

 

2511

 

Johnston

 

RI

 

 

 —

 

 

2,037

 

 

12,724

 

 

2,037

 

 

2,037

 

 

16,014

 

 

18,051

 

 

(1,360)

 

2015

 

35

 

1962

 

Warwick

 

RI

 

 

13,881

 

 

1,050

 

 

17,389

 

 

1,050

 

 

1,050

 

 

19,640

 

 

20,690

 

 

(4,599)

 

2011

 

30

 

2401

 

Germantown

 

TN

 

 

 —

 

 

3,640

 

 

64,588

 

 

3,640

 

 

3,640

 

 

64,699

 

 

68,339

 

 

(3,287)

 

2015

 

40

 

2385

 

Hendersonville

 

TN

 

 

 —

 

 

1,298

 

 

2,464

 

 

1,298

 

 

1,298

 

 

3,035

 

 

4,333

 

 

(542)

 

2012

 

45

 

2381

 

Memphis

 

TN

 

 

 —

 

 

1,315

 

 

9,787

 

 

1,315

 

 

1,315

 

 

10,115

 

 

11,430

 

 

(1,099)

 

2012

 

45

 

2608

 

Arlington

 

TX

 

 

 —

 

 

2,002

 

 

19,110

 

 

2,002

 

 

2,002

 

 

18,729

 

 

20,731

 

 

(4,548)

 

2006

 

40

 

2377

 

Austin

 

TX

 

 

 —

 

 

2,860

 

 

17,359

 

 

2,973

 

 

2,973

 

 

18,443

 

 

21,416

 

 

(4,842)

 

2010

 

45

 

2531

 

Austin

 

TX

 

 

 —

 

 

607

 

 

15,972

 

 

607

 

 

607

 

 

16,242

 

 

16,849

 

 

(659)

 

2015

 

35

 

2588

 

Beaumont

 

TX

 

 

 —

 

 

145

 

 

10,404

 

 

145

 

 

145

 

 

10,197

 

 

10,342

 

 

(4,434)

 

1995

 

45

 

2396

 

Dallas

 

TX

 

 

 —

 

 

2,120

 

 

8,986

 

 

2,120

 

 

2,120

 

 

9,338

 

 

11,458

 

 

(1,203)

 

2012

 

45

 

2438

 

Dallas

 

TX

 

 

 —

 

 

2,091

 

 

11,698

 

 

2,091

 

 

2,091

 

 

12,103

 

 

14,194

 

 

(1,205)

 

2015

 

35

 

2528

 

Graham

 

TX

 

 

 —

 

 

754

 

 

8,803

 

 

754

 

 

754

 

 

9,538

 

 

10,292

 

 

(629)

 

2015

 

35

 

2529

 

Grand Prairie

 

TX

 

 

 —

 

 

865

 

 

10,650

 

 

865

 

 

865

 

 

11,689

 

 

12,554

 

 

(685)

 

2015

 

35

 

1955

 

Houston

 

TX

 

 

46,618

 

 

9,820

 

 

50,079

 

 

9,820

 

 

9,820

 

 

58,413

 

 

68,233

 

 

(13,211)

 

2011

 

30

 

1957

 

Houston

 

TX

 

 

30,615

 

 

8,170

 

 

37,285

 

 

8,170

 

 

8,170

 

 

41,145

 

 

49,315

 

 

(9,238)

 

2011

 

30

 

1958

 

Houston

 

TX

 

 

28,189

 

 

2,910

 

 

37,443

 

 

2,910

 

 

2,910

 

 

43,194

 

 

46,104

 

 

(9,490)

 

2011

 

30

 

2402

 

Houston

 

TX

 

 

 —

 

 

1,740

 

 

32,057

 

 

1,740

 

 

1,740

 

 

32,125

 

 

33,865

 

 

(1,772)

 

2015

 

40

 

2606

 

Houston

 

TX

 

 

 —

 

 

2,470

 

 

21,710

 

 

2,470

 

 

2,470

 

 

22,460

 

 

24,930

 

 

(9,718)

 

2002

 

35

 

2394

 

Kerrville

 

TX

 

 

 —

 

 

1,459

 

 

33,407

 

 

1,459

 

 

1,459

 

 

35,583

 

 

37,042

 

 

(4,324)

 

2012

 

45

 

2389

 

Lubbock

 

TX

 

 

 —

 

 

1,143

 

 

4,656

 

 

1,143

 

 

1,143

 

 

5,202

 

 

6,345

 

 

(748)

 

2012

 

45

 

 

131


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

State/

    

Encumbrances at

    

 

 

    

Buildings and

    

to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

Country

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

2530

 

N Richland Hills

 

TX

 

 

 —

 

 

1,190

 

 

17,756

 

 

1,190

 

 

1,190

 

 

18,693

 

 

19,883

 

 

(950)

 

2015

 

35

 

2379

 

Plano

 

TX

 

 

 —

 

 

590

 

 

6,930

 

 

590

 

 

590

 

 

7,190

 

 

7,780

 

 

(951)

 

2012

 

45

 

2378

 

San Antonio

 

TX

 

 

 —

 

 

2,860

 

 

17,030

 

 

2,880

 

 

2,880

 

 

17,980

 

 

20,860

 

 

(4,621)

 

2010

 

45

 

2532

 

San Antonio

 

TX

 

 

 —

 

 

613

 

 

5,874

 

 

613

 

 

613

 

 

6,735

 

 

7,348

 

 

(518)

 

2015

 

35

 

2607

 

San Antonio

 

TX

 

 

 —

 

 

730

 

 

3,961

 

 

730

 

 

730

 

 

3,961

 

 

4,691

 

 

(1,298)

 

2002

 

45

 

2533

 

San Marcos

 

TX

 

 

 —

 

 

765

 

 

18,175

 

 

765

 

 

765

 

 

19,000

 

 

19,765

 

 

(801)

 

2015

 

35

 

1954

 

Sugar Land

 

TX

 

 

30,149

 

 

3,420

 

 

36,846

 

 

3,420

 

 

3,420

 

 

40,805

 

 

44,225

 

 

(9,196)

 

2011

 

30

 

2510

 

Temple

 

TX

 

 

 —

 

 

2,354

 

 

52,859

 

 

2,354

 

 

2,354

 

 

53,628

 

 

55,982

 

 

(2,256)

 

2015

 

35

 

2400

 

Victoria

 

TX

 

 

 —

 

 

1,032

 

 

7,743

 

 

1,032

 

 

1,032

 

 

7,828

 

 

8,860

 

 

(493)

 

2015

 

30

 

2605

 

Victoria

 

TX

 

 

 —

 

 

175

 

 

4,290

 

 

175

 

 

175

 

 

7,018

 

 

7,193

 

 

(2,520)

 

1995

 

43

 

1953

 

Webster

 

TX

 

 

28,807

 

 

4,780

 

 

30,854

 

 

4,780

 

 

4,780

 

 

34,191

 

 

38,971

 

 

(7,893)

 

2011

 

30

 

2534

 

Wichita Falls

 

TX

 

 

 —

 

 

430

 

 

2,856

 

 

430

 

 

430

 

 

3,602

 

 

4,032

 

 

(351)

 

2015

 

35

 

2368

 

Salt Lake City

 

UT

 

 

 —

 

 

2,621

 

 

22,072

 

 

2,654

 

 

2,654

 

 

23,081

 

 

25,735

 

 

(5,762)

 

2006

 

45

 

2386

 

St. George

 

UT

 

 

 —

 

 

683

 

 

9,436

 

 

683

 

 

683

 

 

10,330

 

 

11,013

 

 

(1,314)

 

2012

 

45

 

2360

 

Arlington

 

VA

 

 

 —

 

 

4,320

 

 

19,567

 

 

4,320

 

 

4,320

 

 

20,577

 

 

24,897

 

 

(5,276)

 

2006

 

45

 

2582

 

Fredericksburg

 

VA

 

 

 —

 

 

2,370

 

 

19,725

 

 

2,370

 

 

2,370

 

 

19,735

 

 

22,105

 

 

(138)

 

2016

 

42

 

2581

 

Leesburg

 

VA

 

 

12,544

 

 

1,340

 

 

17,605

 

 

1,340

 

 

1,340

 

 

17,616

 

 

18,956

 

 

(129)

 

2016

 

42

 

2361

 

Richmond

 

VA

 

 

 —

 

 

2,110

 

 

11,469

 

 

2,110

 

 

2,110

 

 

13,883

 

 

15,993

 

 

(3,193)

 

2006

 

45

 

2514

 

Richmond

 

VA

 

 

 —

 

 

2,981

 

 

54,203

 

 

2,981

 

 

2,981

 

 

55,375

 

 

58,356

 

 

(2,091)

 

2015

 

35

 

2382

 

Appleton

 

WI

 

 

 —

 

 

182

 

 

12,581

 

 

182

 

 

182

 

 

12,841

 

 

13,023

 

 

(1,458)

 

2012

 

45

 

2398

 

Stevens Point

 

WI

 

 

 —

 

 

801

 

 

16,687

 

 

801

 

 

801

 

 

16,900

 

 

17,701

 

 

(1,713)

 

2012

 

45

 

 

 

 

 

 

 

$

553,838

 

$

288,417

 

$

2,447,074

 

$

285,921

 

$

289,240

 

$

2,663,281

 

$

2,952,521

 

$

(413,672)

 

 

 

 

 

Life science

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1482

 

Brisbane

 

CA

 

 

 —

 

 

50,989

 

 

1,789

 

 

39,531

 

 

50,989

 

 

41,322

 

 

92,311

 

 

 —

 

2007

 

**

 

1522

 

Carlsbad

 

CA

 

 

 —

 

 

23,475

 

 

 —

 

 

2,828

 

 

23,475

 

 

2,828

 

 

26,303

 

 

 —

 

2007

 

**

 

1401

 

Hayward

 

CA

 

 

 —

 

 

900

 

 

7,100

 

 

915

 

 

900

 

 

8,015

 

 

8,915

 

 

(2,358)

 

2007

 

40

 

1402

 

Hayward

 

CA

 

 

 —

 

 

1,500

 

 

6,400

 

 

3,682

 

 

1,719

 

 

9,863

 

 

11,582

 

 

(3,677)

 

2007

 

40

 

1403

 

Hayward

 

CA

 

 

 —

 

 

1,900

 

 

7,100

 

 

2,304

 

 

1,900

 

 

9,149

 

 

11,049

 

 

(2,032)

 

2007

 

40

 

1404

 

Hayward                 

 

CA

 

 

 —

 

 

2,200

 

 

17,200

 

 

682

 

 

2,200

 

 

17,883

 

 

20,083

 

 

(4,054)

 

2007

 

40

 

1405

 

Hayward                 

 

CA

 

 

 —

 

 

1,000

 

 

3,200

 

 

7,478

 

 

1,000

 

 

10,678

 

 

11,678

 

 

(5,544)

 

2007

 

40

 

1549

 

Hayward                 

 

CA

 

 

 —

 

 

1,006

 

 

4,259

 

 

3,073

 

 

1,055

 

 

6,020

 

 

7,075

 

 

(2,030)

 

2007

 

29

 

1550

 

Hayward                 

 

CA

 

 

 —

 

 

677

 

 

2,761

 

 

5,583

 

 

710

 

 

8,256

 

 

8,966

 

 

(5,570)

 

2007

 

29

 

1551

 

Hayward                 

 

CA

 

 

 —

 

 

661

 

 

1,995

 

 

4,264

 

 

693

 

 

6,227

 

 

6,920

 

 

(3,266)

 

2007

 

29

 

1552

 

Hayward                 

 

CA

 

 

 —

 

 

1,187

 

 

7,139

 

 

1,346

 

 

1,222

 

 

8,148

 

 

9,370

 

 

(2,944)

 

2007

 

29

 

1553

 

Hayward                 

 

CA

 

 

 —

 

 

1,189

 

 

9,465

 

 

7,361

 

 

1,225

 

 

16,791

 

 

18,016

 

 

(4,274)

 

2007

 

29

 

1554

 

Hayward                 

 

CA

 

 

 —

 

 

1,246

 

 

5,179

 

 

1,867

 

 

1,283

 

 

6,133

 

 

7,416

 

 

(2,424)

 

2007

 

29

 

1555

 

Hayward                 

 

CA

 

 

 —

 

 

1,521

 

 

13,546

 

 

6,354

 

 

1,566

 

 

19,841

 

 

21,407

 

 

(6,060)

 

2007

 

29

 

1556

 

Hayward                 

 

CA

 

 

 —

 

 

1,212

 

 

5,120

 

 

3,049

 

 

1,249

 

 

7,795

 

 

9,044

 

 

(4,389)

 

2007

 

29

 

1424

 

La Jolla                

 

CA

 

 

 —

 

 

9,600

 

 

25,283

 

 

7,908

 

 

9,719

 

 

31,103

 

 

40,822

 

 

(7,689)

 

2007

 

40

 

1425

 

La Jolla                

 

CA

 

 

 —

 

 

6,200

 

 

19,883

 

 

125

 

 

6,276

 

 

19,931

 

 

26,207

 

 

(4,755)

 

2007

 

40

 

1426

 

La Jolla                

 

CA

 

 

 —

 

 

7,200

 

 

12,412

 

 

4,875

 

 

7,291

 

 

16,857

 

 

24,148

 

 

(7,269)

 

2007

 

27

 

1427

 

La Jolla                

 

CA

 

 

 —

 

 

8,700

 

 

16,983

 

 

6,136

 

 

8,746

 

 

22,240

 

 

30,986

 

 

(6,507)

 

2007

 

30

 

1949

 

La Jolla

 

CA

 

 

 —

 

 

2,686

 

 

11,045

 

 

689

 

 

2,686

 

 

11,404

 

 

14,090

 

 

(2,272)

 

2011

 

30

 

2229

 

La Jolla

 

CA

 

 

 —

 

 

8,753

 

 

32,528

 

 

5,299

 

 

8,753

 

 

37,828

 

 

46,581

 

 

(2,645)

 

2014

 

35

 

1488

 

Mountain View           

 

CA

 

 

 —

 

 

7,300

 

 

25,410

 

 

1,901

 

 

7,567

 

 

27,044

 

 

34,611

 

 

(6,786)

 

2007

 

40

 

1489

 

Mountain View           

 

CA

 

 

 —

 

 

6,500

 

 

22,800

 

 

1,866

 

 

6,500

 

 

24,666

 

 

31,166

 

 

(6,265)

 

2007

 

40

 

1490

 

Mountain View           

 

CA

 

 

 —

 

 

4,800

 

 

9,500

 

 

442

 

 

4,800

 

 

9,942

 

 

14,742

 

 

(2,476)

 

2007

 

40

 

1491

 

Mountain View           

 

CA

 

 

 —

 

 

4,200

 

 

8,400

 

 

1,249

 

 

4,209

 

 

8,998

 

 

13,207

 

 

(2,204)

 

2007

 

40

 

1492

 

Mountain View           

 

CA

 

 

 —

 

 

3,600

 

 

9,700

 

 

730

 

 

3,600

 

 

9,703

 

 

13,303

 

 

(2,284)

 

2007

 

40

 

1493

 

Mountain View           

 

CA

 

 

 —

 

 

7,500

 

 

16,300

 

 

1,904

 

 

7,500

 

 

17,603

 

 

25,103

 

 

(4,416)

 

2007

 

40

 

1494

 

Mountain View           

 

CA

 

 

 —

 

 

9,800

 

 

24,000

 

 

203

 

 

9,800

 

 

24,203

 

 

34,003

 

 

(5,749)

 

2007

 

40

 

1495

 

Mountain View           

 

CA

 

 

 —

 

 

6,900

 

 

17,800

 

 

3,245

 

 

6,900

 

 

21,045

 

 

27,945

 

 

(5,553)

 

2007

 

40

 

1496

 

Mountain View           

 

CA

 

 

 —

 

 

7,000

 

 

17,000

 

 

6,364

 

 

7,000

 

 

17,332

 

 

24,332

 

 

(4,149)

 

2007

 

40

 

1497

 

Mountain View           

 

CA

 

 

 —

 

 

14,100

 

 

31,002

 

 

10,111

 

 

14,100

 

 

40,487

 

 

54,587

 

 

(16,468)

 

2007

 

40

 

1498

 

Mountain View           

 

CA

 

 

 —

 

 

7,100

 

 

25,800

 

 

8,101

 

 

7,100

 

 

33,901

 

 

41,001

 

 

(13,149)

 

2013

 

40

 

2017

 

Mountain View           

 

CA

 

 

 —

 

 

 —

 

 

20,240

 

 

1,117

 

 

 —

 

 

21,255

 

 

21,255

 

 

(3,131)

 

2004

 

40

 

1470

 

Poway                   

 

CA

 

 

 —

 

 

5,826

 

 

12,200

 

 

6,048

 

 

5,826

 

 

18,248

 

 

24,074

 

 

(8,589)

 

2007

 

40

 

1471

 

Poway                   

 

CA

 

 

 —

 

 

5,978

 

 

14,200

 

 

4,253

 

 

5,978

 

 

18,453

 

 

24,431

 

 

(7,127)

 

2007

 

40

 

1472

 

Poway                   

 

CA

 

 

 —

 

 

8,654

 

 

 —

 

 

11,908

 

 

8,654

 

 

11,908

 

 

20,562

 

 

(880)

 

2007

 

40

 

1473

 

Poway

 

CA

 

 

 —

 

 

21,730

 

 

2,405

 

 

7,072

 

 

21,730

 

 

9,477

 

 

31,207

 

 

 —

 

2007

 

*

 

1477

 

Poway

 

CA

 

 

 —

 

 

25,359

 

 

2,475

 

 

14,805

 

 

25,359

 

 

17,279

 

 

42,638

 

 

 —

 

2007

 

**

 

1478

 

Poway                   

 

CA

 

 

 —

 

 

6,700

 

 

14,400

 

 

6,145

 

 

6,700

 

 

14,400

 

 

21,100

 

 

(3,390)

 

2007

 

40

 

1499

 

Redwood City            

 

CA

 

 

 —

 

 

3,400

 

 

5,500

 

 

2,373

 

 

3,407

 

 

7,334

 

 

10,741

 

 

(2,357)

 

2007

 

40

 

1500

 

Redwood City            

 

CA

 

 

 —

 

 

2,500

 

 

4,100

 

 

1,220

 

 

2,506

 

 

4,563

 

 

7,069

 

 

(1,358)

 

2007

 

40

 

1501

 

Redwood City            

 

CA

 

 

 —

 

 

3,600

 

 

4,600

 

 

860

 

 

3,607

 

 

5,024

 

 

8,631

 

 

(1,553)

 

2007

 

30

 

1502

 

Redwood City            

 

CA

 

 

 —

 

 

3,100

 

 

5,100

 

 

843

 

 

3,107

 

 

5,690

 

 

8,797

 

 

(1,718)

 

2007

 

31

 

1503

 

Redwood City            

 

CA

 

 

 —

 

 

4,800

 

 

17,300

 

 

3,300

 

 

4,818

 

 

20,583

 

 

25,401

 

 

(5,521)

 

2007

 

31

 

1504

 

Redwood City            

 

CA

 

 

 —

 

 

5,400

 

 

15,500

 

 

969

 

 

5,418

 

 

16,451

 

 

21,869

 

 

(3,830)

 

2007

 

31

 

1505

 

Redwood City            

 

CA

 

 

 —

 

 

3,000

 

 

3,500

 

 

826

 

 

3,006

 

 

4,115

 

 

7,121

 

 

(1,451)

 

2007

 

40

 

1506

 

Redwood City            

 

CA

 

 

 —

 

 

6,000

 

 

14,300

 

 

3,871

 

 

6,018

 

 

17,546

 

 

23,564

 

 

(4,131)

 

2007

 

40

 

1507

 

Redwood City            

 

CA

 

 

 —

 

 

1,900

 

 

12,800

 

 

13,594

 

 

1,912

 

 

26,382

 

 

28,294

 

 

(5,469)

 

2007

 

39

 

1508

 

Redwood City            

 

CA

 

 

 —

 

 

2,700

 

 

11,300

 

 

12,120

 

 

2,712

 

 

23,409

 

 

26,121

 

 

(4,687)

 

2007

 

39

 

1509

 

Redwood City            

 

CA

 

 

 —

 

 

2,700

 

 

10,900

 

 

9,004

 

 

2,712

 

 

19,424

 

 

22,136

 

 

(5,975)

 

2007

 

40

 

1510

 

Redwood City            

 

CA

 

 

 —

 

 

2,200

 

 

12,000

 

 

5,395

 

 

2,212

 

 

17,383

 

 

19,595

 

 

(6,495)

 

2007

 

38

 

1511

 

Redwood City            

 

CA

 

 

 —

 

 

2,600

 

 

9,300

 

 

1,828

 

 

2,612

 

 

10,561

 

 

13,173

 

 

(2,424)

 

2007

 

26

 

1512

 

Redwood City            

 

CA

 

 

 —

 

 

3,300

 

 

18,000

 

 

12,361

 

 

3,300

 

 

30,361

 

 

33,661

 

 

(6,486)

 

2007

 

40

 

1513

 

Redwood City            

 

CA

 

 

 —

 

 

3,300

 

 

17,900

 

 

14,739

 

 

3,326

 

 

32,613

 

 

35,939

 

 

(7,173)

 

2007

 

40

 

0678

 

San Diego

 

CA

 

 

 —

 

 

2,603

 

 

11,051

 

 

3,745

 

 

2,603

 

 

14,796

 

 

17,399

 

 

(4,250)

 

2002

 

39

 

0679

 

San Diego               

 

CA

 

 

 —

 

 

5,269

 

 

23,566

 

 

14,757

 

 

5,669

 

 

37,176

 

 

42,845

 

 

(13,594)

 

2002

 

39

 

0837

 

San Diego               

 

CA

 

 

 —

 

 

4,630

 

 

2,028

 

 

8,982

 

 

4,630

 

 

11,011

 

 

15,641

 

 

(5,483)

 

2006

 

31

 

0838

 

San Diego               

 

CA

 

 

 —

 

 

2,040

 

 

903

 

 

4,975

 

 

2,040

 

 

5,878

 

 

7,918

 

 

(1,822)

 

2006

 

40

 

0839

 

San Diego               

 

CA

 

 

 —

 

 

3,940

 

 

3,184

 

 

5,735

 

 

3,951

 

 

5,689

 

 

9,640

 

 

(1,274)

 

2006

 

40

 

0840

 

San Diego               

 

CA

 

 

 —

 

 

5,690

 

 

4,579

 

 

711

 

 

5,703

 

 

4,851

 

 

10,554

 

 

(1,392)

 

2006

 

40

 

1418

 

San Diego

 

CA

 

 

 —

 

 

11,700

 

 

31,243

 

 

6,403

 

 

11,700

 

 

37,646

 

 

49,346

 

 

(11,440)

 

2007

 

40

 

1420

 

San Diego               

 

CA

 

 

 —

 

 

6,524

 

 

 —

 

 

4,886

 

 

6,524

 

 

4,886

 

 

11,410

 

 

 —

 

2007

 

**

 

1421

 

San Diego

 

CA

 

 

 —

 

 

7,000

 

 

33,779

 

 

1,258

 

 

7,000

 

 

35,037

 

 

42,037

 

 

(7,969)

 

2007

 

40

 

1422

 

San Diego

 

CA

 

 

 —

 

 

7,179

 

 

3,687

 

 

4,528

 

 

7,184

 

 

8,210

 

 

15,394

 

 

(1,632)

 

2007

 

30

 

1423

 

San Diego

 

CA

 

 

 —

 

 

8,400

 

 

33,144

 

 

18

 

 

8,400

 

 

33,162

 

 

41,562

 

 

(7,807)

 

2007

 

40

 

1514

 

San Diego

 

CA

 

 

 —

 

 

5,200

 

 

 —

 

 

 —

 

 

5,200

 

 

 —

 

 

5,200

 

 

 —

 

2007

 

**

 

1558

 

San Diego

 

CA

 

 

 —

 

 

7,740

 

 

22,654

 

 

2,224

 

 

7,888

 

 

24,580

 

 

32,468

 

 

(6,518)

 

2007

 

38

 

1947

 

San Diego

 

CA

 

 

 —

 

 

2,581

 

 

10,534

 

 

3,952

 

 

2,581

 

 

14,486

 

 

17,067

 

 

(2,470)

 

2011

 

30

 

1948

 

San Diego

 

CA

 

 

 —

 

 

5,879

 

 

25,305

 

 

2,481

 

 

5,879

 

 

27,783

 

 

33,662

 

 

(6,359)

 

2011

 

30

 

1950

 

San Diego

 

CA

 

 

691

 

 

884

 

 

2,796

 

 

32

 

 

895

 

 

2,816

 

 

3,711

 

 

(560)

 

2011

 

30

 

2197

 

San Diego

 

CA

 

 

 —

 

 

7,621

 

 

3,913

 

 

3,801

 

 

7,626

 

 

6,417

 

 

14,043

 

 

(2,289)

 

2007

 

33

 

2476

 

San Diego

 

CA

 

 

 

 

 

7,661

 

 

9,918

 

 

2

 

 

7,661

 

 

9,920

 

 

17,581

 

 

(118)

 

2016

 

35

 

2477

 

San Diego

 

CA

 

 

 

 

 

9,207

 

 

14,613

 

 

523

 

 

9,207

 

 

15,136

 

 

24,343

 

 

(174)

 

2016

 

35

 

2478

 

San Diego

 

CA

 

 

 

 

 

6,000

 

 

 —

 

 

 —

 

 

6,000

 

 

 —

 

 

6,000

 

 

 —

 

2016

 

**

 

1407

 

South San Francisco     

 

CA

 

 

 —

 

 

7,182

 

 

12,140

 

 

9,477

 

 

7,182

 

 

17,997

 

 

25,179

 

 

(6,137)

 

2007

 

35

 

1408

 

South San Francisco     

 

CA

 

 

 —

 

 

9,000

 

 

17,800

 

 

1,260

 

 

9,000

 

 

19,060

 

 

28,060

 

 

(4,922)

 

2007

 

40

 

1409

 

South San Francisco     

 

CA

 

 

 —

 

 

18,000

 

 

38,043

 

 

4,850

 

 

18,000

 

 

42,893

 

 

60,893

 

 

(9,465)

 

2007

 

40

 

1410

 

South San Francisco     

 

CA

 

 

 —

 

 

4,900

 

 

18,100

 

 

157

 

 

4,900

 

 

18,257

 

 

23,157

 

 

(4,325)

 

2007

 

40

 

1411

 

South San Francisco     

 

CA

 

 

 —

 

 

8,000

 

 

27,700

 

 

313

 

 

8,000

 

 

28,013

 

 

36,013

 

 

(6,580)

 

2007

 

40

 

1412

 

South San Francisco     

 

CA

 

 

 —

 

 

10,100

 

 

22,521

 

 

2,003

 

 

10,100

 

 

24,524

 

 

34,624

 

 

(5,526)

 

2007

 

40

 

1413

 

South San Francisco     

 

CA

 

 

 —

 

 

8,000

 

 

28,299

 

 

282

 

 

8,000

 

 

28,581

 

 

36,581

 

 

(6,701)

 

2007

 

40

 

1414

 

South San Francisco     

 

CA

 

 

 —

 

 

3,700

 

 

20,800

 

 

2,278

 

 

3,700

 

 

23,078

 

 

26,778

 

 

(5,243)

 

2007

 

40

 

1430

 

South San Francisco     

 

CA

 

 

 —

 

 

10,700

 

 

23,621

 

 

2,143

 

 

10,700

 

 

25,764

 

 

36,464

 

 

(6,078)

 

2007

 

40

 

1431

 

South San Francisco     

 

CA

 

 

 —

 

 

7,000

 

 

15,500

 

 

511

 

 

7,000

 

 

16,012

 

 

23,012

 

 

(3,682)

 

2007

 

40

 

1435

 

South San Francisco

 

CA

 

 

 —

 

 

13,800

 

 

42,500

 

 

36,982

 

 

13,800

 

 

79,483

 

 

93,283

 

 

(16,559)

 

2008

 

40

 

1436

 

South San Francisco

 

CA

 

 

 —

 

 

14,500

 

 

45,300

 

 

36,599

 

 

14,500

 

 

81,899

 

 

96,399

 

 

(17,134)

 

2008

 

40

 

1437

 

South San Francisco

 

CA

 

 

 —

 

 

9,400

 

 

24,800

 

 

45,139

 

 

9,400

 

 

69,938

 

 

79,338

 

 

(12,480)

 

2008

 

40

 

1439

 

South San Francisco     

 

CA

 

 

 —

 

 

11,900

 

 

68,848

 

 

82

 

 

11,900

 

 

68,930

 

 

80,830

 

 

(16,223)

 

2007

 

40

 

132


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

 

    

Encumbrances at

    

 

 

    

Buildings and

    

to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

State

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

1440

 

South San Francisco     

 

CA

 

 

 —

 

 

10,000

 

 

57,954

 

 

6

 

 

10,000

 

 

57,960

 

 

67,960

 

 

(13,644)

 

2007

 

40

 

1441

 

South San Francisco     

 

CA

 

 

 —

 

 

9,300

 

 

43,549

 

 

5

 

 

9,300

 

 

43,554

 

 

52,854

 

 

(10,253)

 

2007

 

40

 

1442

 

South San Francisco     

 

CA

 

 

 —

 

 

11,000

 

 

47,289

 

 

87

 

 

11,000

 

 

47,376

 

 

58,376

 

 

(11,182)

 

2007

 

40

 

1443

 

South San Francisco     

 

CA

 

 

 —

 

 

13,200

 

 

60,932

 

 

1,165

 

 

13,200

 

 

62,097

 

 

75,297

 

 

(13,930)

 

2007

 

40

 

1444

 

South San Francisco     

 

CA

 

 

 —

 

 

10,500

 

 

33,776

 

 

357

 

 

10,500

 

 

34,132

 

 

44,632

 

 

(8,116)

 

2007

 

40

 

1445

 

South San Francisco     

 

CA

 

 

 —

 

 

10,600

 

 

34,083

 

 

5

 

 

10,600

 

 

34,088

 

 

44,688

 

 

(8,024)

 

2007

 

40

 

1449

 

South San Francisco     

 

CA

 

 

 —

 

 

12,800

 

 

63,600

 

 

472

 

 

12,800

 

 

64,072

 

 

76,872

 

 

(15,189)

 

2007

 

40

 

1454

 

South San Francisco

 

CA

 

 

 —

 

 

11,100

 

 

47,738

 

 

9,369

 

 

11,100

 

 

57,108

 

 

68,208

 

 

(16,646)

 

2008

 

40

 

1455

 

South San Francisco

 

CA

 

 

 —

 

 

9,700

 

 

41,937

 

 

6,052

 

 

10,261

 

 

47,428

 

 

57,689

 

 

(13,065)

 

2008

 

40

 

1456

 

South San Francisco

 

CA

 

 

 —

 

 

6,300

 

 

22,900

 

 

8,196

 

 

6,300

 

 

31,096

 

 

37,396

 

 

(9,247)

 

2008

 

40

 

1458

 

South San Francisco     

 

CA

 

 

 —

 

 

10,900

 

 

20,900

 

 

8,264

 

 

10,909

 

 

24,662

 

 

35,571

 

 

(6,514)

 

2007

 

40

 

1459

 

South San Francisco     

 

CA

 

 

 —

 

 

3,600

 

 

100

 

 

220

 

 

3,600

 

 

321

 

 

3,921

 

 

(94)

 

2007

 

**

 

1460

 

South San Francisco     

 

CA

 

 

 —

 

 

2,300

 

 

100

 

 

116

 

 

2,300

 

 

215

 

 

2,515

 

 

(100)

 

2007

 

**

 

1461

 

South San Francisco     

 

CA

 

 

 —

 

 

3,900

 

 

200

 

 

216

 

 

3,900

 

 

416

 

 

4,316

 

 

(200)

 

2007

 

**

 

1462

 

South San Francisco     

 

CA

 

 

 —

 

 

7,117

 

 

600

 

 

4,925

 

 

7,117

 

 

5,176

 

 

12,293

 

 

(1,841)

 

2007

 

40

 

1463

 

South San Francisco

 

CA

 

 

 —

 

 

10,381

 

 

2,300

 

 

17,875

 

 

10,381

 

 

20,175

 

 

30,556

 

 

(4,569)

 

2007

 

40

 

1464

 

South San Francisco     

 

CA

 

 

 —

 

 

7,403

 

 

700

 

 

11,638

 

 

7,403

 

 

12,338

 

 

19,741

 

 

(4,872)

 

2007

 

40

 

1468

 

South San Francisco     

 

CA

 

 

 —

 

 

10,100

 

 

24,013

 

 

4,774

 

 

10,100

 

 

26,642

 

 

36,742

 

 

(6,760)

 

2007

 

40

 

1480

 

South San Francisco

 

CA

 

 

 —

 

 

32,210

 

 

3,110

 

 

11,207

 

 

32,210

 

 

14,317

 

 

46,527

 

 

 —

 

2007

 

**

 

1559

 

South San Francisco     

 

CA

 

 

 —

 

 

5,666

 

 

5,773

 

 

12,966

 

 

5,695

 

 

18,641

 

 

24,336

 

 

(8,348)

 

2007

 

35

 

1560

 

South San Francisco     

 

CA

 

 

 —

 

 

1,204

 

 

1,293

 

 

409

 

 

1,210

 

 

1,681

 

 

2,891

 

 

(1,391)

 

2007

 

5

 

1983

 

South San Francisco

 

CA

 

 

 —

 

 

8,648

 

 

 —

 

 

92,639

 

 

8,648

 

 

92,639

 

 

101,287

 

 

(1,344)

 

2011

 

40

 

1984

 

South San Francisco

 

CA

 

 

 —

 

 

7,845

 

 

 —

 

 

57,009

 

 

7,845

 

 

57,009

 

 

64,854

 

 

 —

 

2011

 

*

 

1985

 

South San Francisco

 

CA

 

 

 —

 

 

13,416

 

 

 —

 

 

98,736

 

 

13,416

 

 

98,736

 

 

112,152

 

 

 —

 

2011

 

*

 

1987

 

South San Francisco

 

CA

 

 

 —

 

 

18,664

 

 

 —

 

 

6,252

 

 

18,664

 

 

6,252

 

 

24,916

 

 

 —

 

2011

 

*

 

1989

 

South San Francisco

 

CA

 

 

 —

 

 

9,169

 

 

 —

 

 

2,631

 

 

9,169

 

 

2,631

 

 

11,800

 

 

 —

 

2011

 

**

 

2553

 

South San Francisco

 

CA

 

 

 —

 

 

2,897

 

 

8,691

 

 

1,566

 

 

2,897

 

 

10,257

 

 

13,154

 

 

(369)

 

2015

 

35

 

2554

 

South San Francisco

 

CA

 

 

 —

 

 

995

 

 

2,754

 

 

 —

 

 

995

 

 

2,754

 

 

3,749

 

 

(85)

 

2015

 

35

 

2555

 

South San Francisco

 

CA

 

 

 —

 

 

2,202

 

 

10,776

 

 

50

 

 

2,202

 

 

10,826

 

 

13,028

 

 

(334)

 

2015

 

35

 

2556

 

South San Francisco

 

CA

 

 

 —

 

 

2,962

 

 

15,108

 

 

 —

 

 

2,962

 

 

15,108

 

 

18,070

 

 

(468)

 

2015

 

35

 

2557

 

South San Francisco

 

CA

 

 

 —

 

 

2,453

 

 

13,063

 

 

 —

 

 

2,453

 

 

13,063

 

 

15,516

 

 

(404)

 

2015

 

35

 

2558

 

South San Francisco

 

CA

 

 

 —

 

 

1,163

 

 

5,925

 

 

 —

 

 

1,163

 

 

5,925

 

 

7,088

 

 

(183)

 

2015

 

35

 

2614

 

South San Francisco

 

CA

 

 

 —

 

 

5,079

 

 

8,584

 

 

1,330

 

 

5,079

 

 

9,914

 

 

14,993

 

 

(2,944)

 

2007

 

35

 

2615

 

South San Francisco

 

CA

 

 

 —

 

 

7,984

 

 

13,495

 

 

3,238

 

 

7,984

 

 

16,733

 

 

24,717

 

 

(4,435)

 

2007

 

35

 

2616

 

South San Francisco

 

CA

 

 

 —

 

 

8,355

 

 

14,121

 

 

1,871

 

 

8,355

 

 

15,992

 

 

24,347

 

 

(4,693)

 

2007

 

35

 

9999

 

Denton

 

TX

 

 

 —

 

 

100

 

 

 —

 

 

 —

 

 

100

 

 

 —

 

 

100

 

 

 —

 

1900

 

**

 

2011

 

Durham

 

NC

 

 

6,780

 

 

448

 

 

6,152

 

 

21,379

 

 

448

 

 

27,494

 

 

27,942

 

 

(3,709)

 

2011

 

30

 

2030

 

Durham

 

NC

 

 

 —

 

 

1,920

 

 

5,661

 

 

34,083

 

 

1,920

 

 

39,744

 

 

41,664

 

 

(5,157)

 

2012

 

30

 

0464

 

Salt Lake City          

 

UT

 

 

 —

 

 

630

 

 

6,921

 

 

1,275

 

 

630

 

 

8,197

 

 

8,827

 

 

(2,910)

 

2001

 

38

 

0465

 

Salt Lake City          

 

UT

 

 

 —

 

 

125

 

 

6,368

 

 

68

 

 

125

 

 

6,436

 

 

6,561

 

 

(2,231)

 

2001

 

43

 

0466

 

Salt Lake City          

 

UT

 

 

 —

 

 

 —

 

 

14,614

 

 

7

 

 

 —

 

 

14,621

 

 

14,621

 

 

(4,545)

 

2001

 

43

 

0507

 

Salt Lake City          

 

UT

 

 

 —

 

 

280

 

 

4,345

 

 

226

 

 

280

 

 

4,572

 

 

4,852

 

 

(1,560)

 

2002

 

43

 

0799

 

Salt Lake City          

 

UT

 

 

 —

 

 

 —

 

 

14,600

 

 

90

 

 

 —

 

 

14,690

 

 

14,690

 

 

(3,609)

 

2005

 

40

 

1593

 

Salt Lake City          

 

UT

 

 

 —

 

 

 —

 

 

23,998

 

 

 —

 

 

 —

 

 

23,998

 

 

23,998

 

 

(4,666)

 

2010

 

33

 

 

 

 

 

 

 

$

7,471

 

$

885,895

 

$

1,977,011

 

$

917,979

 

$

888,397

 

$

2,850,690

 

$

3,739,087

 

$

(626,840)

 

 

 

 

 

Medical office

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0638

 

Anchorage               

 

AK

 

 

 —

 

 

1,456

 

 

10,650

 

 

11,925

 

 

1,456

 

 

22,522

 

 

23,978

 

 

(4,898)

 

2006

 

30

 

2572

 

Springdale

 

AR

 

 

 —

 

 

 —

 

 

27,714

 

 

 —

 

 

 —

 

 

27,714

 

 

27,714

 

 

 —

 

2016

 

35

 

0520

 

Chandler                

 

AZ

 

 

 —

 

 

3,669

 

 

13,503

 

 

2,390

 

 

3,669

 

 

15,601

 

 

19,270

 

 

(5,333)

 

2002

 

40

 

2040

 

Mesa

 

AZ

 

 

 —

 

 

 —

 

 

17,314

 

 

653

 

 

 —

 

 

17,952

 

 

17,952

 

 

(2,049)

 

2012

 

45

 

0468

 

Oro Valley              

 

AZ

 

 

 —

 

 

1,050

 

 

6,774

 

 

925

 

 

1,050

 

 

7,124

 

 

8,174

 

 

(2,622)

 

2001

 

43

 

0356

 

Phoenix                 

 

AZ

 

 

 —

 

 

780

 

 

3,199

 

 

1,401

 

 

780

 

 

3,717

 

 

4,497

 

 

(1,744)

 

1999

 

32

 

0470

 

Phoenix                 

 

AZ

 

 

 —

 

 

280

 

 

877

 

 

104

 

 

280

 

 

946

 

 

1,226

 

 

(316)

 

2001

 

43

 

1066

 

Scottsdale              

 

AZ

 

 

 —

 

 

5,115

 

 

14,064

 

 

3,359

 

 

4,811

 

 

17,076

 

 

21,887

 

 

(5,038)

 

2006

 

40

 

2021

 

Scottsdale              

 

AZ

 

 

 —

 

 

 —

 

 

12,312

 

 

1,400

 

 

 —

 

 

13,665

 

 

13,665

 

 

(3,026)

 

2012

 

25

 

2022

 

Scottsdale              

 

AZ

 

 

 —

 

 

 —

 

 

9,179

 

 

817

 

 

 —

 

 

9,911

 

 

9,911

 

 

(2,358)

 

2012

 

25

 

2023

 

Scottsdale              

 

AZ

 

 

 —

 

 

 —

 

 

6,398

 

 

1,159

 

 

 —

 

 

7,529

 

 

7,529

 

 

(1,452)

 

2012

 

25

 

2024

 

Scottsdale              

 

AZ

 

 

 —

 

 

 —

 

 

9,522

 

 

598

 

 

 —

 

 

10,121

 

 

10,121

 

 

(1,954)

 

2012

 

25

 

2025

 

Scottsdale              

 

AZ

 

 

 —

 

 

 —

 

 

4,102

 

 

1,311

 

 

 —

 

 

5,378

 

 

5,378

 

 

(1,307)

 

2012

 

25

 

2026

 

Scottsdale              

 

AZ

 

 

 —

 

 

 —

 

 

3,655

 

 

981

 

 

 —

 

 

4,596

 

 

4,596

 

 

(829)

 

2012

 

25

 

2027

 

Scottsdale              

 

AZ

 

 

 —

 

 

 —

 

 

7,168

 

 

1,204

 

 

 —

 

 

8,354

 

 

8,354

 

 

(1,658)

 

2012

 

25

 

2028

 

Scottsdale              

 

AZ

 

 

 —

 

 

 —

 

 

6,659

 

 

937

 

 

 —

 

 

7,596

 

 

7,596

 

 

(1,516)

 

2012

 

25

 

0453

 

Tucson                  

 

AZ

 

 

 —

 

 

215

 

 

6,318

 

 

1,363

 

 

326

 

 

7,045

 

 

7,371

 

 

(3,082)

 

2000

 

35

 

0556

 

Tucson                  

 

AZ

 

 

 —

 

 

215

 

 

3,940

 

 

1,081

 

 

267

 

 

4,541

 

 

4,808

 

 

(1,357)

 

2003

 

43

 

1041

 

Brentwood               

 

CA

 

 

 —

 

 

 —

 

 

30,864

 

 

2,658

 

 

187

 

 

32,848

 

 

33,035

 

 

(8,794)

 

2006

 

40

 

1200

 

Encino                  

 

CA

 

 

 —

 

 

6,151

 

 

10,438

 

 

3,954

 

 

6,645

 

 

13,274

 

 

19,919

 

 

(4,553)

 

2006

 

33

 

0436

 

Murietta                

 

CA

 

 

 —

 

 

400

 

 

9,266

 

 

3,463

 

 

638

 

 

11,359

 

 

11,997

 

 

(5,272)

 

1999

 

33

 

0239

 

Poway                   

 

CA

 

 

 —

 

 

2,700

 

 

10,839

 

 

2,822

 

 

2,887

 

 

11,778

 

 

14,665

 

 

(6,400)

 

1997

 

35

 

0318

 

Sacramento              

 

CA

 

 

 —

 

 

2,860

 

 

37,566

 

 

27,051

 

 

2,911

 

 

63,715

 

 

66,626

 

 

(7,765)

 

1998

 

25

 

2404

 

Sacramento              

 

CA

 

 

 —

 

 

1,268

 

 

5,109

 

 

198

 

 

1,299

 

 

5,277

 

 

6,576

 

 

(388)

 

2015

 

30

 

0234

 

San Diego               

 

CA

 

 

 —

 

 

2,848

 

 

5,879

 

 

1,450

 

 

3,009

 

 

5,052

 

 

8,061

 

 

(3,027)

 

1997

 

21

 

0235

 

San Diego               

 

CA

 

 

 —

 

 

2,863

 

 

8,913

 

 

2,913

 

 

3,068

 

 

9,299

 

 

12,367

 

 

(5,939)

 

1997

 

21

 

0236

 

San Diego               

 

CA

 

 

 —

 

 

4,619

 

 

19,370

 

 

4,023

 

 

4,711

 

 

16,976

 

 

21,687

 

 

(9,791)

 

1997

 

21

 

0421

 

San Diego               

 

CA

 

 

 —

 

 

2,910

 

 

19,984

 

 

16,294

 

 

2,964

 

 

34,905

 

 

37,869

 

 

(7,017)

 

1999

 

22

 

0564

 

San Jose

 

CA

 

 

 —

 

 

1,935

 

 

1,728

 

 

2,303

 

 

1,935

 

 

3,338

 

 

5,273

 

 

(1,445)

 

2003

 

37

 

 

133


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent 

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

 

    

Encumbrances at

    

 

 

    

Buildings and

    

to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

State

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

0565

 

San Jose                

 

CA

 

 

 —

 

 

1,460

 

 

7,672

 

 

527

 

 

1,460

 

 

8,192

 

 

9,652

 

 

(3,237)

 

2003

 

37

 

0659

 

Los Gatos

 

CA

 

 

 —

 

 

1,718

 

 

3,124

 

 

622

 

 

1,758

 

 

3,598

 

 

5,356

 

 

(1,194)

 

2000

 

34

 

1209

 

Sherman Oaks            

 

CA

 

 

 —

 

 

7,472

 

 

10,075

 

 

4,988

 

 

7,943

 

 

14,105

 

 

22,048

 

 

(6,483)

 

2006

 

22

 

0439

 

Valencia                

 

CA

 

 

 —

 

 

2,300

 

 

6,967

 

 

3,038

 

 

2,404

 

 

8,172

 

 

10,576

 

 

(3,442)

 

1999

 

35

 

1211

 

Valencia                

 

CA

 

 

 —

 

 

1,344

 

 

7,507

 

 

708

 

 

1,383

 

 

7,972

 

 

9,355

 

 

(2,157)

 

2006

 

40

 

0440

 

West Hills              

 

CA

 

 

 —

 

 

2,100

 

 

11,595

 

 

3,357

 

 

2,259

 

 

11,531

 

 

13,790

 

 

(5,425)

 

1999

 

32

 

0728

 

Aurora                  

 

CO

 

 

 —

 

 

 —

 

 

8,764

 

 

2,283

 

 

 —

 

 

8,726

 

 

8,726

 

 

(2,918)

 

2005

 

39

 

1196

 

Aurora                  

 

CO

 

 

 —

 

 

210

 

 

12,362

 

 

2,306

 

 

210

 

 

14,273

 

 

14,483

 

 

(3,805)

 

2006

 

40

 

1197

 

Aurora                  

 

CO

 

 

 —

 

 

200

 

 

8,414

 

 

2,326

 

 

200

 

 

10,427

 

 

10,627

 

 

(3,096)

 

2006

 

33

 

0882

 

Colorado Springs

 

CO

 

 

 —

 

 

 —

 

 

12,933

 

 

10,672

 

 

 —

 

 

22,462

 

 

22,462

 

 

(6,783)

 

2006

 

40

 

0814

 

Conifer                 

 

CO

 

 

 —

 

 

 —

 

 

1,485

 

 

35

 

 

13

 

 

1,508

 

 

1,521

 

 

(439)

 

2005

 

40

 

1199

 

Denver                  

 

CO

 

 

 —

 

 

493

 

 

7,897

 

 

1,865

 

 

622

 

 

9,401

 

 

10,023

 

 

(3,037)

 

2006

 

33

 

0808

 

Englewood               

 

CO

 

 

 —

 

 

 —

 

 

8,616

 

 

8,336

 

 

11

 

 

16,146

 

 

16,157

 

 

(5,303)

 

2005

 

35

 

0809

 

Englewood               

 

CO

 

 

 —

 

 

 —

 

 

8,449

 

 

3,462

 

 

 —

 

 

10,872

 

 

10,872

 

 

(3,929)

 

2005

 

35

 

0810

 

Englewood               

 

CO

 

 

 —

 

 

 —

 

 

8,040

 

 

7,408

 

 

 —

 

 

14,464

 

 

14,464

 

 

(4,853)

 

2005

 

35

 

0811

 

Englewood               

 

CO

 

 

 —

 

 

 —

 

 

8,472

 

 

3,515

 

 

 —

 

 

11,082

 

 

11,082

 

 

(3,769)

 

2005

 

35

 

0812

 

Littleton               

 

CO

 

 

 —

 

 

 —

 

 

4,562

 

 

2,398

 

 

257

 

 

6,340

 

 

6,597

 

 

(2,505)

 

2005

 

35

 

0813

 

Littleton               

 

CO

 

 

 —

 

 

 —

 

 

4,926

 

 

1,853

 

 

106

 

 

6,201

 

 

6,307

 

 

(1,994)

 

2005

 

38

 

0570

 

Lone Tree               

 

CO

 

 

 —

 

 

 —

 

 

 —

 

 

19,702

 

 

 —

 

 

19,078

 

 

19,078

 

 

(5,989)

 

2003

 

39

 

0666

 

Lone Tree               

 

CO

 

 

 —

 

 

 —

 

 

23,274

 

 

2,637

 

 

 —

 

 

25,501

 

 

25,501

 

 

(7,583)

 

2000

 

37

 

2233

 

Lone Tree

 

CO

 

 

 —

 

 

 —

 

 

6,734

 

 

24,974

 

 

 —

 

 

31,708

 

 

31,708

 

 

(624)

 

2014

 

*

 

1076

 

Parker                  

 

CO

 

 

 —

 

 

 —

 

 

13,388

 

 

782

 

 

8

 

 

14,089

 

 

14,097

 

 

(3,940)

 

2006

 

40

 

0510

 

Thornton                

 

CO

 

 

 —

 

 

236

 

 

10,206

 

 

3,382

 

 

454

 

 

13,345

 

 

13,799

 

 

(4,935)

 

2002

 

43

 

0433

 

Atlantis                

 

FL

 

 

 —

 

 

 —

 

 

5,651

 

 

930

 

 

113

 

 

5,532

 

 

5,645

 

 

(2,703)

 

1999

 

35

 

0434

 

Atlantis                

 

FL

 

 

 —

 

 

 —

 

 

2,027

 

 

274

 

 

5

 

 

2,149

 

 

2,154

 

 

(1,067)

 

1999

 

34

 

0435

 

Atlantis                

 

FL

 

 

 —

 

 

 —

 

 

2,000

 

 

786

 

 

 —

 

 

2,532

 

 

2,532

 

 

(1,323)

 

1999

 

32

 

0602

 

Atlantis                

 

FL

 

 

 —

 

 

455

 

 

2,231

 

 

918

 

 

455

 

 

2,886

 

 

3,341

 

 

(809)

 

2000

 

34

 

0604

 

Englewood               

 

FL

 

 

 —

 

 

170

 

 

1,134

 

 

407

 

 

198

 

 

1,359

 

 

1,557

 

 

(493)

 

2000

 

34

 

0609

 

Kissimmee               

 

FL

 

 

 —

 

 

788

 

 

174

 

 

636

 

 

788

 

 

722

 

 

1,510

 

 

(161)

 

2000

 

34

 

0610

 

Kissimmee               

 

FL

 

 

 —

 

 

481

 

 

347

 

 

739

 

 

493

 

 

1,007

 

 

1,500

 

 

(432)

 

2000

 

34

 

0671

 

Kissimmee               

 

FL

 

 

 —

 

 

 —

 

 

7,574

 

 

2,318

 

 

 —

 

 

8,586

 

 

8,586

 

 

(2,644)

 

2000

 

36

 

0603

 

Lake Worth

 

FL

 

 

 —

 

 

1,507

 

 

2,894

 

 

1,807

 

 

1,507

 

 

4,569

 

 

6,076

 

 

(1,706)

 

2000

 

34

 

0612

 

Margate                 

 

FL

 

 

 —

 

 

1,553

 

 

6,898

 

 

1,302

 

 

1,553

 

 

8,043

 

 

9,596

 

 

(2,521)

 

2000

 

34

 

0613

 

Miami                   

 

FL

 

 

 —

 

 

4,392

 

 

11,841

 

 

3,925

 

 

4,392

 

 

14,606

 

 

18,998

 

 

(4,961)

 

2000

 

34

 

2202

 

Miami

 

FL

 

 

 —

 

 

 —

 

 

13,123

 

 

3,325

 

 

 —

 

 

16,448

 

 

16,448

 

 

(1,858)

 

2014

 

25

 

2203

 

Miami

 

FL

 

 

 —

 

 

 —

 

 

8,877

 

 

1,837

 

 

 —

 

 

10,713

 

 

10,713

 

 

(1,012)

 

2014

 

30

 

1067

 

Milton                  

 

FL

 

 

 —

 

 

 —

 

 

8,566

 

 

269

 

 

 —

 

 

8,816

 

 

8,816

 

 

(2,310)

 

2006

 

40

 

2577

 

Naples

 

FL

 

 

 —

 

 

 —

 

 

29,186

 

 

 —

 

 

 —

 

 

29,186

 

 

29,186

 

 

 —

 

2016

 

37

 

2578

 

Naples

 

FL

 

 

 —

 

 

 —

 

 

18,819

 

 

 —

 

 

 —

 

 

18,819

 

 

18,819

 

 

 —

 

2016

 

46

 

0563

 

Orlando                 

 

FL

 

 

 —

 

 

2,144

 

 

5,136

 

 

4,840

 

 

2,343

 

 

8,731

 

 

11,074

 

 

(3,860)

 

2003

 

37

 

0833

 

Pace                    

 

FL

 

 

 —

 

 

 —

 

 

10,309

 

 

2,899

 

 

26

 

 

10,888

 

 

10,914

 

 

(2,593)

 

2006

 

44

 

0834

 

Pensacola               

 

FL

 

 

 —

 

 

 —

 

 

11,166

 

 

478

 

 

 —

 

 

11,644

 

 

11,644

 

 

(3,020)

 

2006

 

45

 

0614

 

Plantation              

 

FL

 

 

 —

 

 

969

 

 

3,241

 

 

1,535

 

 

1,017

 

 

4,299

 

 

5,316

 

 

(1,444)

 

2000

 

34

 

0673

 

Plantation              

 

FL

 

 

 —

 

 

1,091

 

 

7,176

 

 

1,198

 

 

1,091

 

 

8,019

 

 

9,110

 

 

(2,298)

 

2002

 

36

 

2579

 

Punta Gorda

 

FL

 

 

 —

 

 

 —

 

 

9,379

 

 

 —

 

 

 —

 

 

9,379

 

 

9,379

 

 

 —

 

2016

 

40

 

0701

 

St. Petersburg          

 

FL

 

 

 —

 

 

 —

 

 

13,754

 

 

7,107

 

 

 —

 

 

19,871

 

 

19,871

 

 

(5,021)

 

2006

 

28

 

1210

 

Tampa                   

 

FL

 

 

 —

 

 

1,967

 

 

6,602

 

 

5,668

 

 

2,194

 

 

10,840

 

 

13,034

 

 

(5,008)

 

2006

 

25

 

1058

 

Blue Ridge

 

GA

 

 

 —

 

 

 —

 

 

3,231

 

 

18

 

 

 —

 

 

3,249

 

 

3,249

 

 

(844)

 

2006

 

40

 

2576

 

Statesboro

 

GA

 

 

 —

 

 

 —

 

 

10,234

 

 

 —

 

 

 —

 

 

10,234

 

 

10,234

 

 

 —

 

2016

 

28

 

1065

 

Marion                  

 

IL

 

 

 —

 

 

99

 

 

11,484

 

 

747

 

 

100

 

 

12,205

 

 

12,305

 

 

(3,385)

 

2006

 

40

 

1057

 

Newburgh                

 

IN

 

 

 —

 

 

 —

 

 

14,019

 

 

4,243

 

 

 —

 

 

18,256

 

 

18,256

 

 

(4,583)

 

2006

 

40

 

2039

 

Kansas City

 

KS

 

 

 —

 

 

440

 

 

2,173

 

 

17

 

 

448

 

 

2,181

 

 

2,629

 

 

(301)

 

2012

 

35

 

2043

 

Overland Park

 

KS

 

 

 —

 

 

 —

 

 

7,668

 

 

294

 

 

 —

 

 

7,961

 

 

7,961

 

 

(1,022)

 

2012

 

40

 

0483

 

Wichita                 

 

KS

 

 

 —

 

 

530

 

 

3,341

 

 

537

 

 

530

 

 

3,878

 

 

4,408

 

 

(1,546)

 

2001

 

45

 

1064

 

Lexington               

 

KY

 

 

 —

 

 

 —

 

 

12,726

 

 

1,248

 

 

 —

 

 

13,761

 

 

13,761

 

 

(4,004)

 

2006

 

40

 

0735

 

Louisville              

 

KY

 

 

 —

 

 

936

 

 

8,426

 

 

5,119

 

 

936

 

 

11,402

 

 

12,338

 

 

(9,366)

 

2005

 

11

 

0737

 

Louisville              

 

KY

 

 

 —

 

 

835

 

 

27,627

 

 

4,847

 

 

878

 

 

30,456

 

 

31,334

 

 

(9,862)

 

2005

 

37

 

0738

 

Louisville              

 

KY

 

 

 —

 

 

780

 

 

8,582

 

 

5,202

 

 

851

 

 

12,248

 

 

13,099

 

 

(6,988)

 

2005

 

18

 

0739

 

Louisville              

 

KY

 

 

 —

 

 

826

 

 

13,814

 

 

1,821

 

 

832

 

 

14,190

 

 

15,022

 

 

(4,373)

 

2005

 

38

 

0740

 

Louisville              

 

KY

 

 

 —

 

 

2,983

 

 

13,171

 

 

4,623

 

 

2,991

 

 

16,864

 

 

19,855

 

 

(6,585)

 

2005

 

30

 

1944

 

Louisville              

 

KY

 

 

 —

 

 

788

 

 

2,414

 

 

 —

 

 

788

 

 

2,414

 

 

3,202

 

 

(579)

 

2010

 

25

 

1945

 

Louisville              

 

KY

 

 

 —

 

 

3,255

 

 

28,644

 

 

691

 

 

3,255

 

 

29,034

 

 

32,289

 

 

(6,083)

 

2010

 

30

 

1946

 

Louisville              

 

KY

 

 

 —

 

 

430

 

 

6,125

 

 

152

 

 

430

 

 

6,277

 

 

6,707

 

 

(1,241)

 

2010

 

30

 

2237

 

Louisville              

 

KY

 

 

 —

 

 

1,519

 

 

15,386

 

 

2,563

 

 

1,542

 

 

17,925

 

 

19,467

 

 

(1,345)

 

2014

 

25

 

2238

 

Louisville              

 

KY

 

 

 —

 

 

1,334

 

 

12,172

 

 

1,033

 

 

1,511

 

 

13,028

 

 

14,539

 

 

(1,181)

 

2014

 

25

 

2239

 

Louisville              

 

KY

 

 

 —

 

 

1,644

 

 

10,832

 

 

2,473

 

 

1,718

 

 

13,230

 

 

14,948

 

 

(933)

 

2014

 

25

 

1324

 

Haverhill               

 

MA

 

 

 —

 

 

800

 

 

8,537

 

 

2,122

 

 

869

 

 

9,609

 

 

10,478

 

 

(2,741)

 

2007

 

40

 

1213

 

Ellicott City

 

MD

 

 

 —

 

 

1,115

 

 

3,206

 

 

2,614

 

 

1,222

 

 

5,491

 

 

6,713

 

 

(2,295)

 

2006

 

34

 

0361

 

GlenBurnie             

 

MD

 

 

 —

 

 

670

 

 

5,085

 

 

 —

 

 

670

 

 

5,085

 

 

5,755

 

 

(2,567)

 

1999

 

35

 

1052

 

Towson                  

 

MD

 

 

 —

 

 

 —

 

 

14,233

 

 

3,611

 

 

 —

 

 

15,150

 

 

15,150

 

 

(5,511)

 

2006

 

40

 

0240

 

Minneapolis             

 

MN

 

 

 —

 

 

117

 

 

13,213

 

 

2,343

 

 

117

 

 

15,031

 

 

15,148

 

 

(7,886)

 

1997

 

32

 

 

134


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent 

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

 

    

Encumbrances at

    

 

 

    

Buildings and

    

to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

State

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

0300

 

Minneapolis             

 

MN

 

 

 —

 

 

160

 

 

10,131

 

 

4,566

 

 

160

 

 

13,720

 

 

13,880

 

 

(6,552)

 

1997

 

35

 

2032

 

Independence

 

MO

 

 

 —

 

 

 —

 

 

48,025

 

 

787

 

 

 —

 

 

48,812

 

 

48,812

 

 

(5,068)

 

2012

 

45

 

1078

 

Flowood

 

MS

 

 

 —

 

 

 —

 

 

8,413

 

 

753

 

 

 —

 

 

9,139

 

 

9,139

 

 

(2,712)

 

2006

 

40

 

1059

 

Jackson                 

 

MS

 

 

 —

 

 

 —

 

 

8,868

 

 

114

 

 

 —

 

 

8,982

 

 

8,982

 

 

(2,300)

 

2006

 

40

 

1060

 

Jackson                 

 

MS

 

 

 —

 

 

 —

 

 

7,187

 

 

2,182

 

 

 —

 

 

9,369

 

 

9,369

 

 

(2,954)

 

2006

 

40

 

1068

 

Omaha                   

 

NE

 

 

 —

 

 

 —

 

 

16,243

 

 

1,147

 

 

17

 

 

17,317

 

 

17,334

 

 

(4,687)

 

2006

 

40

 

0729

 

Albuquerque             

 

NM

 

 

 —

 

 

 —

 

 

5,380

 

 

423

 

 

 —

 

 

5,658

 

 

5,658

 

 

(1,749)

 

2005

 

39

 

0348

 

Elko                    

 

NV

 

 

 —

 

 

55

 

 

2,637

 

 

12

 

 

55

 

 

2,649

 

 

2,704

 

 

(1,356)

 

1999

 

35

 

0571

 

Las Vegas               

 

NV

 

 

 —

 

 

 —

 

 

 —

 

 

18,743

 

 

 —

 

 

17,570

 

 

17,570

 

 

(5,859)

 

2003

 

40

 

0660

 

Las Vegas               

 

NV

 

 

 —

 

 

1,121

 

 

4,363

 

 

5,328

 

 

1,302

 

 

7,858

 

 

9,160

 

 

(3,045)

 

2000

 

34

 

0661

 

Las Vegas               

 

NV

 

 

 —

 

 

2,305

 

 

4,829

 

 

5,217

 

 

2,447

 

 

9,006

 

 

11,453

 

 

(3,500)

 

2000

 

34

 

0662

 

Las Vegas               

 

NV

 

 

 —

 

 

3,480

 

 

12,305

 

 

4,869

 

 

3,480

 

 

14,956

 

 

18,436

 

 

(4,874)

 

2000

 

34

 

0663

 

Las Vegas               

 

NV

 

 

 —

 

 

1,717

 

 

3,597

 

 

5,798

 

 

1,724

 

 

8,104

 

 

9,828

 

 

(2,043)

 

2000

 

34

 

0664

 

Las Vegas               

 

NV

 

 

 —

 

 

1,172

 

 

 —

 

 

441

 

 

1,172

 

 

441

 

 

1,613

 

 

 —

 

2000

 

*

 

0691

 

Las Vegas               

 

NV

 

 

 —

 

 

3,244

 

 

18,339

 

 

7,507

 

 

3,273

 

 

24,540

 

 

27,813

 

 

(8,712)

 

2004

 

30

 

2037

 

Mesquite

 

NV

 

 

 —

 

 

 —

 

 

5,559

 

 

206

 

 

 —

 

 

5,754

 

 

5,754

 

 

(683)

 

2012

 

40

 

1285

 

Cleveland               

 

OH

 

 

 —

 

 

823

 

 

2,726

 

 

925

 

 

853

 

 

2,916

 

 

3,769

 

 

(1,156)

 

2006

 

40

 

0400

 

Harrison                

 

OH

 

 

 —

 

 

 —

 

 

4,561

 

 

300

 

 

 —

 

 

4,861

 

 

4,861

 

 

(2,417)

 

1999

 

35

 

1054

 

Durant                  

 

OK

 

 

 —

 

 

619

 

 

9,256

 

 

1,825

 

 

659

 

 

11,021

 

 

11,680

 

 

(2,778)

 

2006

 

40

 

0817

 

Owasso                  

 

OK

 

 

 —

 

 

 —

 

 

6,582

 

 

1,399

 

 

 —

 

 

5,865

 

 

5,865

 

 

(1,637)

 

2005

 

40

 

0404

 

Roseburg                

 

OR

 

 

 —

 

 

 —

 

 

5,707

 

 

700

 

 

 —

 

 

6,407

 

 

6,407

 

 

(2,805)

 

1999

 

35

 

2570

 

Limerick

 

PA

 

 

 —

 

 

925

 

 

20,072

 

 

 —

 

 

925

 

 

20,072

 

 

20,997

 

 

 —

 

2016

 

31

 

2234

 

Philadelphia

 

PA

 

 

 —

 

 

24,264

 

 

99,904

 

 

2,586

 

 

24,288

 

 

102,465

 

 

126,753

 

 

(7,078)

 

2014

 

35

 

2403

 

Philadelphia

 

PA

 

 

 —

 

 

26,063

 

 

97,646

 

 

4,634

 

 

26,084

 

 

102,260

 

 

128,344

 

 

(6,900)

 

2015

 

25

 

2571

 

Wilkes-Barre

 

PA

 

 

 —

 

 

 —

 

 

9,138

 

 

 —

 

 

 —

 

 

9,138

 

 

9,138

 

 

 —

 

2016

 

28

 

2573

 

Florence

 

SC

 

 

 —

 

 

 —

 

 

12,090

 

 

 —

 

 

 —

 

 

12,090

 

 

12,090

 

 

 —

 

2016

 

37

 

2574

 

Florence

 

SC

 

 

 —

 

 

 —

 

 

12,190

 

 

 —

 

 

 —

 

 

12,190

 

 

12,190

 

 

 —

 

2016

 

37

 

2575

 

Florence

 

SC

 

 

 —

 

 

 —

 

 

11,243

 

 

 —

 

 

 —

 

 

11,243

 

 

11,243

 

 

 —

 

2016

 

29

 

0252

 

Clarksville             

 

TN

 

 

 —

 

 

765

 

 

4,184

 

 

60

 

 

772

 

 

4,237

 

 

5,009

 

 

(2,255)

 

1998

 

35

 

0624

 

Hendersonville          

 

TN

 

 

 —

 

 

256

 

 

1,530

 

 

1,585

 

 

256

 

 

2,705

 

 

2,961

 

 

(965)

 

2000

 

34

 

0559

 

Hermitage               

 

TN

 

 

 —

 

 

830

 

 

5,036

 

 

5,914

 

 

851

 

 

9,987

 

 

10,838

 

 

(3,840)

 

2003

 

35

 

0561

 

Hermitage               

 

TN

 

 

 —

 

 

596

 

 

9,698

 

 

4,967

 

 

596

 

 

13,553

 

 

14,149

 

 

(5,366)

 

2003

 

37

 

0562

 

Hermitage               

 

TN

 

 

 —

 

 

317

 

 

6,528

 

 

2,674

 

 

317

 

 

8,523

 

 

8,840

 

 

(3,586)

 

2003

 

37

 

0154

 

Knoxville               

 

TN

 

 

 —

 

 

700

 

 

4,559

 

 

4,863

 

 

700

 

 

9,327

 

 

10,027

 

 

(4,185)

 

1994

 

19

 

0625

 

Nashville               

 

TN

 

 

 —

 

 

955

 

 

14,289

 

 

3,035

 

 

955

 

 

15,880

 

 

16,835

 

 

(4,947)

 

2000

 

34

 

0626

 

Nashville               

 

TN

 

 

 —

 

 

2,050

 

 

5,211

 

 

3,737

 

 

2,055

 

 

8,326

 

 

10,381

 

 

(3,008)

 

2000

 

34

 

0627

 

Nashville               

 

TN

 

 

 —

 

 

1,007

 

 

181

 

 

723

 

 

1,060

 

 

826

 

 

1,886

 

 

(389)

 

2000

 

34

 

0628

 

Nashville               

 

TN

 

 

 —

 

 

2,980

 

 

7,164

 

 

2,722

 

 

2,980

 

 

9,515

 

 

12,495

 

 

(3,460)

 

2000

 

34

 

0630

 

Nashville               

 

TN

 

 

 —

 

 

515

 

 

848

 

 

293

 

 

528

 

 

1,127

 

 

1,655

 

 

(459)

 

2000

 

34

 

0631

 

Nashville               

 

TN

 

 

 —

 

 

266

 

 

1,305

 

 

1,458

 

 

266

 

 

2,536

 

 

2,802

 

 

(941)

 

2000

 

34

 

0632

 

Nashville               

 

TN

 

 

 —

 

 

827

 

 

7,642

 

 

3,891

 

 

827

 

 

10,318

 

 

11,145

 

 

(3,590)

 

2000

 

34

 

0633

 

Nashville               

 

TN

 

 

 —

 

 

5,425

 

 

12,577

 

 

4,491

 

 

5,425

 

 

16,758

 

 

22,183

 

 

(6,486)

 

2000

 

34

 

0634

 

Nashville               

 

TN

 

 

 —

 

 

3,818

 

 

15,185

 

 

8,406

 

 

3,818

 

 

22,746

 

 

26,564

 

 

(8,424)

 

2000

 

34

 

0636

 

Nashville               

 

TN

 

 

 —

 

 

583

 

 

450

 

 

303

 

 

583

 

 

753

 

 

1,336

 

 

(250)

 

2000

 

34

 

2611

 

Allen

 

TX

 

 

 —

 

 

1,330

 

 

5,960

 

 

 —

 

 

1,330

 

 

5,960

 

 

7,290

 

 

(33)

 

2016

 

35

 

2612

 

Allen

 

TX

 

 

 —

 

 

1,310

 

 

4,165

 

 

 —

 

 

1,310

 

 

4,165

 

 

5,475

 

 

(24)

 

2016

 

35

 

0573

 

Arlington               

 

TX

 

 

 —

 

 

769

 

 

12,355

 

 

3,864

 

 

769

 

 

15,434

 

 

16,203

 

 

(4,986)

 

2003

 

34

 

0576

 

Conroe                  

 

TX

 

 

 —

 

 

324

 

 

4,842

 

 

2,421

 

 

324

 

 

6,198

 

 

6,522

 

 

(1,965)

 

2000

 

34

 

0577

 

Conroe                  

 

TX

 

 

 —

 

 

397

 

 

7,966

 

 

2,443

 

 

397

 

 

9,921

 

 

10,318

 

 

(3,276)

 

2000

 

34

 

0578

 

Conroe                  

 

TX

 

 

 —

 

 

388

 

 

7,975

 

 

3,946

 

 

388

 

 

11,733

 

 

12,121

 

 

(4,061)

 

2006

 

31

 

0579

 

Conroe                  

 

TX

 

 

 —

 

 

188

 

 

3,618

 

 

1,338

 

 

188

 

 

4,822

 

 

5,010

 

 

(1,500)

 

2000

 

34

 

0581

 

Corpus Christi          

 

TX

 

 

 —

 

 

717

 

 

8,181

 

 

5,164

 

 

717

 

 

12,420

 

 

13,137

 

 

(4,635)

 

2000

 

34

 

0600

 

Corpus Christi          

 

TX

 

 

 —

 

 

328

 

 

3,210

 

 

3,780

 

 

328

 

 

6,468

 

 

6,796

 

 

(2,573)

 

2000

 

34

 

0601

 

Corpus Christi          

 

TX

 

 

 —

 

 

313

 

 

1,771

 

 

1,693

 

 

325

 

 

2,971

 

 

3,296

 

 

(968)

 

2000

 

34

 

2244

 

Cypress

 

TX

 

 

 —

 

 

 —

 

 

7,704

 

 

22,125

 

 

 —

 

 

29,829

 

 

29,829

 

 

(816)

 

2015

 

*

 

0582

 

Dallas                  

 

TX

 

 

 —

 

 

1,664

 

 

6,785

 

 

3,346

 

 

1,705

 

 

9,225

 

 

10,930

 

 

(3,298)

 

2000

 

34

 

1314

 

Dallas 

 

TX

 

 

 —

 

 

15,230

 

 

162,971

 

 

15,470

 

 

15,860

 

 

175,622

 

 

191,482

 

 

(49,189)

 

2006

 

35

 

0583

 

Fort Worth              

 

TX

 

 

 —

 

 

898

 

 

4,866

 

 

1,933

 

 

898

 

 

6,363

 

 

7,261

 

 

(2,248)

 

2000

 

34

 

0805

 

Fort Worth              

 

TX

 

 

 —

 

 

 —

 

 

2,481

 

 

1,171

 

 

2

 

 

3,432

 

 

3,434

 

 

(1,598)

 

2005

 

25

 

0806

 

Fort Worth              

 

TX

 

 

 —

 

 

 —

 

 

6,070

 

 

508

 

 

5

 

 

6,432

 

 

6,437

 

 

(1,875)

 

2005

 

40

 

2231

 

Fort Worth

 

TX

 

 

 —

 

 

902

 

 

 —

 

 

44

 

 

946

 

 

 —

 

 

946

 

 

(8)

 

2014

 

**

 

1061

 

Granbury                

 

TX

 

 

 —

 

 

 —

 

 

6,863

 

 

1,028

 

 

 —

 

 

7,835

 

 

7,835

 

 

(1,823)

 

2006

 

40

 

0430

 

Houston                 

 

TX

 

 

 —

 

 

1,927

 

 

33,140

 

 

7,424

 

 

2,151

 

 

38,994

 

 

41,145

 

 

(17,729)

 

1999

 

35

 

0446

 

Houston                 

 

TX

 

 

 —

 

 

2,200

 

 

19,585

 

 

9,867

 

 

2,209

 

 

24,196

 

 

26,405

 

 

(16,770)

 

1999

 

17

 

0589

 

Houston                 

 

TX

 

 

 —

 

 

1,676

 

 

12,602

 

 

5,453

 

 

1,706

 

 

16,174

 

 

17,880

 

 

(5,105)

 

2000

 

34

 

0670

 

Houston                 

 

TX

 

 

 —

 

 

257

 

 

2,884

 

 

1,252

 

 

318

 

 

3,681

 

 

3,999

 

 

(1,360)

 

2000

 

35

 

0702

 

Houston                 

 

TX

 

 

 —

 

 

 —

 

 

7,414

 

 

1,754

 

 

7

 

 

8,492

 

 

8,499

 

 

(2,840)

 

2004

 

36

 

1044

 

Houston                 

 

TX

 

 

 —

 

 

 —

 

 

4,838

 

 

3,226

 

 

 —

 

 

7,956

 

 

7,956

 

 

(3,189)

 

2006

 

40

 

2542

 

Houston

 

TX

 

 

 —

 

 

304

 

 

17,764

 

 

 —

 

 

304

 

 

17,764

 

 

18,068

 

 

(818)

 

2015

 

35

 

2543

 

Houston

 

TX

 

 

 —

 

 

116

 

 

6,555

 

 

 —

 

 

116

 

 

6,555

 

 

6,671

 

 

(357)

 

2015

 

30

 

2544

 

Houston

 

TX

 

 

 —

 

 

312

 

 

12,094

 

 

 —

 

 

312

 

 

12,094

 

 

12,406

 

 

(663)

 

2015

 

30

 

2545

 

Houston

 

TX

 

 

 —

 

 

316

 

 

13,931

 

 

 —

 

 

316

 

 

13,931

 

 

14,247

 

 

(582)

 

2015

 

40

 

2546

 

Houston

 

TX

 

 

 —

 

 

408

 

 

18,332

 

 

 —

 

 

408

 

 

18,332

 

 

18,740

 

 

(1,202)

 

2015

 

25

 

2547

 

Houston

 

TX

 

 

 —

 

 

470

 

 

18,197

 

 

 —

 

 

470

 

 

18,197

 

 

18,667

 

 

(1,011)

 

2015

 

30

 

2548

 

Houston

 

TX

 

 

 —

 

 

313

 

 

7,036

 

 

 —

 

 

313

 

 

7,036

 

 

7,349

 

 

(500)

 

2015

 

25

 

2549

 

Houston

 

TX

 

 

 —

 

 

530

 

 

22,711

 

 

 —

 

 

530

 

 

22,711

 

 

23,241

 

 

(836)

 

2015

 

45

 

0590

 

Irving                  

 

TX

 

 

 —

 

 

828

 

 

6,160

 

 

2,652

 

 

828

 

 

8,541

 

 

9,369

 

 

(3,009)

 

2000

 

34

 

0700

 

Irving                  

 

TX

 

 

 —

 

 

 —

 

 

8,550

 

 

3,363

 

 

 —

 

 

11,381

 

 

11,381

 

 

(4,472)

 

2006

 

34

 

1202

 

Irving                  

 

TX

 

 

 —

 

 

1,604

 

 

16,107

 

 

1,000

 

 

1,633

 

 

16,992

 

 

18,625

 

 

(4,537)

 

2006

 

40

 

1207

 

Irving                  

 

TX

 

 

 —

 

 

1,955

 

 

12,793

 

 

1,716

 

 

1,986

 

 

14,466

 

 

16,452

 

 

(3,998)

 

2006

 

40

 

2613

 

Kingwood

 

TX

 

 

 —

 

 

3,035

 

 

32,388

 

 

 —

 

 

3,035

 

 

32,388

 

 

35,423

 

 

(275)

 

2016

 

37

 

1062

 

Lancaster               

 

TX

 

 

 —

 

 

172

 

 

2,692

 

 

1,119

 

 

185

 

 

3,733

 

 

3,918

 

 

(1,356)

 

2006

 

39

 

2195

 

Lancaster

 

TX

 

 

 —

 

 

 —

 

 

1,138

 

 

672

 

 

131

 

 

1,679

 

 

1,810

 

 

(282)

 

2006

 

39

 

0591

 

Lewisville              

 

TX

 

 

 —

 

 

561

 

 

8,043

 

 

1,544

 

 

561

 

 

9,398

 

 

9,959

 

 

(3,090)

 

2000

 

34

 

0144

 

Longview                

 

TX

 

 

 —

 

 

102

 

 

7,998

 

 

665

 

 

102

 

 

8,220

 

 

8,322

 

 

(4,055)

 

1992

 

45

 

 

135


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

 

    

Encumbrances at

    

 

 

    

Buildings and

    

 to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

State

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

0143

 

Lufkin                  

 

TX

 

 

 —

 

 

338

 

 

2,383

 

 

73

 

 

338

 

 

2,416

 

 

2,754

 

 

(1,174)

 

1992

 

45

 

0568

 

Mckinney                

 

TX

 

 

 —

 

 

541

 

 

6,217

 

 

1,636

 

 

541

 

 

7,160

 

 

7,701

 

 

(2,489)

 

2003

 

36

 

0569

 

Mckinney                

 

TX

 

 

 —

 

 

 —

 

 

636

 

 

8,082

 

 

 —

 

 

8,012

 

 

8,012

 

 

(2,565)

 

2003

 

40

 

1079

 

Nassau Bay

 

TX

 

 

 —

 

 

 —

 

 

8,942

 

 

1,198

 

 

 —

 

 

10,006

 

 

10,006

 

 

(2,915)

 

2006

 

40

 

0596

 

N Richland Hills

 

TX

 

 

 —

 

 

812

 

 

8,883

 

 

2,654

 

 

812

 

 

11,114

 

 

11,926

 

 

(3,453)

 

2000

 

37

 

2048

 

North Richland Hills       

 

TX

 

 

 —

 

 

1,385

 

 

10,213

 

 

2,105

 

 

1,400

 

 

12,304

 

 

13,704

 

 

(2,188)

 

2012

 

30

 

1048

 

Pearland                

 

TX

 

 

 —

 

 

 —

 

 

4,014

 

 

4,226

 

 

 —

 

 

7,835

 

 

7,835

 

 

(2,686)

 

2006

 

40

 

2232

 

Pearland

 

TX

 

 

 —

 

 

 —

 

 

3,375

 

 

11,932

 

 

 —

 

 

15,306

 

 

15,306

 

 

(263)

 

2014

 

*

 

0447

 

Plano                   

 

TX

 

 

 —

 

 

1,700

 

 

7,810

 

 

6,310

 

 

1,791

 

 

13,325

 

 

15,116

 

 

(5,751)

 

1999

 

20

 

0597

 

Plano                   

 

TX

 

 

 —

 

 

1,210

 

 

9,588

 

 

3,884

 

 

1,210

 

 

12,500

 

 

13,710

 

 

(4,049)

 

2000

 

34

 

0672

 

Plano                   

 

TX

 

 

 —

 

 

1,389

 

 

12,768

 

 

2,445

 

 

1,389

 

 

13,916

 

 

15,305

 

 

(4,025)

 

2002

 

36

 

1284

 

Plano                   

 

TX

 

 

 —

 

 

2,049

 

 

18,793

 

 

2,198

 

 

2,101

 

 

18,779

 

 

20,880

 

 

(6,705)

 

2006

 

40

 

1286

 

Plano

 

TX

 

 

 —

 

 

3,300

 

 

 —

 

 

 —

 

 

3,300

 

 

 —

 

 

3,300

 

 

 —

 

2006

 

**

 

0815

 

San Antonio             

 

TX

 

 

 —

 

 

 —

 

 

9,193

 

 

1,663

 

 

12

 

 

10,185

 

 

10,197

 

 

(3,237)

 

2006

 

35

 

0816

 

San Antonio             

 

TX

 

 

3,622

 

 

 —

 

 

8,699

 

 

2,822

 

 

174

 

 

10,739

 

 

10,913

 

 

(3,371)

 

2006

 

35

 

1591

 

San Antonio

 

TX

 

 

 —

 

 

 —

 

 

7,309

 

 

562

 

 

12

 

 

7,860

 

 

7,872

 

 

(1,780)

 

2010

 

30

 

1977

 

San Antonio

 

TX

 

 

 —

 

 

 —

 

 

26,191

 

 

1,141

 

 

 —

 

 

27,087

 

 

27,087

 

 

(5,616)

 

2011

 

30

 

2559

 

Shenandoah

 

TX

 

 

 —

 

 

 —

 

 

 —

 

 

19,550

 

 

 —

 

 

19,550

 

 

19,550

 

 

 —

 

2016

 

*

 

0598

 

Sugarland               

 

TX

 

 

 —

 

 

1,078

 

 

5,158

 

 

2,581

 

 

1,170

 

 

7,130

 

 

8,300

 

 

(2,538)

 

2000

 

34

 

0599

 

Texas City              

 

TX

 

 

 —

 

 

 —

 

 

9,519

 

 

157

 

 

 —

 

 

9,676

 

 

9,676

 

 

(2,763)

 

2000

 

37

 

0152

 

Victoria                

 

TX

 

 

 —

 

 

125

 

 

8,977

 

 

394

 

 

125

 

 

9,370

 

 

9,495

 

 

(4,580)

 

1994

 

45

 

2550

 

The Woodlands

 

TX

 

 

 —

 

 

115

 

 

5,141

 

 

 —

 

 

115

 

 

5,141

 

 

5,256

 

 

(242)

 

2015

 

35

 

2551

 

The Woodlands

 

TX

 

 

 —

 

 

296

 

 

18,282

 

 

 —

 

 

296

 

 

18,282

 

 

18,578

 

 

(741)

 

2015

 

40

 

2552

 

The Woodlands

 

TX

 

 

 —

 

 

374

 

 

25,125

 

 

 —

 

 

374

 

 

25,125

 

 

25,499

 

 

(908)

 

2015

 

45

 

1592

 

Bountiful

 

UT

 

 

 —

 

 

999

 

 

7,426

 

 

470

 

 

999

 

 

7,897

 

 

8,896

 

 

(1,658)

 

2010

 

30

 

0169

 

Bountiful               

 

UT

 

 

 —

 

 

276

 

 

5,237

 

 

1,272

 

 

348

 

 

6,052

 

 

6,400

 

 

(2,727)

 

1995

 

45

 

0346

 

Castle Dale             

 

UT

 

 

 —

 

 

50

 

 

1,818

 

 

73

 

 

50

 

 

1,891

 

 

1,941

 

 

(994)

 

1998

 

35

 

0347

 

Centerville             

 

UT

 

 

 —

 

 

300

 

 

1,288

 

 

191

 

 

300

 

 

1,309

 

 

1,609

 

 

(666)

 

1999

 

35

 

2035

 

Draper

 

UT

 

 

5,240

 

 

 —

 

 

10,803

 

 

161

 

 

 —

 

 

10,964

 

 

10,964

 

 

(1,262)

 

2012

 

45

 

0469

 

Kaysville               

 

UT

 

 

 —

 

 

530

 

 

4,493

 

 

226

 

 

530

 

 

4,719

 

 

5,249

 

 

(1,651)

 

2001

 

43

 

0456

 

Layton                  

 

UT

 

 

 —

 

 

371

 

 

7,073

 

 

1,208

 

 

389

 

 

8,023

 

 

8,412

 

 

(3,420)

 

2001

 

35

 

2042

 

Layton

 

UT

 

 

 —

 

 

 —

 

 

10,975

 

 

410

 

 

 —

 

 

11,385

 

 

11,385

 

 

(1,181)

 

2012

 

45

 

0359

 

Ogden                   

 

UT

 

 

 —

 

 

180

 

 

1,695

 

 

228

 

 

180

 

 

1,803

 

 

1,983

 

 

(906)

 

1999

 

35

 

1283

 

Ogden                   

 

UT

 

 

 —

 

 

106

 

 

4,464

 

 

696

 

 

106

 

 

4,205

 

 

4,311

 

 

(4,133)

 

2006

 

40

 

0357

 

Orem                    

 

UT

 

 

 —

 

 

337

 

 

8,744

 

 

1,827

 

 

306

 

 

8,312

 

 

8,618

 

 

(4,195)

 

1999

 

35

 

0371

 

Providence              

 

UT

 

 

 —

 

 

240

 

 

3,876

 

 

374

 

 

282

 

 

3,919

 

 

4,201

 

 

(1,912)

 

1999

 

35

 

0353

 

Salt Lake City          

 

UT

 

 

 —

 

 

190

 

 

779

 

 

164

 

 

201

 

 

921

 

 

1,122

 

 

(476)

 

1999

 

35

 

0354

 

Salt Lake City           

 

UT

 

 

 —

 

 

220

 

 

10,732

 

 

1,856

 

 

220

 

 

12,186

 

 

12,406

 

 

(6,249)

 

1999

 

35

 

0355

 

Salt Lake City          

 

UT

 

 

 —

 

 

180

 

 

14,792

 

 

2,162

 

 

180

 

 

16,429

 

 

16,609

 

 

(8,293)

 

1999

 

35

 

0467

 

Salt Lake City          

 

UT

 

 

 —

 

 

3,000

 

 

7,541

 

 

2,044

 

 

3,145

 

 

9,091

 

 

12,236

 

 

(3,396)

 

2001

 

38

 

0566

 

Salt Lake City          

 

UT

 

 

 —

 

 

509

 

 

4,044

 

 

1,686

 

 

509

 

 

5,317

 

 

5,826

 

 

(1,955)

 

2003

 

37

 

2041

 

Salt Lake City           

 

UT

 

 

 —

 

 

 —

 

 

12,326

 

 

161

 

 

 —

 

 

12,487

 

 

12,487

 

 

(1,353)

 

2012

 

45

 

2033

 

Sandy

 

UT

 

 

 —

 

 

867

 

 

3,513

 

 

757

 

 

1,122

 

 

4,015

 

 

5,137

 

 

(979)

 

2012

 

20

 

0482

 

Stansbury               

 

UT

 

 

 —

 

 

450

 

 

3,201

 

 

380

 

 

450

 

 

3,422

 

 

3,872

 

 

(1,256)

 

2001

 

45

 

0351

 

Washington Terrace         

 

UT

 

 

 —

 

 

 —

 

 

4,573

 

 

2,331

 

 

17

 

 

6,433

 

 

6,450

 

 

(3,478)

 

1999

 

35

 

0352

 

Washington Terrace         

 

UT

 

 

 —

 

 

 —

 

 

2,692

 

 

1,297

 

 

15

 

 

3,382

 

 

3,397

 

 

(1,569)

 

1999

 

35

 

2034

 

West Jordan

 

UT

 

 

 —

 

 

 —

 

 

12,021

 

 

56

 

 

 —

 

 

12,077

 

 

12,077

 

 

(1,288)

 

2012

 

45

 

2036

 

West Jordan

 

UT

 

 

753

 

 

 —

 

 

1,383

 

 

808

 

 

 —

 

 

2,190

 

 

2,190

 

 

(424)

 

2012

 

20

 

0495

 

West Valley City

 

UT

 

 

 —

 

 

410

 

 

8,266

 

 

1,002

 

 

410

 

 

9,268

 

 

9,678

 

 

(4,238)

 

2002

 

35

 

0349

 

West Valley City

 

UT

 

 

 —

 

 

1,070

 

 

17,463

 

 

128

 

 

1,036

 

 

17,581

 

 

18,617

 

 

(8,974)

 

1999

 

35

 

1208

 

Fairfax                 

 

VA

 

 

 —

 

 

8,396

 

 

16,710

 

 

6,594

 

 

8,494

 

 

22,607

 

 

31,101

 

 

(7,815)

 

2006

 

28

 

2230

 

Fredericksburg

 

VA

 

 

 —

 

 

1,101

 

 

8,570

 

 

 —

 

 

1,101

 

 

8,570

 

 

9,671

 

 

(592)

 

2014

 

40

 

0572

 

Reston

 

VA

 

 

 —

 

 

 —

 

 

11,902

 

 

575

 

 

 —

 

 

11,827

 

 

11,827

 

 

(4,244)

 

2003

 

43

 

0448

 

Renton                  

 

WA

 

 

 —

 

 

 —

 

 

18,724

 

 

2,211

 

 

 —

 

 

19,685

 

 

19,685

 

 

(9,485)

 

1999

 

35

 

0781

 

Seattle                 

 

WA

 

 

 —

 

 

 —

 

 

52,703

 

 

15,124

 

 

 —

 

 

63,876

 

 

63,876

 

 

(20,187)

 

2004

 

39

 

0782

 

Seattle                 

 

WA

 

 

 —

 

 

 —

 

 

24,382

 

 

12,330

 

 

126

 

 

34,970

 

 

35,096

 

 

(12,005)

 

2004

 

36

 

0783

 

Seattle                 

 

WA

 

 

 —

 

 

 —

 

 

5,625

 

 

1,318

 

 

183

 

 

6,633

 

 

6,816

 

 

(6,208)

 

2004

 

10

 

0785

 

Seattle                 

 

WA

 

 

 —

 

 

 —

 

 

7,293

 

 

4,796

 

 

 —

 

 

10,875

 

 

10,875

 

 

(3,710)

 

2004

 

33

 

1385

 

Seattle                 

 

WA

 

 

 —

 

 

 —

 

 

45,027

 

 

3,450

 

 

 —

 

 

48,299

 

 

48,299

 

 

(13,505)

 

2007

 

30

 

2038

 

Evanston

 

WY

 

 

 —

 

 

 —

 

 

4,601

 

 

9

 

 

 —

 

 

4,610

 

 

4,610

 

 

(555)

 

2012

 

40

 

 

 

 

 

 

 

$

9,615

 

$

257,661

 

$

2,641,298

 

$

674,982

 

$

265,244

 

$

3,180,514

 

$

3,445,758

 

$

(827,741)

 

 

 

 

 

Other non-reportable segments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other-Hospitals

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0126

 

Sherwood

 

AR

 

 

 —

 

 

709

 

 

9,604

 

 

709

 

 

709

 

 

9,587

 

 

10,296

 

 

(5,517)

 

1989

 

45

 

0113

 

Glendale

 

AZ

 

 

 —

 

 

1,565

 

 

7,050

 

 

1,565

 

 

1,565

 

 

7,050

 

 

8,615

 

 

(4,130)

 

1988

 

45

 

1038

 

Fresno

 

CA

 

 

 —

 

 

3,652

 

 

29,113

 

 

3,652

 

 

3,652

 

 

51,048

 

 

54,700

 

 

(15,131)

 

2006

 

40

 

0423

 

Irvine

 

CA

 

 

 —

 

 

18,000

 

 

70,800

 

 

18,000

 

 

18,000

 

 

70,800

 

 

88,800

 

 

(34,732)

 

1999

 

35

 

0127

 

Colorado Springs

 

CO

 

 

 —

 

 

690

 

 

8,338

 

 

690

 

 

690

 

 

8,338

 

 

9,028

 

 

(4,780)

 

1989

 

45

 

0887

 

Atlanta

 

GA

 

 

 —

 

 

4,300

 

 

13,690

 

 

4,300

 

 

4,300

 

 

11,890

 

 

16,190

 

 

(5,846)

 

2007

 

40

 

0112

 

Overland Park

 

KS

 

 

 —

 

 

2,316

 

 

10,681

 

 

2,316

 

 

2,316

 

 

10,680

 

 

12,996

 

 

(6,481)

 

1988

 

45

 

1383

 

Baton Rouge

 

LA

 

 

 —

 

 

690

 

 

8,545

 

 

690

 

 

690

 

 

8,496

 

 

9,186

 

 

(3,621)

 

2007

 

40

 

2031

 

Slidell

 

LA

 

 

 —

 

 

3,000

 

 

 —

 

 

3,000

 

 

3,000

 

 

643

 

 

3,643

 

 

 —

 

2012

 

**

 

0886

 

Dallas

 

TX

 

 

 —

 

 

1,820

 

 

8,508

 

 

1,820

 

 

1,820

 

 

7,454

 

 

9,274

 

 

(1,832)

 

2007

 

40

 

1319

 

Dallas

 

TX

 

 

 —

 

 

18,840

 

 

155,659

 

 

18,840

 

 

18,840

 

 

157,084

 

 

175,924

 

 

(43,809)

 

2007

 

35

 

1384

 

Plano

 

TX

 

 

 —

 

 

6,290

 

 

22,686

 

 

6,290

 

 

6,290

 

 

28,202

 

 

34,492

 

 

(11,476)

 

2007

 

25

 

2198

 

Webster

 

TX

 

 

 —

 

 

2,220

 

 

9,602

 

 

2,220

 

 

2,220

 

 

9,602

 

 

11,822

 

 

(1,415)

 

2013

 

35

 

Other-Post-acute/skilled nursing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2469

 

Rural Retreat

 

VA

 

 

 —

 

 

1,876

 

 

14,720

 

 

1,876

 

 

1,876

 

 

14,720

 

 

16,596

 

 

(509)

 

2013

 

35

 

Other-United Kingdom

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2210

 

Adlington

 

EG

 

 

 —

 

 

500

 

 

6,492

 

 

594

 

 

594

 

 

8,180

 

 

8,774

 

 

(469)

 

2014

 

45

 

2211

 

Adlington

 

EG

 

 

 —

 

 

519

 

 

3,944

 

 

519

 

 

519

 

 

3,944

 

 

4,463

 

 

(237)

 

2014

 

60

 

2216

 

Alderley Edge

 

EG

 

 

 —

 

 

1,143

 

 

7,963

 

 

1,143

 

 

1,143

 

 

7,963

 

 

9,106

 

 

(432)

 

2014

 

60

 

2217

 

Alderley Edge

 

EG

 

 

 —

 

 

1,112

 

 

6,236

 

 

1,112

 

 

1,112

 

 

6,236

 

 

7,348

 

 

(355)

 

2014

 

60

 

2340

 

Altrincham

 

EG

 

 

 —

 

 

1,594

 

 

17,073

 

 

1,594

 

 

1,594

 

 

17,073

 

 

18,667

 

 

(652)

 

2015

 

45

 

2312

 

Armley

 

EG

 

 

 —

 

 

408

 

 

2,439

 

 

408

 

 

408

 

 

2,439

 

 

2,847

 

 

(162)

 

2015

 

45

 

2313

 

Armley

 

EG

 

 

 —

 

 

914

 

 

2,844

 

 

914

 

 

914

 

 

2,844

 

 

3,758

 

 

(195)

 

2015

 

45

 

2309

 

Ashton under Lyne

 

EG

 

 

 —

 

 

593

 

 

4,116

 

 

593

 

 

593

 

 

4,116

 

 

4,709

 

 

(274)

 

2015

 

40

 

2206

 

Bangor

 

EG

 

 

 —

 

 

352

 

 

1,885

 

 

352

 

 

352

 

 

1,885

 

 

2,237

 

 

(140)

 

2014

 

50

 

2207

 

Batley

 

EG

 

 

 —

 

 

593

 

 

2,925

 

 

593

 

 

593

 

 

2,925

 

 

3,518

 

 

(299)

 

2014

 

45

 

2336

 

Birmingham

 

EG

 

 

 —

 

 

618

 

 

2,238

 

 

618

 

 

618

 

 

2,787

 

 

3,405

 

 

(263)

 

2015

 

45

 

2320

 

Bishopbriggs

 

EG

 

 

 —

 

 

828

 

 

3,805

 

 

828

 

 

828

 

 

3,804

 

 

4,632

 

 

(263)

 

2015

 

40

 

2323

 

Bonnyrigg

 

EG

 

 

 —

 

 

865

 

 

5,698

 

 

865

 

 

865

 

 

5,697

 

 

6,562

 

 

(374)

 

2015

 

40

 

2335

 

Cardiff

 

EG

 

 

 —

 

 

1,310

 

 

4,418

 

 

1,310

 

 

1,310

 

 

5,097

 

 

6,407

 

 

(393)

 

2015

 

45

 

2223

 

Catterick Garrison

 

EG

 

 

 —

 

 

729

 

 

1,340

 

 

729

 

 

729

 

 

1,340

 

 

2,069

 

 

(194)

 

2014

 

50

 

2226

 

Christleton

 

EG

 

 

 —

 

 

482

 

 

4,661

 

 

482

 

 

482

 

 

4,661

 

 

5,143

 

 

(250)

 

2014

 

50

 

2327

 

Croydon

 

EG

 

 

 —

 

 

1,458

 

 

2,278

 

 

1,458

 

 

1,458

 

 

2,293

 

 

3,751

 

 

(170)

 

2015

 

45

 

2221

 

Disley

 

EG

 

 

 —

 

 

315

 

 

1,480

 

 

315

 

 

315

 

 

1,480

 

 

1,795

 

 

(115)

 

2014

 

50

 

2227

 

Disley

 

EG

 

 

 —

 

 

630

 

 

3,620

 

 

630

 

 

630

 

 

3,620

 

 

4,250

 

 

(199)

 

2014

 

60

 

2306

 

Dukinfield

 

EG

 

 

 —

 

 

692

 

 

3,702

 

 

692

 

 

692

 

 

3,702

 

 

4,394

 

 

(240)

 

2015

 

40

 

2316

 

Dukinfield

 

EG

 

 

 —

 

 

358

 

 

2,275

 

 

358

 

 

358

 

 

2,275

 

 

2,633

 

 

(137)

 

2015

 

50

 

2317

 

Dukinfield

 

EG

 

 

 —

 

 

482

 

 

2,567

 

 

482

 

 

482

 

 

2,568

 

 

3,050

 

 

(180)

 

2015

 

40

 

2318

 

Dumbarton

 

EG

 

 

 —

 

 

840

 

 

3,493

 

 

840

 

 

840

 

 

3,494

 

 

4,334

 

 

(249)

 

2015

 

40

 

2303

 

Eckington

 

EG

 

 

 —

 

 

457

 

 

1,496

 

 

457

 

 

457

 

 

1,496

 

 

1,953

 

 

(124)

 

2015

 

40

 

2333

 

Edinburgh

 

EG

 

 

 —

 

 

4,140

 

 

22,043

 

 

4,140

 

 

4,140

 

 

22,552

 

 

26,692

 

 

(1,371)

 

2015

 

40

 

2208

 

Elstead

 

EG

 

 

 —

 

 

816

 

 

2,795

 

 

816

 

 

815

 

 

2,796

 

 

3,611

 

 

(228)

 

2014

 

45

 

2328

 

Forfar

 

EG

 

 

 —

 

 

779

 

 

5,662

 

 

779

 

 

778

 

 

6,052

 

 

6,830

 

 

(399)

 

2015

 

40

 

2214

 

Gilroyd

 

EG

 

 

 —

 

 

911

 

 

1,544

 

 

911

 

 

911

 

 

1,544

 

 

2,455

 

 

(212)

 

2014

 

50

 

2330

 

Glasgow

 

EG

 

 

 —

 

 

1,693

 

 

6,069

 

 

1,693

 

 

1,693

 

 

7,172

 

 

8,865

 

 

(567)

 

2015

 

40

 

2307

 

Hyde

 

EG

 

 

 —

 

 

1,273

 

 

4,698

 

 

1,273

 

 

1,273

 

 

4,699

 

 

5,972

 

 

(338)

 

2015

 

45

 

2324

 

Lewisham

 

EG

 

 

 —

 

 

1,755

 

 

6,497

 

 

1,755

 

 

1,755

 

 

7,048

 

 

8,803

 

 

(501)

 

2015

 

40

 

2332

 

Linlithgow

 

EG

 

 

 —

 

 

1,322

 

 

6,790

 

 

1,322

 

 

1,322

 

 

7,337

 

 

8,659

 

 

(494)

 

2015

 

40

 

2213

 

Ilkley

 

EG

 

 

 —

 

 

871

 

 

2,300

 

 

871

 

 

871

 

 

2,299

 

 

3,170

 

 

(265)

 

2014

 

45

 

2209

 

Kingswood

 

EG

 

 

 —

 

 

952

 

 

3,547

 

 

952

 

 

952

 

 

3,547

 

 

4,499

 

 

(267)

 

2014

 

45

 

2212

 

Kirk Hammerton

 

EG

 

 

 —

 

 

400

 

 

512

 

 

400

 

 

400

 

 

512

 

 

912

 

 

(86)

 

2014

 

50

 

2310

 

Kirkby

 

EG

 

 

 —

 

 

519

 

 

2,477

 

 

519

 

 

519

 

 

2,477

 

 

2,996

 

 

(175)

 

2015

 

40

 

136


 

Table of Contents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life on Which

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Capitalized

 

Gross Amount at Which Carried

 

 

 

 

 

 

Depreciation in

 

 

 

 

 

 

 

 

 

 

Initial Cost to Company

 

Subsequent

 

As of December 31, 2016

 

 

 

 

Year

 

Latest Income

 

 

    

    

    

 

    

Encumbrances at

    

 

 

    

Buildings and

    

 to

    

 

 

    

Buildings and

    

 

 

    

Accumulated

    

Acquired/

    

Statement is

 

City

 

 

 

State

 

December 31, 2016

 

Land

 

Improvements

 

Acquisition

 

Land

 

Improvements

 

Total(1)

 

Depreciation

 

Constructed

 

Computed

 

2304

 

Knotty Ash

 

EG

 

 

 —

 

 

593

 

 

2,077

 

 

593

 

 

593

 

 

2,077

 

 

2,670

 

 

(157)

 

2015

 

40

 

2322

 

Laindon

 

EG

 

 

 —

 

 

1,088

 

 

2,531

 

 

1,088

 

 

1,088

 

 

2,531

 

 

3,619

 

 

(191)

 

2015

 

40

 

2215

 

Leeds

 

EG

 

 

 —

 

 

460

 

 

726

 

 

460

 

 

460

 

 

727

 

 

1,187

 

 

(129)

 

2014

 

45

 

2326

 

Limehouse

 

EG

 

 

 —

 

 

2,027

 

 

2,894

 

 

2,027

 

 

2,027

 

 

2,915

 

 

4,942

 

 

(235)

 

2015

 

40

 

2321

 

Luton

 

EG

 

 

 —

 

 

976

 

 

2,894

 

 

976

 

 

976

 

 

2,895

 

 

3,871

 

 

(195)

 

2015

 

40

 

2339

 

Manchester

 

EG

 

 

 —

 

 

1,539

 

 

13,824

 

 

1,539

 

 

1,539

 

 

13,824

 

 

15,363

 

 

(538)

 

2015

 

45

 

2225

 

N Wadebridge

 

EG

 

 

 —

 

 

272

 

 

5,625

 

 

272

 

 

271

 

 

5,625

 

 

5,896

 

 

(341)

 

2014

 

50

 

2331

 

Paisley

 

EG

 

 

 —

 

 

1,125

 

 

3,649

 

 

1,125

 

 

1,125

 

 

3,660

 

 

4,785

 

 

(256)

 

2015

 

40

 

2308

 

Prescot

 

EG

 

 

 —

 

 

494

 

 

1,766

 

 

494

 

 

494

 

 

1,767

 

 

2,261

 

 

(144)

 

2015

 

40

 

2305

 

Prescot

 

EG

 

 

 —

 

 

581

 

 

2,176

 

 

581

 

 

581

 

 

2,175

 

 

2,756

 

 

(165)

 

2015

 

40

 

2219

 

Ripon

 

EG

 

 

 —

 

 

173

 

 

827

 

 

173

 

 

173

 

 

827

 

 

1,000

 

 

(85)

 

2014

 

45

 

2319

 

Sheffield

 

EG

 

 

 —

 

 

680

 

 

2,470

 

 

680

 

 

680

 

 

2,470

 

 

3,150

 

 

(176)

 

2015

 

40

 

2314

 

Stalybridge

 

EG

 

 

 —

 

 

643

 

 

3,295

 

 

643

 

 

643

 

 

3,295

 

 

3,938

 

 

(221)

 

2015

 

40

 

2315

 

Stalybridge

 

EG

 

 

 —

 

 

507

 

 

1,723

 

 

507

 

 

507

 

 

1,723

 

 

2,230

 

 

(123)

 

2015

 

50

 

2218

 

Stapeley

 

EG

 

 

 —

 

 

908

 

 

5,928

 

 

908

 

 

908

 

 

5,928

 

 

6,836

 

 

(374)

 

2014

 

60

 

2325

 

Stirling

 

EG

 

 

 —

 

 

828

 

 

4,502

 

 

828

 

 

828

 

 

4,914

 

 

5,742

 

 

(339)

 

2015

 

40

 

2329

 

Stirling

 

EG

 

 

 —

 

 

1,013

 

 

3,691

 

 

1,013

 

 

1,013

 

 

4,281

 

 

5,294

 

 

(344)

 

2015

 

40

 

2224

 

Stockton-on-Tees

 

EG

 

 

 —

 

 

267

 

 

1,905

 

 

267

 

 

267

 

 

1,905

 

 

2,172

 

 

(158)

 

2014

 

50

 

2220

 

Thornton-Cleveleys

 

EG

 

 

 —

 

 

834

 

 

4,170

 

 

834

 

 

834

 

 

4,171

 

 

5,005

 

 

(317)

 

2014

 

50

 

2228

 

Upper Wortley

 

EG

 

 

 —

 

 

415

 

 

3,074

 

 

415

 

 

414

 

 

3,074

 

 

3,488

 

 

(209)

 

2014

 

50

 

2311

 

Wigan

 

EG

 

 

 —

 

 

655

 

 

2,430

 

 

655

 

 

654

 

 

2,429

 

 

3,083

 

 

(213)

 

2015

 

40

 

2337

 

Wigan

 

EG

 

 

 —

 

 

494

 

 

1,662

 

 

494

 

 

493

 

 

1,676

 

 

2,169

 

 

(142)

 

2015

 

40

 

2338

 

Wigan

 

EG

 

 

 —

 

 

433

 

 

3,460

 

 

433

 

 

432

 

 

3,481

 

 

3,913

 

 

(229)

 

2015

 

40

 

2222

 

Woolmer Green

 

EG

 

 

 —

 

 

760

 

 

5,536

 

 

760

 

 

760

 

 

5,536

 

 

6,296

 

 

(380)

 

2014

 

50

 

2334

 

Wotton under Edge

 

EG

 

 

 —

 

 

581

 

 

2,275

 

 

581

 

 

581

 

 

2,424

 

 

3,005

 

 

(208)

 

2015

 

40

 

 

 

 

 

 

 

$

 —

 

$

117,537

 

$

618,028

 

$

117,631

 

$

117,624

 

$

651,878

 

$

769,502

 

$

(156,417)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total operations properties

 

 

 

 

 

$

624,598

 

$

1,870,192

 

$

10,369,449

 

$

2,313,407

 

$

1,881,487

 

$

12,093,091

 

$

13,974,578

 

$

(2,648,841)

 

 

 

 

 

Corporate and other assets

 

 

 

 

 

 

(806)

 

 

 —

 

 

 —

 

 

338

 

 

 —

 

 

182

 

 

182

 

 

(89)

 

 

 

 

 

Total

 

 

 

 

 

$

623,792

 

$

1,870,192

 

$

10,369,449

 

$

2,313,745

 

$

1,881,487

 

$

12,093,273

 

$

13,974,760

 

$

(2,648,930)

 

 

 

 

 


 

 

*

Property is in development and not yet placed in service or taken out of service and placed in redevelopment.

**

Represents land parcels which are not depreciated.

(1)

At December 31, 2016, the tax basis of the Company’s net real estate assets is less than the reported amounts by $1.2 billion (unaudited).

(b)

A summary of activity for real estate and accumulated depreciation follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31,

 

 

 

2016

 

2015

 

2014

 

Real estate:

 

    

 

    

 

    

    

 

    

 

Balances at beginning of year

 

$

14,330,257

 

$

12,931,832

 

$

12,592,841

 

Acquisition of real estate and development and improvements

 

 

987,135

 

 

1,930,931

 

 

756,043

 

Disposition of real estate

 

 

(577,799)

 

 

(121,374)

 

 

(169,311)

 

Impairments

 

 

 —

 

 

(3,118)

 

 

 —

 

Balances associated with changes in reporting presentation(1)

 

 

(764,833)

 

 

(408,014)

 

 

(247,741)

 

Balances at end of year

 

$

13,974,760

 

$

14,330,257

 

$

12,931,832

 

Accumulated depreciation:

 

 

 

 

 

 

 

 

 

 

Balances at beginning of year

 

$

2,476,015

 

$

2,190,486

 

$

1,965,592

 

Depreciation expense

 

 

465,945

 

 

418,591

 

 

384,019

 

Disposition of real estate

 

 

(109,949)

 

 

(17,251)

 

 

(55,745)

 

Balances associated with changes in reporting presentation(1)

 

 

(183,081)

 

 

(115,811)

 

 

(103,380)

 

Balances at end of year

 

$

2,648,930

 

$

2,476,015

 

$

2,190,486

 


(1)

The balances associated with changes in reporting presentation represent real estate and accumulated depreciation related to fully depreciated assets written off, properties placed into discontinued operations or where the lease classification has changed to direct financing leases.

 

(a) 2.Exhibits

 

See the Exhibit Index immediately following the signature page of this Annual Report on Form 10-K.

 

 

137


 

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: February 13, 2017

 

HCP, Inc. (Registrant)

 

 

 

/s/ THOMAS M. HERZOG

 

Thomas M. Herzog,

 

Chief Executive Officer

(Principal Executive Officer and

Principal Financial Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature

 

Title

 

Date

 

 

 

 

 

 

 

 

 

 

/s/ MICHAEL D. MCKEE

 

Executive Chairman of the Board

 

February 13, 2017

Michael D. McKee

 

 

 

 

 

 

 

 

 

/s/ THOMAS M. HERZOG

 

Chief Executive Officer

 

February 13, 2017

Thomas M. Herzog

 

(Principal Executive Officer and Principal Financial Officer), Director

 

 

 

 

 

 

 

/s/ Scott A. Anderson

 

Executive Vice President and Chief

 

February 13, 2017

Scott A. Anderson

 

Accounting Officer (Principal Accounting Officer)

 

 

 

 

 

 

 

/s/ Brian G. Cartwright

 

Director

 

February 13, 2017

Brian G. Cartwright

 

 

 

 

 

 

 

 

 

/s/ Christine N. Garvey

 

Director

 

February 13, 2017

Christine N. Garvey

 

 

 

 

 

 

 

 

 

/s/ David B. Henry

 

Director

 

February 13, 2017

David B. Henry

 

 

 

 

 

 

 

 

 

/s/ James P. Hoffmann

 

Director

 

February 13, 2017

James P. Hoffmann

 

 

 

 

 

 

 

 

 

/s/ Peter L. Rhein

 

Director

 

February 13, 2017

Peter L. Rhein

 

 

 

 

 

 

 

 

 

/s/ Joseph P. Sullivan

 

Director

 

February 13, 2017

Joseph P. Sullivan

 

 

 

 

 

138


 

Table of Contents

EXHIBIT INDEX

 

 

 

 

 

 

 

 

Exhibit

 

 

 

Incorporated by reference herein

Number

   

Description

   

Form

   

Date Filed

2.1

 

Purchase and Sale Agreement, dated as of October 16, 2012, by and among BRE/SW Portfolio LLC, those owner entities listed on Schedule 1 thereto, HCP, Inc. and Emeritus Corporation; and First Amendment to such Purchase and Sale Agreement, by and among such parties, dated as of December 4, 2012.***

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

May 2, 2013

2.2

 

Master Contribution and Transactions Agreement, dated April 23, 2014, by and between HCP, Inc. and Brookdale Senior Living Inc.***

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

2.3

 

Separation and Distribution Agreement, dated October 31, 2016, by and between HCP and Quality Care Properties, Inc.

 

Current Report on Form 8-K

(File No. 001-08895)

 

October 31, 2016

3.1

 

Articles of Restatement of HCP.

 

Registration Statement on Form S‑3 (Registration No. 333‑182824)

 

July 24, 2012

3.2

 

Fifth Amended and Restated Bylaws of HCP.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

February 11, 2015

3.3

 

Amendment No. 1 to Fifth Amended and Restated Bylaws of HCP.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

February 1, 2016

4.1

 

Indenture, dated as of September 1, 1993, between HCP and The Bank of New York, as Trustee.

 

Registration Statement on Form S‑3/A (Registration No. 333‑86654)

 

May 21, 2002

4.1.1

 

First Supplemental Indenture dated as of January 24, 2011, to the Indenture, dated as of September 1, 1993, by and between HCP and The Bank of New York Mellon Trust Company, N.A., as Trustee.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

January 24, 2011

4.2

 

Indenture, dated November 19, 2012, between HCP and The Bank of New York Mellon Trust Company, N.A., as trustee.

 

Current Report on Form 8‑K

(File No. 001‑ 08895)

 

November 19, 2012

4.2.1

 

First Supplemental Indenture, dated November 19, 2012, between HCP and The Bank of New York Mellon Trust Company, N.A., as trustee.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

November 19, 2012

4.2.2

 

Second Supplemental Indenture, dated November 12, 2013, between HCP and The Bank of New York Mellon Trust Company, N.A., as trustee.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

November 13, 2013

4.2.3

 

Third Supplemental Indenture dated February 21, 2014, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

February 24, 2014

4.2.4

 

Fourth Supplemental Indenture, dated August 14,  2014, between HCP and The Bank of New York Mellon Trust Company, N.A., as trustee.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

August 14, 2014

4.2.5

 

Fifth Supplemental Indenture, dated January 21, 2015, between HCP and The Bank of New York Mellon Trust Company, N.A., as trustee.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

January 21, 2015

139


 

Table of Contents

Exhibit

 

 

 

Incorporated by reference herein

Number

   

Description

   

Form

   

Date Filed

4.2.6

 

Sixth Supplemental Indenture, dated May 20, 2015, between HCP and The Bank of New York Mellon Trust Company, N.A., as trustee.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

May 20, 2015

4.2.7

 

Seventh Supplemental Indenture dated December 1, 2015, between HCP and The Bank of New York Mellon Trust Company, N.A., as trustee.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

December 1, 2015

4.3

 

Form of Fixed Rate Global Medium‑Term Note.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

November 20, 2003

4.4

 

Form of Floating Rate Global Medium‑Term Note.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

November 20, 2003

4.5

 

Form of Fixed Rate Global Medium‑Term Note.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

February 17, 2006

4.6

 

Form of Floating Rate Global Medium‑Term Note.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

February 17, 2006

4.7

 

Officers’ Certificate, dated April 22, 2005, pursuant to Section 301 of the Indenture, dated as of September 1, 1993, by and between HCP and The Bank of New York, as Trustee, establishing a series of securities entitled “55/8% Senior Notes due May 1, 2017”.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

April 27, 2005

4.8

 

Officers’ Certificate, dated February 17, 2006, pursuant to Section 301 of the Indenture, dated as of September 1, 1993, by and between HCP and The Bank of New York, as trustee, setting forth the terms of HCP’s Fixed Rate Medium‑Term Notes and Floating Rate Medium‑Term Notes.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

February 17, 2006

4.9

 

Form of 3.75% Senior Notes due 2019.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

January 23, 2012

4.10

 

Form of 3.15% Senior Notes due 2022.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

July 23, 2012

4.11

 

Form of 2.625% Senior Notes due 2020.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

November 19, 2012

4.12

 

Form of 4.250% Senior Notes due 2023.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

November 13, 2013

4.13

 

Form of 4.20% Senior Notes due 2024.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

February 24, 2014

4.14

 

Form of 3.875% Senior Notes due 2024.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

August 14, 2014

4.15

 

Form of 3.400% Senior Notes due 2025.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

January 21, 2015

4.16

 

Form of 4.000% Senior Notes due 2025.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

May 20, 2015

4.17

 

Form of 4.000% Senior Notes due 2022.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

December 1, 2015

10.1

 

Second Amended and Restated Director Deferred Compensation Plan.*

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

November 3, 2009

 

140


 

Table of Contents

Exhibit

 

 

 

Incorporated by reference herein

Number

   

Description

   

Form

   

Date Filed

10.2

 

Amended and Restated Executive Retirement Plan, effective as of May 7, 2003.*

 

Annual Report on Form 10‑K

(File No. 001‑08895)

 

March 15, 2004

10.3

 

2006 Performance Incentive Plan, as amended and restated.*

 

Annex 2 to HCP’s Proxy Statement

(File No. 001‑08895)

 

March 10, 2009

10.3.1

 

Form of Employee 2006 Performance Incentive Plan Performance Restricted Stock Unit Agreement with five‑year installment vesting.*

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

April 28, 2009

10.3.2

 

Form of Director 2006 Performance Incentive Plan Director Stock Unit Award Agreement with four‑year installment vesting.*

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

August 4, 2009

10.3.3

 

HCP, Inc. Terms and Conditions Applicable to Restricted Stock Unit Awards Granted Under the 2006 Performance Incentive Plan.*

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

May 3, 2011

10.3.4

 

Form of Employee 2006 Performance Incentive Plan Nonqualified Stock Option Agreement.*

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

May 1, 2012

10.3.5

 

Form of Employee 2006 Performance Incentive Plan Performance‑Based Restricted Stock Unit Agreement.*

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

May 1, 2012

10.3.6

 

Form of Employee 2006 Performance Incentive Plan Time‑Based Restricted Stock Unit Agreement.*

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

May 1, 2012

10.3.7

 

Restricted Stock Unit Award Agreement, dated as of October 3, 2013, by and between HCP and Timothy M. Schoen.*

 

Quarterly Report on Form 10‑Q

(File 001‑ 08895)

 

November 4, 2013

10.3.8

 

Amended 2013 Restricted Stock Award Agreement, dated as of December 20, 2013, by and between HCP and Lauralee E. Martin.*

 

Annual Report on Form 10‑K

(File No. 001‑08895)

 

February 11, 2014

10.3.9

 

HCP Executive Severance Plan

 

Quarterly Report on Form 10-Q

(File No. 001-08895)

 

November 1, 2016

10.4

 

HCP, Inc. 2014 Performance Incentive Plan.*

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

May 6, 2014

10.4.1

 

Form of 2014 Performance Incentive Plan Non-Employee Director Restricted Stock Unit Award Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.2

 

Form of 2014 Performance Incentive Plan CEO Annual LTIP Restricted Stock Unit Award Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.3

 

Form of 2014 Performance Incentive Plan CEO Annual LTIP Option Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.4

 

Form of 2014 Performance Incentive Plan CEO 3-Year LTIP Restricted Stock Unit Award Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.5

 

Form of 2014 Performance Incentive Plan NEO Annual LTIP Restricted Stock Unit Award Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.6

 

Form of 2014 Performance Incentive Plan NEO Annual LTIP Option Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.7

 

Form of 2014 Performance Incentive Plan NEO 3-Year LTIP Restricted Stock Unit Award Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

141


 

Table of Contents

Exhibit

 

 

 

Incorporated by reference herein

Number

   

Description

   

Form

   

Date Filed

10.4.8

 

Form of 2014 Performance Incentive Plan Non-NEO Restricted Stock Unit Award Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.9

 

Form of 2014 Performance Incentive Plan Non-NEO Option Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.10

 

Form of 2014 Performance Incentive Plan Non-Employee Directors Stock-for-Fees Program.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.4.11

 

Form of CEO 3-Year LTIP RSU Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

May 5, 2015

10.4.12

 

Form of CEO 1-Year LTIP RSU Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

May 5, 2015

10.4.13

 

Form of CEO Retentive LTIP RSU Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

May 5, 2015

10.4.14

 

Form of NEO 3-Year LTIP RSU Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

May 9, 2015

10.4.15

 

Form of  NEO 1-Year LTIP RSU Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

May 5, 2015

10.4.16

 

Form of NEO Retentive LTIP RSU Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

May 9, 2015

10.4.17

 

Form of Non-Employee Director RSU Agreement.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

May 5, 2015

10.5

 

Change in Control Severance Plan.*

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

October 30, 2012

10.5.1

 

HCP Change in Control Severance Plan (as Amended and Restated as of May 6, 2016).*

 

Quarterly Report on Form 10-Q (File No. 001 08895)

 

November 1, 2016

10.6

 

Amended and Restated Dividend Reinvestment and Stock Purchase Plan, amended as of July 25, 2012.

 

Registration Statement on Form S‑3

(Registration No. 333‑182824)

 

July 24, 2012 and as supplemented on July 25, 2012

10.7

 

Amended and Restated Dividend Reinvestment and Stock Purchase Plan, amended as of June 26, 2015.

 

Registration Statement on Form S‑3

(Registration No. 333‑205241)

 

June 26, 2015 and as supplemented on June 26, 2015

10.8

 

Form of Directors and Officers Indemnification Agreement.*

 

Annual Report on Form 10‑K, as amended (File No. 001‑08895)

 

February 12, 2008

10.9

 

Employment Agreement, dated as of January 26, 2012, by and between HCP and Paul F. Gallagher.*

 

Current Report on Form 8‑K

(File 001‑08895)

 

February 1, 2012

10.10

 

Employment Agreement, dated as of January 26, 2012, by and between HCP and Timothy M. Schoen.*

 

Current Report on Form 8‑K

(File 001‑08895)

 

February 1, 2012

10.10.1

 

Amendment No. 1, dated as of April 5, 2013, to the Employment Agreement, dated as of January 26, 2012, by and between HCP and Timothy M. Schoen.*

 

Current Report on Form 8‑K

(File 001‑08895)

 

April 5, 2013

10.10.2

 

Term Sheet Amendment to Employment Agreement, dated as of October 3, 2013, by and between HCP and Timothy M. Schoen.*

 

Current Report on Form 8‑K

(File 001‑ 08895)

 

October 3, 2013

10.10.3

 

Amendment No. 2, dated as of October 31, 2013, to the Employment Agreement, dated as of January 26, 2012, by and between HCP and Timothy M. Schoen.*

 

Quarterly Report on Form 10‑Q

(File 001‑08895)

 

November 4, 2013

 

142


 

Table of Contents

Exhibit

 

 

 

Incorporated by reference herein

Number

   

Description

   

Form

   

Date Filed

10.11

 

Employment Agreement, dated as of October 2, 2013, by and between HCP and Lauralee E. Martin.*

 

Current Report on Form 8‑K

(File 001‑08895)

 

October 3, 2013

10.12

 

Employment Agreement, effective as of September 8, 2015, by and between HCP and J. Justin Hutchens.*

 

Quarterly Report on Form 10‑Q

(File 001‑08895)

 

November 3, 2015

10.12.1

 

Amendment No. 1 to Employment Agreement, dated as of September 1, 2015, by and between HCP and J. Justin Hutchens.*

 

Quarterly Report on Form 10‑Q

(File 001‑08895)

 

November 3, 2015

10.13

 

Amended and Restated Limited Liability Company Agreement of HCPI/Utah, LLC, dated as of January 20, 1999.

 

Annual Report on Form 10‑K

(File No. 001‑ 08895)

 

March 29, 1999

10.14

 

Amended and Restated Limited Liability Company Agreement of HCPI/Utah II, LLC, dated as of August 17, 2001, as amended.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

November 9, 2012

10.15

 

Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, dated as of October 2, 2003.

 

Quarterly Report on Form 10‑Q

(File No. 001‑ 08895)

 

November 12, 2003

10.15.1

 

Amendment No. 1 to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, dated as of September 29, 2004.

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

November 8, 2004

10.15.2

 

Amendment No. 2 to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, dated as of October 29, 2004.

 

Annual Report on Form 10‑K

(File No. 001‑08895)

 

March 15, 2005

10.15.3

 

Amendment No. 3 to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC and New Member Joinder Agreement, dated as of October 19, 2005, by and among HCP, HCPI/Tennessee, LLC and A. Daniel Weyland.

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

November 1, 2005

10.15.4

 

Amendment No. 4 to Amended and Restated Limited Liability Company Agreement of HCPI/Tennessee, LLC, effective as of January 1, 2007.

 

Annual Report on Form 10‑K, as amended (File No. 001‑08895)

 

February 12, 2008

10.16

 

Amended and Restated Limited Liability Company Agreement of HCP DR California II, LLC, dated as of June 1, 2014.

 

Quarterly Report on Form 10-Q

(File No. 001‑08895)

 

August 5, 2014

10.17

 

Credit Agreement, dated March 11, 2011, by and among HCP, as borrower, the lenders referred to therein, and Bank of America, N.A., as administrative agent.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

March 15, 2011

10.17.1

 

Amendment No. 1 to Credit Agreement, dated March 27, 2012, by and among HCP, as borrower, the lenders referred to therein and Bank of America, N.A., as administrative agent.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

March 29, 2012

143


 

Table of Contents

Exhibit

 

 

 

Incorporated by reference herein

Number

   

Description

   

Form

   

Date Filed

10.17.2

 

Amendment No. 2 to Credit Agreement, dated May 7, 2013, by and among HCP, as borrower, the financial institutions referred to therein, and Bank of America, N.A., as administrative agent.

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

August 2, 2013

10.17.3

 

Amendment No. 3 to Credit Agreement, dated March 31, 2014, by and among the Company, as borrower, the financial institutions referred to therein, and Bank of America, N.A., as administrative agent.

 

Current Report on Form 8‑K

(File No. 001‑08895)

 

March 31, 2014

10.17.4

 

Amendment No. 4 to Credit Agreement, dated November 24, 2014, by and among the Company, as borrower, the financial institutions referred to therein, and Bank of America, N.A., as administrative agent.

 

Annual Report on Form 10‑K

(File No. 001‑08895)

 

February 10, 2015

10.17.5

 

Amendment No. 5 to Credit Agreement, dated September 27, 2016, by and among the Company, as borrower, the financial institutions referred to therein, and Bank of America, N.A., as administrative agent.

 

Current Report on Form 8‑K

(File No. 001‑ 08895)

 

September 28, 2016

10.18

 

Master Lease and Security Agreement, dated as of October 31, 2012, by and between HCPI Trust, HCP Senior Housing Properties Trust, HCP SH ELP1 Properties, LLC, HCP SH ELP2 Properties, LLC, HCP SH ELP3 Properties, LLC, HCP SH Lassen House, LLC, HCP SH Mountain Laurel, LLC, HCP SH Mountain View, LLC, HCP SH Oakridge, LLC, HCP SH River Valley Landing, LLC and HCP SH Sellwood Landing, LLC, as lessor, and Emeritus Corporation, as lessee.**

 

Annual Report on Form 10‑K

(File No. 001‑08895)

 

February 12, 2013

10.18.1

 

First Amendment to Master Lease and Security Agreement, dated as of December 4, 2012, by and between HCPI Trust, HCP Senior Housing Properties Trust, HCP SH ELP1 Properties, LLC, HCP SH ELP2 Properties, LLC, HCP SH ELP3 Properties, LLC, HCP SH Lassen House, LLC, HCP SH Mountain Laurel, LLC, HCP SH Mountain View, LLC, HCP SH Oakridge, LLC, HCP SH River Valley Landing, LLC and HCP SH Sellwood Landing, LLC, as lessor, and Emeritus Corporation, as lessee.**

 

Annual Report on Form 10‑K

(File No. 001‑08895)

 

February 12, 2013

 

144


 

Table of Contents

Exhibit

 

 

 

Incorporated by reference herein

Number

   

Description

   

Form

   

Date Filed

10.18.2

 

Omnibus Amendment to Leases, dated as of July 31, 2014, which amends the Master Lease and Security Agreement, dated as of October 31, 2012, by and between HCPI Trust, HCP Senior Housing Properties Trust, HCP SH ELP1 Properties, LLC, HCP SH ELP2 Properties, LLC, HCP SH ELP3 Properties, LLC, HCP SH Lassen House, LLC, HCP SH Mountain Laurel, LLC, HCP SH Mountain View, LLC, HCP SH Oakridge, LLC, HCP SH River Valley Landing, LLC and HCP SH Sellwood Landing, LLC, as lessor, and Emeritus Corporation, as lessee, as amended.**

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

November 4, 2014

10.19

 

Amended and Restated Master Lease and Security Agreement, dated as of August 29, 2014, by and between HCP AUR1 California A Pack, LLC, HCP EMOH, LLC, HCP Hazel Creek, LLC, HCP MA2 California, LP, HCP MA2 Massachusetts, LP, HCP MA2 Ohio, LP, HCP MA2 Oklahoma, LP, HCP MA3 California, LP, HCP MA3 South Carolina, LP, HCP MA3 Washington LP, HCP Partners, LP, HCP Senior Housing Properties Trust, HCP SH Eldorado Heights LLC, HCP SH ELP1Properties, LLC, HCP SH ELP2 Properties, LLC, HCP SH ELP3 Properties, LLC, HCP SH Lassen House, LLC, HCP SH Mountain Laurel, LLC, HCP SH Mountain View, LLC, HCP SH River Valley Landing, LLC, HCP SH Sellwood Landing, LLC, HCP ST1 Colorado, LP, HCP, Inc. and HCPI Trust, as their interests may appear, as lessor, and Emeritus Corporation, Summerville at Hazel Creek, LLC and Summerville at Prince William, Inc., as lessee.**

 

Quarterly Report on Form 10‑Q

(File No. 001‑08895)

 

November 4, 2014

10.19.1

 

First Amendment to Amended and Restated Master Lease and Security Agreement and Option Exercise Notice, dated as of December 29, 2014, by and between HCP, Inc. and Brookdale Senior Living Inc.**

 

Annual Report on Form 10-K (File No. 1-08895)

 

February 10, 2015

10.19.2

 

Second Amendment to Amended and Restated Master Lease and Security Agreement, dated as of January 1, 2015, by and among the entities collectively defined therein as Lessor, consisting of HCP and certain of its subsidiaries, the entities collectively defined therein as Lessee, each a subsidiary of Brookdale Senior Living Inc., and Brookdale Senior Living Inc. as guarantor.**

 

Annual Report on Form 10-K (File No. 1-08895)

 

February 10, 2015

 

145


 

Table of Contents

Exhibit

 

 

 

Incorporated by reference herein

Number

   

Description

   

Form

   

Date Filed

10.19.3

 

Third Amendment to Amended and Restated Master Lease and Security Agreement, dated as of May 1, 2015, by and among the entities collectively defined therein as Lessor, consisting of HCP and certain of its subsidiaries, the entities collectively defined therein as Lessee, each a subsidiary of Brookdale Senior Living Inc., and Brookdale Senior Living Inc. as guarantor.

 

Quarterly Report on Form 10-Q (File No. 1-08895)

 

August 4, 2015

10.20

 

At-the-Market Equity Offering Sales Agreement, dated June 26, 2015, among HCP, J.P. Morgan Securities LLC, BNY Mellon Capital Markets, Citigroup Global Markets Inc., LLC, Credit Agricole Securities (USA) Inc., Credit Suisse Securities (USA) LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, RBC Capital Markets, LLC and UBS Securities LLC.

 

Current Report on Form 8-K (File No. 1-08895)

 

June 26, 2015

21.1

 

Subsidiaries of the Company.†

 

 

 

 

23.1

 

Consent of Independent Registered Public Accounting Firm—Deloitte & Touche LLP.†

 

 

 

 

31.1

 

Certification by Thomas M. Herzog, HCP’s Principal Executive Officer and Principal Financial Officer, Pursuant to Securities Exchange Act Rule 13a‑14(a).†

 

 

 

 

32.1

 

Certification by Thomas M. Herzog, HCP’s Principal Executive Officer and Principal Financial Officer, Pursuant to Securities Exchange Act Rule 13a‑14(b) and 18 U.S.C. Section 1350.†

 

 

 

 

101.INS

 

XBRL Instance Document.†

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema Document.†

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document.†

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document.†

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Labels Linkbase Document.†

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document.†

 

 

 

 


*       Management Contract or Compensatory Plan or Arrangement.

**     Portions of this exhibit have been omitted pursuant to a request for confidential treatment with the SEC.

***   Certain schedules or similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplemental copies of any of the omitted schedules or attachments upon request by the SEC.

†       Filed herewith. 

146